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Abstract 
Managing the demand for elective orthopaedic surgery: Challenges, strategies, and results 
in New Zealand. 
Introduction. There is increasing demand for orthopaedic surgery and public health 
systems, in NZ and around the world, are struggling to manage. In New Zealand emphasis 
has been placed on fairness, timeliness, and giving the patient certainty which has led to the 
development of prioritisation systems and explicit rationing. This thesis of publications is 
based on research undertaken in Dunedin over the past 20 years. During this period there 
has been an increasing mismatch between demand and capacity for orthopaedic surgery in 
general, and hip and knee arthroplasty in particular. A variety of strategies have been 
employed to try to improve access to elective orthopaedic surgery. 
Methods 
The thesis is divided into chapters examining various aspects of the problem.  
1) Drivers for the increasing demand for elective orthopaedic surgery, and competing
demands for resource including acutes.
2) Carpal tunnel syndrome. What we can achieve with good access.
3) Prevention. Neonatal screening for developmental hip dysplasia
4) Alternatives to surgery. Improving non-operative management and comparing results
with surgery.
5) Scoring, prioritisation and consequences of rationing with respect to total joint
replacement (TJR).
6) Improving the perioperative management of patients.
7) Results of surgical treatment. Getting it right first time and improving the outcomes
of surgery
Results.  
There is not equity of publicly funded provision of total joint replacement (TJR) across the 
country. The demand for surgery in Otago has been quantified and is increasing. There is 
little that can be done to prevent the demand. However, screening for Developmental 
Dysplasia of Hip (DDH) can reduce late presenting hip dislocation and its long-term 
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sequelae. Alternative models of care have been effective in managing CTS. There is a high 
incidence of CTS in the elderly with good results from surgery. 
Non-operative management through a dedicated physiotherapy led clinic can be helpful for 
patients with hip and knee osteoarthritis (OA). Patients with knee OA are more likely to 
benefit than those with hip OA. However, the functional results at long term follow up are 
poorer than those who have undergone surgery. The scoring tools used to prioritise TJR 
have been validated but they are not discriminatory around the threshold. Declining surgery 
and returning patients to their General practitioner (GP) achieves little especially for 
patients with hip OA who are more likely to deteriorate. The long-term effects of rationing 
and under provision leads to worsening severity of patients qualifying for public surgery. 
Gains in health related quality of life are related to severity at presentation but those most 
severely affected may not get as good a final result. Hip and knee replacement are highly 
cost-effective procedures by three years. 
Enhanced recovery protocols have resulted in improved efficiency and shorter patient stays 
despite older and sicker patients. Excellent long term results have been achieved following 
Total Hip Replacement (THR) with up to 95% revision free survival at 18 to 20 years which 
match or surpass published international results. Choice of implant fixation is important 
with hybrid fixation in THR having the lowest risk of revision surgery.  
Conclusions Elective orthopaedic interventions such as carpal tunnel decompression and 
total joint replacement are highly effective. There is a limited role for non-operative 
treatment in end stage hip and knee OA. Scoring and rationing may be effective up to a 
point. There have been gains in efficiency despite older and sicker patients presenting for 
surgery. Despite these efforts, there remains a significant mismatch between demand and 
capacity and there is a clear need for increased investment in elective orthopaedic surgery. 
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Introduction 
There is increasing demand for orthopaedic surgery and public health systems in New 
Zealand (NZ) and around the world are struggling to manage. Waiting lists for elective 
orthopaedic surgery are a feature of most publicly funded healthcare systems.  They can 
stretch to several years and have typically been targeted by increasing short term funding to 
do additional operating lists.   This puts pressures on hospitals and staff and is not usually a 
sustainable solution. In contrast in New Zealand government policy has tried to limit wait 
times and placed the emphasis on clarity for the patient, timeliness of surgery and fairness. 
If resources are limited there is an explicit requirement that they are allocated on the basis 
of clinical priority and ability to benefit. [1]  
To understand the current environment in NZ it is helpful to understand a number of key 
changes made over the last 25 years. In 1996 Ministry of Health policy changed and a 
booking and prioritization system was introduced, in effect “abolishing” waiting lists.[2] In 
the new system patients were required to be seen within 6 months for a First Specialist 
Assessment (FSA) and if advised surgery were to have their surgery within 6 months of the 
certainty decision.   Compliance was monitored via the Elective Surgery Performance 
Indicators (ESPIs).  ESPI 2 relates to the wait for outpatient appointments and ESPI 5 to the 
wait for surgery.  The 6-month wait was progressively reduced to 4 months where it now 
stands.  District Health Boards (DHBs) are required to prioritise patients so that those with 
the greatest need are given certainty for either an FSA or surgery. This led to the 
development of scoring and prioritization systems.  These are termed the Clinical Priority 
Access Criteria (CPAC).   They initially took the form of tables with a priority of 1 - 5 for 
conditions, each of which had a prescribed score.   Subsequently other scoring systems have 
been developed which are discussed during the course of this thesis. To remain compliant 
with ESPIs it was possible for a DHB to decline to see the patient or decline surgery if they 
were unable to guarantee it within the 4-month period.  
The second change was the introduction of Accident Compensation Corporation (ACC) 
Elective Services contracts in 1997. [3] This transferred the purchase of elective services for 
patients who had a claim accepted by the Accident Compensation Corporation from the 
Regional Health Authorities to ACC. This resulted in a separate stream for procedures such 
as knee arthroscopy, rotator cuff repairs etc. This put less pressure on public hospital lists 
for post- traumatic elective procedures as most are done in the private sector. As a result 
the bulk of most public hospitals’ work is lower limb arthroplasty for degenerative 
osteoarthritis and trauma.  
When I commenced work as a consultant orthopaedic surgeon in 2001 there were problems 
with unmet need for joint replacement surgery in NZ but access in Dunedin was among the 
best in the country.  In 2003 the New Zealand Orthopaedic Association published a paper 
‘The ageing of New Zealand’ that outlined the impact of the ageing population on musculo-
skeletal conditions including hip fractures and joint replacement. [4] It detailed the number 
of hip replacements that would be required and the implications for orthopaedic funding 
and training. This resulted in the Ministry of Health funding the ‘Orthopaedic Initiative’ 
which ran from 2004 to 2008, with a requirement to double the number of elective hip and 
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knee joint replacements performed in public hospitals.[5] This was successful at improving 
access across the country but had less impact in Otago. [6]  
Funding for the District Health Boards was reviewed under a population based funding 
formula (PBFF). [7] The details of this formula lack clarity but include weightings for age, 
gender, ethnicity, and deprivation. It also includes adjusters for unmet need, rurality and 
overseas patients. [8] Under PBFF and the associated Future Funding Pathway the share of 
income to the Otago District Health Board has slowly decreased over the last 20 years.   
Well-publicized budget deficits have put pressure on Dunedin Hospital and access to 
elective orthopaedic surgery has significantly declined. In 2010 the Otago and Southland 
DHBs combined to become the Southern DHB (SDHB). This has had little effect on 
orthopaedics as both base hospitals (Dunedin and Southland) have remained independent 
in operational terms. However, it has become harder to extract data at the hospital level 
due to all reporting being combined. 
I have maintained a public hospital clinical practice for the last 19 years and was Clinical 
Leader/Director for 10 years.   My clinical practice is predominantly hip and knee 
arthroplasty but also general orthopaedics and trauma.  When I took up the post of Clinical 
Leader of the Orthopaedic Department in 2009 there were significant issues with access to 
both orthopaedic surgery and orthopaedic outpatient appointments.  Approximately a third 
of patients referred for an orthopaedic FSA were being declined and a third or more of 
patients that were recommended for elective surgery and in particular total joint 
replacement were not qualifying. When I somewhat naïvely wrote to the Chairman of the 
DHB advising him of this, I received the facetious reply ”There is only so much money, if you 
need more then tell me who I should take it from”. This led to my first paper Quantifying the 
demand for hip and knee replacement in Otago, New Zealand as I sought to use academic 
papers to prove the need for change and publicise the issues.[6] 
After several years of lobbying a large project was developed called “The Orthopaedic 
Patient Pathway Programme” (OPP).  The Ministry of Health, under the Elective Services 
Productivity and Workforce Programme (ESPWP), funded this with the aim of producing “an 
end to end transformational change” of the “orthopaedic patient journey” in Dunedin. The 
projects and key performance indicators (KPIs) set by the Ministry of Health implied that:  
1) improved non-operative management of patients with hip and knee OA could reduce the
demand for surgery
2) too many patients were being seen for follow up appointments so there was inadequate
capacity for FSA
3) surgeons were not prioritizing patients consistently and “soft scoring” was driving the
demand
4) patients were being cancelled on the day of surgery leading to inefficient list utilization
5) inadequate discharge planning was leading to longer lengths of stay
6) non-medical resource could do many of the jobs that would free up surgeons’ time.
I was sceptical about some of these assumptions and the need or the ability of the OPP to 
generate transformational change but felt that it was an opportunity to improve the service. 
I believed that the system was working well with most of the issues due to a true mismatch 
between demand and capacity and problems such as bed block and over-load of acute 
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admissions. I was designated Clinical Champion and, in addition, a Programme Coordinator 
and a Facilitator were appointed.   The goals of the projects within the programme included 
the development of the Joint Clinic to improve access and non-operative care of patients 
with hip and knee osteoarthritis, streamlining of both inpatient and outpatient processes 
including the introduction of enhanced recovery after surgery (ERAS) techniques, and the 
use of non-clinical resource to help prioritise referrals and patients for surgery. The 
programme ran from 2012 to 2014 and led to many of the publications in this thesis.  
As surgeons I believe we are in the best position to assess the effects of operative, non-
operative and management solutions with real world experience.  We need to question 
dogma, received wisdom, published results and the next new idea, often imported from 
overseas, promoted by Ministry of Health or hospital management.  The thesis does this and 
explores the strategies that we have employed to try to improve elective surgery provision 
in Otago. It includes 37 papers covering research done over a 20-year period and has a New 
Zealand perspective due to the environment in which we work.  However the problems and 
solutions are not unique to New Zealand and will be relevant to other healthcare systems 
under financial stress. 
Chapter 1 quantifies the demand for joint replacement in Otago, looks at drivers for the 
increasing demand including age and obesity, the equity of access to joint replacement 
across NZ and the problems with the balance between acute and elective surgery including 
the effect of overseas tourists requiring orthopaedic admission.    
Chapter 2 uses carpal tunnel decompression as an example of a high volume, low cost, low 
complexity procedure with similar challenges that is being managed effectively.  
Chapter 3 reports the results of our programme to  prevent hip disease through neonatal 
hip screening. 
Chapter 4 looks at alternatives to surgery and improving non-operative management.   The 
first section reports on the development, implementation, early and long-term results of the 
Joint Clinic, a physiotherapist and nurse led clinic for patients with hip and knee OA.   The 
second part compares outcomes of surgery and non-operative treatment with respect to 
acute Achilles tendon rupture.  
Chapter 5 reports on surgical prioritisation, scoring tools and their validation, a new referral 
prioritization tool and the consequences of the use of these tools to ration services in 
Otago. 
Chapter 6 includes papers on improving the perioperative management of patients. It 
covers care pathways introduced 20 years ago and enhanced recovery after surgery (ERAS) 
results from more recently. It also includes papers on the use of intraoperative fluoroscopy 
to reduce complications of surgery.   
Chapter 7 looks at the results of surgery. By “getting it right first time” complications and 
the need for repeat surgery can be reduced. This will save theatre time and costs. 
Appropriate implant choice can reduce the revision burden but as hip and knee replacement 
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is typically successful this requires large long term studies.  This chapter includes cohort 
studies on the outcomes of THR and Total Knee Replacement (TKR) that include patient 
reported functional results and long-term results and large local series focusing on revision 
rates with different implants and modes of fixation at long-term follow up. Finally it includes 
some papers reporting on uncommon complications and the ensuing problems, need for 
revision surgery and costs. 
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Chapter 1 
Drivers for the increasing demand for elective orthopaedic surgery, 
and competing demands for resource. 
The increasing demand for elective orthopaedic surgery has been driven mainly by the 
ageing population and the increasing incidence of obesity. In Otago we have also seen the 
impact of a reduction in Ministry of Health funding under population based funding.  
In ‘Quantifying the demand for hip and knee replacement in Otago, New Zealand’ I first 
quantified the unmet demand for joint replacement and explored the causes. I concluded 
that the main reasons were an increased proportion of the population aged over 55 years 
and a backlog of cases due to under-provision in previous years. The Otago DHB had missed 
an opportunity under the orthopaedic initiative to use “ring-fenced” funding. This was 
primarily due to a reluctance to out-source cases privately despite having inadequate public 
hospital capacity. 
In ‘Equity of publicly-funded hip and knee replacement surgery in New Zealand: Results of a 
national observational study’ we reported significant differences in access to joint 
replacement across New Zealand. Despite increasing numbers of procedures being 
performed the rate of publicly funded joint replacement surgery was barely keeping up with 
population increases. Larger DHBs had poorer age and ethnicity standardised rates than 
smaller ones. 
We have also looked at the effect of overseas tourists on local services. Our region includes 
the tourist hot spots of Queenstown and Wanaka. There is an overseas adjuster in the PBFF 
but it is not clear how this applied and whether it has kept pace with changes in tourist 
numbers. The first paper ‘Non-resident orthopaedic admissions to Dunedin Hospital: 1997-
2004’ was prompted by changes in ACC legislation that meant that all tourists were covered 
for accidental injury when in NZ. The implication of this was that any tourist with an acute 
injury requiring admission was treated for free and could not use their insurance. Our follow 
up paper ‘Non-resident orthopaedic admissions to Southern DHB 1997-2016: Changes over a 
20 year period’ highlighted that the increasing numbers of tourists in our area was costing 
Southern DHB a disproportionate amount of their revenue as well as occupying beds and 
theatre space. 
Finally in ‘The projected burden of knee osteoarthritis in New Zealand: healthcare 
expenditure and total joint provision’ we respond to a paper on the effect of obesity and its 
implications for demand for knee replacement and highlight the mismatch between 
theoretical modelling and the real world and the resultant implications for policy makers.  
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Quantifying the demand for hip and knee replacement in 
Otago, New Zealand 
David Gwynne-Jones 
Abstract 
Aim The purpose of this study is to quantify the current demand in Otago for hip and 
knee replacement. 
Methods Hospital databases and the New Zealand Joint Registry were used to 
calculate the intervention rate for primary total hip (THR) or knee (TKR) replacement 
between February 2010 and February 2012. All patients meeting the clinical threshold 
but waiting for surgery were also recorded over the same period. 
Results The intervention rate for THR and TKR in NZ in 2011 was 33.0/10000 while 
in Otago it has varied from 30.7 to 42.6 over the last 5 years. This is at or above the 
national average based on population share. Over a 2-year period the numbers 
reaching the clinical threshold and waiting for primary joint replacement surgery rose 
from 247 to 347 patients, while 1496 primary elective joints replacements were 
performed. The current demand for primary THR and TKR is 798 per year 
(41.7/10000 per year). The unmet demand is 73 cases per year. 
Conclusion The increased demand in Otago compared to the NZ average is due to 
greater numbers of people over the age of 55 years and the backlog of patients due to 
under provision relative to demand in previous years. 
Osteoarthritis is a common condition affecting about 15% of adult New Zealanders.
1
It is typically a disease of older age and hence the prevalence is likely to increase 
further as the population ages.  
Hip and knee replacement are highly successful operations for symptomatic 
osteoarthritis. In response to increasing demand the Ministry of Health introduced the 
joint initiative in 2004 with the aim of increasing the rate of publicly funded major 
joint replacements. In Otago the agreed volumes were an increase of 160 cases from a 
base contract of 315 to a new target of 475 major joints. 
It is government policy that there should be nationally consistent access to surgery. 
Prioritisation tools such as the Clinical Priority Access Criteria (CPAC) score and the 
Hip and Knee prioritisation tool developed by the Orthopaedic Working Group of the 
National Waiting Times Project are used to varying degrees across the country. 
Currently the target national standardised intervention rate (SIR) for publicly funded 
major joint replacement (primary, bilateral or revision hip or knee replacement) is 
21.0/ 10000 population per year.  
In 2009, following the end of the joint initiative, the minimum number of joints 
required to be performed in Otago was reduced from 475 to 425 in order to match the 
SIR. It appears that the clinical need for surgery is significantly greater than this. 
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A DHB must not offer certainty of surgery to a patient if they are unable to perform 
the surgery within 5 months (6 months until June 2012) (Elective Surgery 
Performance Indicator (ESPI) 5). Patients not meeting this “financial threshold” may 
be placed on Active Review (AR) if their condition is likely to deteriorate and meet 
the threshold within the foreseeable future, or they are returned to their General 
Practitioner (GP) for ongoing care and monitoring. 
In Otago the financial threshold has risen to an unacceptably high level in order to 
maintain ESPI compliance. This has led to an increasing number of significantly 
disabled patients now not qualifying for surgery in the public sector. 
The purpose of this study is to quantify the current incidence of hip and knee arthritis 
in Otago that is severe enough to justify primary hip or knee replacement and 
compare it with local and national intervention rates in both public and private 
sectors. 
Methods 
All patients undergoing hip and knee replacement in NZ are registered in the NZ joint registry (NZJR) 
for which there is 98% compliance.
2
 Figures for primary and revision total hip (THR) and total knee 
replacement (TKR) and unicompartmental knee replacement (UKR) were obtained for calendar years 
2007–2011.  
Numbers performed at Dunedin Public Hospital (DPH) and Mercy Hospital, Dunedin were also 
obtained from the NJR and cross referenced with numbers of cases performed at the hospitals from 
prospectively gathered figures. Bilateral cases are counted as two separate procedures in the NJR, but 
as one procedure to calculate the SIR for major joint replacement. UKRs were included in the figures 
for TKR. THRs for acute hip fractures were excluded. 
The Public sector financial year runs from 1 July to 30 June. DPH figures were available by month 
from July 2006 to June 2012. Cases performed at a private hospital under contract from the DHB were 
classified as publicly funded. ACC funded cases were classified separately or included in private 
figures. Patients were placed on the public waiting list if they had failed medical management and were 
judged by a consultant orthopaedic surgeon to be a suitable candidate for THR or TKR.  
The hip and knee replacement tool developed by the Orthopaedic Working Group of the National 
Waiting Times Project (Appendix 1) was used to score the patient and an Oxford hip or knee score 
(OHKS)
3 
given to the patient to complete. For the last 2 years the threshold for certainty has been 79 
points or higher and active review over 62 points. Patients falling below the threshold for active review 
are classified as Clinical Benefit (CB). These patients are returned to their GP for ongoing care. 
Surgery is rarely advised if the score is less than 50 points. 
Total numbers of patients in each category have been recorded over the past 3 years. The two years 
2010 and 2011 were analysed to determine the current level of demand based on intervention rates and 
changes in total waiting list numbers.  
An audit of all patients seen for FSA at DPH with a hip or knee problem between February and August 
2012 was performed. The outcome of the consultation, (wait list, discharge, further investigation etc), 
CPAC score and Oxford score were recorded and final decision regarding certainty, active review or 
return to GP was noted. All patients on active review are sent a questionnaire including an OHKS. For 
this study the OHKS was scored from 0-48 with 0 the worst and 48 the best possible score.
3 
Population figures (191,361) for the Otago region (excluding Queenstown) were based on the latest 
estimates from Southern DHB funding and planning department. The national population figure was 
taken as 4,271,223.  
The 2006 Census figures with 5-year age bands were used to compare Otago to New Zealand.
4
Comparative raw intervention rates for England and Wales and Australia were calculated from their 
respective joint registries.5,6  
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Results 
The intervention rate for primary THR or TKR in New Zealand has risen from 
28.9/10000 in 2005 to 33.0/10000 in 2011. In Otago the rate has varied from 29.2 in 
2005 to 42.6 /10000 in 2010 with the variation chiefly occurring in the public sector 
(Figure 1). 
Figure 1 Intervention rates per 10,000 population per year for primary elective 
THR, TKR in Otago calendar years 2007–2011 
The breakdown of major joint replacements in the public sector is shown in Figure 2. 
Figure 2. DHB-funded elective major joint replacements (financial years ending 
30 June 2007–2012) 
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Fewer than the target volume of 475 joints were performed in years ending June 2008 
and 2009 due to problems with dropped lists due to acute cases, and lack of beds, 
theatre and anaesthetic resource. The target volume was reduced to 425 joints for year 
ending June 2010. Over the last 3 years there has been a shortfall of only nine joints.  
Otago comprises approximately 4.5% of the NZ population. Since 2007 Otago has 
provided major joint replacements at or above the national average based on its 
population share. (Figure 3). This is mainly due to high rates of primary hip 
replacement with the rate of primary knee replacements below the population share 
for three of the past 4 years.  
Figure 3. Percentage of joint replacements performed in Otago compared with 
New Zealand total (public and private combined)  
From 1 February 2010 to 1 February 2012 the number of patients on the public 
waiting list for primary hip and knee replacement surgery rose by 100 from 247 to 
347 patients. (Table 1) During this time 4389 referrals were received at DPH, 2558 
(58%) were seen and 1183 referrals (27%) were returned. These included 234 patients 
referred with hip or knee arthritis.  
In the same period a total of 1496 primary elective joints were performed in Otago 
(mean 748 per year): 827 (55.2%) were funded by the DHB, 53 (3.6%) by ACC and 
616 (41.2%) in private (insurance or self-funding). (Table 2)  
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Table 1. Waiting list at Dunedin Public Hospital 

















Table 2. Details of primary joint replacements performed in Otago 2010–2012 
Feb 2010–Feb 2012 % Per year Intervention rate/10000 per year 
Joints performed 1496 748 39.1 
Public 827 55.2 414 21.6 
Private 616 41.2 308 16.1 
ACC 53 3.6 27 1.4 
Change in total waiting +100 +50 2.6 
Total demand 1596 798 41.7 
Therefore the current minimum demand for primary hip and knee replacement in 
Otago is 798 per year. This equates to an intervention rate of 41.7/10000 per year. 
Currently there is funding for approximately 390 primary hip or knee replacements or 
20.4/10000 per year by the DHB for the Otago region. This assumes no change in the 
number of revisions or bilateral procedures performed. An additional 335 are 
performed in private or under ACC.  
This gives a shortfall of 73 primary joints per year. If these were to be funded by the 
DHB then the contracted volume would need to rise by 17% to 498 major joint 
replacements per year. 
Over the 6-month period February to August 2012 the total public wait list for 
primary hip or knee replacement increased by a further 47 patients despite performing 
209 procedures (Table 1). During this period a total of 225 patients were seen at DPH 
out-patients with a hip or knee problem. 155 (69%) were listed for primary TKR or 
THR of whom 96% had a Oxford score of 20 or less, 74% less than 15 and 37% less 
than 10 points.  
124 (80%) scored over 70 points on the CPAC score, while 76 (49%) scored 79 points 
or more. In total 81 patients (52%) were given certainty, 61 patients (39%) were 
placed on active review and 13 (8%) were classified as clinical benefit and returned to 
their GP.  
On average over the last 12 months, 82% of patients, initially classified as active 
review, have moved to certainty.  
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Discussion 
It is difficult to estimate demand for primary hip and knee replacement. In this study 
we have collected data on all patients meeting the clinical threshold for THR or TKR 
whether they were placed on the certainty or active review list or were returned to 
their GP with advice.  
Our end point therefore is based on orthopaedic assessment, radiographs and patient 
reported scores in a patient suitable for surgery. In order to accurately compare our 
figures with other DHBs similar data need to be collected. 
Using intervention rates allows comparison between countries but assumes no limit 
on access. In 2009 Germany had the highest rate of hip and knee replacement at 
50.1/10000.
7
 The rates for Australia and England and Wales are 30.6 and
30.5/10000.
5,6
 In New Zealand the combined public and private intervention rate in
2011 was 33.0/10000.  
The intervention rate for primary THR and TKR in Otago (public and private 
combined) has been at or higher than the national average for many years. Despite 
this current demand exceeds capacity by 7–10% per annum.  
We made a number of assumptions in calculating the demand for primary joint 
replacement in Otago. In the private sector these include that there is no limit on 
private hospital capacity, there is no net flow of private patients in or out of the 
province and the number insured and the number prepared to self-fund remain 
constant. These are reasonable assumptions but may underestimate the future demand 
for publicly funded surgery.  
There is good access to primary healthcare in Otago and this may be a cause for the 
high number of referrals made requesting an FSA. The limited access to FSA is likely 
to underestimate the potential demand. During the 2 year study period 234 referrals of 
patients with hip or knee arthritis were returned. At least some of these are likely to 
have reached the clinical threshold for joint replacement. However, many of these 
may have subsequently been re-referred and will appear on the waiting list figures.  
There may be a number of reasons for the increased demand. In the public sector raw 
intervention rates are corrected to the standardised rate by a formula that includes age, 
gender, rural location and deprivation. Revision procedures are also counted in the 
standardised intervention rate. A higher number of revisions will reduce the number 
of primary procedures that can be performed. Nationally the revision burden 
(percentage of revisions to primaries) is approximately 13% for hips and 8% for 
knees. In Otago the rates are 12.3% and 4.3%.
2
The proportion of patients with health insurance or able to afford private healthcare 
may influence demand in the public sector. However, high rates of private provision 
may not be associated with better access to publicly funded surgery.
8 
Otago does not
appear to have a smaller than average private sector.  
In 2010/11, DHBs had widely differing rates for the percentage of joint replacements 
performed in a private hospital (range 9% to 73%). 
2 
These figures include public
cases contracted out to private hospitals so reflect the use of out-sourcing as well as 
the private market.  
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Otago was on the median for the country with 44% of cases performed in a private 
hospital but during this time only 14 joint replacements were out-sourced. It has been 
reported that rural populations have a higher need for hip replacement
9,10
 but not for
knee replacement.
10 
This may partially explain why there is a much higher rate of
THR than TKR in Otago.  
The local orthopaedic surgeons do not appear to be more likely to recommend joint 
replacement than average. In the audited 6-month period the Oxford scores of those 
patients wait-listed in public were less than 20 in 96%, less than 15 in 74% and less 
than 10 in 37%. In a large study from Scotland the average OHKS for patients 
undergoing THR or TKR was 18.3 and 18.7 respectively.
11
Age is strongly associated with increasing demand for joint replacement. Eighty eight 
per cent of primary hip and knee replacements in NZ are performed in the over 55 age 
group.
2 
Despite having a large young student population there is a higher proportion of people 
for each 5-year age group over 50 years in Otago than the NZ average (Figure 3). The 
prevalence of people over 55 years relative to the NZ average is 1.13 and over 65 
years is 1.18.  
Adjusting the national intervention rate of 33.0/10000 to reflect this would result in an 
age adjusted rate of approximately 39/10000 pa which more closely matches our 
estimated demand. In the public sector an increase of 73 joints per year from 425 
would equate to a 17% increase.  
Figure 3. Proportion of Otago population in 5-year bands compared to New 
Zealand population (figures from 2006 Census)
4 
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Another key determinant of demand is the backlog of patients awaiting surgery. In the 
public sector there has been a shortfall of nine patients over the last 3 years against the 
minimum target of 425 major joints. The target for years ending June 2008 and 2009 
was 475 joints (315 base contract plus 160 joint initiative).  
The Dunedin Public Hospital capacity was restricted at this time by a shortage of 
anaesthetists and beds. This resulted in a backlog of 210 joints against potential public 
funding. Only a limited number of cases (34) were outsourced to the private sector 
between April and November 2008.  
If the volumes had not been reduced in 2010 and 475 joints (12% greater than NZ 
average to reflect the age of the Otago population) had been performed each year for 
the last 5 years then an additional 358 joint replacements could have been performed 
which would almost eliminate the current waiting list of 394 patients.  
Anecdotally we hear that some DHBs have very similar problems to Otago while in 
others patients are qualifying for surgery with a lower score or less severe symptoms 
regardless of whether their DHB is over or under providing against the national 
average. Some DHBs have no patients on active review while others have more than 
recommended. This may reflect either implementation of policy, or possibly a lower 
financial threshold.  
When the clinical priority criteria were introduced the two crucial issues were whether 
they would correctly and consistently prioritise patients according to symptoms and 
ability to benefit from surgery and whether the thresholds would be chosen so as not 
to leave patients with clear needs untreated.
12
We believe that the scoring tools are useful but lose the ability to discriminate at 
higher scores. However it is clear that currently the financial threshold in Otago is too 
high and many patients with severe symptoms who would benefit from joint 
replacement are not qualifying for surgery.  
In conclusion in Otago the current demand for primary hip and knee replacement is 
approximately 41.7/10000. Current funding from the DHB is for approximately 
20.4/10000 with the private sector and ACC providing 17.5/100000.  
There is an unmet demand of at least 73 cases per year or 3.8/10000. The two main 
reasons for this are the greater numbers of people over the age of 55 years in Otago 
and the backlog of patients due to under provision in previous years.  
To address both the ongoing local demand and the backlog, there needs to be 
additional provision for joint replacement surgery by the DHB or the situation will 
continue to deteriorate.  
The problem is unlikely to be isolated to Otago and similar data needs to be collected 
to allow direct comparison between other DHBs. Using standardised intervention 
rates to determine volumes will not necessarily result in equity of access across the 
country. 
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Appendix 1. Hip and knee prioritisation tool 
Criterion Category Category Descriptions – Assign patient to highest scoring category that applies 
(Patient must be on optimal medical therapy at time of rating) 
Points 
Pain 
1 No Pain 0 
2 Episodic activity-related pain 
4 May use occasional analgesics 
3 Daily pain with weight-bearing activity 
10 2-3 times/week pm use of simple analgesics/NSAIDs 
4 
Pain which cannot be ignored with activity and at rest 
19 Sleep disturbance 2-3 times / week due to pain 
Daily analgesics/NSAIDs 
5 Dominates life and interferes with sleep every night 
27 Pain poorly controlled by analgesics 
Personal Functional Limitation 
DUE to Hip or Knee 
Orthopaedic 
Condition 
1 No Limitation 0 
2 
Minimal restriction of personal activities e.g. trouble reaching toes 
3 Walking stick used for longer walks 
3 
Moderate restriction of personal activities e.g. requires help with socks/shoes 
9 Requires help cutting toenails 
Use of walking stick indoors and outdoors 
4 Severe Restriction of personal activities e.g. requires help with dressing or 
showering 
18 
Consistently uses 2 crutches or wheelchair 
1 No Limitation 0 
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Social Limitation DUE to Hip or 
Knee Orthopaedic Condition 
2 
3 
Mild Restriction e.g. can’t walk >1 hour 4 
Some limitation of leisure activity e.g. golf or tennis 
Moderate Restriction e.g. can walk 15-60 mins 
10 Significant limitation of leisure activity 
Can manage garden or bowls 
4 
Severe Restriction e.g. can’t walk > 15 mins - slow 
19 
Difficulty with steps or stairs 
Severe limitation on leisure activity – can’t maintain garden 
Requires help with shopping 
Some limitation to work 
5 
Profound Restriction e.g. confined to the property 
23 Shopping done by others 
Requires meals or other domestic help 
Can’t work due to orthopaedic condition 
Potential to Benefit from 
Operation (for patient, 
dependents or community) 
1 Small Improvement Likely – significant residual symptoms +/or functional limitation 0 
2 Moderate Improvement Likely – some residual symptoms +/or functional limitation 6 
3 Return to near normal likely – asymptomatic + full return of function 
Consequence of delay >6 
months (for patient, 
dependents or community) 
1 Little risk will deteriorate over next 6 months 0 
2 Considerable risk will deteriorate and result in increased disability during next 6 
months 
7 
3 Likely to progress to major complication during next 6 months with increased clinical 
costs, e.g. impending fracture or structural failure 
24 
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Equity of publicly-
funded hip and knee joint 
replacement surgery in 
New Zealand: results from a 
national observational study
Helen Harcombe, Gabrielle Davie, Sarah Derrett, Haxby Abbott, 
David Gwynne-Jones
ABSTRACT
AIM: This study examines equity in the provision of publicly-funded hip and knee total joint replacement 
(TJR) surgery in New Zealand between 2006 and 2013 to: 1) investigate national rates by demographic 
characteristics; 2) describe changes in national rates over time; and 3) compare rates of provision between 
District Health Boards (DHBs).
METHODS: Hospital discharge data for people aged 20 years or over who had at least one hip or knee TJR 
between 2006 and 2013 was obtained from the Ministry of Health’s National Minimum Dataset.
RESULTS: Higher TJR rates were observed among those aged 75–84 years, females, those of Māori ethnicity, 
those not living in rural or main urban areas and those in the most deprived socio-economic groups. 
TJRs increased from 7,053 in 2006 to 8,429 in 2013, however the rate was highest in 2007. In 2012–13, 
age-ethnicity-standardised rates varied between DHBs from 196 to 419/100,000 person years, with larger 
DHBs having lower rates than smaller DHBs.
CONCLUSION: There was evidence of geographic inequity in TJR provision across New Zealand. Despite 
increased numbers of procedures, rates of publicly-funded TJR surgery are barely keeping up with 
population increases. Reasons behind differences in provision should be examined.
Healthcare budgets are constrained and 
there are perennial concerns about the 
potential mismatch between health-care 
need and the provision of publicly-funded 
services. Ageing populations1 and techno-
logical advances2 are increasing pressures 
on healthcare budgets and the prioritisation 
of healthcare services can be required.3 One 
area that is likely to be affected by these 
pressures is total joint replacement (TJR) 
surgery. The most common reason for TJR 
surgery in New Zealand is osteoarthritis 
(OA)4 that is not responding adequately 
to conservative treatment. OA has a high 
prevalence among older adults5,6 with 29% 
of New Zealanders aged over 65 years 
diagnosed with this condition.7 This is 
important to consider as, currently in New 
Zealand, those aged over 65 years comprise 
14% of the population but this is predicted 
to increase to 27% in 2063.8 Therefore, 
demand for TJR will likely increase substan-
tially. In New Zealand, hip TJR surgery 
(including privately-funded procedures) has 
already increased between 1999 and 2013 
by 75%; there was a corresponding 158% 
increase for knee TJR surgery.6 However, 
despite these increases, concerns have been 
raised that the provision of these proce-
dures may not be expanding sufficiently to 
keep up with increases in clinical need or 
population changes.9
Publicly-funded healthcare in New 
Zealand is provided by 20 District Health 
Boards (DHBs) “…responsible for providing 
or funding the provision of health services 
in their district.”10 In New Zealand, priori-
tisation scoring tools are used to determine 
access to publicly-funded TJR surgery. This 
should ensure equitable access across the 
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country. However, Derrett et al (2009)11 
found a lack of equity between DHBs in the 
provision of elective hip and knee TJR (2000 
to 2005), and an analysis of New Zealand 
newspaper articles and Parliamentary 
questions from 2000–2006 found that “…
access inequities remained a persistent 
theme…” (p.57).12 Although there has been 
an increase in funding for TJR surgery in 
New Zealand in recent years it is not clear 
whether that has translated into increased 
rates of surgical provision. Additionally, 
any increases in provision of TJR should be 
equitable with regard to geographic and 
demographic determinants such as place of 
residence, age, sex, ethnicity and socioeco-
nomic deprivation.13 This paper examines 
publicly-funded elective hip and knee TJR 
surgery provision among DHBs in New 
Zealand from 2006–2013. The aims of this 
study are to: 
1. describe changes in rates of public-
ly-funded hip and knee TJR surgery
nationally between 2006 and 2013,
2. investigate whether national rates
vary according to age, sex, ethnicity,
small-area deprivation and rurality,
and
3. determine whether the provision of
publicly-funded hip and knee TJR
surgery is equitable across DHBs in
New Zealand.
Methods
This study examined New Zealand 
hospital discharge data for publicly-funded 
hip and knee TJR surgery from 2006–2013. 
Ethical approval for the study was received 
from the University of Otago Human Ethics 
Committee (Reference number D13/253). 
Relevant hospital discharge data was 
obtained from the Ministry of Health’s 
National Minimum Dataset (NMDS).14 The 
NMDS is a national collection containing 
publicly-funded hospital discharges and 
some privately-funded hospital discharges. 
Data was obtained for patients with at 
least one publicly-funded hip or knee TJR 
procedure who were discharged between 1 
January 2006 and 31 December 2013. This 
time period was chosen as similar work on 
this topic11 analysed data up until the end of 
2005, and 2013 data was the latest available 
at the time this study commenced. The 
variables obtained from the NMDS included 
the International Classification of Diseases 
version 10 (ICD10) clinical code, age at 
discharge, sex, domicile code, ethnicity, type 
of admission, diagnosis type, event dates 
and the principal health service purchaser. 
As well as waiting list admissions, arranged 
admissions defined as “a planned admission 
where: the admission date is less than seven 
days after the date the decision was made 
by the specialist that the admission was 
necessary…”14 were also included as these 
were likely to capture urgent sub-acute OA 
patients. Acute admissions and injury admis-
sions (primary diagnosis code within ICD10 
S00-T98)15 were excluded as were those 
under 20 years of age at time of surgery 
and overseas residents. Hip and knee TJR 
surgeries were identified using the clinical 
codes in the 3rd edition of the Australian 
Modification of ICD10.15 The specific proce-
dures included were: total arthroplasty of 
hip, total arthroplasty of knee, total arthro-
plasty of knee with bone graft to femur 
or to tibia, total arthroplasty of knee with 
bone graft to femur and tibia and total 
replacement arthroplasty of patellofemoral 
joint of knee. Hemiarthroplasty of the knee 
was also included because indications for 
this are similar to TJR and their popularity 
may vary across the country. Revisions of 
hip and knee joint replacements were not 
included as the aim was to focus on primary 
procedures. Records with missing or historic 
domicile codes that could not be forward-
mapped were excluded as these could not 
be analysed by DHB, area-level deprivation 
or rurality. Self-identified ethnicity data 
collected at the patient’s health event was 
obtained from the NMDS. The recording 
of at least one ethnicity is mandatory, and 
two additional ethnic group codes may be 
recorded.14 As the DHB-level denominator 
data was only available by ‘prioritised 
ethnicity’, this approach was used in our 
analyses with estimates obtained for 
Māori, Pacific, Asian and Other ethnicity 
groupings. Prioritisation follows a Statistics 
New Zealand (SNZ) algorithm with the end 
result being each person associated with 
only one ethnic group.16 Māori ethnicity has 
the highest priority, meaning that people 
who identified as both Māori and any other 
ethnicities are classified as Māori. For 
example, those who identify as both Māori 
ARTICLE
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and Pacific are classified as Māori. Pacific 
ethnicity is given the next highest priority 
with those who identify as Pacific and any 
other ethnicity (apart from Māori) being 
classified as Pacific.
The New Zealand Deprivation Index 
(NZDep2006) is a “…small-area index of 
relative socio-economic deprivation…”17 
(p.S7) derived from 2006 Census data. The 
NZDep scale runs from one (an area in the 
least deprived 10% of small areas) to 10 (in 
the 10% most deprived small areas). The 1:1 
mapping between domicile codes available 
in the NMDS and Census area units used by 
SNZ enabled NZDep to be assigned to each 
TJR discharge record. Rurality was also 
derived from domicile codes by 1:1 mapping 
with SNZ’s Census area units and SNZ’s 
Urban/Rural Profile Classification.18 The 
seven categories of the Urban/Rural profile 
were categorised for analysis as: 
1. ‘Main Urban’ (described as being “…
very large and centred on a city or
main urban centre… minimum popu-
lation of 30,000”),18
2. ‘Other Urban’ which consisted of
‘Satellite Urban’ (“defined as urban
areas (other than main urban areas)
where 20 percent or more of the
usually resident employed popula-
tion’s workplace address is in a main
urban area”18 and ‘Independent
Urban’ (defined as for Satellite Urban
but <20 percent with a main urban
area workplace), and
3. ‘Rural’ comprising the four rural
profiles (‘Rural Areas with a High
Urban Influence,’ ‘Rural Areas with
a Moderate Urban Influence,’ ‘Rural
Areas with a Low Urban Influence’
and ‘Highly Remote Areas’).
Denominator data were sourced from 
SNZ, and restricted to those aged 20 years 
and above. Annual resident population 
estimates by year, ethnicity, sex, age group 
and DHB region for 2006–2013 were calcu-
lated by SNZ. Usually resident population 
counts from the 2006 Census were used for 
calculations involving rurality and depri-
vation. In 2010 the Southern DHB was 
created from a merger of two DHBs (Otago 
and Southland); for this study we combined 
data from those DHBs and considered them 
as the Southern DHB throughout the period 
analysed. Crude rates per 100,000 person 
years (py) were calculated and presented 
alongside exact Poisson 95% Confidence 
Intervals (CIs). Age-standardised rates (ASRs) 
were calculated using direct standardisation 
and five-year age groups. Ten five-year age 
groups (<45, 45–49…80–84, 85+) were used 
for sex and ethnicity ASRs. Denominator data 
for deprivation and rurality ASRs was not 
available disaggregated by age for those over 
65 years so these ASRs were calculated using 
age groups <45, 45–49, 50–54, 55–59, 60–64, 
65+ years. Age- and ethnicity-standardised 
rates (AESRs) by DHBs were calculated in 
a similar way using four prioritised ethnic 
groups: Māori, Pacific, Asian and Other. 
Linear trends in rates were analysed using 
Poisson regression. Pitman’s variance ratio 
test was used to compare the distribution 
of AESRs by DHB over time. Analyses were 
carried out using Stata/SE (version 13.1).19
Results
Of the 74,784 procedures obtained from 
the NMDS for people with at least one 
publicly-funded hip or knee TJR and a date 
of discharge between 2006 and 2013, 62,907 
(84.1%) met the inclusion criteria. Figure 
1 details the exclusions. Of these 62,907 
publicly-funded primary hip or knee TJR 
procedures, 2% were bilateral joint replace-
ments giving a total of 64,222 primary hip or 
knee joints replaced (Table 1).
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Table 1: Publicly-funded primary total hip and knee joint replacement procedures in those aged 20 
years and over, 2006–2013 by District Health Board (DHB).




Population* Overall Crude Rate** 
(95% CI)
Ranking/20***
Auckland 3,472 1.8 330,660 131.3 (126.9, 135.7) 20
Bay of Plenty 4,373 1.9 149,663 365.2 (354.5, 376.2) 5
Canterbury 6,781 2.5 367,993 230.3 (224.9, 235.9) 16
Capital and Coast 3,001 5.4 211,259 177.6 (171.3, 184.0) 19
Counties Manukau 5,636 2.8 318,674 221.1 (215.3, 226.9) 17
Hawke's Bay 2,703 0.2 109,900 307.4 (296.0, 319.3) 11
Hutt Valley 1,918 5.3 100,735 238.0 (227.5, 248.9) 15
Lakes 1,827 1.4 71,043 321.5 (306.9, 336.6) 9
Mid Central 2,719 1.2 118,968 285.7 (275.1, 296.6) 12
Nelson Marlborough 3,015 2.4 102,653 367.1 (354.2, 380.5) 4
Northland 2,987 1.8 112,131 333.0 (321.2, 345.1) 8
South Canterbury 1,460 0.3 41,890 435.7 (413.6, 458.6) 3
Southern 4,734 2.7 222,008 266.5 (259.0, 274,2) 14
Tairawhiti 889 0.1 31,134 356.9 (333.8, 381.2) 7
Taranaki 2,013 1.3 79,248 317.5 (303.8, 331.7) 10
Waikato 5,757 1.4 256,493 280.6 (273.4, 287.9) 13
Wairarapa 866 0.9 29,839 362.8 (339.0, 387.8) 6
Waitemata 6,274 2.0 378,591 207.1 (202.1, 212.3) 18
West Coast 871 0.6 24,241 449.1 (419.8, 480.0) 1
Whanganui 1,611 0.8 45,012 447.4 (425.8, 469.8) 2
Total 62,907 2.1 3,102,133 253.5 (251.5, 255.5)
*Population = Average DHB population for 2006–2013 of those aged 20 years and over.
** Rate/100,000 person years.
***Ranking is from highest to lowest overall crude rate for the 20 DHBs.
Table 2: Publicly-funded hip and knee total joint replacement procedures in New Zealand for those 
aged 20 years and over from 2006–2013 by year.
Discharge Year Denominator Number Rate* 95% CI
2006 2982345 7,053 236.5 (231.0, 242.1)
2007 3015800 7,943 263.4 (257.6, 269.2)
2008 3046505 7,535 247.3 (241.8, 253.0)
2009 3083845 7,934 257.3 (251.7, 263.0)
2010 3124770 7,745 247.9 (242.4, 253.4)
2011 3158140 7,950 251.7 (246.2, 257.3)
2012 3185125 8,318 261.2 (255.6, 266.8)
2013 3220535 8,429 261.7 (256.2, 267.4)
*Rate/100,000 person years of those aged 20 years and over.
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Nationally, the number of publicly-funded 
hip and knee TJR procedures increased 
by 19.5% from 7,053 in 2006 to 8,429 in 
2013 (Table 2) while the rate increased 
by only 10.7%. The rate peaked in 2007 at 
263/100,000 py before decreasing (2008–
2011) and returning to 261 and 262/100,000 
py in 2012 and 2013 respectively. Although 
there was a statistically significant increase 
in the rates from 2006 onwards (p-value 
<0.001), there is no evidence to suggest 
a linear change in the rates from 2007 
onwards (p-value=0.2).
From 2006 to 2013 inclusive, the highest 
rate of publicly-funded hip and knee TJR 
procedures was for those aged 75–84 years 
at the time of surgery (1,063/100,000 py) 
followed by those aged 65–74 (907/100,000 
py), with the lowest rate among those aged 
less than 55 years (45/100,000 py) (Table 
3). ASRs were significantly higher for 
females (260/100,000 py) than for males 
(246/100,000 py).
The crude TJR rate of 300/100,000 py 
was highest among those categorised as 
‘Other’ ethnicity (ie those not identifying 
Table 3: Publicly-funded primary hip and knee total joint replacement procedures for those aged 20 years 
and over for 2006–2013 by socio-demographic characteristics.
Denominator* N Annual 
crude 
rate
(95% CI)** ASR*** (95% CI)
Overall 3,102,133 62,907 253.5 (251.5, 255.5) -- -- --
Age group (years)
<55 2,066,311 7,405 44.8 (43.8, 45.8) -- -- --
55–64 474,338 14,939 393.7 (387.4, 400.0) -- -- --
65–74 311,123 22,581 907.2 (895.4, 919.2) -- -- --
75–84 183,611 15,611 1062.8 (1046.2, 1080.0) -- -- --
85+ 66,751 2,371 444.0 (426.3, 462.2) -- -- --
Sex
Female 1,612,114 34,075 264.2 (261.4, 267.0) 259.7 (257.0, 262.5)
Male 1,490,019 28,832 241.9 (239.1, 244.7) 246.2 (243.4, 249.1)
Prioritised Ethnicity
Māori 366,255 5,793 197.7 (192.7, 202.9) 303.1 (294.8, 311.5)
Pacific 158,319 1,809 142.8 (136.3, 149.6) 224.2 (213.4, 235.0)
Asian 327,923 1,259 48.0 (45.4, 50.7) 93.8 (88.2, 99.3)
Other**** 2,249,636 54,046 300.3 (297.8, 302.9) 258.3 (256.1, 260.4)
Rurality
Main Urban Area 2,037,012 40,003 245.5 (243.1, 247.9) 258.6 (256.1, 261.1)
Other Urban Area 399,417 14,672 459.2 (451.8, 466.7) 361.6 (355.7, 367.5)
Rural 362,802 8,230 283.6 (277.5, 289.8) 295.9 (289.4, 302.3)
NZDep
1–3 (least deprived) 785,292 13,314 211.9 (208.3, 215.6) 219.6 (215.9, 223.4)
4–7 1,136,757 26,780 294.5 (291.0, 298.0) 279.9 (276.6, 283.3)
8–10 (most deprived) 877,113 22,806 325.0 (320.8, 329.3) 342.0 (337.6, 346.5)
*Uses 2006–2013 resident population estimates for all except Rurality and NZDep comparisons which use 2006 usually 
resident Census counts.
**Rate/100,000 person years (≥20 year- olds).
***Age-standardised rate. 
****The numerator of those classified as ‘other’ ethnicity includes those with ethnicity recorded as ‘Don’t Know,’ ‘Refused 
to answer,’ ‘Response unidentifiable’ or ‘Not Stated’ to align with denominator.
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as Māori, Pacifi c or Asian). Māori had the 
second highest crude rate (198/100,000 py). 
However, Māori had the highest ASR of 
procedures (303/100,000 py) followed by 
those of ‘Other’ and Pacifi c ethnicities (258 
and 224/100,000 py respectively). Those of 
Asian ethnicity had a substantially lower 
ASR (94/100,000 py). Differences in crude 
and ASRs between prioritised ethnic groups 
were all statistically signifi cant.
Rates were highest for people living in 
‘Other Urban Areas’ (ie urban areas other 
than those classifi ed as centred on a city 
or main urban centre) with a crude rate of 
459/100,000 py and an ASR of 362/100,000 
py). This ASR was signifi cantly higher than 
the ASR for those in ‘Rural’ (296/100,000 py) 
and ‘Main Urban Areas’ (259/100,000 py).
There was a clear linear relationship 
between TJR procedure rates and socio-eco-
nomic deprivation, with people that lived 
in the most deprived three deciles (deciles 
8–10) having a signifi cantly higher ASR 
(342/100,000 py) than those in deciles 4–7 
(280/100,000 py) and similarly those who 
lived in the least deprived deciles (deciles 
1–3) had a substantially lower ASR again 
(220/100,000 py).
Of the 20 DHBs, 10 had increases in their 
age- and ethnicity-standardised rate (AESR) 
of TJR procedures between the periods 
2006–07 to 2012–13, one was unchanged 
and nine had a reduced rate (Figure 2). Of 
the eight largest DHBs by population, fi ve 
had an increase in AESR: Bay of Plenty 
(31%), Auckland (22%), Waitemata (25%), 
Canterbury (19%) and Counties Manukau 
(7%). Southern’s AESR remained unchanged 
and Capital Coast’s and Waikato’s fell by 7% 
and 22% respectively. In contrast, AESRs fell 
between the periods 2006–07 to 2012–13 in 
seven of the 12 smaller DHBs: West Coast, 
Wairarapa, Tairawhiti, South Canterbury, 
Taranaki, Hawke’s Bay and Northland. 
However, in 2012–13, the six smallest DHBs 
by population (with the exception of South 
Canterbury) had AESRs higher than fi ve of 
the six DHBs with the largest populations. 
Five of the eight largest DHBs (Auckland, 
Canterbury, Capital and Coast, Southern 
and Waikato) were below the New Zealand 
average of 261/100,000 py in 2012–13 as 
were three of the smallest DHBs (Hawkes 
Bay, Taranaki and South Canterbury). To 
assess whether the variation in AESRs by 
DHB had changed over time, the standard 
deviation of DHB’s AESRs for 2006–07 
was compared with that from the rates 
for 2012–13. Excluding one outlier (West 
Coast), there was no statistically signifi cant 
difference over time (ratio of standard devi-
ations 1.13, (95% CI 0.70, 1.82), p=0.6).
There were also variations by DHB for 
those in the most deprived deciles. For 
those in the most deprived three deciles, 
considering the eight years of the study 
combined, the ASRs varied from 236/100,000 
py (Auckland) to 514/100,000 py (South 
Canterbury) (results not shown). Again, the 
smaller DHBs had greater provision within 
this group of the population, with the fi ve 
smallest DHBs by population having ASRs 
of at least 400/100,000 pys, a rate which was 
not reached for the most deprived deciles in 
any of the other larger DHBs.
Figure 2: Age- and ethnicity-standardised rates of publicly-funded hip and knee total joint replace-
ments per 100,000 person-years by District Health Board from 2006–2013.
ARTICLE
31
15 NZMJ 23 September 2016, Vol 129 No 1442ISSN 1175-8716                 © NZMA
www.nzma.org.nz/journal
Discussion
This study demonstrates that national 
rates of publicly-funded elective hip and 
knee TJR procedures have not increased 
beyond their 2007 peak. Higher rates were 
observed in older adults, females, those 
not living in ‘Rural’ or ‘Main Urban Areas’ 
and those living in areas of greater social 
deprivation. Rates varied between DHBs, 
even when age- and ethnicity-standardised. 
In general, there were higher rates of the 
provision of publicly-funded hip and knee 
TJR procedures among the smallest DHBs 
in New Zealand compared with the largest 
population DHBs in 2012–13.
A strength of this study was the use of 
consistently collected data for the entire 
New Zealand population. A limitation 
is that domicile was obtained from the 
National Health Index database which is 
updated when patients present at their 
DHB and therefore may no longer reflect 
the domicile as it was at the time of surgery 
for all participants. This study is restricted 
to publicly-funded procedures, therefore 
it does not consider the overall provision 
of TJR surgery, some of which are private-
ly-funded. Comparing NMDS discharge 
data of publicly-funded hip and knee TJR 
with National Joint Registry data which 
includes both privately- and publicly-funded 
procedures,4 it appears that approximately 
65% of TJR were publicly-funded in New 
Zealand between 2006–2012. The provision 
of privately-funded procedures may vary 
by DHB and may influence the provision 
of publicly-funded procedures. Derrett et 
al11 previously reported that DHBs with 
low rates of publicly-funded hip and knee 
TJR procedures had high rates of private-
ly-funded procedures. A further limitation 
of our analyses is that we have reported 
on the provision of TJR; provision does not 
necessarily reflect demand for procedures 
or the severity of disease. Previous research 
has suggested that there is unmet need 
for these procedures in New Zealand.9,13 
Demand may vary across the country9 and 
in some DHBs, 33–41% of patients listed 
for TJR are being returned to their General 
Practitioner without surgery due to waiting 
time targets.20 There was an increase in the 
number of publicly-funded hip and knee TJR 
procedures carried out nationally between 
2006 and 2013 in those aged 20 years and 
over. However, the bulk of the increase in 
both numbers and rate occurred between 
2006 and 2007 as the Orthopaedic Joint 
Initiative (“…a programme of increased 
funding specifically targeting major joint 
replacement…”) (p.15)21 finished. During the 
period of this study, 2006–2013, the rate was 
highest in 2007. Between 2007 and 2013 the 
number of publicly-funded TJR procedures 
increased by 486 (6%) but the rate decreased 
by 0.6% suggesting that the increased 
number of publicly-funded TJR proce-
dures is barely keeping up with population 
increases. Hooper et al22 have predicted 
that numbers of hip and knee replacements 
will increase significantly by 2026. Such a 
predicted increase has clear implications 
for public funding of TJRs. The highest rate 
of hip and knee TJR procedures was for 
those people aged 75–84 years followed by 
65–74 year olds. This is not surprising and 
aligns with the higher prevalence of OA 
among older age groups.5 As life expectancy 
increases, it is likely that demand in the over 
85 year-olds will increase.
Although the rate of procedures was 
higher among females, the difference 
between males and females was relatively 
small and probably reflects the higher prev-
alence of OA among women.5
Nationally, people in the least deprived 
deciles had the lowest rate of public-
ly-funded TJR procedures while those in 
the most deprived deciles had the highest 
rate. This is open to a number of different 
interpretations. Poorer access to medical 
care in the lower deciles might be expected 
to lead to a decreased rate of TJR rather than 
the increased rate seen. It is likely that there 
is greater use of private surgery by those of 
higher socio-economic status either through 
insurance or self-funding. However the 
findings may also reflect greater need for 
TJR among people of lower socio-economic 
status (for example, if need is related to 
type of occupation). However, no direct link 
between socio-economic deprivation and 
joint replacement has yet been identified 
other than possibly obesity; people in the 
most deprived areas of New Zealand having 
higher rates of obesity compared with those 
in the least deprived areas.23
Nationally, by prioritised ethnicity, Māori 
had the highest ASR of publicly-funded TJR 
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procedures. In a series of patients from a 
regional registry, Singleton et al24 found that 
Māori were younger, had poorer pre-op-
erative function than non-Māori patients 
and comprised 13.7% of their TJR proce-
dures but only 11.2% of their population. 
Hooper et al22 reported a relative rate in 
Māori of 0.72 for hip and 0.76 for knee TJR 
compared with those of ‘European’ ethnicity 
using data from the New Zealand Joint 
Registry. The main differences between 
that study and the current study are that 
privately-funded and acute procedures are 
included in the Joint Registry figures and 
that their analysis was based on joints not 
procedures. Their use of total response 
rather than prioritised ethnicity will not 
affect the rate for Māori as Māori are given 
top priority in our analysis by prioritised 
ethnicity. It is possible that lower rates of 
private utilisation among Māori may explain 
the difference in findings. It is not clear 
whether the higher rate of TJR in the current 
study is a reflection of an additional need 
among Māori or whether it is due to greater 
demand in the public sector due to lower 
private provision. It has been recognised 
previously that ethnicity data collected 
in the NMDS may undercount people of 
Māori ethnicity25 which may have influ-
enced the findings of this study. However, 
if Māori undergoing TJR surgery were less 
likely to be classified as Māori in the NMDS, 
the rate reported for Māori would be an 
under-estimate. It is unclear why rates 
were substantially lower among those of 
Asian ethnicity compared with those of 
Māori, Pacific or ‘Other’ ethnicities. It is 
possible that this may relate to more private-
ly-funded procedures among this ethnic 
group. However Hooper et al22 found similar 
results while including privately-funded 
procedures and suggested that older Asians 
living in New Zealand may return to their 
home country for joint surgery.22 The ASR of 
TJR for people of Pacific ethnicity was over 
twice the rate for those of Asian ethnicity 
but was still significantly lower than the 
rate for those of Māori and ‘Other’ ethnic-
ities. It is unclear why this is the case given 
Pacific people are highly represented in the 
most deprived areas of New Zealand and 
have higher rates of obesity compared with 
other ethnicities.23 As the DHB-level denomi-
nator data was only available by ‘prioritised 
ethnicity,’ estimates for Pacific people do 
not include those who identified with both 
Māori and Pacific ethnic groups. Similarly, 
those who responded as being of both 
Pacific and Asian ethnicity are only included 
as Pacific.
There were differences in procedure rates 
by rurality with the highest rate for those 
living in ‘Other Urban Areas’ and the lowest 
rate for those in ‘Main Urban Areas.’ The 
lower rate for those living in ‘Main Urban 
Areas’ may have been influenced by a 
greater availability of private procedures in 
these areas but we cannot determine that in 
this study. While there may be some rela-
tionship between rurality and DHB-specific 
rates, the denominator data available for 
this analysis precluded examining this.
In the current study, AESRs varied by 
DHB with a 3.8 fold rate variation between 
lowest and highest in 2006–07 and a two-fold 
rate variation in 2012–13. However, if one 
outlier was excluded, there was no statis-
tically significant change in the variation 
between DHBs from 2006–07 to 2012–13. In 
other words, there has been no apparent 
improvement in the equity of provision of 
publicly-funded TJR across DHBs over the 
eight years of the study period. Derrett et 
al,11 although not standardising for ethnicity 
and also including revision procedures, 
reported nearly a five-fold variation of ASRs 
for publicly-funded TJR between DHBs in 
2001–2002. They also reported geographic 
inequity for those in the poorest three 
deciles and found that rates of public-
ly-funded procedures were lowest for this 
group of people in DHBs that had the highest 
rates of privately-funded procedures.11 
Examining the ASR of publicly-funded TJR 
procedures by DHB for those in the most 
deprived deciles in the current study also 
found that rates varied considerably.
The larger DHBs typically had lower rates 
of publicly-funded TJR compared with the 
smaller DHBs and five of the eight largest 
DHBs had rates that were below the New 
Zealand average in 2012–13. These findings 
indicate that those living within the largest 
DHBs (by population) may be disadvantaged 
in terms of access to publicly-funded hip 
and knee TJR surgery. We cannot determine 
the reasons behind these findings. There 
may be greater access to private surgery in 
the larger DHB regions which may reduce 
ARTICLE
33
17 NZMJ 23 September 2016, Vol 129 No 1442ISSN 1175-8716                 © NZMA
www.nzma.org.nz/journal
the demand for public surgery. It has also 
been suggested that higher rates of private 
surgery could lead to lower rates of public-
ly-funded surgery due to surgeons not being 
available for public work.11 Other factors 
such as high acute loads and complex 
tertiary referrals, which are likely to be more 
common in larger DHBs, may also influence 
access to publicly-funded procedures.
Conclusion
Despite an increase in the number of 
publicly-funded hip and knee TJR proce-
dures between 2006 and 2013, the national 
increase in rate has been negligible since 
2007 suggesting that the increased number 
of procedures may be only just keeping up 
with increases in the population. While the 
data demonstrated higher rates in older 
adults, females, people of Māori ethnicity, 
and those living in areas of greater social 
deprivation and ‘other urban areas,’ there 
was no systematic evidence of inequities 
disadvantaging vulnerable, higher needs 
or isolated groups, although this study did 
not include privately-funded procedures. 
In general, there were higher rates of the 
provision of publicly-funded hip and knee 
TJR procedures among the smallest DHBs in 
New Zealand, by population, compared with 
the largest population DHBs. The finding 
that rates vary between DHBs, even when 
age- and ethnicity- standardised, suggest 
equity among DHBs is not being achieved 
nationally. This indicates that further work 
is required to meet one of the key objectives 
in the New Zealand Ministry of Health’s 
programme for elective surgery which is to 
“Work towards everyone having equal access 
to elective surgery no matter where they 
live”.26 Further research, using validated 
scoring tools, is needed to compare access 
to TJR according to need and to examine 
reasons behind differences in provision.
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Non-resident orthopaedic admissions to Dunedin Hospital,
New Zealand: 1997 to 2004
David Gwynne Jones
Abstract
Aims. The purpose of this study is to audit the numbers of non-residents requiring
orthopaedic admission to our hospital and determine the effect of increasing tourist
numbers and changes in Accident ACC regulations on healthcare resources.
Methods. Details of non-resident orthopaedic admissions for fiscal years 1997/8 to
2003/4 were analysed with respect to country of residence, mechanism of injury, case
weights consumed, and actual costs.
Results. There has been no change in numbers of admissions or cost, averaging 32
cases (50 case weights [CWs]) per year. Most patients came from Asia (59 cases;
26%), then Australia (52 cases; 23%) and UK (40 cases; 18%). Snowsports accounted
for 40% of admissions, Motor vehicle accidents (MVA) for 17%, and falls for 29%.
Non-resident, non-MVA admissions have averaged 21 CWs per year since the
changes in ACC regulations in 1999.
Discussion. Despite increasing tourist numbers, there has been no increase in
numbers or CW of non-residents requiring orthopaedic admission. Although
representing only a small proportion of the orthopaedic budget, they generate many
hidden costs. The 50 CWs annually equates to approximately 13 major joint
replacements per year. The increase in CWs consumed due to the ACC changes have
had no corresponding increase in contracted orthopaedic volumes.
There has been a much heralded increase in tourist numbers to New Zealand in the
past decade. In Otago, there has been an expansion in skifields and other adventure
tourist activities. There are invariably accidents leading to overseas patients requiring
admission for acute orthopaedic surgery. Tourists have a high profile on the ward, and
create a large amount of work for nursing, medical, and administrative staff. They
also generate costs which are not reflected in hospital-coding and reporting systems.
Patients from Australia and UK are eligible for healthcare in New Zealand under
reciprocal arrangements. Prior to 1 July 1999, non-resident patients with accidental
injuries were only covered by the Accident Compensation Corporation (ACC) if
involved in a motor vehicle accident (MVA). Since July 1999, however, all non-
residents with accidental injuries are covered by ACC at no cost to themselves while
in New Zealand.1
Under transitional arrangements which ended in July 2002, hospitals could bill the
Ministry of Health for non-resident, non-MVA cases. The hospital is bulk funded by
ACC for the acute care of all patients sustaining accidental injury. The contracted
volume of elective and acute orthopaedic surgery is calculated by case weights
(CWs).
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Any increase in acute case weights negatively impacts on the elective surgery
volumes. The value of a case weight has varied over the study period from NZ$2478
to $2565 (2004) and is currently valued at $2855.
The purpose of this study is to audit the numbers of non-residents requiring admission
to the orthopaedic wards, their country of origin, and mechanism of injury; and also to
determine whether the increasing tourist numbers and the change in ACC regulations
are having an impact on healthcare resources.
Materials and methods
All patients admitted under orthopaedic surgery for fiscal years ending June1998 to June 2004 with an
overseas home address were identified from the Dunedin Hospital patient administration system.
Records were cross-checked with ward and in-patient records. Students and people in employment
were excluded. The demographics of the patients were recorded including age, sex, cause of injury,
diagnosis, and country of residence. The case weights consumed and hence ‘revenue’ to the department
was recorded. The actual cost to the hospital was estimated by the monitoring systems used by the
Otago District Health Board (ODHB). Patient and billing details were cross-referenced with ODHB
invoices to the Ministry of Health for non-resident, non-MVA patients.
Results
Patients—There has been little change in numbers of overseas patients during the
previous 7 years; averaging 32 cases per year (Figure 1). Most patients came from
Asia (59 cases, 26%), then Australia (52 cases, 23%) and UK (40 cases 18%)
respectively (Figure 2).
Mechanism of injury—The commonest cause of injury was skiing or snowboarding,
with 89 admissions (13 per year, range 8–16) comprising 40% of all non-resident
admissions over the study period. Motor vehicle accidents made up 39 admissions
(17%), while falls comprised 64 cases (29%). Commercial or organised tourist
activities (such as parachuting, fly-by-wire, go-karting) counted for 21 cases (9.3%).
Cost—The case weights consumed have ranged from 42.8–55.5 per year with a mean
of 50 CWs per year (Figure 1). The monetary value of 50 CWs is approximately
$128,000 per year from the department budget. The estimated actual cost is $155,526.
The contracted volumes for the Orthopaedic Department have remained relatively
constant for the years 2001–2004. The current budget is 4332 CWs/year, so overseas
admissions represent 1.1% of the total workload of the department. Skiing and
snowboarding accidents, motor vehicle accidents, and falls contributed fairly equally
to the numbers of CWs consumed. (Table 1)
ACC changes—For the years 1997/8 and 1999/9 (prior to the ACC changes), there
were on average 17 non-resident patients (17.5 CWs) requiring admission for non-
MVA accidents. The actual cost was $49,613 while revenue for these years averaged
$62,276. Since the ACC changes, there have been an average 13.6 cases per year in
this category who have accounted for a mean 21.1 CWs per year ($53,655), with an
estimated actual cost of $64,369 per year.
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Figure 2. Countries and continents of residence of patients requiring orthopaedic
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For fiscal years ending 2000, 2001, and 2002, an average of 13 CWs ($32,364) per
year were refunded by the Ministry of Health to the Hospital under transitional
arrangements. Since this arrangement has ceased, there has been no corresponding
increase in orthopaedic volumes contracted by ODHB.
Table 1. Dunedin Hospital admissions and case weights by mechanism of injury
for fiscal years ending 1998-2004
Variable Snowsports MVAs Falls Tourist activities Other
Admissions 89 39 64 25 7
Total CWs 104 85.6 104.2 44.3 13.6
CWs/year 14.9 12.2 15.3 5.7 1.9
Actual cost/year $45703 $40140 $45303 $20009 $4058
CWs=case weights; MVA=motor vehicle accidents, Tourist activities=commercial activities such as parachuting,
fly-by-wire, and go-karting.
Discussion
There has been a 43% increase in visitor arrivals to New Zealand: from 1.48 million
in 1998 to 2.11 million in 2003.2 Tourist numbers in the Otago region would be
expected to have similarly increased. Indeed, a common perception, both in the
hospital and in the lay press,3,4 is that there are increasing numbers of tourists
requiring orthopaedic admission due to snowsport injuries and motor vehicle
accidents. However, this study shows that the number of non-residents requiring
orthopaedic admission has not increased significantly over the previous 7 years (1997
to 2004). Patients from Asia make up the largest proportion of orthopaedic admissions
(26%), followed by Australia (23%) and the UK (18%).
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Whilst Australians make up 33% of visitor numbers to New Zealand (Asians are 24%
and UK residents 11%, respectively), the figures for visitor nights are: Asia 20%,
Australia 19.7%, UK 18.0%, USA and Canada 10.6%, and Europe 8.7% thus
reflecting varying lengths of stay among those groups (2003 figures).2
Snowsports, as expected, were the commonest reason for the accident. According to
ACC figures, skifield visits doubled from 1998 to 2001 with 1.25 million visits in
New Zealand in 2001. Snowsport injuries cost ACC $3.7 million in 2003.5 New
Zealand skifields estimate an injury rate of less than 5/1000 participants compared to
international figures of 8 per 1000.3 The cost of inpatient snowsport injuries was
relatively low, averaging 1.17 CWs or $3600 actual costs per patient.
In contrast, there were fewer MVAs involving tourists but each admission averaged
2.2 CW and cost an average of $7216 thus reflecting the greater severity of injuries
associated with higher velocity mechanisms.
Tourists have a high profile on the ward because of the need for translators, the lack
of family support, international telephone calls, and the involvement of insurance
companies and airlines in discharge planning. This creates a large amount of work for
nursing, medical, and administrative staff and hidden costs which are not reflected in
hospital coding and reporting systems.
The cost and case weights consumed is only a small proportion of the orthopaedic
budget averaging around 1%. However, these 50 CWs represent approximately 13
major joint replacements per year. The change in ACC regulations have meant that an
average of 21 CW/year are now coming from the orthopaedic budget with no
corresponding increase in contracted volume.
Despite an increase in the number of tourists there has not been an increase in
numbers or case weight load of non-residents requiring orthopaedic admission over
the previous 7 years. The changes in ACC regulations have had a small impact on the
provision of orthopaedic services in the Otago region.
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to Dunedin Hospital 1997 
to 2017 and Southland 
Hospital 2011 to 2017
Annabel Merrett, Jennifer Keys, Chris Crane, 
David Gwynne-Jones
Over the past several decades, New Zealand’s tourism industry has expe-rienced exceptional growth, and fore-
casts for the sector indicate this expansion 
will continue. Statistics New Zealand has 
recorded that New Zealand attracted 3.5 mil-
lion international visitors in the year ending 
December 2016.1 This has risen from 1.48 
million in 1998 and is projected to increase 
to 4.5 million by 2022.1,2 
In the Otago and Southland regions, due 
to the popularity of the tourist resorts of 
Queenstown and Wanaka, there is a higher 
ratio of international tourists to local resi-
dents and a forecast growth in tourism that 
is higher than for other regions. This puts 
relatively higher pressure on the local infra-
structure, including healthcare, compared 
to other regions.2 In overseas studies the 
most common reason for admission for 
overseas residents is trauma.3,4 In New 
Zealand in general, and Otago and Southland 
in particular, adventure tourism, snow 
sports and motor vehicle accidents involving 
overseas drivers may all lead to admissions 
to the orthopaedic service. Concerns over this 
burden has led to previous studies looking 
at overseas admissions to Dunedin Hospital 
from 1997–2004 and snow sports injuries 
admitted to Invercargill during 2009.5,6
ABSTRACT
AIMS: The purpose of this study is to audit the numbers of non-residents requiring orthopaedic admission 
to Dunedin and Southland Hospitals and determine the e ects of increasing tourist numbers on healthcare 
resources. 
METHOD: All non-resident orthopaedic admissions to Dunedin Hospital from January 2005 to December 
2017 and Invercargill Hospital from January 2011 to December 2017 were analysed with respect to country 
of residence, mechanism of injury, primary diagnosis and case weights consumed. The results were 
combined with figures from 1997–2004 to give a 21-year series for Dunedin Hospital. 
RESULTS: There has been a significant increase in the number of admissions and case weights (CW) over 
the past 21 years at Dunedin Hospital (p<0.001). The most common mechanisms of injury were snow sports 
at Dunedin Hospital and falls for Southland Hospital. Between 2011 and 2017 there were on average 50 
non-resident admissions per year (92.9 CW/year) to Dunedin Hospital and 74 admissions (120.7 CW/year) 
in Southland. 
CONCLUSION: Increasing tourist numbers have resulted in an increase number of orthopaedic admissions 
to Dunedin Hospital over the last two decades although it remains a small proportion of the total workload. 
Southland Hospital is relatively more a ected. These patients represent an annual cost in excess of 
$1,000,000 to Southern DHB. 
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Each DHB receives funding according 
to the population-based funding formula 
(PBFF). Public Health Acute services (PHAS) 
are funded from this. Since July 1999, all 
non-residents with accidental injuries are 
covered by the Accident Compensation 
Corporation (ACC) while in New Zealand. 
Prior to 1999, non-residents were only 
covered by the ACC if their injury was the 
result of a motor vehicle accident. The DHB 
are expected to cover all acute costs through 
PHAS, from their bulk funding. The Crown 
recovers these costs from ACC at a national 
level but not directly to individual DHBs. 
Therefore the cost of treating patients from 
overseas comes directly from the base 
funding of the DHB.
The Otago DHB and Southland DHBs 
merged in 2010 to form the Southern 
DHB (SDHB).The Southern DHB has had 
well-publicised problems with a fi nancial 
defi cit and diffi  culties with access to elective 
orthopaedic surgery.7,8 Any increase in 
non-resident admissions over and above 
normal adjustments may have impacts on 
healthcare costs and directly and indirectly 
on elective service delivery.
The base hospitals in Dunedin and Inver-
cargill both provide an orthopaedic trauma 
service. Patients from Queenstown have 
traditionally been transferred to Invercargill 
and those from Wanaka and Central Otago 
to Dunedin. Due to the nature and increased 
volume of tourism throughout the district it 
is hypothesised that there will have been an 
increase in overseas orthopaedic admissions 
since our original study.
The primary objective of this study is to 
audit the numbers and details of non-res-
ident orthopaedic admissions to Dunedin 
Hospital over the 21-year period 1997 to 
2017. The secondary outcome is to compare 
the equivalent fi gures from 2011 to 2017 for 




We used the same methodology as for 
our previous study.5 Hospital adminis-
tration systems were used to identify all 
non-resident patients that were admitted 
under orthopaedic surgery from January 
2005 to December 2017 for Dunedin 
Hospital, and January 2011 to December 
2017 for Southland Hospital. The search 
included residency status of all patients 
and overseas address, which is determined 
at the time of admission and captured in 
the electronic record. Patients who were 
students or people in employment in New 
Zealand including those on working visas 
were excluded as in our previous study. All 
cases identifi ed were individually checked 
including a review of admission notes if 
required. The demographics of the patients 
were recorded, including age, sex, country of 
residence, mechanism of injury and primary 
diagnosis. The case weights (CW) consumed 
were also recorded. The price per CW in 
2017 was $4,921 and allowed the cost to the 
hospital was estimated. The proportion of 
the total orthopaedic workload was then 
calculated based on both total discharges 
and CWs from DHB reporting systems for 
both hospitals.
The results of this study were then 
combined with the previous study to create 
one continuous data set for numbers of 
patients and case weights consumed from 




There were a total of 651 patients 
admitted (mean 50/year). The average length 
of stay (LOS) was 4.9 days (median three 
days). There were a total of 3,128 bed nights 
used over this period (240/year). The total 
case weights were 1,159 (mean 89.1/year).
The majority of patients in Dunedin come 
from Australia (201 patients, 31.0%), followed 
by the UK (115 patients, 17.7%) and Europe 
(111 patients, 17.1%,). Despite increasing 
numbers of Asian tourists there were only 88 
patients (13.6%) during this time.
Mechanism of injury
The most common cause of injury was 
skiing and snowboarding with 200 admis-
sions (mean 15.4 admissions per year), 
comprising 30% of all non-resident admis-
sions. Falls were the second most common 
cause with 168 admissions (26%) (13/year). 
Motor vehicle accidents (MVAs) caused 83 
admissions (13%) (6/year) with bicycle acci-
dents causing 41 admissions (6%) (3/ year). 
Commercial tourist activities such as para-
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gliding, bungy jumping and canyoning only 
led to 15 admissions (2%) over the 13-year 
period (Figure 1). The mean case weight 
per discharge (CW/D) was 2.8 for patients 
admitted due to MVAs, 2.4 for commercial 
tourist activities and 1.6 to 1.8 for snow 
sports, falls and bicycle accidents (Table 1). 
Table 1: Details of mechanism of injury and case weights for non-resident orthopaedic admissions to Dunedin Hos-
pital 2005–2017 and Southland Hospital 2011–17.
Dunedin 2005–2017 Southland 2011–2017
Mechanism Number % CW  CW/D Number % CW  CW/D
Snowsports 200 30 346 1.7 141 27 217 1.5
Falls 168 26 294 1.8 161 31 312 1.9
MVAs 83 13 230 2.8 42 8 76.4 1.8
Fall from bike 41 6 66 1.6 59 11 87 1.5
Lacerations, amputations, 
crush injuries and infection
36 6 36 1.0 27 5 34 1.3
Sports 16 2 34 2.1 10 2 14.2 1.4
Commercial tourist activities 15 2 36 2.4 30 6 43.7 1.5
Fall from horse 5 1 6 1.2 11 2 23.9 2.2
Other 26 4 43 1.7 12 2 10.9 0.9
Unknown 61 9 68 1.1 24 5 25.6 1.1
Total 651 100 1,159 1.8 517 100 845 1.6
CW; Case Weight, CW/D; Case weight/discharge, MVA; Motor vehicle Accident.
Figure 1: Numbers of non-resident orthopaedic admissions to Dunedin Hospital by mechanism of 
injury 2005 to 2017. 
Commercial tourist activities include: canyoning, parachuting, jetboating, skydiving, hang gliding, scenic flights, go-
karting, bungy jumping, fly-by-wire and paragliding.
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The most common injuries seen were 
lower limb fractures and dislocations, which 
made up 42% of admissions followed by 
upper limb fractures (28%) with 47 patients 
(7%) having spinal injuries (Table 2).
Changes 1997–2017
Linear regression analysis shows a 
signifi cant increase in numbers of non-res-
ident patients (p=0.0002) and case weights 
(p=0.006) consumed in Dunedin Hospital 
during the previous 21 years (Figure 2). 
Numbers have increased from 32 patients 
per year from 1997–2004 to 50 patients 
a year (+60%). The case weights ranged 
between 44 CW (2001) and 133 CW (2016). 
The mean case weight/year from 1997–2004 
was 50, rising to 85.5 CW/year for the period 
2005–2010 and 92.9 CW/year between 2011 
and 2017. This represents an 86% increase. 
The mean CW/D has increased from 1.67 
(1997–2004) to 1.9 (2011–17) (+14%). 
Table 2: Details of injury for non-resident orthopaedic admissions to Dunedin Hospital 2005–2017.
Primary diagnosis Number of patients % CW
Lower limb fractures and dislocations 272 42 557
Upper limb fractures and dislocations 181 28 280
Spinal injuries 47 7 80
Hip and pelvis fractures and dislocations 31 5 55
Laceration, crush injuries and amputations 24 4 24
Tendon and ligament injuries 28 4 36
Infection and so  tissue injuries 24 4 26
Multiple fractures and injuries 8 1 42
Other 18 3 59
Unknown 18 3
Total 651 100 1,159
Figure 2: Number and case weights of non-resident orthopaedic admissions to Dunedin Hospital, 
January 1997 to October 2017.
ARTICLE
45
45 NZMJ 8 May 2020, Vol 133 No 1514ISSN 1175-8716                 © NZMA
www.nzma.org.nz/journal
Southland site 2011 to 2017
At Southland Hospital there were a total of 
517 admissions (845CW) over the seven-year 
period. The average was 74 discharges/year 
(120.7 CW/year). The numbers also showed 
a rising trend though there was a dip in 2017 
(linear regression p= 0.23, ns) (Figure 3). 
The case weights consumed for non-resident 
orthopaedic admissions are also showed 
an increasing trend year to year with the 
exception of 2017 (linear regression, p=0.17) 
(Figure 3). The mean LOS was 3.6 days, 
(median 3) with an average of 270 bed 
nights per year.
Patients most commonly were from 
Australia (226, 43.7%), followed by UK (80, 
15.5%), and Europe (77, 14.9%) and Asia. 
Australians made up a signifi cantly higher 
proportion of admissions in Southland than 
in Dunedin (Fisher exact test, p<0.001).
Falls were the most common cause of 
admission with 161 admissions (23 per 
year, 31.1% of all non-resident admissions), 
followed by skiing and snowboarding with 
141 admissions (20.1 per year, 27.3% of 
all non-resident admissions), and bicycle 
accidents with 59 admissions (8.4 per year, 
11.4% of all non-resident admissions). 
Commercial tourist activities led to 30 
admissions (5.8%) (Table 1).
The mean CW/discharge was lower in 
Southland at 1.6 CW compared to 1.8 CW 
in Dunedin. The mean CW/discharge was 
highest for falls from horse (2.2), falls 
(1.9) and MVAs at 1.8 CW/D and 1.5 CW/D 
for snow sports, bicycle accidents and 
commercial tourist activities.
There was a similar mix of injuries to 
Dunedin with lower limb fractures most 
common (39%), then upper limb fractures 
(34%) but a higher proportion of spinal 
injuries at 72 (13%).
Proportion of workload in 
Southern DHB
In 2004 the total orthopaedic budget in 
Dunedin was 4,332 CW. In 2017 this had 
risen to 6,421 CW. The proportion consumed 
by overseas patients was 1.1% in the period 
1997–2005. Between 2007–17 this had 
increased to 1.6% of total CW and 1.8% of 
all discharges. Overseas cases accounted for 
3.1% of acute admissions and CWs. In dollar 
terms, using 2017 CW values, the cost in 
Dunedin was $620,046 in 2016 and $418,285 
in 2017. 
In Southland overseas cases accounted 
for 3.9% of all discharges and 3.8% of total 
CW for the period 2011–17. They accounted 
for 6.9% of acute admissions and 7.2% 
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acute CWs during this period. The cost was 
$728,000 in 2016 and $585,600 in 2017.
The cost for Southern DHB for the 
seven-year period 2011–17 has averaged 
214 CW or 2.3% of the total orthopaedic 
budget. Using 2017 values, this represents 
an average annual cost of $1,051,125 (range 
$853,795 to $1,348,354).
Discussion
With the increase in tourist numbers in 
New Zealand, there has been a subsequent 
increase in the number of non-resident 
admissions and case weights consumed 
over the past 21 years for Dunedin hospital, 
and over the seven-year study period at 
Southland Hospital. The commonest causes 
of admission are due to snow sports, MVAs 
and falls. Australian residents compromise 
the largest proportion of admissions. 
Overseas admissions only comprise 3.1% of 
the acute orthopaedic budget in Dunedin but 
7.2% in Southland, which is disproportion-
ately affected. 
In the six years (2010–2016) there was a 
27.9% increase in annual visitor arrivals to 
New Zealand (2,525,044–3,499,939).1 This 
increase in tourist numbers has occurred 
throughout New Zealand, including Otago 
and Southland. In Otago in 2015, the ratio 
of annual visitor count to resident popu-
lation was 4.9, which was the second highest 
ratio in New Zealand, after the West Coast.2 
Therefore, it would be expected that this 
rise in tourism would lead to an increase in 
non-resident hospital admissions. 
Our previous study showed that while 
there was a 43% increase in visitor arrival to 
New Zealand between 1997 and 2004, there 
was no signifi cant increase in the number 
of non-resident orthopaedic admissions at 
Dunedin hospital over that time period.5 
However, over the 21-year period between 
1997 and 2017, there is an increasing trend 
in terms of numbers of non-resident admis-
sions, case weights consumed and the 
proportion of the total orthopaedic budget 
at Dunedin Hospital. Between 1997 and 2004 
there were on average 32 patients per year, 
which has increased by 50% to 49 during 
the last seven years of this study. Southland 
Hospital carries a higher burden than 
Dunedin with 74 non-resident orthopaedic 
patients/year accounting for 3.8% of the total 
orthopaedic budget. The appointment of a 
trauma surgeon in Southland has meant that 
fewer patients are transferred out to larger 
centres. However, the CW/D ratio is lower 
for Southland than Dunedin suggesting that 
it is high numbers of less complex cases that 
makes up the bulk of their load. 
From 2012 to 2016, tourists from Australia 
made up 40% of our annual visitors, those 
from Asia made up 23%, and tourists from 
the US and UK made up 8% and 6% respec-
tively.1 As expected, patients from Australia 
make up the largest proportion of ortho-
paedic admissions (31% at Dunedin hospital, 
43.7% at Invercargill Hospital). This may 
be due to an increase in the number of 
direct fl ights into Queenstown Airport from 
Australia. However, those from Asia only 
made up 13.5% of admissions at Dunedin 
Hospital and 12.8% at Invercargill Hospital. 
This is in contrast to our previous paper 
covering 1997 to 2004 when patients from 
Asia made up the largest proportion of 
orthopaedic admissions (26%), followed by 
Australia (23%) and the UK (18%).5 
It is a common perception that snow 
sport injuries and motor vehicle accidents 
(MVAs) are a major cause of non-residents’ 
hospital admissions. This study confi rmed 
that snow sports were the most common 
reason for admission at Dunedin Hospital 
and the second most common reason for 
admission at Invercargill Hospital. Burgess 
and Namazie6 reported that in 2009, 59 
overseas patients (85 CW) were admitted to 
Southland Hospital following snow sports 
injuries over a four-month period. This 
represented two-thirds of admissions for 
snow sport injuries over the same period. 
This is much higher than in subsequent 
years which suggests either that 2009 was 
a bad year prompting their study or safety 
measures in the snow sport industry have 
improved. They recorded country of origin 
and patients may have been categorised as 
an overseas patient even if they had a local 
address and were working or studying. 
In their study the average CW/D was 1.44 
($7,086, 2017 values) compared with 1.54 
CW/D ($7,578) in Southland and 1.72 CW/D 
($8,464) in Dunedin in in this study. This 
suggests that the severity of injury and 
hence cost is increasing. 
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There were fewer non-residents admitted 
after MVAs, however each admission cost 
an average of 2.8 CW ($13,779) for Dunedin 
Hospital, and 1.95 ($9,596) for Southland 
Hospital due to the greater severity of 
injuries. More seriously injured patients are 
usually transferred to Dunedin Hospital by 
rescue helicopter regardless of the location 
of their accident. 
This study found that the average case 
weights per year from 2011 to 2017 was 92.9 
CW for Dunedin Hospital and 120.7 CW for 
Invercargill, which equates to approximately 
$457,161 and $590,520 respectively (2017 
values). In our previous study non-resident 
orthopaedic admissions accounted for 1.1% 
of the total orthopaedic workload.5 This is 
now 1.6% in Dunedin and 3.9% in Southland. 
Consequently the burden of overseas resi-
dents on the service has increased in both 
absolute and relative terms. This is despite 
signifi cant increases in the orthopaedic 
elective budget due to the Orthopaedic Joint 
Initiative and other policies. 
There may be both direct and indirect 
consequences of this work on elective 
surgery. Bed block and theatre access 
problems can lead to cancellation of elec-
tives. The fi nancial cost per year adds to the 
budget defi cit and could be used to employ 
more staff. The cost and number of CWs/ 
year across Southern DHB would equate to 
approximately 65 elective hip replacements. 
A weakness of the study is that the 
inclusion criteria was to have an overseas 
home address listed on their patient records 
or in-patient notes. However, some overseas 
patients report a local address that they 
are currently staying at and may not have 
been identifi ed as an overseas resident. 
However, residency status is routinely 
checked at the time of admission and was 
used to help identify non-residents. We 
excluded students studying in New Zealand 
and those in employment, for example on 
working visas, as they were considered to 
be paying New Zealand taxes. We used the 
same methodology in our previous study 
so that trends were more likely to be valid. 
However, the results are still likely to be 
an underestimate. Outpatient and fracture 
clinic costs for patients treated with more 
minor injuries have not been collected so 
the true cost to SDHB of injuries to overseas 
residents will be greater. 
This study focused solely on Southern 
DHB and there is a lack of national data 
with which to compare these results.  
However, data presented at the NZOA 
trauma meeting this year suggests that the 
total overseas delivery funded through the 
Population-based funding formula (PBFF) in 
Southern DHB is the highest in New Zealand 
and in excess of $2 million.10 Further work 
at a national level will help identify the 
workload caused by overseas tourists. If 
signifi cant anomalies exist then this should 
have an impact on future funding decisions 
such as the mechanism used by ACC to fund 
acute care for each DHB.
Conclusion
Increasing tourist numbers have resulted 
in an increased number of orthopaedic 
admissions to Dunedin Hospital over the last 
two decades. It remains a small proportion 
of the total departmental workload while 
Southland Hospital is relatively more 
affected. These patients represent a cost in 
excess of $1,000,000 per annum to Southern 
DHB, which has to be funded from its share 
of population-based funding. 
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The projected burden 
of knee osteoarthritis in 
New Zealand: healthcare 
expenditure and total joint 
provision 
David Gwynne-Jones, Gary Hooper
We commend Wilson and Abbott on their paper highlighting the projected burden of knee osteo-
arthritis in New Zealand.1 Their projections 
are worrying and match our previous fi nd-
ings.2–4 However, we have concerns regard-
ing the accuracy of their fi gures, the clinical 
implications and their conclusions. They un-
derestimate the demand as the model does 
not allow for patients who need bilateral 
TKR and does not appear to include unicom-
partmental replacement (UKR), which is also 
performed for knee OA. 
In 2013, 7,419 knee replacements were 
performed in New Zealand (6,694 TKR and 
725 UKR), of which osteoarthritis was the 
diagnosis of 95%.5 Therefore, the baseline 
number performed for OA was 7,048 
rather than 5,070 used in their model. By 
2017 there were 9,352 knee replacements 
(8,298 TKR and 1,054 UKR), so the burden 
for OA of approximately 8,884 is already 
well in excess of 5,770 in their model. It 
has already surpassed the 8,613 projected 
by Hooper et al for 20262 and is fast 
approaching the projections of Wilson and 
Abbott for 2038. The numbers performed 
in 2017 were 54% higher than Wilson and 
Abbott’s estimate, so extrapolating from 
this the total burden could approach 14,000 
TKR/UKR annually by 2038 or an increase of 
almost 7,000 from 2013. 
They also modeled the effect of rising 
rates of obesity on projected numbers of 
patients needing TKR. Obesity has a major 
impact on a wide range of other orthopaedic 
conditions. Procedures are more complex, 
take longer and have higher complication 
rates. We fully concur with their conclusion 
that public health measures are needed to 
reduce population obesity rates. However, 
there will be a lead time of many years 
before we are likely to see any effect on 
demand for TKR. 
While they state in their introduction 
that there are capacity constraints, they 
do not expand on this in the discussion. 
The average orthopaedic surgeon in New 
Zealand performs 36 TKR per year. This 
increases to 41 per year if UKR is also 
included.5 To perform the additional 4,000 
procedures predicted by Wilson and Abbott 
would potentially need a further 100 ortho-
paedic surgeons or an increase of 50% on 
the 206 surgeons who performed knee 
arthroplasty in 2013. In addition, there will 
be a need for more supporting staff (anaes-
thetists, nurses, physiotherapists, etc) and 
infrastructure (beds, operating facilities and 
surgical time).
In the discussion they state that “effective, 
low cost, early interventions such as 
exercise therapy, can alleviate symptoms, 
improve quality of life and reduce the need 
for costly treatment, such as TKR, later in 
the disease course.” They conclude that 
without these changes the number of TKRs 
will increase by 4,000 by 2038 with a subse-
quent increase in the fi scal burden.
We agree that a more coordinated 
approach and effective non-operative 
treatment, including exercise therapy, has 
an important role in all patients with knee 
OA. However, the two papers they cite add 
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little to support the statement that TKR can 
be reduced in New Zealand by non-oper-
ative measures. The study by Teoh et al6 is 
from Australia, which has a very different 
healthcare system and access thresholds 
to New Zealand. The MOA study from New 
Zealand only has follow-up to two years 
by which time 35% of patients had already 
undergone hip or knee replacement.7 A 
recent study has shown that it may be 
possible to delay surgery for fi ve years 
in up to 50% of patients who initially did 
not qualify for TKR with an individualised 
non-operative programme.8 However, while 
they avoided surgery, they had no clinically 
relevant improvement.
Exercise therapy may be cost-effective in 
the short term, but TKR, while expensive up 
front, has been shown to be highly cost-ef-
fective with gains lasting many years.9 The 
18-year survival of a TKR in New Zealand
is 92.3%, so for the majority of patients it is
one procedure that will last their lifetime.5
The healthcare burden of knee OA and 
other musculoskeletal conditions will 
continue to grow. Robust modeling is 
important to help inform long-term funding 
decisions but should include a clinical 
perspective in order to be relevant and 
credible. Public health initiatives to reduce 
obesity are essential but the demand for TKR 
will continue to rise. We need to plan for this 
from both economic and workforce training 
perspectives. Unless adequate provision 
is made for TKR, the inevitable conse-
quence will be rising threshold scores for 
publicly funded surgery, explicit rationing 
and increasing numbers of patients being 
declined surgery.4
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Chapter 2  
Carpal tunnel syndrome (CTS) - a success story. 
One of the highest volume procedures we perform is carpal tunnel decompression (CTD). 
This straightforward procedure can be performed endoscopically which may require general 
anaesthetic or regional nerve block  and is also be performed by plastic surgeons or 
neurosurgeons sometimes using an operating microscope in a fully equipped theatre.  In 
contrast in the public sector we usually perform it open, under local anaesthetic, in the day 
surgery unit (DSU) or on the Mobile Surgical Services bus by a consultant or suitably 
experienced registrar. Our ageing DSU comprises two small theatres of which the smaller is 
little more than a procedure room. The Mobile Surgical bus visits small centres such as 
Oamaru, Balclutha and Queenstown every 5 weeks. We have relatively good access and can 
treat 6-8 patients in a 4 hour session without the need for an anaesthetist. It has also freed 
up our fully equipped theatres for major procedures such as joint replacement. In addition 
we have enjoyed a first class service provided by Dr Peter Taylor, our neurophysiologist, 
who has a keen interest and contributed to several of the papers in this chapter. As a result 
of this approach we have provided CTD above the national rate for many years in marked 
contrast to joint replacement surgery.  
In ‘Incidence of Carpal Tunnel Syndrome Requiring Surgical Decompression: A 10.5-Year 
Review of 2,309 Patients’  we reported primarily on the epidemiology of CTS. We found that 
the highest rates of surgically treated CTS were found in the elderly rather than middle-aged 
women as traditionally thought.  Over the age of 65 years males and females had an equal 
incidence. The neurophysiological changes were more severe with increasing age. This may 
account for previous reports that suggested that elderly patients are more likely to do 
poorly. This did not match our experience and led to an early publication ‘The outcome of 
carpal tunnel decompression in elderly patients’. In this we report good outcome scores in 
patients over 70 years that were comparable to those in younger patients in published 
studies, and a satisfaction rate of 94%.  
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http://dx.doi.org/10.1016/j.jhsa.2015.07.029SCIENTIFIC ARTICLEIncidence of Carpal Tunnel Syndrome Requiring
Surgical Decompression: A 10.5-Year Review
of 2,309 PatientsJohn H. J. English, MB, ChB,* David P. Gwynne-Jones, BM, BCh*Purpose To describe the demographics, neurophysiological grading, and incidence of patients
undergoing carpal tunnel decompression (CTD) for carpal tunnel syndrome (CTS) in a single
region.
Methods A retrospective review of 2,313 patients aged greater than 16 years who underwent
3,073 CTDs between January 2000 and August 2010. Crude annual and age- and sex-specific
incidences were calculated for the study period. Nerve conduction study grades were recorded
and compared with age and sex.
Results Of the 2,313 patients 1,419 (61%) were female and 890 (39%) were male. Mean age
at surgery was 56 years (range, 16e93 years). Females had a significantly higher CTD
incidence compared with males (161 vs 108/100,000 person-years, respectively). The
highest rates of CTD were seen in the 70- to 79-year age group for both men and women
(307/100,000 person-years). Neurophysiological grade increased in severity with
increasing age despite using an age-adjusted grading system, with higher grades in patients
aged greater than 65 years.
Conclusions This study suggests that carpal tunnel syndrome has the highest incidence in older
people who tend to have more severe neurophysiological changes. (J Hand Surg Am.
2015;40(12):2427e2434. Copyright  2015 by the American Society for Surgery of the
Hand. All rights reserved.)
Type of study/level of evidence Prognostic II.
Key words Carpal tunnel syndrome, epidemiology, incidence.CARPAL TUNNEL SYNDROME (CTS) is the most com-mon upper limb entrapment neuropathy. Tra-ditionally, it has been considered a disease of
middle-aged women. In 1966, Phalen1 stated that
“the typical patient with this syndrome is a middle-
aged housewife.” Other studies have shown that itnedin, New Zealand.
ly 29, 2015.
d related directly or
King Street, Dunedin
 254can occur frequently in older people and in young
working individuals.2e5 Recently, a higher surgical
incidence has been reported in older women.6 In our
experience, CTS is often seen in both the elderly and in
younger working individuals and middle-aged
women.2,3 It is a major cause of disability and has
impacts both socially and economically, including lost
days at work and sleep disturbance.7,8 Refractory cases
not responsive to conservative treatment will usually
be treated with carpal tunnel decompression (CTD).9
The diagnosis is usually a clinical one based on
history and examination.10,11 Neurophysiological
testing can be useful to confirm a clinical diagnosis
of CTS and provide information on the severity
of median nerve compression. It also allows for015 ASSH r Published by Elsevier, Inc. All rights reserved. r 2427












6 (severe) Absent Absent
5 (very marked) > 7.0 SD or absent and > 4.0 SD
4 (marked) > 5.0 SD or > 5.0 SD and > 4.5 to < 7.0 SD
or absent
or > 4.0 SD
3 (moderate) > 4.0e5.0 SD or > 4.0 to < 5.0 SD and < 4.5 SD or < 4.0 SD
2 (mild) > 3.0 SD or > 3.0e4.0 SD or > 3.0 to < 4.0 SD and < 3.0 SD and < 3.0 SD
1 (borderline) 2.5e3.5 SD and < 3.0 SD and < 3.0 SD and < 3.0 SD and < 3.0 SD
0 (normal) All < 2.5 SD and < 2.5SD and < 2.5 SD and < 2.5 SD and < 2.5 SD
For conduction velocity and amplitudes, SD refers to SDs less than the mean. For distal motor latencies and palmar latencies, SD refers to SDs greater
than the mean.
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plete decompression or nerve injury.9
The purpose of this study was to describe the
epidemiology of CTS severe enough in a single region
to require surgical release. Nerve conduction studies
(NCS) were used to compare severity of median nerve
compression with the age and sex of patients. This
may then allow an estimate of the appropriate demand
for CTD in a given population based on age and sex.
MATERIALS AND METHODS
Our region has a population estimate of 193,800
people, with 130,000 people living in the main city. It
covers a large geographical area of 31,000 km2,
which is predominantly rural.12 There is one univer-
sity public hospital and a private hospital. Rural
centers are serviced periodically by a publicly funded
mobile surgical bus.
After we gained ethical approval from the Health
and Disability Ethics Committee to perform a retro-
spective review, we collected details of all patients aged
16 years or older undergoing CTD between January
2000 and August 2010. These included public and
private hospital patients, cases performed on the mobile
surgical bus, and those performed as office procedures
in private offices. Data were collected through a com-
bination of hospital International Classification of Dis-
eases codes, local surgical audit, surgical bus records,
and private clinic and hospital records.
During the study period, all NCS were performed by
the sole neurophysiologist in our region using stan-
dardized techniques. Nerve conduction study grades
were expressed as SD away from an age- and body
masseadjusted population mean (Table 1).3,13,14
Neurophysiological data were analyzed on 1,104 pa-
tients in the latter part of the study from 2005 to 2010.J Hand Surg Am. r Vol55In patients with bilateral disease, the hand with the
higher-grade neurophysiological change was used for
the analysis. Our practice is to perform an open carpal
tunnel release under local anesthesia as a day case.
During the timeof the study, all carpal tunnel procedures
were performed by 1 of the 9 orthopedic surgeons or
their residents. Indications for surgery were symptom-
atic CTS with confirmatory neurophysiological testing
usually showing at least grade 3 (moderate) compres-
sion.Our country has free public surgery, and our region
has good access to family doctors. During the study
period, there was no noteworthy limitation on access to
publicly funded carpal tunnel surgery.
Crude annual and age- and sex-specific incidences
were calculated for the study period. The national
census (2006) was used to obtain local population
data.12 The incidences were also standardized using
World Health Organization European Standard pop-
ulation as the reference population.15 We used Stu-
dent t test to evaluate statistical differences in crude
age- and sex-specific incidences. Chi-square test was
used to evaluate statistical differences between a
population aged less than 65 years and aged 65 years
and older.
RESULTS
From January 2000 to August 2010, 2,313 patients
underwent 3,073 CTDs. A total of 760 patients had
bilateral procedures (simultaneous or staged); 1,419
patients were female (61%) and 890 were male
(39%). Mean age at surgery was 56 years (confidence
interval [CI], 55.7e57.0) for both males (range,
17e91 years) and females (range, 16e93 years).
Mean number of CTDs per year was 217. There
was no significant change in number of CTDs over
the first and second halves of the study period. Mean. 40, December 2015
FIGURE 1: Annual crude and sex-specific incidence (per 100,000 person-years). Note: Year 2010 has been adjusted to an estimate of a
full year.
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significantly lower than females (133; CI, 117e149)
(P < .001) (Fig. 1).
The annual average crude incidence (2000e2010)
was 136/100,000 person-years (CI, 121e150) and
the age-standardized (AS) incidence was similar, at
137/100,000 person-years. The sex-specific incidence
showed a significantly higher incidence in females 161
(AS, 164) per 100,000 person-years (CI, 142e181)
compared with males 108 (AS, 110) per 100,000
person-years (CI, 97e119) (P < .001). The ratio of
female to male annual average incidence was 1.5:1.
The incidence of CTD increased with increasing
age, with the highest rates (307/100,000 person-years)
occurring in the group aged over 70 years (Fig. 2).
In males, there was a steady increase in incidence
with increasing age, reaching a maximum incidence
of 317/100,000 person-years at 70 to 74 years. In
females, there was a bimodal distribution, with a
small peak between age 50 and 54 years of 289/
100,000 person-years and a second higher peak at age
75 to 79 years of 331/100,000 person-years (Fig. 3).
The incidence of CTD was significantly higher in
patients aged 65 years or greater compared with the
group aged less than 65 years (261 vs 110/100,000
person-years; P < .001). There was no significant
difference in incidence between men and women
aged 65 years and above.
Nerve conduction study data were available for
1,104 patients (88%) in the later half of the studyJ Hand Surg Am. r Vol56period, from 2005 to 2010. Mean age and sex pro-
portions were similar to those of patients over whole
study period. Median time from NCS to surgery was
160 days; 80% of patients had their CTD performed
within 10 months of their NCS.
Mean NCS grade was 4.0 (CI, 3.9e4.0); more than
60% of patients in both sexes had an NCS grade at least
of 4 (marked compression). Mean NCS grades increased
with increasing age. Those aged 80 years and above had
a mean NCS grade of 4.8 or higher. Patients aged 65
years or higher had a significantly higher mean NCS
grade (4.4; CI, 4.3e4.5) than those aged less than 65
years (3.7; CI, 3.6e3.8; P< .001). Males tended to have
more severe neurophysiological changes than did fe-
males at all ages, but this was statistically significant
only for patients over age 65 years (males, 4.7 [CI,
4.5e4.8]; females, 4.2; CI, 4.1e4.4]; P< .001) (Fig. 4).DISCUSSION
Carpal tunnel syndrome is traditionally thought to
affect middle-aged women most commonly.1,4,5,16
The incidence of CTS varies depending on which
diagnostic definition is used as an end point. The
prevalence has been reported to be as high as 5.8% in
women and 0.6% in men.16 A study of over half a
million Korean patients with CTS noted that the
highest incidence was in women aged 50 to 59 years,
with an incidence of 1,811/100,000 person-years.
However, only 115/100,000 person-years underwent. 40, December 2015
FIGURE 2: Age-specific annual average incidences of CTD.
FIGURE 3: Sex- and age-specific annual average incidences of carpal tunnel release.
2430 INCIDENCE OF CARPAL TUNNEL SYNDROMECTD.17 The incidence for clinically and/or NCS-
confirmed CTS ranges from 104 to 496/100,000
person-years.17e24 The incidence is much lower
when CTD is used as the end point: between 29 and
148/100,000 person-years17,19,21,25e30 (Table 2).
In our study, we used CTD as the end point for dis-
ease. During the study period, therewere few limitations
to access to surgery, whether publicly or privately fun-
ded. We thought this improved our accuracy for a trueJ Hand Surg Am. r Vol57diagnosis of CTS because it represented patients with
both clinically andneurophysiologically confirmedCTS
that was sufficiently symptomatic to require CTD.
Our CTD incidence of 137/100,000 person-years
was similar to those of Keller et al26 and Hanrahan
et al,27 144 and 148, respectively, who also reported
surgical rates. In women, our incidence (164/100,000
person-years) was similar to that of Mattioli et al29
(166/100,000 person-years). However, their incidence. 40, December 2015
FIGURE 4: Mean NCS grades by age group.
INCIDENCE OF CARPAL TUNNEL SYNDROME 2431in males was less than half of what was recorded in our
study: 44 compared with 110/100,000 person-years.
A more recent study looking at the incidence
of CTD in an ambulatory care setting in the United
States6 demonstrated a 38% increase in the number
of procedures between 1996 and 2006. The overall
incidence in males was 170/100,000 person-years,
and in females was 360/100,000. The incidence rose
with age in both sexes, with a peak of approximately
500/100,000 person-years in women aged over
50 years and a lower peak of almost 400/100,000
person-years in men aged 60 to 69 years. Although
surgery was used as the end point, no data were pre-
sented on the diagnostic criteria used.6 In contrast,
Gelfman and Amadio31 reported an incidence of 171/
100,000 person-years in females and 96/100,000
person-years in males in their population, which is
similar to our incidence.
In males, we found a general trend for the CTD
incidence to increase until advanced age, with the
highest incidence occurring in males aged 70 to 74
years (317/100,000 person-years). Other authors
showed a similar single peak in the seventh or eighth
decades.17,24,25 However, Mondelli et al20 showed a
bimodal distribution inmales that reached a peak in the
group aged 50 to 59 years and a second higher peak in
the group aged 70 to 79 years.J Hand Surg Am. r Vol58The incidence in females also gradually increased
with age, but with a biphasic peak. The first peak (289/
100,000 person-years) occurred in the group aged 50
to 54 years and a second higher peak occurred in the
group aged 75 to 70 years (330/100,000 person-years).
Gelfman et al24 also had a bimodal distribution in their
CTD incidence for women, with similar incidences in
the groups aged 50 to 59 years and 70 to 79 years of
293 and 281 per 100,000 person-years, respectively.
Liss et al. reported a higher peak in the 50-54 year age
group of 368 and a lower peak at 75-79 year age group
of 281 per 100,000 person-years.25 Mondelli et al20
showed a more classical distribution, with a single
peak incidence in the group aged 50 to 59 years.
It is not clear why the incidence of surgically treated
CTS should increase with age. Hormonal factors such as
menopause, oophorectomy, pregnancy, and hormone
replacement therapy are all associated with an increased
risk of developing CTS in middle-aged women.5,32
Most original descriptions of idiopathic CTS describe
nonspecific tenosynovitis and synovial thickening or
fibrosis leading to an increase in pressure within the
carpal tunnel, which compresses the median nerve,.1,33
Coexistent disease such as diabetes mellitus, inflam-
matory arthritis, obesity, hypertension, hypothyroidism,
gout, vitamin B6 deficiency, uremia, and acromegaly all
have known associations with CTS.32,34 However, a. 40, December 2015
TABLE 2. Comparison of CTS Incidence Reported in the Literature







Latinovic et al 2000 United Kingdom 28,706 Clinical 82 199 136 2.4
Roh et al 2005e2007 Korea 538,711 Clinical 276 712 496 2.6




52 149 105 2.9




258 490 377 1.9
Bongers et al 1987 Netherlands 113 Clinical
& NCS















316 362 339 1.1
Mondelli et al 1991e1998 Sienna 3,142 Clinical
& NCS







60 121 104 2
Bongers et al 2001 Netherlands 672 Clinical
& NCS
90 280 180 3.1
Roh et al 2005e2007 Korea 106,792 Clinical
& NCS
58 138 98 2.4
Gelfman et al 1981e2005 Olmsted County,
United States
2,823 Surgical 79 138 109 1.7
Liss et al 1988 Ontario, Canada 9,757 Surgical 67 138 103 2.1
Hanrahan et al 1990e1993 Wisconsin,
United States
Surgical 148
Keller et al 1993 Maine 1,677 Surgical 144
Ebskov et al 1993e1994 Denmark 6,182 Surgical 61
Rossignol et al 1994e1995 Montreal 238 Surgical 40 120 90 3
Mattioli et al 1997e2002 Tuscany 82,743 Surgical 44 166 106 3.8
Latinovic et al 2000 United Kingdom 889 Surgical 26.7 59.2 2.2
Roh et al 2005e2007 Korea 31,148 Surgical 8 49 29 5.8
English et al 2000e2010 Otago, New Zealand 2,309 Surgical 110 164 137 1.5
2432 INCIDENCE OF CARPAL TUNNEL SYNDROMErecent large-scale study from Taiwan showed a stronger
association with these comorbidities in a younger pop-
ulation.34 We believe that degenerative changes within
the carpus may have a role.
Some authors have found that the incidence of CTS
decreases with advanced age.17,20 We only saw a
decrease in the very elderly patients, over age 80 years.
This late drop-off might be the result of patients either
not presenting or not being diagnosed and referred.
In our region, we have excellent access to neuro-
physiological testing. The grading system we haveJ Hand Surg Am. r Vol59developed has been adjusted for age to account for the
natural slowing of conduction velocity through the
median nerve with increasing age.13,14,35 Our results
showed a trend of increasing severity of the neu-
rophysiological grade with increasing age, despite
adjusting for age. A mean neurophysiological grade of
at least 4 was seen in men aged older than 60 years
and women aged older than 70 years. The most severe
mean neurophysiological grade was seen in the group
aged over 80 years, at 4.8. Bland and Rudolfer21 noted
a similar increase in median nerve severity in elderly. 40, December 2015
INCIDENCE OF CARPAL TUNNEL SYNDROME 2433patients. Delay in diagnosis or referral may contribute
to this. However, there are good outcomes from CTD
in elderly patients in all but the most severe cases.3,36
Therefore if the diagnosis is suspected in an elderly
patient, it should be investigated promptly.
Previous studies have found that females have a
lower mean neurophysiological grade across all age
groups than men, as in this series. Women may
perceive their health differently from men, and when
they have symptoms of CTS, they may seek medical
attention earlier. Men may be more tolerant, reporting
fewer and or milder symptoms for the same neuro-
physiological grade.35,37 Padua et al37 also found that
women usually have greater functional impairment
for the same neurophysiological grade.
There are some limitations to our study. Because it
is a retrospective review, we may have missed some
patients. Not all patients had neurophysiological
testing and we were not able to report outcomes of the
surgery. However, we believe that the large numbers,
consistent surgical indications, and widespread use of
neurophysiological testing by a single neurophysiol-
ogist are strengths. There was no significant barrier to
access neurophysiological testing or surgery during
the study period and the intervention rates did not vary
over time. The median delay from NCS to CTD of
160 days and the severity of NCS grade show that
only refractory cases were treated surgically. This
may explain why the incidences we report were
significantly lower than those reported by the National
Survey of Ambulatory Surgery.6
This study showed that a diagnosis of CTS should
be carefully considered in both older men and women.
Although the greatest numbers of CTD operations are
on women aged 50 to 59 years, the highest incidence
was in patients aged over 70 years. Over age 65 years
there was no difference in incidence between men and
women, and the neurophysiological changes were
more severe. Awareness and appropriate funding de-
cisions may ensure that these patients can benefit from
a straightforward surgical intervention.ACKNOWLEDGMENT
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The Outcome of Carpal Tunnel
Decompression in Elderly Patients
David N. Townshend, MBBS, Peter K. Taylor, PhD,
David P. Gwynne-Jones, BM BCh, Dunedin, New Zealand
Purpose: To determine the outcomes of carpal tunnel decompression in elderly patients and
whether outcomes can be predicted by the severity of presurgical nerve conduction study results.
Methods: We performed a retrospective study of all patients over 70 years of age who had
elective carpal tunnel release at Dunedin Hospital between April 1999 and April 2002 with a
minimum of 1-year follow-up evaluation. A grading system for presurgical nerve conduction
studies was formulated that scored patients from 1 to 6 according to severity. Patients were
evaluated by a mailed questionnaire (Symptom Severity Score) with follow-up telephone calls
to nonresponders.
Results: Eighty-three carpal tunnel release procedures performed in 70 patients were included in
the study. Eighty percent had marked to severe neurophysiologic changes (grades 4–6). The
median postsurgical Symptom Severity Score was 1.3 (inter-quartile range, 1.1–1.7). Patients
expressed satisfaction with the outcome of the surgery in 78 of 83 cases (94%). There was a
significant relationship between presurgical nerve conduction grade and postsurgical Symptom
Severity Score.
Conclusions: This study shows that elderly patients have low postsurgical symptom scores and
express high levels of satisfaction after surgery for carpal tunnel syndrome. There was a
significant relationship between severity of neurophysiologic abnormalities and a higher
Symptom Severity Score after surgery. Severe abnormality, however, should not exclude
elderly patients from surgery. (J Hand Surg 2005;30A:500 –505. Copyright © 2005 by the
American Society for Surgery of the Hand.)














arpal tunnel syndrome (CTS) is a common condi-
ion whose incidence increases with age.1,2 Decom-
ression of the median nerve in CTS is associated
enerally with a good result although the reported
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62atient satisfaction rates vary widely. A number of
actors have been reported to influence the outcome
f surgery including gender, alcohol use, mental
ealth status, attorney involvement, and presence of
bjective neurologic signs.1,3,4 It has been suggested
hat increasing age also may have an independent
dverse effect on outcome.3,5 Tomaino and Weiser,6
owever, reported recently very good subjective re-
ults in a small group of patients over 70 years of age
ith advanced disease.
Presurgical nerve conduction studies (NCSs) are
sed to aid the diagnosis and assessment of median
erve integrity. The predictive value of NCSs, how-
ver, remains controversial.3,7,8
The main aim of this study was to investigate the


































































Townshend, Taylor, and Gwynne-Jones / Carpal Tunnel Decompression in the Elderly 501CTD) in patients over 70 years of age. A secondary
im was to determine whether patients with more
evere presurgical neurophysiologic abnormalities
ad a worse subjective outcome.
aterials and Methods
etween April 1999 and April 2002, 108 elective
TDs in 93 patients over 70 years of age were
erformed in our unit. Inclusion criteria were as
ollows: patient over 70 years of age at time of
urgery, elective surgery (emergency release for
cute CTS was excluded), a minimum of 1 year of
ollow-up evaluation, neurophysiologically proven
edian nerve compression, and patient’s ability to
omplete a standardized questionnaire. Of the 93
atients 8 had died, 5 had dementia and were unable
o fill out the questionnaire, 9 patients had not had
CSs, and 1 patient with motor neurone disease was
xcluded. This gave 83 hands in 70 patients for
eview. There were 13 bilateral procedures (2 simul-
aneous), 24 left hands, and 33 right hands. Mean age
as 78.5 years (range, 70–90 y) and 42 (55%) of the
atients were women (46 hands).
It is the practice of our unit to request NCSs on the
ajority of patients with suspected CTS. All NCSs
ere performed by a single clinical neurophysiolo-
ist (P.K.T.) using standardized techniques.9,10
hese consisted of recording orthodromic median
nd ulnar sensory action potentials from middle and
mall finger stimulation, respectively, with measure-
ents of peak-to-peak amplitude and conduction ve-
ocities calculated from both take-off and peak. If the
edian sensory conduction velocity and amplitude
ere normal or equivocal palmar studies were per-
ormed by stimulating the median nerve in the sec-






6 (Severe) — —
5 (Very marked) — —
4 (Marked) — 5.0 SD
3 (Moderate) — 4.0 to 5.0 SD
2 (Mild) 3.5 SD or 3.0 to 4.0 SD
1 (Borderline) 2.5–3.5 SD and 3.0 SD
0 (Normal) All 2.5 SD and 2.5SD
NOTE: For conduction velocity and amplitudes SD refers to SDs les
to SDs greater than the mean.nd and third interspaces and the ulnar nerve in the n
63ourth interspace, 8 cm from the recording electrodes
t the wrist. Median and ulnar motor conduction
tudies also were performed with stimulation at the
rist and elbow (median) or wrist only (ulnar) and
ecording from the lateral thenar eminence (median)
nd hypothenar eminence (ulnar). Measurements of
istal motor latency and amplitude were made for
oth nerves and additionally forearm conduction ve-
ocity, dispersion, and amplitude change from elbow
timulation were calculated for the median nerve. All
tudies were performed with skin temperature at or
bove 33°C. Individual measurements were ex-
ressed as the number of SDs from the mean using
ge and body size variables calculated from a normal
opulation.9,10 In our unit needle electromyography
s not performed routinely on patients with suspected
TS because this does not increase the diagnostic
ensitivity of the neurophysiologic investigation.11
NCS results were graded as shown in Table 1. This
s an amplitude-weighted grading system that we
elieve matches median nerve pathophysiology most
ccurately to patient symptoms.
Carpal tunnel decompressions were performed as
ay cases under local anesthesia by either a registrar or
onsultant. The transverse carpal ligament was divided
nder direct vision. No surgeon in this unit currently
erforms endoscopic release. The mean time from
CSs to surgery was 6.3 months (range, 0–74 mo) and
he mean time from surgery to follow-up evaluation
as 29.2 months (range, 12–49 mo).
The Symptom Severity Questionnaire of Levine et
l12 was mailed to all patients. This validated, con-
ition-specific questionnaire has 11 questions based









— 7.0 SD or
absent
and 4.0 SD




or 4.0 to 5.0 SD and 4.5 SD or 4.0 SD
or 3.0 to 4.0 SD and 3.0 SD and 3.0 SD
and 3.0 SD and 3.0 SD and 3.0 SD
and 2.5 SD and 2.5 SD and 2.5 SD
he mean. For distal motor latencies and palmar latencies, SD refersg Neu
n





















































502 The Journal of Hand Surgery / Vol. 30A No. 3 May 2005ucible, sensitive to clinical change, and internally
onsistent. Each question is scored from 1 to 5,
here 1 is normal or no symptoms and 5 is the worst
core. A mean score then is calculated for each
atient. The patients also were asked if they were
atisfied with the result of surgery and would have
he surgery again. Nonresponders and incomplete or
ncorrectly answered questionnaires were fol-
owed-up by telephone by an independent reviewer.
Statistical analysis was performed using statistical
oftware (Stata 8.1 package; Stata Corp LP, College
tation, TX). Relationships were calculated by using
inear regression analysis clustered to patient to allow
or lack of independence arising from patients who
ad bilateral surgery.
esults
he distribution of presurgical NCS grades is shown
n Figure 1. Eighty percent had marked to severe
europhysiologic changes (grades 4–6).
igure 1. Distribution of presurgical neurophysiologic grades.
igure 2. Distribution of postsurgical Symptom Severity Scor
worst symptoms).
64The median postsurgical Symptom Severity Score
or all 83 hands was 1.3 (interquartile range, 1.1–1.7)
nd the mean was 1.57 (SD, 0.48) The score is
alculated as an average of the responses for the 11
uestions. A score of 1 indicates no symptoms and a
core of 5 indicates severe symptoms. The Symptom
everity Score was less than 2.0 (none to mild symp-
oms) in 68 hands (82%), between 2.0 and 2.7 (mild
o moderate symptoms) in 9 hands (11%), and be-
ween 3.0 and 4.2 (moderate to severe symptoms) in
hands (7%) (Fig. 2). All 6 hands with a postsurgical
ymptom Severity Score greater than 3 had a pre-
urgical NCS result of grade 4 or greater. Patients
enerally expressed satisfaction with the result of the
urgery and indicated they would have the surgery
gain in 78 of 83 cases (94%). Only 2 of the 6
atients with Symptom Severity Scores greater than
.0 were dissatisfied. The other 3 dissatisfied patients
ad scores of 1.8 to 1.9.
We divided the Symptom Severity Score questions
nto 3 groups: 5 questions (1–5) were concerned with
ain, 4 questions (6, 8–10) with numbness and tin-
ling, and 2 questions (7, 11) with function and
trength. This showed little difference in outcomes
ith regard to pain or sensory symptoms and a
lightly worse outcome for function (Table 2).
The second aim of this study was to determine
hether there were poorer outcomes in patients with
ore severe presurgical neurophysiologic grade. A
inear regression analysis with robust standard errors
lustered to patient was performed because it is not
ossible to adjust with a correlation for the lack of
ndependence arising from patients having bilateral
urgery. There was a significant relationship between








































































Townshend, Taylor, and Gwynne-Jones / Carpal Tunnel Decompression in the Elderly 503erve conduction grade and Symptom Severity Score
p  .0391) (Fig. 3) and scores from the questions
elating to function (p  .006) and sensory symp-
oms (p  .037) but none with the questions con-
erning pain (p  .271) (Table 2). Despite this rela-
ionship a full range of scores from 1.1 to 3.8 were
een in the most severe grades and 34 of the 37
atients with the most severe changes (grades 5, 6)
ere satisfied with the outcome of their surgery.
There was no relationship between postsurgical
ymptom Severity Score and time from NCS to
urgery or duration of follow-up evaluation.
iscussion
pen CTD in appropriately selected patients is usu-
lly an effective procedure with both objective and
ubjective improvements in symptoms and NCS re-
ults. Many studies show complete relief or marked
mprovement in symptoms in 80% to 100% of pa-
ients.7,8,13,14 Bland3 commented that more widely
ased studies had lower satisfaction rates (70% to
0%). His large study showed success in 74% but
1.4% were worse after surgery. These figures are
imilar to those of Porter et al5 who had 77% satisfied
nd 11.5% dissatisfied after surgery. Katz et al4 re-
orted 66% of patients completely satisfied after
urgery.
In most centers neurophysiologic studies play an
mportant role in the diagnosis and management of
TS.15 Part of this role is to provide information
bout the degree of pathologic change in the median
erve at the wrist. Various grading scales have been
roposed that are based largely on conduction veloc-
ty criteria plus a presence/absence criterion for mo-
or and sensory action potentials.3,7,16 We believe,
owever, that changes to motor and sensory ampli-
udes are more likely to reflect the degree of clini-
Table 2. Postsurgical Symptom Severity Scores by Q
Grade
Pain Questions Sen
Median score 1.2 1
Interquartile range 1.2–1.8 1
Mean score 1.58 1
Regression coefficient with
NCS grade (SE) 0.393 (0.354) 0
p value .271
SE, standard error.
*p value significant.ally relevant pathology (axonal loss and conduction t
65lock) in the median nerve and have developed a
rading scale that incorporates amplitude criteria.
he more severe grades in all grading systems fea-
ure neurophysiologic changes that mainly reflect
xonal loss. Patients occupying these grades, there-
ore, may be expected to require longer recovery
eriods or may have incomplete recovery. Although
he retrospective nature of our study did not allow us
o determine time to recovery accurately our results
id show that the more severe grades were associated
ith less complete recovery and persistence of symp-
oms. This is consistent with the findings of Bland3
ho reported less successful outcome from surgery
or more severe grades in a non–age-selected popu-
ation of CTS patients. Despite these less successful
utcomes the majority of our patients reported satis-
action from surgery even when their nerves had
hown marked presurgical pathology. The short re-
rowth distances for axonal regeneration from the
arpal tunnel to the skin and muscles of the hand are
ikely to be an important factor in facilitating this
ecovery. Another important factor, however, may be
he expectation regarding surgical outcome that pa-
ients with more severe neurophysiologic changes
ave been given before surgery.
Increasing age has been reported to lead to poorer
esults in some series3,5 but not others.4,14 Porter5
howed that patients over 60 years of age had sig-
ificantly less improvement in symptom severity and
unctional status and only 66% were satisfied after
urgery compared with 87% satisfaction in patients
nder 60 years of age. Bland3 found that older pa-
ients had a poorer prognosis independent of other
actors but the effect was weak and did not preclude
ood outcomes. We found the satisfaction rate after
urgery to be very high (94%). The median Symptom
everity Score of 1.3 and mean of 1.58 in our pa-
















































































504 The Journal of Hand Surgery / Vol. 30A No. 3 May 2005cores of 1.3 to 1.9 from other studies using this
nstrument.5,12,14,17 Only 6 patients in our study had
cores of 3.0 or higher, indicating moderate to severe
esidual symptoms. Four of these patients expressed
atisfaction with surgery; therefore they may have
ad an improvement from their presurgical status
espite residual symptoms. Our results confirm those
f Tomaino and Weiser6 who showed a high rate of
atisfaction in a group of 13 patients over 70 years of
ge who were shown to have severe presurgical
europhysiologic abnormalities. If a patient with
europhysiologically confirmed median nerve com-
ression has no improvement at all after surgery it
ay be caused by an inadequate decompression
ather than irreversible nerve damage.
A problem in comparing the results of surgery is
he number of different outcome measures used to
eport results.18 Both Amadio et al19 and Katz et al4
ave found that subjective outcome scores were more
ensitive to change than traditional physical mea-
ures and that physical examination had little useful-
ess for predicting postsurgical functional limita-
ions, symptoms, or satisfaction. Improvements have
een reported in general outcomes scores such as the
rthritis Impact Measurement Scale and the Short-
orm 36; however, these changes were not as great as
hose seen with the condition-specific Symptom Se-
erity Score.19 This instrument also has been the
ost widely reported and therefore the one we chose.
ecause of the retrospective nature of our study a
ostsurgical general outcome score would have had
ittle relevance and therefore was not included. A
igure 3. Scatter plot showing relationship between Sympt
oefficient, 0.143; p  .039).eakness in this retrospective study is the lack of c
66resurgical Symptom Severity Scores, which pre-
ludes an accurate assessment of the surgical benefit.
he postsurgical score, however, does allow compar-
son with the results from other series. The low
cores found translate directly into absent or mild
ymptoms in 82% of patients. We were concerned
hat the relative weighting of pain symptoms (5 ques-
ions) over neurologic symptoms may generate error
n an elderly population that is more likely to be
ffected by comorbidities such as osteoarthritis. This
ay explain why preoperative Symptom Severity
cores have not been shown previously to correlate
ith outcome.8 Postsurgical Symptom Severity
cores, however, should pick up poor results caused
y complications of surgery such as neuropathic
ain, scar tenderness, and pillar pain. One of our
atients who expressed satisfaction with surgery but
ad a high Symptom Severity Score indicated that
he thought her rheumatoid arthritis may have caused
er pain and functional deficit rather than CTS. Al-
hough we saw a significant relationship between the
resurgical NCS grade and postsurgical total Symp-
om Severity Score and the sensory and functional
omponents there was no relationship with pain
cores.
We have shown that high satisfaction rates and
ood outcomes can be expected in CTS surgery in
he elderly even when neurophysiologic tests show
arked abnormalities. The postsurgical Symptom
everity Scores in our group compare favorably with
ublished scores in younger patients. Severe presur-
ical neurophysiologic abnormalities should not pre-

















Townshend, Taylor, and Gwynne-Jones / Carpal Tunnel Decompression in the Elderly 505hey tend to have higher Symptom Severity Scores
efore surgery than the milder grades they still are
ikely to be satisfied with surgery, particularly if
ealistic expectations about surgical outcome are es-
ablished at the outset.
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Chapter 3 
Prevention: Neonatal Hip screening.
Any reduction in patients requiring acute orthopaedic surgery will have an effect on our 
ability to maintain elective volumes. The use of bisphosphonates is recommended for the 
treatment of osteoporosis and has been associated with a reduction in fragility fractures 
including hip fractures. Safety programmes to reduce road trauma and neuromuscular 
training to reduce sports injuries all have a role to play in prevention of musculoskeletal 
injury. In contrast, there is little that can be done to prevent many conditions that may 
require elective orthopaedic surgery. Advances in the medical management of rheumatoid 
arthritis have reduced the surgical burden significantly. However, the high volume/ high cost 
procedures such as total hip and knee replacement and spinal surgery are typically caused 
by degenerative osteoarthritis for which there is little effective medical treatment. 
Osteoarthritis is the primary diagnosis in 87% of hip replacements and 95% of knee 
replacements.[1] Lifestyle changes such as weight loss may have an effect if implemented 
early enough but we are likely to see a large increase in demand due to the current obesity 
epidemic.  
One area, which has made a small impact, is neonatal screening for congenital dislocation of 
the hip (CDH), now better known as developmental dysplasia of the hip (DDH). DDH is given 
as the principal diagnosis in 2.2% of THRs in the New Zealand Joint Registry. However, it is 
likely that acetabular dysplasia of lesser degree is the underlying cause of many patients 
with secondary osteoarthritis. [2,3] The clinical tests of Barlow and Ortolani have been 
effective in detecting hip instability at birth. It is now very uncommon to see patients with 
high riding dislocated hips in adulthood. We have provided a clinical screening service by 
orthopaedic surgeons for many years. We have also used ultrasound scans for both 
screening and management of neonatal hip instability. 
The first paper in this chapter ‘The diagnosis and management of neonatal hip instability: 
Results of a clinical and targeted ultrasound screening program’ reviews the results of our 
clinical screening and targeted ultrasound program that has been in place since 1989. The 
second paper ‘Ultrasound measurements in the management of unstable hips treated with 
the Pavlik harness: reliability and correlation with outcome’ investigates various ultrasound 
measurements and their role in the management of unstable hips during treatment in a 
Pavlik harness. The third paper ‘Late presenting dislocation of sonographically stable 
hips’reports on a series of babies with hips that were stable on ultrasound screening that 
subsequently dislocated. Although some of the hips were unstable at birth, all had stabilised 
by the time of their ultrasound at 2-6 weeks. This helps confirm that hip dysplasia forms a 
spectrum of disease and is important from a medico-legal perspective. 
1. New Zealand Joint Registry. www.cdhb.govt.nz/njr/  accessed 1/9/2019
2. Murphy NJ, Eyles JP, Hunter DJ. Hip Osteoarthritis: Etiopathogenesis and Implications for
Management. Adv Ther. 2016;33(11):1921–1946. doi:10.1007/s12325-016-0409-3
3. Boyle M.  Adult Developmental Hip Dysplasia and periacetabular osteotomy. NZOA ASM Rotorua 2018.
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ORIGINAL ARTICLE
The Diagnosis and Management of Neonatal
Hip Instability
Results of a Clinical and Targeted Ultrasound Screening Program
Andrew G. S. Vane, MBBS, David P. Gwynne Jones, FRACS (Orth), John D. Dunbar, FRACS (Orth),
and Jean-Claude Theis, FRACS (Orth)
Abstract: This article reports the results of a neonatal hip screening
program comprising clinical screening and targeted ultrasound
performed by orthopaedic surgeons. Over 7 years, from 1995 to
2001, there were 15,397 live births in the authors’ region. Seven
hundred thirty-three babies (4.8% of births) were referred for hip
ultrasound: 80% for risk factors and 20% for instability. Eighty-three
babies (5.4/1,000) were splinted in a Pavlik harness. Three of these
subsequently required surgery (1.9/1,000). Ten patients (0.65/1000)
presented with hip dislocation after 12 weeks of age, nine of whom
required open or closed reduction (0.56/1,000). From 1978 to 1985,
when neonatal pediatricians clinically screened all babies, 18 babies
presented late from 13,707 births (1.3/1000). Since the introduction
of orthopaedic screening and targeted ultrasound, there has been
a significant reduction in late diagnosis in the authors’ institution.
Key Words: hip dislocation, congenital, ultrasonography, screening
(J Pediatr Orthop 2005;25:292–295)
I t is generally accepted that newborn babies should bescreened for hip instability by clinical examination using the
Barlow and Ortolani tests. In the best reported series, the
incidence of established dislocation of the hips was reduced to
0.1 per 1,0001 from a rate prior to screening programs of 1.55
per 1,000.2 Although not all programs have been able to
achieve these results, the ideal practice remains clinical
examination on at least two or three occasions in the first 6
weeks of life.3 Ultrasound of pediatric hips was introduced
approximately 20 years ago to help in the diagnosis of neonatal
hip instability. While routine ultrasound of all newborns has
been advocated, it has not been shown to be practical or cost-
effective and is not recommended by the American Academy
of Pediatrics.4 Targeted programs with screening of high-risk
infants have not been shown to reduce the late presentation
of developmental dysplasia of the hip (DDH) below that of
the best clinical series.5–8 This may be because up to 69% of
babies with late-diagnosed DDH have no risk factors.9 We
have used clinical and targeted ultrasound screening by an
orthopaedic surgeon since 1989 and report our experience
since 1995.
PATIENTS AND METHODS
Since 1989 our screening program has consisted of in-
hospital examination of newborn babies by a pediatrician and
one of three consultant orthopaedic surgeons. Babies dis-
charged early are seen back either on the ward or at an ortho-
paedic clinic. Babies born in peripheral centers are seen by
visiting orthopaedic surgeons. Indications for ultrasound are
clinical instability, major risk factors (breech, family history,
foot deformity, torticollis) or an equivocal clinical examina-
tion. The scan is performed at 2 to 4 weeks of age, at a
dedicated clinic, by an orthopaedic surgeon and an experi-
enced sonographer. Coronal and transverse scans and stress
views are performed as described by Graf,10 Morin et al,11 and
Clarke et al.12 Treatment with a Pavlik harness is instigated at
birth if the hip is dislocated or grossly unstable or at the time of
the ultrasound if there is persisting instability or acetabular
dysplasia. Any treated babies are followed by ultrasound and
the harness is removed when the hip is stable clinically and
sonographically and the head coverage is at least 40%. If the
hips fail to stabilize or develop normally, then further treat-
ment (abduction bracing, closed reduction, or open reduction)
is performed as required. Radiographs are performed in
preference to ultrasound after the age of 4 months.
Records of all births at our institution from January 1995
to December 2001 were obtained and checked with official
birth statistics. All babies subsequently seen in the ultrasound
clinic were identified from radiology department records and
hospital notes. We defined late-presenting DDH as greater than
12 weeks of age at diagnosis.5,13 Late-presenting cases were
identified from our surgical audit for the period from 1989.
Orthopaedic surgeons throughout New Zealand with an
interest in pediatrics were surveyed to see whether any babies
born in our region had subsequently presented elsewhere with
a late dislocation.
An historical comparison was made with the period
1978 to 1985. Details of all cases of late-treated and severe
DDH had been identified from a previous study and compared
with birth rates (Dickson N, personal communication). Statis-
tical comparison was performed using chi-square analysis with
Yates correction.
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RESULTS
Over the period 1995 to 2001 there were 15,397 live
births in Otago. An audit of the clinical screening diaries
revealed that an average of 81% of babies born at our insti-
tution were clinically screened by the orthopaedic service. This
is a minimum figure, as babies attending pediatric orthopaedic
clinics and peripheral clinics come on an informal basis.
Seven hundred thirty-three babies were referred for
ultrasound scan (4.8% of all babies). Of these, 593 (80%) were
referred for risk factors and had a normal clinical examination
and normal ultrasound scan and were discharged. One hundred
forty babies (9/1,000 live births) were referred for varying
degrees of instability. Fifty-seven with minor clinical in-
stability or equivocal findings were followed without treatment
until a normal examination and a normal ultrasound were
obtained. Eighty-three babies with unstable hips were treated
in a Pavlik harness: 77 after the initial clinical examination
(mean 1.8 days old), 5 after the first ultrasound scan (mean
10.6 days), and one after a second scan at 59 days. This gave
a splintage rate of 5.4 per 1,000. Eight of 83 splinted babies
failed to stabilize after 6 weeks of splintage. Five responded to
extended harness treatment or abduction bracing, but three
(babies 1–3, Table 1) required early closed reduction and hip
spica application after a period out of the harness. One of these
(baby 2) subsequently required open reduction and bilateral
femoral osteotomies.
Ten cases (seven girls, three boys) presented after 12
weeks of age, giving a late presentation rate of 0.65 per 1,000.
The average age was 12 months (range 12 weeks to 26 months)
at diagnosis. Nine had been born at our institution and one at
another hospital. There were three cases of bilateral dislo-
cation, two right and four left dislocations, and one dysplastic
acetabulum. Six had been examined by an orthopaedic
surgeon at birth with no instability detected; one of these
(patient 8) also had two ultrasound scans with no instability
seen. Three babies had missed orthopaedic screening: all were
premature births. One baby (patient 4) had been diagnosed
with instability at birth at another center and treated with
a Pavlik harness. An ultrasound and clinical examination at
37 days showed no persisting instability, and treatment was
discontinued. A pelvic radiograph at 6 months showed
bilateral dislocations. Eight babies underwent closed reduc-
tion, one had bilateral open reductions and subsequent femoral
osteotomies, and one baby stabilized after treatment with an
abduction brace for 8 weeks. Two children treated with closed
reduction have subsequently required late Salter osteotomies
for persisting acetabular dysplasia. This gives a surgical rate of
0.58 per 1,000 for late presentation and 0.19 per 1,000 for
failure of Pavlik harness treatment, and a total surgical rate of
0.77 per 1,000 over the 7-year period.
Historical Comparison
From 1978 to 1985, experienced neonatal pediatricians
examined the hips of all babies born at our institution in
addition to the routine neonatal examination. An audit of hip
diaries in 1983–84 revealed that 42 babies out of 2,479
TABLE 1. Details of Patients Treated Surgically
Pt.











1 F None Yes
Unstable
Yes Day 1 R Yes Closed No No
2 F First born Yes
Unstable
Yes Day 1 L Yes Closed (failed)
then open
Yes No
3 F First born C section Yes
Unstable
Yes Day 1 Bilat Yes Closed Yes No




6/12 Bilat dislocations Yes Closed Yes No
5 F Breech, premature,
30 wks
No No 7 months R acetabular
dysplasia
No Abduction brace No No
6 F Premature 35 wks No No 26/12 Bilat No Open but failed Yes Femoral
shortening
30 months
7 M Renal anomalies Yes
Stable
No 19/12 R No Closed Yes Salter 4 yrs





23/12 R No Closed Yes Salter 5 yrs
9 M No Yes
Stable
No 11/12 L No Closed Yes No
10 F No Yes
Stable
No 11/12 L No Closed Yes No
11 F Postural talipes Yes
Stable
No 5/12 L No Closed No No
12 F Family history Yes
Stable
No 9/12 L No Closed No No
13 M Premature, renal
anomalies
No No 3/12 Bilat No Closed No No
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examined were referred to an orthopaedic surgeon for clinical
instability (17/1,000). During the 8-year period, out of 13,707
births, there were 18 dislocations that presented after 18
weeks, giving a late presentation rate of 1.3 per 1,000.
Orthopaedic surgeons assumed responsibility for screening
and introduced ultrasound in 1989. In the period 1989 to 2001
there were 14 late-presenting cases (after 12 weeks) out of
30,089 live births (0.47/1,000). This reduction is significant
(P = 0.0038).
DISCUSSION
A consultant orthopaedic surgeon examines at least
81% of all babies born at our institution, representing 66% of
total births in our region. We believe that this can be improved
by implementing a formal recall system and endeavoring to
include the neonatal intensive care unit (NICU) on rounds.
Some babies are discharged from NICU directly home, and
three babies who presented late, having missed orthopaedic
screening, were premature.
In populations with clinical screening programs, the
detection rate of hip instability ranges from 5 to 34 per 1,000.14
Our rate of 9 per 1,000 compares with the American Academy
of Pediatrics baseline estimate of DDH of 11.5 per 1,000.4
Hadlow diagnosed instability in 32 per 1,000, half of which
stabilized without treatment.1 Historically, in our institution, the
neonatal pediatricians diagnosed instability in 17 per 1,000.
Bjerkreim et al found that 77% of 799 babies with late
DDH had had a documented normal clinical hip examination at
birth.15 In our series 7 of 10 babies presenting late with DDH had
been examined at birth or shortly after by an orthopaedic surgeon.
In two cases ultrasound examination had also shown stable hips.
This supports the concept of developmental dysplasia.
It was hoped that the use of ultrasound would sig-
nificantly increase the sensitivity of neonatal hip screening.
General routine ultrasound screening of all babies has been
advocated but is impracticable and still may not reduce the
incidence of late presentation.4,16 It detects minor degrees of
abnormality, which may lead to treatment rates as high as
34 per 1,000.7 Marks et al showed that 90% of these ultrasound
abnormalities resolve by 9 weeks but found five babies
(0.57/1,000) with persisting ultrasound abnormalities who had
no risk factors or instability and who would not have otherwise
been identified by clinical examination or targeted ultrasound
screening.17 Other targeted ultrasound programs have scan
rates ranging from 1.4% to 7% of live births.5,6,9,18 Our average
scan rate, currently 4.8% of all babies, is decreasing, as we are
scanning fewer babies with minor risk factors alone. In this
study, no baby scanned for risk factors was subsequently
treated. This is probably because clinical instability was
detected by an orthopaedic surgeon in those babies with risk
factors who required treatment. However, three of the babies
who presented late had risk factors but were not referred for
scan. One was not screened, but the other two should have been
scanned as per protocol. We therefore still recommend targeted
ultrasound for patients with any suggestion of instability or an
equivocal examination, a positive family history, breech
position, foot deformity, torticollis, oligohydramnios, or
combinations of these, including female sex and birth rank.
We treat at birth if the hip is dislocated or Barlow or
Ortolani positive. By delaying splintage in cases of minor
instability until a scan and re-examination at 2 to 4 weeks, our
treatment rate is 5.4 per 1,000. This is similar to the rates of 3.1
to 6 per 1,000 in other series where ultrasound is used,5,6,13,19,20
while Hadlow treated 16 per 1,000 in his study using clinical
screening alone.1 Ultrasound influenced us to commence
treatment in six babies (0.39/1,000)—in five cases after the
first scan showed acetabular dysplasia and dynamic instability
and in one after the second scan at 6 weeks showed persisting
instability. In retrospect, two other patients had persisting
borderline ultrasound abnormalities at 5 to 6 weeks, although
the hips were stable clinically and ultrasonographically. Boeree
and Clarke found that ultrasound influenced them to treat in
0.63 per 1,000.5
The babies we treated in a Pavlik harness remained in
harness for an average of 41 days until they were stable
clinically and on ultrasound had at least 40% head coverage. A
similar length of treatment time (6.3 weeks) was reported
by Sochart and Paton,13 who also use ultrasound to aid in
diagnosis and to monitor treatment. Hangen et al21 found
a significantly shorter treatment time in babies with DDH who
were followed by serial ultrasound than those that did not have
ultrasound. Reducing the time splinted may also reduce the
risk of avascular necrosis.13 We believe that monitoring the
treatment of DDH with ultrasound is valuable as it allows us to
tailor the treatment time both by decreasing the duration of
splintage in hips that have stabilized and have normal anatomy
and by identifying treatment failure early.
It has been shown that careful examination of neonatal
hips by experienced personnel can significantly decrease the
rate of late-presenting hip dislocation.1,22 Barlow suggested
the true rate of neonatal hip dislocation in unscreened popu-
lations to be 1.55 per 1,000 births.2 Our rate of late-presenting
hip dislocation of 0.65 per 1,000 for this 7-year study period,
and 0.47 per 1,000 since 1989, lies within the range of 0 to 0.9
per 1,000 reported by centers with established neonatal hip
screening programs.1,5,6,9,13,19 It is now over 2 years since the
last babies were born, and therefore it is unlikely that further
late cases will present.
Before screening programs were implemented, the rate
of surgery approximately equaled the rate of dislocation at
1.63 per 1,000 live births.5 Others have reported surgical rates
of 2.1 per 1,000.23 Our combined surgical rate of 0.77 per
1,000 includes all closed reductions, with or without adductor
tenotomy, as well as open reduction and femoral or pelvic
osteotomy to avoid surgeon preference bias when comparing
figures. Boeree and Clarke5 reported a surgical rate including
adductor tenotomies of 0.4 per 1,000, while Paton et al6
reported a rate of 0.87 per 1,000 for open reduction and/or
pelvic or femoral osteotomy.
We have seen a significant reduction in late presentation
rates of DDH at our institution since orthopaedic surgeons
have assumed responsibility for the screening program. It is
possible that the reduction may be due to improved accuracy of
the clinical screening when performed by an orthopaedic
surgeon compared with an experienced pediatrician. However,
we find ultrasound to be an essential part of the screening
program. Boeree and Clarke also noted a significant reduction
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in surgical treatment of DDH after the introduction of their
program, which included targeted ultrasound.5 Targeted
ultrasound screening may not have reduced the late pre-
sentation rate below that of the best clinical series, but it is still
better than many clinical series.23
We recommend the use of ultrasound as an adjunct to
clinical screening when performed with an orthopaedic
surgeon in attendance. We also find it is useful in monitoring
the treatment of DDH, preventing overtreatment, and detecting
failure of treatment early.
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Ultrasound Measurements in the Management
of Unstable Hips Treated With the Pavlik Harness
Reliability and Correlation With Outcome
David P. Gwynne Jones, MA, FRACS (Orth),*Þ Andrew G.S. Vane, MBBS,* Gareth Coulter, MBBS,*
Peter Herbison, PhD,Þ and John D. Dunbar, FRACS (Orth)*
Abstract: The purposes of this study were to determine the
interobserver and intraobserver reliability of ultrasound measurements
in unstable neonatal hips treated with the Pavlik harness and to
determine whether ultrasound measurements correlate with radiological
outcome at 6 months. Sixty-four babies treated from birth with
the Pavlik harness for neonatal hip instability were scanned at 2
and 6 weeks. The > and A angles of Graf, the combined (H) angle
of Hosny, and the femoral head coverage (FHC) were measured
by 3 observers and remeasured by each observer on a minimum
of 50 scans. From 248 scans, 792 sets of measurements were made.
Hips were categorized as normal, abnormal, or borderline for each
parameter; and interobserver and intraobserver repeatability coeffi-
cients and Kappa values were calculated. The > angle had the smallest
interobserver range (17 degrees), the H angle range was 21 degrees,
and the A angle 28 degrees. Kappa values were best for the FHC
and A angle (0.66Y0.8). The mean acetabular index (AI) of all
hips at 6 months was 26 degrees (SD, 4.9). The AI was 30
degrees or greater in 24 hips (18 babies) despite prolonged
splintage in 9 hips (6 babies). A stepwise linear regression analysis
showed that the FHC at 6 weeks was predictive of AI at 6 months
(regression coefficient j0.27; 95% confidence interval j0.42 to
j0.12; P G 0.001). We recommend the FHC as being reproducible,
useful, and predictive of outcome in neonatal hips treated for instability.
Key Words: developmental dysplasia of hip, ultrasound
(J Pediatr Orthop 2006;26:818Y822)
U ltrasound has been widely used to aid in the diagnosisand the management of neonatal hip instability. It is
helpful in determining whether a hip is dislocated or unstable
and whether it is reduced in a Pavlik harness.1Y4 It is
important that quantitative measures of the neonatal hip
should be reliable and reproducible to aid in management
decisions. Ideally, ultrasound measurements should also be
predictive of the subsequent outcome. Static measurements of
the neonatal hip include the > and A angles of Graf,5 and the
femoral head coverage (FHC) as determined by the d/D ratio
of Morin et al.6 The > angle and FHC have generally been
found the most reliable.7Y10 However, they have limited value
in predicting the subsequent outcome of a hip, with persisting
instability being the most useful indicator.11 Many of these
studies have been using ultrasound as a screening tool and
have also included a high proportion of normal hips.
Recently, Hosny et al12 introduced a new combined angle
that correlated with the > angle; and they found it to be the
most reproducible.
The purpose of this study was to compare the inter-
observer and intraobserver reliability of Graf’s angular mea-
surements (> and A angles), the combined angle of Hosny (H
angle), and the FHC in a group of babies treated with a Pavlik
harness from birth for clinical instability. Secondly, we inves-
tigated whether any of the ultrasound measurements at 2 and
6 weeks were predictive of radiographic outcome at 6 months.
METHODS
We have previously described our screening and
management of neonates with developmental dysplasia of
the hip (DDH).13 Since 1989, our screening program has
consisted of in-hospital examination of all newborn babies by
1 of 3 consultant orthopaedic surgeons. We treat most babies
with definite clinical instability (Barlow or Ortolani positive
hips) from birth with a Pavlik harness for 6 weeks. Babies
with clinical instability, an equivocal examination, or major
risk factors (breech presentation, family history, foot defor-
mity, torticollis, etc) are referred for ultrasound scan. Our
treatment rate is approximately 5.4/1000.13 Ultrasounds are
performed by an experienced sonographer with 1 of 2
pediatric orthopaedic surgeons in attendance at 2 and 6 weeks
of age if the hip is unstable. Coronal and transverse scans and
stress views are performed as described by Graf,5 Morin
et al,6 and Clarke et al.1 Treatment decisions are based on
clinical and sonographic stability, FHC, and acetabular mor-
phology. We have not formally measured angles or the FHC.
Hips that have not stabilized by 6 weeks or have persisting
dysplasia remain in a Pavlik harness or an abduction brace.
Splintage is discontinued when the hip is stable and the
acetabulum appears to be developing normally.
Three observers (1 orthopaedic surgeon and 2 ortho-
paedic residents) blinded to the outcome reviewed the
sonograms performed at 2 and 6 weeks and the 6-month
radiographs of a consecutive series of 64 babies treated from
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birth for clinical hip instability. There were 55 girls and 9
boys. Nine babies (all girls) required prolonged splintage with
an abduction brace. Four of these babies (6 hips) subsequently
required closed reduction. There were no significant compli-
cations from the Pavlik harness treatment.
The >, A, and H angles of both hips were measured
using a standard goniometer. A wax pencil was used so that
marks were completely removed from the sonogram before
second measurements were made. The FHC was calculated
by measuring the d/D ratio as described by Morin et al6 and
multiplying by 100 to give a percentage figure. The acetabu-
lar index (AI) of Sharp14 was measured from the 6-month
radiograph. An AI greater than 30 degrees was defined as
definite dysplasia, as this equates to approximately greater than
2 standard deviations above normal at this age, and mild dys-
plasia if greater than 25 degrees.15
Each observer then repeated the measurements on a
minimum of 50 scans on a separate occasion.
Statistical Analysis
Interobserver and intraobserver repeatability coeffi-
cients were calculated using 95% confidence interval (CI) of
the differences between repeated measurements.16 Each
angular measurement and FHC was also assigned a category
of normal, borderline, or abnormal according to the modified
values used by Nimityongskul et al17 and Hosny et al12 (Table 1).
Kappa values for interobserver reliability were then calculated
for each category.
An average value was calculated for each measurement
on each sonogram. By taking the mean of 3 to 5 values, the
accuracy of this figure is approximately double to that of a
single measurement. A stepwise linear regression analysis was
then performed on these mean values to assess any relationship
between ultrasound measurements at 2 or 6 weeks and outcome
as determined by AI at 6 months. After the regression was
performed, a further regression analysis of the significant in-
dependent variables and the requirement for prolonged treat-
ment was performed.
RESULTS
There were 64 babies (128 hips) with 2 scans performed
at 2 and 6 weeks of age (248 sonograms). Two babies were
missing a 2-week scan and 2 babies a 6-week scan. Each scan
was measured by at least 2 examiners, and each examiner
remeasured a minimum of 50 scans so that a total of 792
scans were measured and analyzed. Repeatability coeffi-
cients are given in Table 2. The value shown is a range
within which there is a 95% CI that a second measure will
fall from the first. Of the ultrasound angular measurements,
the > angle had the smallest range (17 degrees) for
interobserver and intraobserver repeatability and the A angle
had the worst. The combined angle was intermediate. The FHC
had a range of approximately 30%.
Each measurement was categorized as normal, abnormal,
or borderline. Kappa values were calculated for intraobserver
and interobserver agreement (Table 3). There was good to
excellent intraobserver agreement for >, A, and FHC for all
categories; and there was good interobserver agreement for
hips categorized as normal. The FHC had the best interob-
server agreement for hips in the borderline range, and the
FHC and A angle had the best interobserver agreement for
abnormal hips and overall. The combined angle had the least
interobserver and intraobserver agreement for classifying
hips in any of the 3 categories.
Details of the mean values and the proportion of hips in
each category are given in Table 4. Using the narrower range
of 40% to 55% for the borderline zone of FHC as suggested
by Nimityongskul et al,17 we found 68 hips (55%) at 2 weeks
and 64 hips (52%) in this category. There were 38 abnormal
scans (30%) at 2 weeks, falling to 24 (19%) at 6 weeks. The >,
A, and H angles were in the abnormal range in only 4% to 6%
of hips at 6 weeks.
TABLE 1. Normal Values Used for >, A, H Angles and d/D Ratio
Normal Borderline Abnormal
> angle (degrees) 955 45Y55 G45
A angle (degrees) G55 55Y75 975
H angle (degrees) G75 75Y85 985
FHC (%) 955 40Y55 G40
Normal Mild Dysplasia Marked Dysplasia
AI (degrees) e25 26Y29 Q30
Adapted from Nimityongskul et al17 and Hosny et al.12 Acetabular index adapted
from Tonnis.15
TABLE 2. Interobserver and Intraobserver Repeatability
Coefficients for Ultrasound Measurements and AI
> A Combined FHC AI
Interobserver 17.0 27.8 21.1 31.6 8.1
Intraobserver
1 17.1 31.8 22.8 34.1 7.1
2 17.1 28.4 22.0 34.3 7.2
3 15.4 20.0 16.5 29.3 13.6
The numbers represent the value within which there is 95% confidence that a second
observation will fall from the first.
TABLE 3. Interobserver and Intraobserver Agreement







> angle 0.68 0.63 0.48 0.49 0.55
A angle 0.80 0.76 0.50 0.93 0.77
H angle 0.53 0.48 0.31 0.44 0.44
FHC 0.73 0.76 0.59 0.61 0.66
Expressed as kappa values (0.6Y0.8, good agreement; 90.8 excellent agreement).
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The mean AI of all hips at 6 months was 26 degrees (SD,
4.9). The AI was 30 degrees or greater in 24 hips (18 babies)
despite prolonged splintage in 9 hips (6 babies); 6 of these hips
(4 babies) subsequently required closed reduction. A further
42 hips had mild dysplasia (AI, 26Y29 degrees). Eight of
12 babies with severe unilateral dysplasia had mild dysplasia
of the contralateral hip.
The stepwise linear regression analysis showed that
the FHC at 6 weeks was independently predictive of the AI
at 6 months (regression coefficient, j0.27; 95% CI, j0.42 to
j0.12; P G 0.001). None of the other measurements were
associated with the AI. There is a significantly different
relationship between FHC at 6 weeks and AI for those with
prolonged treatment than for those without (P = 0.034).
However, the main effect of FHC at 6 weeks on AI is not
greatly changed (P = 0.001 toP = 0.004). There is no significant
difference in AI between the prolonged treatment group and
those without prolonged treatment (P = 0.6). Therefore,
although prolonged treatment had an effect in combination
with FHC, it had no independent effect on the AI.
Of the 24 hips with severe dysplasia, there were 11 with
FHC of 40% or less at the 6-week scan, and 10 hips were in the
borderline range of 41% to 55%. Only 1 had normal coverage
of 62%. The 6-week scans of 2 babies were missing.
DISCUSSION
Although ultrasound is widely used in the diagnosis and
management of DDH, there are a number of problems and
questions surrounding its use. Scans may be performed by
radiographers or radiologists, with or without an orthopaedic
surgeon in attendance, and often are reported by radiologists
or orthopaedic surgeons from the recorded images. This may
affect the reliability of the results. Our measurements were
taken from recorded images and none had particularly good
reproducibility. The > angle was the best with a 95% CI of
17 degrees compared with 28 degrees for the A angle. Cheng
et al7 found no significant intraexaminer variability for >
angle (mean difference,j0.5; SD, 3.2; P = 0.22), but there
was a significant variation for A angle (mean difference, 2.7;
SD, 7.5; P = 0.0037). Roovers et al10 found mean
interobserver within-subject SDs of 3.2 degrees for > angle
and 6.0 degrees for A angle. However, neither of these articles
quoted 95% CI. Dias et al8 found only fair reproducibility
with limits of agreement of 11.4 degrees for intraobserver and
12.6 degrees for interobserver for the > angle compared with
14.9 and 19 degrees for A angle. Hosny et al12 found limits of
agreement of 6.24 to 9.64 degrees for > angle and 11.8 to 13.3
degrees for A angle, but found the combined (H) angle to be the
most reproducible, with agreement limits of 2.2 to 4 degrees. In
contrast, we found this angle difficult to measure accurately;
and our interobserver limits of agreement were approximately
21 degrees. Femoral head coverage as determined by the bony
rim percentage or d/D ratio has been found to be reproducible.
Measuring bony rim percentage, Terjesen et al18 found a mean
difference of 3.9% (SD, 3.2; range, 0%Y12%) for intraobserver
reliability and 3.4% (SD, 2.7; range, 0%Y10%) for interob-
server reliability. Hosny et al12 found limits of agreement of
8.9% to 12.4% for bony coverage. Jomha et al19 found that
bony rim percentage measurements were quite repeatable but
had a significant difference between examiners. A very high
proportion of measurements (93%) fell into the wide borderline
zone of Morin et al6 (d/D ratio between 33% and 58%), which
limits its usefulness in practice. Riad et al9 found that the FHC
in normal hips varies with age and at 6 weeks averaged 66%,
with 55% the lower limit of normal (SD, j2). They reported
narrow 95% CI of agreement of 7% to 8%, which they
attributed to skilled pediatric sonographers who took the
measurements at the time of the scan.
The FHC in our series had a wider range of limits of
agreement than we expected at around 32% for 95% CI. This
may be explained in part by the inaccuracy of taking linear
measurements from a small printed image. It also may reflect
the wider range of values due to the high incidence of abnormal






No. Hips (%) No. Hips (%) No. Hips (%)
2 wk
> angle 124 51.7 6.7 44 (35) 62 (50) 18 (15)
A angle 124 55.0 12.0 79 (64) 35 (28) 10 (8)
H angle 124 84.0 8.7 67 (54) 35 (28) 22 (18)
FHC 124 41.8 15.5 18 (15) 68 (55) 38 (30)
6 wk
> angle 124 54.1 6.4 61 (49) 56 (45) 7 (6)
A angle 124 49.1 5.4 101 (81) 20 (16) 3 (3)
H angle 124 88.2 7.0 86 (69) 34 (27) 4 (4)
FHC 124 42.7 11.7 36 (29) 64 (52) 24 (19)
6 mo
AI 128 26 4.9 62 (48) 42 (33) 24 (19)
Mean values from repeated measurements, numbers and percentages in normal, borderline, and abnormal categories.
> and A angles (Graf), combined angle of Hosny (H angle), FHC, and AI.
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hips in our group when compared with other series that had a
majority of normal hips. We found better agreement when hips
were categorized into normal, abnormal, or borderline, with the
FHC and A angle showing the best overall agreement. The
H angle had the worst interobserver and intraobserver
agreement for all categories.
The other significant problem of ultrasound is that it
detects many abnormalities in the first few weeks of life that
resolve spontaneously.20Y23 A scan at 4, 6, or 9 weeks is more
specific than an earlier scan;20,22,24 but this limits its use-
fulness in screening. Sucato et al23 looked at the natural his-
tory of ultrasound abnormalities in clinically stable hips and
found that no ultrasound measure at less than 1 month of age
was predictive of dysplasia. Castelein et al21 found only 4 of
144 hips with isolated ultrasound abnormalities at birth that
developed acetabular dysplasia.
In a general ultrasound screening program, 38% of
grade 5 (dislocated) hips at birth, 8.5% of grade 4 hips (mean
BRP, 28.6% T 8.4%), and 2.75% of grade 3 hips (mean BRP,
51.6% T 7%) required treatment after they failed to resolve by
6 weeks of age.20,22
Engesaeter et al11 reported that in a group of 100 babies
referred to the DDH clinic with risk factors or instability, only
dynamic stability correlated with radiographic outcome. The
unstable hips in their group did not have a significantly lower
d/D ratio than the stable hips.
Hangen et al2 found that there was no clearly sig-
nificant relationship between stability and geometric mea-
surements in treated unstable hips. They noted an improvement
in > angle in successfully treated hips and found that ultra-
sound was particularly helpful in identifying treatment
failure early.
In our group, all hips were clinically unstable (dis-
located or dislocatable) when examined by an orthopaedic
surgeon within a day or two of birth and therefore were treated
in a Pavlik harness. It is accepted that up to 60% of hips
unstable at birth may spontaneously stabilize.25 However, in
this group of babies, we would still expect to see a high
proportion of abnormal scans. This is reflected in the low
mean values for > angle and FHC at 2 and 6 weeks. By taking
55% as the lower limit of normal for FHC at 6 weeks and less
than 40% as abnormal, we found 24 abnormal (19%) and 64
borderline (52%) hips at 6 weeks. Eleven of these hips
subsequently developed severe radiographic dysplasia at
6 months (AI 9 30 degrees). The > and A angles and the
combined angle of Hosny were only abnormal in 4% to 6%
of the hips in our study at 6 weeks, suggesting that these
angular measurements are not sensitive enough to be useful
in practice. In contrast, Irha et al26 have suggested that
linear parameters are less sensitive than angular measure-
ments for dysplastic hips but were highly specific for normal
hip development.
Unlike other authors,2,11 we found that the FHC at
6 weeks was predictive of outcome at 6 months as
determined by the AI. This is not a natural history study,
as all hips were treated until the 6-week scan when we used
persisting instability or low FHC as our criterion for further
splintage. If we had not continued treatment in those hips
with a low FHC at 6 weeks, then the association may have
been stronger. The AI at 6 months was used as the end
point of this study. We do not necessarily regard this as
predictive of the final outcome of an individual hip.
However, all hips in this study that required subsequent
surgical treatment had an AI of greater than 30 degrees
at 6 months.
This study has focused on static measurements.
However, it is very important that a dynamic assessment of
the hip is performed at the time of the ultrasound, as a scan
should not be considered normal based on static morphology
alone, especially in the first month of life. We believe this is
best done by an orthopaedic surgeon. We rely on clinical
examination for diagnosis at birth and use ultrasound mainly
to monitor response to treatment.
We believe that the FHC is the most useful static mea-
surement in assessing a baby with DDH. This study shows that
it is reproducible in determining the category of a hip and, at 6
weeks, is predictive of the AI at 6 months in hips treated from
birth for instability.
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Late presenting dislocation of sonographically stable hips
David P. Gwynne Jonesa, John D. Dunbarb and Jean-Claude Theisa
We report on seven developmental hip dislocations in five
babies (age 6–22 months) in whom ultrasound had
demonstrated reduced and stable hips. Four hips in three
babies had been diagnosed as having clinical instability
(Barlow positive) at birth, which had stabilized by the time
of the scan (16–45 days). Femoral head coverage ranged
from 36 to 56%. One hip had minimal sonographic laxity on
stress examination. Hips that are reduced and stable
sonographically at 2–6 weeks of age can subsequently
dislocate. Any child with instability at birth should be
reviewed with a pelvic radiograph at 4–6 months, even if an
ultrasound scan appears to be normal. J Pediatr Orthop B
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Introduction
Developmental dysplasia of the hip (DDH) is a spectrum
of disease ranging from irreducible dislocation at birth to
mild acetabular dysplasia. The change in terminology
from congenital dislocation of the hip reflects this and
also implies that the abnormality may not be present at
birth [1]. The majority of cases are detectable at birth
and, of these, approximately 60% subsequently stabilize
[2]. Rarely, however, clinically stable hips may subse-
quently dislocate [3,4]. Ultrasound has demonstrated
abnormalities not detectable on clinical examination, but
most of these spontaneously resolve [5,6]. Therefore,
there has been a trend towards treating only those hips
that fail to stabilize or those that have persisting
ultrasound abnormalities at 6–8 weeks [7–9].
The purpose of this report is to describe five babies in
whom ultrasound demonstrated reduced and stable hips
and relatively minor morphological abnormalities that
subsequently developed established dislocations.
Methods
Screening programme
We have used ultrasound in the diagnosis and manage-
ment of neonatal hip instability for 15 years [10]. Three
orthopaedic surgeons examine all babies in hospital and
scan babies with hip instability or risk factors. We treat
dislocated (Ortolani positive) hips from birth with a
Pavlik harness, but delay treatment when there is
uncertainty or more minor instability. Scans are per-
formed at 2 weeks and at 6 weeks if there are persisting
clinical or sonographic abnormalities. A sonographer
performs the scan with an orthopaedic surgeon present.
A static coronal scan is performed with the transducer
placed laterally. An anteroposterior transverse scan is then
obtained and a stress view taken as the surgeon performs
Barlow’s manoeuvre. We have not formally measured
angular measurements of the acetabulum but assess the
femoral head coverage (FHC), acetabular morphology
and stability. Pelvic radiographs are performed after 4–6
months.
Case 1
Case 1 is of the second-born girl of a normal pregnancy
with no risk factors. She was born in another hospital and
examined at birth by a consultant paediatrician who
diagnosed bilateral hip instability. When she was seen in
our ultrasound clinic at 5 weeks of age both hips were
reduced and stable clinically and on ultrasound. The
FHC was low borderline at 36 and 41% according to the
criteria of Morin et al. [11].
As a result of geographical remoteness, the patient did
not return for review until 6 months of age at which time
she had bilateral hip dislocations. She required closed
reduction, adductor tenotomy and hip spica for 3 months
and subsequent abduction bracing. Despite this, she has
persisting acetabular dysplasia at 7 years with centre-edge
angles of 121 right and 101 left hip.
Case 2
Case 2 is of a girl, breech presentation with no family
history of DDH, born at 36 weeks gestation. The hips
were examined by an orthopaedic surgeon and found to
be stable at birth. An ultrasound was performed in view of
the breech presentation at 31 days and the hips were
reduced and stable. By Graf ’s criteria [12], the right hip
was type II and the left hip type I. The FHC was 36%
(right) and 37.5% (left). No treatment was instituted.
A second scan was performed at 45 days, which showed
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both hips were reduced and stable with slightly improved
head coverage at 40%.
The patient failed to present for follow-up radiology at
4–6 months. She re-presented at 22 months with a
dislocated right hip. She underwent a closed reduction
and adductor tenotomy but later required a right Salter
pelvic osteotomy at 5 years 6 months.
Case 3
Case 3 is of a first-born girl, with no family history of
DDH, a cephalic presentation and a forceps delivery at 39
weeks. When examined at birth by an orthopaedic
surgeon there was laxity of the left hip (Barlow positive,
Ortolani negative). At 16 days the hip was clinically
stable. A little laxity on ultrasound but a well formed
acetabulum (Graf I) and an FHC of 50% were noted. (Fig.
1a and b) Therefore, no treatment was instituted. Follow-
up radiographs were not obtained until 7 months of age
and showed a dislocated left hip (Fig. 1c). The patient
underwent closed reduction, adductor tenotomy and hip
spica followed by abduction bracing.
Case 4
Case 4 is of a girl, a cephalic presentation with no risk
factors, who, on a neonatal hip examination, had a Barlow-
positive right hip. This was not treated initially. At 20
days of age, she had no clinical instability and an
Fig. 1
Case 3. Ultrasound (coronal) left hip (a), right hip (b) and radiograph pelvis at the age of 7 months showing dislocated left hip (c)
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ultrasound showed a well formed acetabulum (Graf I)
with no instability (Fig. 2a). The FHC was 41% for the
right hip. No formal follow-up was arranged and she was
referred back at 9 months with a dislocated right hip (Fig.
2b). She was treated with closed reduction and hip spica.
Case 5
Case 5 is of a girl, second child born by caesarian section
at full term. Both hips were stable at birth according to an
orthopaedic surgeon. An ultrasound was performed at 5
weeks in view of a maternal history of DDH. No
instability was observed. The hips were Graf type II
with an FHC of 43% on the right and 45% on the left. No
treatment was instituted but at review at 7 months of age
she was found to have bilateral dislocations. She under-
went a closed reduction and adductor tenotomy.
Discussion
Screening programmes by experienced examiners have
reduced late presenting DDH to very low levels (0.2 per
1000) [13]. It has been recognized that not all cases of
DDH can be identified at birth by clinical examination
[1,3]. Ultrasound can detect abnormalities not apparent
on clinical examination but 90% may resolve by 9 weeks
[5,6]. Marks et al. [6] noted that their rate of detection of
unstable hips by ultrasound alone (0.57 per 1000) was
very similar to their historical rate of late presenting
DDH (0.68 per 1000). Subsequently, Bache et al. [7]
have reported no cases of late presenting DDH,
as a global ultrasound programme was instituted
with static views obtained by a sonographer at birth.
Therefore, it appears that there is a small group of babies
who may have persisting ultrasound abnormalities
that would not otherwise be detectable by clinical
screening [5,6].
In continental Europe, orthopaedic surgeons may perform
the ultrasound examination but elsewhere in the world it
is more commonly performed by radiologists or sonogra-
phers [14]. An ultrasound scan should include a scan in
the coronal plane with the hip at rest, and a dynamic
assessment in the transverse plane with the hip under
stress [14]. Acetabular morphology is assessed from the
coronal scan and most commonly classified using the
system of Graf [12]. Many hips are immature with an
a angle between 50 and 601 and should be observed,
while < 501 is abnormal [15]. No angular measurements
before 4–6 weeks of age are predictive of outcome [5].
A recent review recommended a scan at 4–6 weeks of age
and stated that angular measurements of acetabular
landmarks are optional [14].
Morin et al. [11] described the d/D ratio as normal if
> 58%, borderline if 33–58% and abnormal if < 33%. The
wide borderline zone, however, limits its usefulness in
screening [16]. Nimityongskul et al. [15] modified the
classification and defined a d/D ratio of > 55% as normal,
40–55% as borderline and < 40% as abnormal, while
Terjesen et al. [17] defined hips with < 50% FHC
coverage at birth as potentially abnormal. We have not
routinely measured angles but look at the general
morphology, stability and FHC. We now regard hips with
less than 40% coverage as abnormal (Table 1).
At the time of the ultrasound scan, nine of the hips in our
group were stable clinically and on ultrasound, and one
hip with minimal laxity on stress views had a normal
acetabular morphology. If we categorized the babies
according to Graf ’s morphological system, then of the
seven dislocated hips, two were type I and five were type
II. The FHC was in the borderline zone of Morin et al.
[11] in all 10 hips, including those seven that subse-
quently dislocated. Using the modified criteria of
Nimityongskul et al. [15], there was one normal hip,
eight borderline hips of which six subsequently dis-
located and one abnormal hip. This hip (patient 1, right
Fig. 2
Case 4. Coronal ultrasounds of hips (a) and radiograph pelvis at the
age of 9 months showing dislocated right hip (b).
Late dislocation of stable hips Gwynne Jones et al. 259
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.80
hip), in retrospect, should have been treated despite
being reduced and stable sonographically at 6 weeks.
A widespread trend is to delay treatment until there are
persisting ultrasound abnormalities or clinical instability.
Splintage rates have been reduced from 16 per 1000 [13]
with a clinical screening programme to 3–6 per 1000
[7,9,18–20] when an ultrasound is used. We have
previously reported a splintage rate of 5.4 per 1000, of
which 93% were treated from birth [10]. More recently,
we have tended to delay splintage of unstable hips until
the baby is seen at the ultrasound clinic. The five babies
who comprise this report were all identified by the
screening programme initially and were born since this
change in practice. A natural reluctance to start splintage
at the time of scan is noted if the hip is stable and there
are only borderline sonographic abnormalities. We find it
concerning that two of these babies (cases 3 and 4) with
laxity at birth had what we usually regard as acceptable
stability and morphology at the time of their scan, and
were therefore not splinted, whereas previously they
might have been splinted from birth for 6–8 weeks.
Patients 2 and 5 had clinically normal hips from birth,
which were also stable on ultrasound. These patients
belong to the small group described by Marks et al. [6], in
which abnormal hips can only be detected by ultrasound.
The FHC in these cases, however, was in the borderline
zone and not clearly abnormal.
The change in terminology from congenital dislocation to
developmental dysplasia as advocated by Klisic [1] is
important medicolegally. It recognizes the spectrum of
disease from neonatal dislocation to acetabular dysplasia.
It remains controversial whether dislocations are ‘missed’
on neonatal screening or whether the hip can dislocate
late. The phenomenon of a late developmental disloca-
tion is well recognized by paediatric orthopaedic surgeons
but there has been little radiographic evidence to support
this view, to our knowledge, in the English language
literature. Ilfeld et al. [4] reported on 15 cases of late
dislocation after repeated normal clinical examinations by
experienced surgeons. In only three of the cases,
however, had normal radiographs been documented, of
which two were taken in the first week of life and one at
31 months during treatment of dislocation of the
contralateral hip. Babies with persisting ultrasound
abnormalities have been treated by some authors, with
a reduction in the rates of late dislocation and acetabular
dysplasia [7], but it is not clear which babies should be
treated and which will develop problems.
We believe that these cases add support to the concept of
late developmental dislocations. They demonstrate that
hips that are reduced and stable clinically and sonogra-
phically at 2–6 weeks, with either a normal scan or
borderline ultrasound abnormalities, can develop an
established dislocation. It is important that an ultrasound
must be interpreted in combination with the clinical
findings and should include a stress view, preferably
performed with an orthopaedic surgeon present. All
babies should have careful follow-up with a pelvic
radiograph at 4–6 months if there has been instability at
birth or persisting ultrasound abnormality.
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Chapter 4   
Alternatives to surgery: Improving non-operative management. 
a) The Joint Clinic
A general principle of elective surgery is that it should be used after failure of non-operative 
treatment. In patients with osteoarthritis of hip and knee this should include lifestyle 
modifications, physiotherapy and exercise, simple analgesia and non-steroidal anti-
inflammatory drugs. These can usually be co-ordinated in the primary care setting but there 
has been a move toward a chronic disease management approach using multi-disciplinary 
clinics.  
We developed the Joint Clinic, as part of the Orthopaedic Patient Pathway Programme, 
based on similar clinics in Australia. Its goal was to improve access to the orthopaedic 
service for patients with hip and knee OA. Many patients referred by their GP for 
consideration of THR and TKR were being declined an orthopaedic appointment due to 
capacity constraints. Best practice protocols were developed to improve non-operative 
care of these patients with the ability to refer those in most need on for surgical 
management.  This series of papers covers its development and implementation, the results 
of the first 2 years of operation, the factors associated with response to treatment and the 5 
year outcomes. The final paper in the Joint Clinic series, ‘The functional outcomes of patients 
with knee osteoarthritis managed non-operatively at the Joint Clinic at 5 year follow up: Does 
surgical avoidance mean success?’ compares patient reported outcomes in attempt to 
determine whether avoidance of surgery constitutes successful non-operative 
management. The findings showed that patients who had undergone surgery had improved 
functional outcomes compared with those that had continued non-operative treatment.  
b) Comparing operative and non-operative treatment.
There are relatively few randomized controlled trials of orthopaedic surgical procedures 
which leads to criticism from advocates of evidence-based medicine. Surgery is usually 
reserved for failure of non-operative treatment. If there is a subsequent improvement it is 
taken as evidence of surgical success. In the acute setting it is not possible to trial non-
operative treatment for extended periods. A decision usually needs to be made soon after 
presentation. If the results of non-operative treatment are equivalent to surgery there is 
the potential to reduce the operative burden on the hospital and reduce the risk of 
potential harm to the patient.   
Management of acute Achilles tendon rupture has always been a controversial topic 
amongst orthopaedic surgeons. Many surgeons believe that there is a lower re-rupture rate 
and improved functional outcomes with surgery. Improvements in management including 
functional bracing led to us developing an identical rehabilitation protocol in patients 
treated both surgically and non-operatively. We report on the epidemiology of this injury 
and the results with respect to re-rupture and surgical complications of this protocol in 
‘Acute Achilles Tendon Rupture: Epidemiology and outcomes of 363 patients with operative 
or non-operative treatment using an identical functional bracing protocol.’ We found a 
higher rate of this injury in woman than previously reported elsewhere. This allowed some 
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comparison of gender differences. The paper does still show an advantage to surgery in 
terms of a reduced re-rupture rate which is consistent with meta-analyses in the literature. 
The surgical complication rate including re-ruptures was very low compared with major 
international centres. Non-operative management including functional bracing resulted in 
low re-rupture rates in patients over 40 years especially in females. The paper has been 
highly cited indicating its global relevance (52 citations). 
The follow up to this study ‘Functional outcome of acute Achilles tendon rupture with and 
without operative treatment using Identical functional bracing protocols ‘ compares the 
functional outcomes at longer term follow up. It showed no difference in patient reported 
outcomes using the Achilles tendon rupture score (ATRS) and gratifyingly high scores 
compared to other series. 
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Abstract
Background: Osteoarthritis is the most common form of arthritis, principally affecting the older population. Highly
prevalent, disabling diseases such as osteoarthritis strain the capacity of health systems, and can result in unmet
need for services. The Joint Clinic was initiated to provide secondary care consultations and access to outpatient
services for people with advanced hip or knee osteoarthritis, who were referred by their general practitioner for
orthopaedic consultation but not offered an orthopaedic specialist appointment.
Methods: This longitudinal programme evaluation comprised four components: a proof-of-concept evaluation; an
implementation evaluation; a process evaluation; and an outcomes evaluation. Interviews and surveys of general
practitioners, staff, and patients were conducted pre- and post-implementation. Interviews were transcribed, and
thematic analysis was completed. In addition, Joint Clinic patient visits and outcomes were reviewed.
Results: One hundred and eleven primary care physicians (GPs) and 66 patients were surveyed, and 28 semi-structured
interviews of hospital staff and GPs were conducted. Proof of concept was satisfied. Interim and final implementation
evaluations indicated adherence to the concept model, high levels of acceptance of and confidence in the programme
and its staff, and timely completion within budget. Process evaluation revealed positive impacts of the programme and
positive stakeholder perceptions, with some weaknesses in communication to the outer context of primary care. The
Joint Clinic saw a total of 637 patient visits during 2 years of operation. Unmet need was reduced by 90%. Patient and
referring physician satisfaction was high. Hospital management confirmed that the programme will continue.
Conclusions: This evaluation indicates that the Joint Clinic concept model is fit for purpose, functioned well within the
organisation, and achieved its primary objective of reducing unmet need of secondary care consultation for those
suffering advanced hip or knee osteoarthritis.
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Osteoarthritis (OA) is the most common form of arth-
ritis, principally affecting the older population. The Glo-
bal Burden of Diseases, Injuries, and Risk Factors Study
2015 found that the prevalence of OA increased 32% be-
tween 2005 and 2015 [1]. The high prevalence and in-
creasing disability burden of OA mean it is a high
priority condition, and has been formally recognised as
such by the World Health Organisation (WHO) [2].
Many health systems worldwide will need to adapt to a
higher proportion of older people as population demo-
graphics change. In New Zealand, those over the age of
65 years will make up over one quarter of the population
by the late 2030’s [3]. Osteoarthritis of the hip and knee is
the most common condition for which joint replacements
are indicated, and as the population ages, demand for joint
replacement surgery is predicted to rise significantly [3].
This scenario will place significant stress on the health re-
sources in New Zealand. The Southern District Health
Board (SDHB), the public health services provider for
Dunedin, New Zealand, has seen a substantial rise in de-
mand for joint replacement surgery, and a shortfall of
orthopaedic specialist resources to meet the demand of
general medical practitioner (GP) referrals for patients
with osteoarthritis [4, 5]. This has resulted in a growing
unmet need for secondary care consultations and OA
management. A report by the SDHB general practitioner
liaison [6] and subsequent audit research [4] found that
up to 44% of patients with OA of the hip or knee referred
for orthopaedic specialist consultation were unable to be
offered an appointment, and were instead referred straight
back to the referring GP without review or advice regard-
ing ongoing management.
The Joint Clinic, a clinical service of the Orthopaedic
Outpatient Department, Dunedin Hospital, was proposed
and introduced to address the unmet need for secondary
care consultation for people with late-stage hip and knee
OA. Contemporary clinical practice guidelines for the
management of OA recommend non-operative interven-
tions – including exercise therapy and education – as core,
first line management for all patients with hip or knee OA
[7–9]. The Joint Clinic proposal was based on locally con-
ducted research into the effectiveness of non-operative in-
terventions [10–13]. The Joint Clinic was designed to
contribute to the New Zealand Ministry of Health object-
ive to provide better, sooner, more convenient care by
improving the management of hip or knee OA at the inter-
face between primary and secondary care [13, 14]. There is
evidence to show that multidisciplinary collaboration and
communication are essential to promote continuous, co-
ordinated, patient-centred care with regard to OA [15].
The goal of this study was to conduct a comprehensive,
longitudinal programme evaluation of the implementation
of the Joint Clinic initiative. This programme evaluation
was planned a priori and completed to assess whether the
initiation and operation of the Joint Clinic achieved its
four main objectives. These four objectives were to estab-
lish whether or not: 1) a physiotherapist-led clinic in a sec-
ondary care setting would be feasible as a method of
meeting an unmet need for secondary care consultations
and management in patients with hip or knee OA; 2) this
new programme could be successfully implemented as
proposed; 3) the new programme would operate as
planned and be well accepted by stakeholders; and 4) the
Joint Clinic was perceived to bridge the gap in care of
those with OA of the hip and knee in a secondary setting
in a cost-effective way, increase efficiency in its secondary
care setting, and provide support for GPs in primary care.
Methods
The 'Joint Clinic' programme
The Joint Clinic was developed as a clinical service of
the Orthopaedic Outpatient Department at Dunedin
Hospital. The patient referral pathway for OA patients
referred from primary care to the Orthopaedic Depart-
ment is illustrated in Fig. 1. To be eligible for inclusion,
patients must have undergone clinical assessment by
their GP and referred for orthopaedic consultation in
secondary care (Dunedin Hospital) including current
plain radiographs.
It was proposed that advanced competency physiothera-
pists would examine patients with hip or knee OA re-
ferred to the orthopaedic department and provide initial
conservative management, education, referral and reassur-
ance. A key component was referral to outpatient physio-
therapy for a programme of exercise physiotherapy, when
indicated, delivered either individually or in groups, in 6
visits of 40min duration (see Additional file 1). Referrals
could be made to an orthopaedic consultant, orthotics,
dietetics, or community physical activity providers. All eli-
gible patients managed in the Joint Clinic services would
be followed up in clinic every 6months until discharged.
Discharge would occur when the programme course was
completed, the patient stable, or when referral elsewhere
was indicated. It was planned that the Joint Clinic would
accomplish this with the support of an experienced ortho-
paedic nurse, consultant orthopaedic surgeons, and the
Outpatient Physiotherapy Department.
The goals of the Joint Clinic programme were to in-
crease efficiency in secondary care by decreasing time
spent by Orthopaedic Consultants on patients not re-
quiring surgery; to provide a much needed support for
GPs in primary care by providing review and advice re-
garding ongoing management; to meet the unmet need
described above; to improve patient outcomes; and dem-
onstrate potential to make savings in both direct and in-
direct economic costs.
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Fig. 1 Referral pathway for OA patients referred from primary care to the Orthopaedic Department. Note: GP = general medical (family
practice) practitioner
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Is the model consistent with 
best practices?
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Fig. 2 Components of the programme evaluation. Note: GP = general medical (family practice) practitioner
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Programme evaluation study design
This study was an utilisation-focussed, end-to-end
programme evaluation of the Joint Clinic. We struc-
tured and conducted the evaluation using the frame-
work described by Hollander et al. [16] An overview of
the evaluation structure and data collection methods
are summarised in Fig. 2. The programme logic model
is reported in Additional file 2. The initial phase was a
proof-of-concept evaluation. In this phase the rationale
for the programme was evaluated, the need for the ser-
vice in the local community was assessed, and the key
characteristics of the model were weighed against best
practices in the field. An implementation evaluation
was conducted, in an interim and a final phase. This
assessed the extent to which the programme was exe-
cuted in accordance with the proposed model. In con-
cert, a process evaluation was done to assess whether
the programme operated smoothly and efficiently, was
adequately resourced and staffed, and was functioning
as intended. Finally, an outcomes evaluation investi-
gated whether or not the programme was achieving
intended outcomes and objectives.
The primary outcome that the programme intended
to address was unmet need for orthopaedic consulta-
tions for patients referred with OA, measured by
number (proportion) of referrals sent back to the GP
without consultation. Secondary outcomes included
GP satisfaction with the service, acceptability of the
programme by providers and patients, and service-
level efficiency outcomes. Key outcomes assessed in
each of the phases of the programme evaluation are
summarised in the programme logic model (Add-
itional file 2).
Literature review and expert opinion
The literature review and appraisal of expert opinion
were conducted to indicate whether or not a
physiotherapist-led clinic in a secondary care setting
would likely be feasible and effective as a method of
meeting an unmet need. The model was assessed
against best practices, as identified by a review of the
literature [15, 17–20], and by the leaders and staff of
comparable OA clinics in Australia. Principals and
staff from these clinics were consulted, site visits were
conducted, and key characteristics of those services
considered in the context of best practice recommen-
dations [15, 17, 19, 20]. The programme was based on
principles of chronic care [21–23]. Interventions in-
cluded within the model, in particular the key physio-
therapy component were investigated for support by
clinical practice guidelines of effectiveness research
[7–10], as well as a systematic review of cost-
effectiveness [24].
Surveys of GPs, staff, and patients
Both pre- and post-implementation surveys and interviews
were conducted, to assess objectives 2 and 3 relating to im-
plementation and process. Survey design and delivery was
based on best-practice evidence from the literature [25].
The surveys [see the appendices in Additional file 3] were
intended to gauge Dunedin GPs’ satisfaction with the
Orthopaedic Outpatient Department service, as well as
their opinion regarding the need for the proposed new ser-
vice. The pre-implementation survey consisted of three
questions regarding access to an orthopaedic first specialist
appointment (FSA). The post-implementation version con-
sisted of eight questions; the first three questions were the
same as those in the first survey, and the next five questions
were about perceptions of the Joint Clinic operations. Par-
ticipants were also invited to add free-text comments at the
end of the survey.
All Dunedin GPs were mailed the survey, a reply-paid
envelope and a pen [25]. After 4 weeks, non-responders
with a known email address were sent an email with a
link to the survey online. Non-responders without a
known email address were posted a reminder letter, a
second copy of the survey and a reply-paid envelope.
Each patient who had been seen for at least one
follow-up appointment at the Joint Clinic by the end of
year 1, was mailed a user perceptions survey [see the ap-
pendices in Additional file 3]. Eligible patients were con-
tacted in the same manner as the GPs. Two weeks later
non-responders were sent a reminder letter and another
copy of the survey. The survey aimed to assess patient
satisfaction at the Joint Clinic. The survey included
questions about their satisfaction with wait time, the
knowledge and expertise of staff, the treatment offered
their overall experience, and whether or not they would
recommend the Joint Clinic to others.
Interviews of GPs and staff
One-on-one interviews were conducted at the interim
and post-implementation phases. The sampling frame
included staff members from the Joint Clinic and the
wider orthopaedic service, administration and manage-
ment personnel, and GPs. In the interim evaluation, key
stakeholders of the Joint Clinic were identified and in-
vited to interview, and a chain sampling technique was
used to recruit further interviewees. Two interviewers
conducted the interim evaluation interviews. Chain sam-
pling is a respondent-driven process, and involves identi-
fying potential participants from key informants, and
thus produces a ‘snowball’ effect [26]. In the post-
implementation evaluation, six Southern District Health
Board (SDHB) staff and seven General Practitioners
(GPs) were invited to take part in a one-on-one in-depth
interview. One interviewer (HH), familiar with the insti-
tution and environment and experienced in qualitative
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research, conducted the interviews. SDHB staff invited
to take part were those identified as being closely in-
volved with the Joint Clinic. GPs were selected, from
those GPs referring patients that had had a follow-up
appointment at the Joint Clinic, using a semi-random
process to ensure that each GP interviewed was from a
different practice.
The semi-structured interview questions aimed to as-
sess the appropriateness, efficiency and effectiveness of
the model’s implementation. Questions focussed on ap-
propriate care provision, continuity of care, and compe-
tence of personnel [see the appendices in Additional file
3]. Interviews included open-ended questions to elicit
large amounts of information from a relatively small
number of key informants, to maximize data saturation.
Thus, interviewees could produce specific answers as
well as varied broad perspectives of individual experi-
ences, opinions and motivations [27].
Monthly reports and patient-level data
To complement the surveys and interviews, monthly
reporting on service-level and patient-level statistics
were used to inform the outcomes evaluation. Monthly
reports generated by the SDHB implementation project
team provided statistics regarding department referrals,
patient visits and pathways of care. A financial report
was produced by the SDHB Business Analyst, and com-
pared against the project budget.
Data analysis
Survey data were analysed using Excel 2011 (Microsoft),
and descriptive statistics were used to describe survey
results. Themes were analysed from free-text comment
data, and the main ideas were summarised.
All interviews were digitally recorded and transcribed by
an independent transcription company. Transcriptions
were checked against the interview recordings by the
interviewer and corrected if necessary. Thematic analysis
was carried out, which involved stages of familiarisation,
identification of a thematic framework, indexing, charting
and mapping and interpretation, based on the Framework
Method [28]. NVivo software, version 10 (QSR Inter-
national Pty Ltd), was used to organise the data [29].
Descriptive statistics were tabulated for service-level
outcomes, the net marginal unit cost for all Joint Clinic
services and physiotherapy treatments provided was cal-
culated, and costs of programme implementation
assessed against the budget allocated. Patient-level out-
comes have been reported separately [30, 31].
Results
Surveys of GPs, staff, and patients
Pre-implementation surveys were sent to 111 GPs.
Eighty-one respondents completed the survey, for a 73%
response rate. The survey found that approximately 90%
of GPs were ‘unsatisfied’ or ‘very unsatisfied’ with the ac-
cess to FSA for their patients with advanced hip or knee
OA. Once referred patients were seen, however, approxi-
mately 65% of GPs were ‘satisfied’ or ‘very satisfied’ with
overall patient management provided, although approxi-
mately 30–35% expressed dissatisfaction with the overall
management of their patients. Specific comments indi-
cated that GPs thought “getting patients into the system
is difficult” and “too many referrals are returned unseen”,
and that “Re-referral wastes time (GP and Specialist)”
[see the appendices in Additional file 3].
Post-implementation surveys were sent to 111 GPs.
Fifty-eight surveys were completed, for a response rate
of 52%. Most GP respondents (78%) had patients seen at
the Joint Clinic. The majority of GPs (91%) remained
‘very unsatisfied’ or ‘unsatisfied’ with patient access to a
FSA. Sixty percent of GPs reported being ‘satisfied’ or
‘very satisfied’ with overall patient access to the Joint
Clinic; however, 40% reported being ‘unsatisfied’. Most
GPs (91%) were ‘satisfied’ or ‘very satisfied’ with the
quality and timeliness of feedback from the Joint Clinic
appointment, and 76% were ‘satisfied’ or ‘very satisfied’
with the overall patient management regarding the Joint
Clinic [see the appendices in Additional file 3 for figures
and additional data].
Specific comments about the Joint Clinic indicated
that GPs were “… very pleased to have the Joint Clinic in
the current environment where specialist appointments
are so difficult to get” and “I think the joint clinic overall
does a good job. I think patients also appreciate this ser-
vice”. However, some thought the Clinic added to the
waiting problem, saying “In my experience the Joint
Clinic whilst no doubt well-intentioned functions as a
further delay for patients whose need for joint replace-
ment is already pressing by the time I have made a refer-
ral to orthopaedics”, and suggested that “…The joint
clinic would be good for those at an earlier stage of the
disease process - not those really for an operation but de-
clined because of insufficient funding”.
The patient survey indicated the majority of patients
were ‘satisfied’ or ‘very satisfied’ with the knowledge and
expertise of Joint Clinic staff (98%), the treatment plan
given by Joint Clinic staff (89%), their treatment at
Physiotherapy Outpatients (92%) and other treatments
provided (82%). Most patients were ‘satisfied’ or ‘very
satisfied’ to be seen by Joint Clinic staff rather than an
Orthopaedic Surgeon (70%). The majority of patients
(86%) were ‘satisfied’ or ‘very satisfied’ with the time they
waited to be seen at the Clinic.
Interim interviews of GPs and staff
Interim evaluation interviews were conducted among
staff and GPs. After three phases of the chain sampling
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process, there were a total of 21 potential respondents,
of which 16 were interviewed. These comprised six
Orthopaedic Department or Joint Clinic clinicians, one
allied health clinician, seven hospital administrative or
managerial staff, one SDHB Māori (New Zealand’s indi-
genous peoples) liaison, and one GP. Overall, data from
the interim implementation evaluation indicated that the
Joint Clinic had been implemented in close concordance
with the proposed model and was well accepted by the
key stakeholders, staff, and patients. Six major themes
resulted: staffing, appropriate care provision, care coord-
ination, promotion of the service, the Joint Clinic model
and Hauora Māori (health and wellbeing of Māori).
Recurrent themes relating to staffing included high
levels of confidence in the competence of personnel, and
concerns regarding adequacy of allocated administrative
staff time in light of heavier than expected additional
workload. One aspect of the proposed model that was not
implemented was the employment of “advanced physio-
therapy practitioners”. Instead, due to loss of the initial
lead physiotherapist the Joint Clinic role was filled by an
experienced physiotherapist without advanced practice ex-
perience or specific OA expertise. However a training
programme had been provided. Staff surveys found that
adequate leave cover for both the physiotherapist and the
nurse were lacking. A physiotherapist was allocated and
trained for ‘back-up’ cover, but became unavailable.
Some planned aspects were not concordant. It was
found that some GPs wrote referrals of patients directly
to the Joint Clinic, instead of following the existing
protocol that referrals should be triaged by the ortho-
paedic surgeons, as any other referral would be. Also,
clinic staff reported occasional difficulty in accessing
orthopaedic surgeons for discussion regarding complex
patients, leading to gaps in communication. The lead
orthopaedic surgeon’s time spent discussing cases with
Joint Clinic staff had not been budgeted a priori.
Final implementation interviews
In the final implementation evaluation, six SDHB staff
and seven GPs were invited to take part in one-on-one
in-depth post-implementation interviews; all but one GP
accepted and were interviewed. Six themes resulted from
the data: clinic impacts, clinic value, access, knowledge
and understanding of the clinic, communication, and the
future of the clinic.
The main impacts of the Joint Clinic were generally seen
as positive, as patients who previously would have been
returned to their GPs were being seen at a secondary level.
Providers commented that “...it’s absolutely plugged a huge
gap...” (SDHB staff), “…instead of the referrals being
triaged and sent back to the GP, not being seen at all...
they’re now being seen” (SDHB staff) “…more quickly, more
efficiently, and more to the point...and help GP[s] to, to
manage a long term problem” (GP).
Interviewees had the impression that patients valued the
service as well, and had benefited, at least psychologically,
commenting that “...patients do have the perception that
they, that something’s happening” (GP), and “All of them
[patients] have had an improvement in their function.
That doesn’t translate into leading, needing less pain relief.
It doesn’t translate into not needing joint replacement. It
does translate into believing that they haven’t been aban-
doned by the system, into realising that they will recover
from what is major surgery and holds considerable fear for
most people still” (GP).
The perception was raised that some may patients ex-
press initial disappointment because they didn’t get to
see an orthopaedic surgeon: “...patients might feel fobbed
off if the purpose of the Joint Clinic has not been ex-
plained to them” (GP); “There are some patients that are
initially quite upset or potentially frustrated with actu-
ally the fact that they’re not seeing an orthopaedic doc-
tor. However, I think with just a little bit of explanation
of what that clinic actually involves, I think they realise
that what the clinic has to offer is really, is really quite
beneficial for them” (SDHB).
The Joint Clinic was valued by the GPs interviewed,
but the idea was raised that not all patients would gain
substantial value from the clinic. While typical GP com-
ments conveyed that they “…think it’s enormously valu-
able” (GP), and “Most of my patients would be
enormously grateful for the care they receive. All of them
have had an improvement in function” (GP), some also
commented that “They like meeting the people, but it
hasn’t helped their hip” (GP).
The SDHB staff interviewed generally agreed the
programme was helping to meet unmet need, and
there was good acceptance of the programme among
the interdisciplinary team. “It’s helping the demand for
FSA which it was, is also in excess of what we could
supply” (SDHB staff ) and “...the GPs are definitely
coming on board too. Because, I mean on their refer-
rals they’re actually, quite a few of them are very pro-
active in writing that they think their patient would
be suitable for the Joint Clinic” (SDHB). The consen-
sus was unequivocal that “the allied health team do a
really great job with it” (Participant 2, SDHB)
and“There’s a lot of trust and respect there within that
relationship [between staff members]” (SDHB).
Lack of clarity and understanding about the Joint
Clinic was a noted weakness: “I think the perceptions of
what the Joint Clinic’s trying to achieve or is actually
doing differ across the primary care, secondary care sort
of interface. So I’m not sure it’s, people are totally clear
about what’s happening” (SDHB). During interviews it
was suggested that, to be successful in the future, the
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Joint Clinic needed to increase its visibility, communi-
cate its mission clearly to stakeholders, maintain its
funding, and decrease attrition among physiotherapists
and staff. Further details of the themes, subthemes, and
additional data are available in the online-only supple-
mental material [see the appendices in Additional file 3].
Service level outcomes
Over 2 years, 358 new patients and 279 follow-ups were
seen at the Joint Clinic, for a total of 637 patient visits dur-
ing 2 years of operation (Table 1). Un-notified ‘did not at-
tends’ (DNAs) were low with only 11 DNAs overall (3.8%)
in the first year, and 16 DNAs (4.3%) in the second year.
The primary outcome of reducing unmet need for sec-
ondary care consultations and management in patients
with hip or knee OA was achieved, with the proportion
of GP referrals for hip or knee OA returned without
offer of consultation reduced by 90%. Increased effi-
ciency in its secondary care setting was demonstrated by
reductions in overall (all-cause) referrals returned to
GPs without consultation, despite an overall decrease in
FSAs provided by the Department. The Joint Clinic
resulted in an overall 5.7% increased capacity of the
Orthopaedic Outpatient service to provide initial consul-
tations compared with the year prior to implementation
of the Joint Clinic. These changes were observed on a
background of a decreased volume of referrals received
overall (Table 2).
Patient level outcomes have been reported elsewhere
[30, 31]. In summary, approximately 60% of patients were
managed non-operatively by the Joint Clinic, with a sig-
nificant improvement (18% improvement on baseline Ox-
ford score, p = .0013 for change by paired, 2-tailed t-test)
noted in that group; the remaining 143/358 (40%) were re-
ferred for FSA, with 115 (80%) received or were listed for
surgery [31]. At referral to Joint Clinic, no differences in
age, sex, or patient-reported outcome measures were evi-
dent between those with hip versus knee OA, however
mean BMI was higher in the knee OA group. Patients
with knee OA improved significantly, on average, while
patients with hip OA were more likely to deteriorate sig-
nificantly and require surgery [30].
Cost-effectiveness
The net marginal unit cost for all Joint Clinic services
and physiotherapy treatments provided in the Physio-
therapy Outpatient Department decreased in each finan-
cial year from $550 per patient in year one to $384 per
patient in the second year of operation, due to greater
efficiency of clinician time allocated. The Joint Clinic op-
erated significantly below budget in each financial year
due to lower than budgeted total personnel costs.
Discussion
As the world’s population ages, health care systems will
come under greater pressure to meet the increasing bur-
den of all musculoskeletal disorders, and OA in particular
[1]. In New Zealand, the demand for joint replacement
surgery is predicted to rise dramatically, placing substan-
tial pressure on orthopaedic outpatient consultation ser-
vices, which assess potential candidates for joint
replacement surgery, and manage end-stage OA [3]. The
results of this programme evaluation of an end-stage
hip and knee OA Joint Clinic demonstrates that a
service dedicated to meeting the unmet need in this
area can be successfully implemented at the interface
of primary and secondary care.
The proof-of-concept model for the Joint Clinic was sup-
ported by best-practice literature for OA care and by exter-
nal experts [15, 17–20]. The Joint Clinic service delivery
model was similar to others, such as those presented in the
UK National Health and Australian healthcare systems [17,
32], and was founded on clinical evidence and experience
from the Management of Osteoarthritis (MOA) Research
Trial programme conducted locally at the University of
Otago [10]. The MOA Trial was a randomised clinical trial
Table 1 Description of the patients and patient pathways of
the first 2 years of Joint Clinic operation
Total
Patients referred to Joint clinic 376
Declined 9 2.4%
Did not attend 9 2.4%
Patients attending Joint Clinic 358
Patient characteristics (of 358)
Age (SD) 76 9.8
Female 200 55.9%
Hip OAa 155 43.3%
Knee OAa 199 55.6%
Not OAa 19 5.3%
Met inclusion criteriab 339 94.7%
Joint Clinic management
Initial consultation 358 95.2% (of 376)
1 follow-up 252 74.3% (of 339)
2 follow-ups 114 36.6% (of 339)
3 follow-ups 28 8.3% (of 339)
mean (SD) visits 2.1 0.91
Referred for FSA:
Initial visit 59 16.5% (of 358)
Subsequent visit 74
By another service 15
Total 148 41.3%
GP General medical practitioner (family practice physician). aOA as the primary
cause of hip or knee symptoms was the inclusion criterion for Joint Clinic
management; sums to > 100 due to multisite OA. bOA of the hip or knee
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which included an economic evaluation [10–12]. This local
evidence was supported by broader evidence for both ef-
fectiveness [10] and cost-effectiveness [11, 12]. The Joint
Clinic structure also included several elements that are con-
sistent with the Wagner Chronic Care Model, a model
which aims to support patients with chronic conditions to
self-manage their condition [21–23, 33, 34].
Government health policy [35], workforce recommenda-
tions [36], and local need [5] supported the rationale for
the programme. The primary outcome of the Joint Clinic
was intended to be reduction in unmet need for primary
care referrals to secondary care. In Dunedin, the local un-
met need is centred around access to orthopaedic FSAs
and wait times for surgery, both of governed by the ration-
ale for resource allocation [37]. This primary outcome was
reduced by 90%. We have established that the new
programme was successfully implemented as proposed,
with the exception of the inability to retain the employment
of “advanced physiotherapy practitioners”. However the use
of an experienced physiotherapist after provision of a train-
ing programme was successful and stakeholder satisfaction
with the clinical staff was very high. We also were able to
establish that the new programme was able to operate as
planned and be well accepted by stakeholders. Dissatisfac-
tion with access to orthopaedic surgeon FSAs was un-
changed, post-implementation, from the high level (90%)
reported pre-implemention, despite Joint Clinic facilitating
access to FSA for 40% of patients who would otherwise
have been sent back to the GP without consultation or ad-
vice. The qualitative data of the free-text responses support
the interpretation that this reflects ongoing frustration with
orthopaedic secondary care access problems more gener-
ally. Those data also indicated that the Joint Clinic was a
helpful alternative, with some concerns also expressed that
it was merely a ‘delaying tactic’ stalling access for patients
who really required surgery/FSA.
The data indicated that the Joint Clinic was perceived to
bridge the gap in care of those with OA of the hip and
knee in a secondary setting satisfactorily, and provided
welcome support for GPs in primary care. Referral vol-
umes were lower than anticipated during implementation,
and then increased to the intended capacity. The estab-
lishment of the Joint Clinic was observed to increase
efficiency of orthopaedic surgeon appointment resources
in the secondary care setting, in terms of increased
provision of patient assessments overall, and shifting ‘non-
surgical’ consultations from orthopaedic surgeons to Joint
Clinic. The unit cost was lower than many other unit costs
for non-pharmacological, non-surgical interventions for
osteoarthritis reported in the literature, which indicate
that the cost of intervention being more than recouped by
savings in other health services over 1–2 year [12, 24, 38] .
The SDHB concluded the Joint Clinic was a cost-
effective use of resources and renewed programme
funding. The service concluded the Joint Clinic was a
cost-effective use of resources, and resolved to con-
tinue the new programme indefinitely.
Limitations of the evaluation include the uncertainty
that results from background changes to referral patterns
and Department capacity unrelated to the implementation
of the programme. Overall referrals to the Department for
FSA decreased in year 1, and recovered somewhat in year
2 but not to the level observed pre-implementation. The
reason for this decrease cannot be concluded from the
evaluation data, but may be due to ongoing education of
GPs by the Orthopaedic Department on appropriate refer-
ral criteria and prioritisation criteria. We also cannot draw
conclusions regarding the generalisability of the Joint
Clinic to other regions or services with differing referral
drivers, unmet need, or policy mechanisms.
Stakeholder interviews and survey data raised the con-
cept of a primary care version of a Joint Clinic-like ser-
vice, targeting OA earlier in the course of disease. The
case for translating this service to a primary care setting
is strong, to target OA earlier in the course of the dis-
ease. This approach is supported by research evidence
[15, 17], indicating that conservative care is more effect-
ive in patients at earlier stages of OA progression [39,
40], and that early intervention can delay or prevent the
need for joint replacement surgery [41, 42].
Conclusions
This programme evaluation has established that a
physiotherapist-led clinic in a secondary care setting is
feasible, effective in reducing unmet need, and is accept-
able to all stakeholders. The Joint Clinic offers another
Table 2 Reductions in the number of patient referrals received by Orthopaedic Outpatients, number of First Specialist Assessments
(FSAs) delivered, and number of referrals sent back to the GP without consultation: baseline and first 2 years of Joint Clinic operation
Year 0a Year 1 Change Year 0–1 Year 2 (cumulative total) Change Year 0–2b
Referrals 2,078 1,584 −24% 1539 (3123) −25%
FSAs 1,305 1,134 −13% 1267 (2401) −8%
Referrals returned to GP 557 390 −30% 462 (852) −24%
Referrals returned to GP [hip, knee OA only] 74 5 −93% 10 (15) −90%
athe year prior to Joint Clinic implementation; bannual change = 1-([cumulative total/2]/year 0 total); GP General medical practitioner (family practice physician)
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option for patients with OA of the hip and knee, and the
services that provide care in a secondary setting. The
service appears to provide a much-needed support for
GPs in primary care. Thus the Joint Clinic services ap-
pear to be sustainable and there is the capacity for in-
creased volume to extend the scope of the service.
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Background: There are increasing problems with access to both outpatient assessment and joint
replacement surgery for patients with hip or knee osteoarthritis.
Methods: Data were collected on all patients seen at the Joint Clinic over a 2-year period with minimum
12-month follow-up. Patients were assessed by a nurse and a physiotherapist, baseline scores and de-
mographic details collected, and an individualized personal care plan developed. Patients could be
referred for a first specialist assessment (FSA) if their severity justified surgical assessment.
Results: Three hundred fifty-eight patients were seen at Joint Clinic, of whom 150 (44%) had hip and 189
(56%) had knee OA. The mean age was 67.4 years and there were 152 men (45%) and 187 women (55%).
The mean baseline Oxford score was 19.8 (standard deviation 8.2). Fifty-four patients were referred
directly to FSA (mean Oxford score 13.0, standard deviation 6.7) and 89 after a subsequent review. The
scores of patients referred for FSA were significantly worse than those managed in the Joint Clinic
(P < .001). Of the 143 referred for FSA, 115 underwent or were awaiting surgery, 18 were recommended
surgery but scored below prioritization threshold, and 10 were not recommended surgery. The Oxford
scores of the 194 patients managed non-operatively improved from 22.0 to 25.0 (P ¼ .0013).
Conclusion: This study shows that the Joint Clinic was effective as a triage tool with 93% of those referred
for FSA being recommended surgery. This has freed up surgeon time to see only those patients most in
need of surgical assessment.
© 2017 Elsevier Inc. All rights reserved.With an ageing population there has been an increase in the
incidence of hip and knee osteoarthritis (OA). Effective non-
operative treatment may be an option for some patients espe-
cially those with less severe disease [1e3]. Total hip and knee
replacements are very effective interventions for the management
of end-stage OA [4]. An ageing population, confidence in theon improving patient flows in
w Zealand).
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95outcomes, and increasing demands from younger patients are
leading to an increase in demand for these procedures [5e7]. As a
consequence, public health services are struggling to cope [8,9].
In New Zealand, policy measures intended to balance demand
with supply include financial penalties to District Health Boards
(DHBs) if a patient is not seen for a first specialist assessment (FSA)
within 4 months of the referral being accepted or if surgery is not
provided within 4 months of offer to the patient. Prioritization
scoring systems have been developed for patients recommended
surgery at FSA with up to 40% of patients not qualifying for surgery
in some DHBs and being returned to their general practitioner (GP)
for further care and monitoring [10e12]. In order to achieve
compliance referrals are also being returned to GP without the
patient being seen due to capacity constraints. In this environment
it is important that those patients seen at FSA are the most
appropriate in terms of disease severity and potential to benefit. In
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 33 (2018) 983e987984response to this, we developed a physiotherapy-led outpatient
service for the assessment and management of OA of hip and
knee [13].
The objectives of this study were to assess the effectiveness of
the Joint Clinic in prioritizing those patients deemed most in need
of FSA and optimizing non-operative management for those who
may not need surgical assessment.
Methods
Our institution is the main hospital for a population of 200,000
covering one city of 125,000 and a sparsely populated area of
32,000 km2. There are 10 orthopedic surgeons and 1 arthroplasty
fellow who perform approximately 400 primary hip and knee
arthroplasties per year.
The design and implementation of the clinic has been previously
described [13]. It is staffed by a 0.5 full time equivalent (FTE)
physiotherapist and 0.2 FTE orthopedic nurse. This nurse is also
involved in the prioritization of patients wait-listed for hip or knee
replacement [12]. An additional 0.5 FTE physiotherapist was
appointed in outpatients to manage the increased load of outgoing
referrals from Joint Clinic. Clinical oversight was provided by a
senior orthopedic surgeon with an interest in arthroplasty. The
program was funded as part of a wider program on improving
patient flows in orthopedic surgery by the National Health Board.
The study reports on 358 patients seen in Joint Clinic for the
initial 2-year period from June 1, 2012 until May 31, 2014. Patients
referred by GP with hip or knee OA were triaged by an orthopedic
consultant to Joint Clinic based on the details in the referral letter
and radiographs. A full assessment including history and relevant
physical examination was performed and further radiological
investigations organized as required. Advice and counseling was
given to the patients on their disease including optimization of
analgesia. Referrals could be made for outpatient physiotherapy,
dietitian advice, orthotic care, and occupational therapy. Patients
could be fast tracked after discussion with the supervising
orthopedic consultant to an FSA if they had severe symptoms.
Patients with a very mild presentation could be discharged back
to their GP. Patients referred with problems that were not OA of
hip or knee were excluded from further analysis. Patients were
offered a follow-up appointment at 6 months. At this stage, they
could continue under Joint Clinic review, be discharged back
to GP, or be referred for FSA if there had been a significant
deterioration.
Details of initial demographics including age, gender, and
diagnosis were noted. Baseline Oxford hip (OHS) and knee (OKS)
scores were also collected. The OHS and OKS are widely used
patient reported outcome measures, designed to assess joint-
specific impairment of the hip and knee. In this study, the modi-
fied Oxford score was used, which contained 12 questions scored
between 0 and 4, with 4 being the best outcome, thus yielding a
total from 0 (worst outcome) to 48 (best outcome) [14].
The final outcomes including OHS and OKS completed at the
patients' final Joint Clinic visit were collected until May 31, 2015 to
give a minimum 12-month follow-up.
Statistical analysis was performed using Stata version 13
(College Station, TX). Analysis of variance and paired 2 tailed t-tests
were used to compare continuous variables and chi-squared test
was used for categorical data.
Results
Three hundred fifty-eight new patients referred with hip and
knee joint OA were seen in the Joint Clinic. The median time to
Joint Clinic appointment from referral was 18 days. Nineteen96patients triaged to the Joint Clinic were found to not have OA of
hip or knee and were excluded from subsequent analysis. Six of
these patients had a spinal problem, of which 4 were referred
for an FSA, and 13 had hip or knee problems that were not OA,
of which only 1 had an FSA and subsequently underwent a
knee arthroscopy. This left 339 patients with hip or knee OA
(Fig. 1).
One hundred fifty patients (44%) had hip OA including 14 pa-
tients with bilateral disease and 2 with concomitant knee OA. One
hundred eighty-nine patients (56%) had knee problems, of which
33 were bilateral. Details are given in Table 1.
Male patients presenting with knee OA were significantly older
(69.2 years, standard deviation [SD 8.6]) than those men presenting
with hip OA (65.0, SD 11.8) (P ¼ .012). No further significant dif-
ferences were observed in age, between genders, ratio of hips to
knees, or initial Oxford score (Table 1).
Two hundred forty-six patients were seen on more than one
occasion at Joint Clinic with a total of 401 follow-up visits. The
average number of visits was 2.6 (range 2-4). Ninety-three patients
only attended Joint Clinic on one occasion: 54 were referred
directly for FSA, 23 self-discharged or failed to attend a follow-up
appointment, 8 chose to go privately, 4 had died or had severe
illness, and 4 were discharged directly to their GP.
The outcomes are summarized in Figure 1.
Fifty-four patients were referred to see a specialist after their
first Joint Clinic visit. Their mean OHS and OKS of 13.0 were
significantly worse than the remaining 285 patients (P < .001)
(Table 2). A further 89 of these 285 patients (31%) were referred
after subsequent Joint Clinic visits. The average wait for referral
for this second group of patients was 309 days (SD 177) from
their initial Joint Clinic appointment. Their Oxford scores at
initial assessment were not significantly worse than those not
referred for FSA (P ¼ .972). However, by the time they were
referred, they had deteriorated to the same level as the initial
54 and were significantly worse than those not referred for FSA
(P < .001) (Table 2).
Of the 143 patients referred on for FSA (42% of all patients),
115 patients (80% of those referred for FSA and 34% of all patients)
qualified for surgery, 18 (12.6%) were scored below threshold for
surgery, and 10 were judged not to need surgery (7.4% of FSA).
The conversion rate from Joint Clinic referral for FSA to recom-
mendation for surgery was therefore 92.6%, with 80% of
those referred from Joint Clinic qualifying for surgery after
prioritization.
Patients with hip OA were significantly more likely to be
referred for FSA than those with knee OA (81 of 150, 54% vs 62 of
189, 33%; chi-square 15.4, P < .0001). They were also significantly
more likely to qualify for surgery than those with knee OA (70 of
150, 47% vs 45 of 189, 24%; chi-square 19.5, P < .0001).
Twenty-one patients (15 hips and 6 knees, 6% of all patients) had
elected to go to the private sector either after initial Joint Clinic
appointment or after an FSA and scoring below the threshold for
surgery. Their initial scores were significantly better than those
qualifying for public surgery (P < .001) (Table 2). A total of 136
patients (40% of whole group) had had surgery in either the public
or private sector or were waiting for it with certainty of access to
surgery within 4 months assured by the DHB.
At final follow-up, 194 of 339 (57%) patients seen at Joint
Clinic with OA hip or knee were still being managed
non-operatively. If the 54 patients who were referred for FSA at
their initial appointment are excluded then 69% of the 285 pa-
tients who were treated and managed at Joint Clinic are still
being managed non-operatively. The mean Oxford scores for
these patients at last follow-up had improved by 3.1 points
(P ¼ .0013) (Table 2).




















Baseline Characteristics and Scores.
All Hips Knees P Valuea
Number 339 150 189
Age 67.4 ± 10.4 66.5 ± 11.5 68.1 ± 9.29 .155
Male 152 (45%) 66 (44%) 86 (46%)
Female 187 (55%) 84 (56%) 103 (54%)
Oxford score 19.8 (8.2) 20.3 (8.7) 19.4 (7.8) .32
a Difference between hips and knees.
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 33 (2018) 983e987986Discussion
This study has shown that the Joint Clinic model has been
successful in helping prioritize and managing patients referred
from primary care with a diagnosis of OA of the hip or knee.
Previously, these patients would have either been returned to the
referring GP without offer of assessment, or been seen in a
specialist clinic after a lengthy wait.
Only 42% of patients seen were referred for FSA, with 196
specialist appointments potentially saved. Patients were only
referred for specialist opinion if their symptoms were deemed
severe enough to warrant surgery. The conversion rate from
outpatient to recommendation for surgery was 92.6% and 80% of
those referred qualified for surgery despite our need for explicit
rationing.
Other studies have been less effective. Rogers et al [15] reported
their experience with a multi-professional triage team assessing
patients referred with lower limb problems. The correct diagnosis
was made in only 47% and 69% of patients were subsequently
referred to a hospital consultant with a significant delay compared
with those referred directly.
Systematic reviews on Extended-Scope Physiotherapists (ESPs)
in musculoskeletal triage and decision making have shown support
for the clinical effectiveness in terms of diagnostic accuracy and
satisfaction [16,17]. There is support for ESPs listing patients for
surgery, with Parfitt et al [18] reporting 127 of 130 listed for hip
replacement by the physiotherapist undergoing surgery. Griffiths
et al [19] surveyed primary care-based ESPs referring onto
secondary care and found an average 74% surgical conversion rate
with a variation from 71% for mixed specialty team ESPs to 80% for
individual sub-specialist ESPs. Desmeules et al compared an
advanced practice physiotherapist's diagnosis with orthopedic
surgeons in 120 patients referred for a hip (9%) or knee (91%)
problem. Only 37 patients (31%) of the whole cohort were deemed
in need of surgery by a surgeon with agreement in 33 (89%) by the
physiotherapist [20]. Our results, with 93% of Joint Clinic referrals
being recommended surgery and 80% of Joint Clinic referrals to FSA
converting to surgery, compare favorably with those reports.Table 2
Change in Oxford Hip or Knee Score for Final Outcome Groups Defined in Figure 1.
Outcome N Initial Oxford Score (SD) Latest
FSA after initial JC 54 13.0 (6.65) e
FSA after subsequent JC 89 18.2 (7.28) 13.1 (
Privatea 21 20.8 (7.11) 17.1 (
Current JC patients 43 21.0 (7.46) 23.5 (
Discharge to GPb 116 22.5 (8.1) 26.0 (
Self-discharge 35 23 (7.87) 25.6 (
All non-operative 194 22.2 25.3
Death/illness 9 21.1 (8.20) 24 (
Scores in bold are all significantly worse than all other groups (P < .001).
JC, Joint Clinic.
a Includes 3 patients who had a specialist appointment, but were found to be under t
b Includes 15 patients who had a specialist appointment, but were found to be under
98In our study, the Joint Clinic was explicitly set up to deal with hip
and knee OA. All GP referrals to the department had to include
relevant radiographs; therefore, the focus of the Joint Clinic
assessment was more on education, non-operative management,
and prioritization rather than diagnosis. Nevertheless, 19 patients
triaged to the Joint Clinic were found not have OA of hip or knee
with 6 having spinal problems.
The Oxford scores show that the most severe patients
attending Joint Clinic were referred for FSA with scores of 13
compared with 22 points for those not referred. This difference
is both clinically and statistically significant. The 18 patients
who scored below threshold after FSA had a mean score of
20.6 which is not significantly different from those not referred.
It is possible that these patients were dissatisfied with their
Joint Clinic assessment and insisted on an FSA despite being less
severe.
A basic principle of the New Zealand Ministry of Health's pri-
oritization policy is to give patients certainty. Unfortunately, this
may mean that 30%-40% of patients who recommended total joint
replacement surgery do not qualify [10e12]. In this study, only 21
patients (6%) chose to pay for private surgery being advised at
their Joint Clinic appointment that they would be unlikely to
qualify or being scored below threshold. The rate of transfer to the
private sector is low and similar to the rate of 5.9% seen in our
previous study reporting on the outcomes of 374 patients returned
to GP after being recommended surgery [21]. It may be related to a
number of factors including poorer socioeconomic status, a his-
torically good provision of public surgery, and awareness in the
community of the problems with access to surgery so that patients
who had the financial means may have been initially referred
privately. The mean Oxford score of the patients who underwent
private surgery was no different to those patients who did not get
referred for FSA and significantly better than those undergoing
public surgery. This suggests that many of those not referred for
FSA would have had surgery recommended if there was no
rationing within the public system, or were of sufficient means to
self-fund.
There are limitations to this study. We cannot conclude whether
the Joint Clinic model is generalizable to other settings. Although
demand for hip and knee replacement is increasing and healthcare
budgets are stretched, other countries or regions may not have the
need for explicit rationing and prioritization that we face. For those
reasons, the patients referred were of greater severity than antici-
pated when the clinic was being set up. This limited the options for
effective non-operative management. However, 69% of those
patients not referred directly for FSAwere still being managed non-
operatively at a minimum of 12 months after initial assessment
with improvements in mean Oxford score of 3 points whichmay be









threshold and 10 who were not advised to have surgery.
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mentation evaluation phase of this project that the Joint Clinic
should sit within a primary care setting rather than in the or-
thopedic department [13]. All the interventions used by the
Joint Clinic staff can be accessed in primary care. However, we
believe that the close interaction among the orthopedic sur-
geons, lead physiotherapist, and the prioritization is a key
contributor to the program's success. By keeping it within the
orthopedic service, we have maintained control of the quality
and quantity of referrals and avoided it becoming a depository
for any patient with lower limb musculoskeletal pain. Both pa-
tients and GPs appear to have a strong acceptance of the
hospital-based service.
A further criticism is that Joint Clinic is trying to stop patients
from accessing surgery rather than expediting their referral. We are
working within a financially constrained environment. However,
we have found the clinic to be an effective part of our prioritization
process. If a patient is seen and has severe disease they can be fast-
tracked to an FSA and surgery, while patients without severe
disease are diverted from taking up limited FSA resource. The time
to Joint Clinic appointment from GP referral (median 18 days) is
much shorter than the 4-month wait for an FSA if accepted.
Conclusion
This study shows that the Joint Clinic was effective as a triage
tool. The diagnostic accuracy was excellent with the most severely
affected patients being referred and 93% of those referred for FSA
being recommended joint replacement surgery. This has freed up
surgeon time to see only those patients most in need of surgical
assessment. Over half of the patients triaged to Joint Clinic with hip
and knee OA are still being managed non-operatively at minimum
12-month follow-up with a small improvement in patient reported
scores.
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Background: The objective of the study was to investigate the effectiveness of, and factors associatedwith,
response to a chronic disease management program for patients with hip and knee osteoarthritis (OA).
Methods: Over a 2-year period (2012-2014), 218 patients (97 hip OA; 121 knee OA) weremanaged with an
individualized program of interventions that could include education, physiotherapy, orthotics, occupa-
tional therapy, or dietitian referral. Changes in Oxford Hip Score or Oxford Knee Score and Short Form-12
(SF-12) Physical and Mental Component Summary Score (PCS, MCS) were analyzed by joint affected,
both unadjusted, and gender and age adjusted. A further analysis also adjusted for body mass index.
Results: At mean 12-month follow-up, patients with knee OA had a statistically significant improvement
in Oxford Knee Score and PCS, while patients with hip OA had a statistically significant deterioration in
all 3 scores. There was evidence that these changes differed between joints for Oxford and PCS scores.
Older age was associated with worse outcomes for Oxford scores. Higher body mass index was associated
with worse outcomes for Oxford and PCS scores. Patients with hip OA (35%) were more likely to dete-
riorate to a clinically significant extent (5 points) for Oxford scores than those with knee OA. Gender was
not associated with outcomes. Patients with hip OA (54%) were more likely than those with knee OA
(24%) to have subsequently had surgery (P < .001).
Conclusions: Patients with knee OA were more likely to improve with a chronic disease management
plan than patients with hip OA and efforts should be directed to them.
© 2018 Elsevier Inc. All rights reserved.In New Zealand and elsewhere, increasing numbers of patients
arebeing referred forassessmentof hip andkneeosteoarthritis (OA),
and the demand for surgery is rising [1,2]. This is putting pressure on
many public health-care systems. Hip and knee total jointd any potential or pertinent
conflict with this work. For
016/j.arth.2018.04.011.
n improving patient flows in
ew Zealand).
h, FRACS (Orth), Department
at King Street, Dunedin, New
10arthroplasty (TJA) are very effective interventions for the manage-
ment of end-stageOA. They have excellent long-term results and are
cost-effective [3e6]. However, up to 15%-20% of patients may be
dissatisfied with the outcome of knee arthroplasty [7]. It is impor-
tant, therefore, that surgery is reserved for failure of nonoperative
treatment which should be maximized and effective.
Nonoperative treatment may include pharmacological treat-
ments, exercise and physiotherapy programs, dietary advice and
weight loss, and education and advice [8e10]. There is evidence for
the effectiveness of nonoperative measures in both knee and hip
OA [9,11e13]. However, there is conflicting evidence on predictors
of response to nonoperative treatment. Studies have been based on
patient populations in differing settings, with varying interventions
and variable severity of disease [13e15]. There has been a trend0
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 33 (2018) 2780e2786 2781toward the development of a chronic disease management model
with multidisciplinary input aimed at implementing an individu-
alized program for the management of hip and knee OA [8,15]. This
may have advantages in optimizing nonoperative care, reducing the
need for surgery, or delaying it to a more appropriate time, setting
expectations, prehabilitating patients and hopefully may result in
fewer dissatisfied patients [7,12,15,16].
In our institution, we have limited capacity to match the
increasing demand for both out-patient assessment and for surgery
[17e19]. This led us to develop a physiotherapist- and nurse-led
clinic to assess and manage patients with hip and knee OA
[20,21]. We have shown this to be effective as a triage tool which
has freed up surgeon time to see only those most in need of surgical
assessment [21]. The main purpose of the clinic, however, was to
maximize nonoperative management of patients referred with hip
and knee OA.
The purpose of this study was to determine the effectiveness of
and to identify factors associated with response to an individual-
ized multidisciplinary nonoperative program for patients with hip
or knee OA who were initially assessed as being below the
threshold for surgery.Patients and Methods
The joint clinic was developed as part of a wider program to
improve orthopedic patient flows. After a literature review and
consultation, a physiotherapist led out-patient clinic set within the
Orthopaedic Department of our institution was developed [20,21].
Patients referred by their general practitioner (GP) for orthopedic
consultation for symptomatic hip or knee OA were triaged by an
orthopedic consultant surgeon to the joint clinic, on the basis of the
referral letter and radiographs. At the joint clinic, patients were
assessed and examined by a seniormusculoskeletal physiotherapist
and orthopedic nurse, and appropriate radiological investigations
were performed. Patients were given advice and education on their
OA including lifestyle modifications and optimization of analgesia.
An individualized program of interventions was developed which
could include referral to a dietitian, physiotherapist, occupational
therapist, and/or orthotist to develop a chronic disease manage-
ment program aimed at optimizing nonoperative treatment.
Patients could be referred for specialist assessment for surgery
either at initial appointment or at a follow-up appointment. Review
appointments were offered at 6 months and then every 6 months
according to the need. Patients could be referred back before 6
months if their condition had deteriorated.
The inclusion criteria for this study were all patients seen and
subsequently reviewed at the joint clinic. Exclusions were patients
referred for surgical assessment at the initial appointment, those
who chose to go to the private sector, incorrect diagnosis of hip or
knee OA, death or severe illness, and those discharged directly back
to their GP because of a mild clinical presentation. Twenty-threeTable 1
Demographic Details and Baseline Scores for all Patients.
All Patients Male Female
Number (%) 218 100 (46%) 118 (54%)
Age (y), mean (SD) 67.6 (9.4) 67.6 (9.4) 67.7 (9.4)
BMI, mean (SD) for n ¼ 89 29.8 (5.6) 29.7 (4.9) 29.9 (6.2)
OHKS, mean (SD) 21.1 (7.7) 20.8 (7.8) 21.4 (7.6)
SF-12 PCS, mean (SD) 33.4 (8.9) 33.8 (8.9) 33.1 (8.9)
SF-12 MCS, mean (SD) 50.1 (11.0) 50.0 (11.3) 50.3 (10.8)
P values are from Mann-Whitney U tests.
BMI, body mass index; OHKS, Oxford Hip or Knee Score; SF-12 PCS, Short Form-12 Ph
standard deviation.
101patients self-discharged from clinic or failed to attend for planned
follow-up at 6 months.
This study reports on 218 patients with hip or knee OA seen at
the joint clinic over a 2-year period from June 5, 2012 to May 27,
2014 and reviewed at a mean 12 months from the first assessment.
There were 121 (56%) patients with knee OA and 97 (44%) with hip
OA (Table 1.).
Patient-reported outcome measures (PROMs) were collected at
the initial assessment and at follow-up appointments at the joint
clinic. The Oxford score is a condition-specific self-reporting in-
strument commonly used for OA of hip and knee. In this study, the
modified Oxford score was used, which contained 12 questions
scored between 0 and 4, with 4 being the best outcome, thus
yielding a total from 0 (worst outcome) to 48 (best outcome) [22].
The SF-12 is a measure of general well-being, composed of physical
component summary (PCS) and mental component summary
(MCS) scores. The 2 component scores were computed from the
responses to 12 questions yielding a range from 0 (worst outcome)
to 100 (best outcome) [23].
Responders were defined as patients who had an improvement
greater than the minimum clinically important difference (MCID)
for each score. The MCID for the Oxford score may be as low as 2
points between groups. We used a change of 5 points as being a
clinically important difference for an individual patient [22,24]. The
change on SF-12 PCS has also been calculated as 5 points for pa-
tients after TKA [25]. No equivalent figures could be found for MCS
in TJA, but an MCID of 4.4 points has been described following
anterior cruciate ligament reconstruction [26]. Therefore, the MCID
was also, conservatively, taken as 5 points for the MCS.Statistical Analysis
Comparisons between groups were performed using Mann-
Whitney U tests for continuous measures and chi-squared tests
for categorical measures. Spearman's correlations were calculated
for associations between continuous outcomes. Paired t tests were
used to compare changes in each of the 3 outcomes from baseline
to follow-up where the assumption of normally distributed
changes was satisfied. Marginal homogeneity of changes using
MCIDs for pairs of outcome scores was tested using the Stuart-
Maxwell test.
Further analysis were performed using linear regression for
continuous outcomes (changes in each of Oxford, SF-12 PCS, and
SF-12 MCS scores) and multinomial logistic regression for clinically
significant changes in these outcomes (with categories of worse,
stable, and improved based on MCIDs of 5 as described previously).
Analyses were performed including only joint and baseline
outcome scores in the models and then adjusted for baseline age
and gender. Additional analyses were performed adding baseline
body mass index (BMI) to the model where this was available. In-
teractions between each independent variable (age, gender, BMI,Male vs Female (P) Hip Knee Hip vs Knee (P)
97 (44%) 121 (56%)
.991 66.5 (9.7) 68.5 (9.1) .177
.780 28.4 (5.2) 30.8 (5.6) .048
.590 22.1 (8.2) 20.3 (7.2) .104
.606 34.7 (9.6) 32.3 (8.1) .056
.795 50.4 (10.9) 49.9 (11.2) .453
ysical Component Score, SF-12 MCS, Short Form-12 Mental Component Score; SD,
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 33 (2018) 2780e27862782and baseline value) and joint were similarly examined in turn using
likelihood ratio tests. As time until follow-up may affect responses,
sensitivity analyses were performed by adding categories for time
to follow-up to all adjusted models. All statistical analyses were
performed using R version 3.4.3 and libraries as follows: nnet (7.3-
12) for multinomial logistic regression, lmtest (0.9-35) for likeli-
hood ratio tests, andmultcomp (1.4-8) for general linear hypothesis
estimates and tests. Standard model diagnostics were used for all
models, including inspecting linear regression model residuals for
normality and homoscedasticity. Two-sided P < .05 was considered
statistically significant.
Ethics approval was given by the Lower South Regional Ethics
Committee of the New Zealand Ministry of Health (ethics ref. LRS/
12/EXP/018). All participants gave written informed consent.Results
There were 218 eligible patients (mean age 67.6 years; 54% fe-
male) with hip (n ¼ 97, 44%) or knee (n ¼ 121, 56%) OA seen at the
joint clinic on more than one occasion. The mean duration of
follow-up was 365 days (median 353, range 52-1046 days). Oxford
scores at baseline and follow-up were available for all 218 patients
with 194 patients having complete SF-12 scores. There was no
significant difference in age or gender balance between patients
with hip or knee OA, although there was evidence of higher BMIs in
the knee OA group. There was no difference in any of the PROMs at
baseline between genders or between patients with hip or knee OA.
Both SF-12 PCS and MCS scores were positively correlated with
Oxford scores (Spearman's P < .001) but not with each other
(Spearman's P ¼ .137). Demographic details and baseline scores are
summarized in Table 1.
Patients with hip OA deteriorated on all 3 outcome scores (Ox-
ford 3.7 points, SF-12 PCS 2.2 points, and SF-12MCS 3.3 points) (P
.027), while there was evidence of improvements in the Oxford (1.9
points) and SF-12 PCS (2.0 points) (P  .022) but not for the SF-12
MCS for those with knee OA (Fig. 1, Table 2).
There were no statistically significant difference in changes in
scores for either gender or between genders with the mean dif-
ferences in changes <1 point between males and females for Ox-
ford, PCS and MCS.
In multivariable regression models, older patients were more
likely to deteriorate on Oxford score regardless of the joint affected
(P < .001). A similar association with age was seen on SF-12 PCS forFig. 1. Comparison of change in outcome sco
10patients with hip OA (P¼ .002) but not thosewith knee OA. Age had
no significant association with change in SF-12 MCS.
BMI data at original presentation were only available for 89
patients. Worse changes were noted for the Oxford and SF-12 PCS
for those with higher BMI (both P .027) with no effect seen on SF-
12 MCS. Adjusting for BMI when available resulted in similar
findings to those described previously aside from slightly attenu-
ating the age association for SF-12 for thosewith hip OA, which was
no longer statistically significant (P ¼ .056) and revealing a signif-
icant negative association between age and changes in SF-12 MCS
scores (P ¼ .008).
Patients with knee OA had a significantly greater change in
Oxford (P < .001) and SF-12 PCS (P ¼ .009) than those with hip OA,
with a nonstatistically significant tendency for the same pattern
with the SF-12 MCS (P ¼ .081). These differences in the mean Ox-
ford score between patients with hip and knee OA remained after
adjusting for age and gender with the difference increasing to 5.5
points on Oxford and 3.4 points on SF-12 PCS. Similar results were
found when also adjusting for BMI.
In total, 57 of 218 (26%) patients responded with an improved
Oxford score  the MCID of 5 points with similar proportions
responding on the SF-12 PCS (27%) and MCS (25%). In contrast, 70
(32%) on Oxford, 53 (27%) on PCS, and 78 (40%) onMCS deteriorated
by  5 points. There were more patients with knee OA who
responded on Oxford score (35%) and fewer with a deterioration
(21%) than those with hip OA (15%, 45%). However, a greater pro-
portion of patients with knee OA (37%) deteriorated by > MCID for
MCS than on Oxford (21%, Stuart-Maxwell test, P ¼ .007) or PCS
(23%, P ¼ .075) (Fig. 2).
Associations between variables for worsening (score worsening
by 5 or more points) or responding (scores improving by 5 or more
point) were evaluated against remaining stable (Table 3). After
adjusting for baseline characteristics, there was evidence for
greater odds of deterioration on Oxford score in patients with hip
OA comparedwith knee OA (adjusted odds ratio [aOR] 2.6, P¼ .006)
and with increasing age (aOR 1.31/5 years, P ¼ .005), while male
gender almost reached significance (aOR 0.5, P ¼ .050). Increasing
age was also associated with higher odds for worsening >5 points
on both SF-12 PCS (aOR 1.35/5 years, P ¼ .007) and MCS (OR 1.24/5
years, P ¼ .021).
Adjusted regression models were rerun adding a variable indi-
cating duration of follow-up, based on categories of <10 months,
(n ¼ 101, 46.3%), 10-14 months (n ¼ 75, 34.4%), and >14 months
(n ¼ 42, 19.3%). This made little change to the results in theres for patients with hip and knee OA.
2
Table 2
Changes for Each Outcome Measure and Associations With These for Patient Characteristics.
Outcome
Oxford SF-12 PCS SF-12 MCS
Pre Post Difference/
Slope
95% CI P value Pre Post Difference/
Slope
95% CI P value Pre Post Difference/
Slope
95% CI P value
Unadjusted
Hips 22.1 18 3.7 5.4 to 2.0 <.001 34.7 32.5 2.2 4.1 to 0.2 .027 50.4 47.1 3.3 5.7 to 0.8 .010
Knees 20.3 22 1.9 0.4 to 3.3 .012 32.3 34.3 2.0 0.3 to 3.7 .022 49.9 49.4 0.5 2.7 to 1.6 .625
Joints: hips compared
with knees




0.7 2.8 to 1.4 .531 0.1 2.3 to 2.1 .924 0.3 3.1 to 2.6 .847
Age (per 5 y) 1.0 1.6 to 0.5 <.001 0.4 1.1 to 0.4 .346
Age (per 5 y) for hips 1.4 2.2 to 0.5 .002
Age (per 5 y) for knees 0.1 1.0 to 0.8 .800
Joints: hips compared
with knees
5.5 7.6 to 3.3 <.001 3.4 5.6 to 1.1 .004 2.6 5.5 to 0.2 .073
Pre-post tests are from paired t tests; all other results are from linear regression models adjusting for baseline values and other variables as indicated. Bold text denotes
statistical significance (P value < .05).
CI, confidence interval; SF-12 PCS, Short Form-12 Physical Component Score, SF-12 MCS, Short Form-12 Mental Component Score.
a Adjusted for all other variables in the model.
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 33 (2018) 2780e2786 2783continuous or MCID models. Follow-up category was associated
with outcomes on Oxford (P¼ .022), with worse outcomes for those
with 10- to 14-month follow-up. For the Oxford MCID model,
follow-up category was again significant (P ¼ .013); the non-
statistically significant tendency towards lower odds for hips
responding became statistically significant (OR 0.44, 95% CI 0.20-
0.95, P ¼ .036). For SF-12 PCS, follow-up category was not statisti-
cally significant for the continuous model (Wald P ¼ .103) but was
for theMCIDmodel (Wald P¼ .035), where themiddle category had
the lowest odds of improving. For SF-12 MCS, there was no evi-
dence for any association with follow-up category (Wald P ¼ .769
for continuous and P ¼ .525 for the MCID model).
Eighty-one patients (37%) subsequently underwent surgery of
which 9 patients had elected to self-fund in the private sector.
Patients with hip OA (52 of 97, 54%) were significantly more likely
than those with knee OA (29 of 121, 24%) to have undergone sub-
sequent surgery (chi-square, P < .001).Discussion
This study, in a secondary care setting, with patients referred by







Improved No Change Deteriorated
Fig. 2. Comparison between proportion of patients with hip and knee OA changing by
greater than Minimum Clinical Important Difference (MCID) of 5 points from baseline
to final visit on each score.
103nonsurgical management with an individualized chronic disease
management program can result in a clinically significant
improvement in Oxford scores in 26% of patients while 32% deteri-
orate. Younger patients and those with knee OAweremore likely to
respond. Increasing age, increasedBMIat baseline, andpatientswith
hip OA had an increased risk of deteriorating. This is consistentwith
systematic review evidence that indicates that increasing age is
predictive of long-termprogression of hip and kneeOA and that BMI
was a strong predictor for long-term progression of knee OA [27,28].
There is evidence to show that nonoperative treatment for both
hip and knee OA can be effective even in patients referred for or-
thopedic assessment with advanced disease. Skou et al conducted a
randomized clinical trial (RCT) comparing TKA with nonoperative
treatment and showed that while TKAwas more effective, the knee
injury and osteoarthritis score in the nonoperative group improved
by 16 points and only 26% of the group underwent surgery in the
next 12 months [29]. In another RCT by the same group, a 12-week
nonsurgical treatment program was compared with usual care in
patients falling below the clinical threshold for total knee arthro-
plasty (TKA) [11].The knee injury and osteoarthritis score improved
by 18.7 points and was 9.6 points higher than usual care. However,
the proportion improving by at least 15% from baseline score (64%
compared to 50%) was not significantly greater than the usual care
group. In a large study of patients with mild knee OA, the odds ratio
of improvement in pain was higher by a factor of 2 in patients
receiving physiotherapy or multimodal treatment with radio-
graphic severity not associated with improvement in pain [30].
Svege et al [12], in a randomized trial, compared education and
exercise therapy with education alone in patients with symptom-
atic and radiographic OA of hip. Exercise delayed the median time
to total hip arthroplasty (THA) from 3.5 to 5.4 years, with 41%
survival of the native hip at 6 years compared to 25% in the edu-
cation only group. However, Bennell et al [31] in a RCT comparing
sham treatment with physiotherapy showed no improvement with
the active program in patients with hip OA.
Some studies have included patients with hip and knee OA,
though the effect of joint on response has been inconsistent. Weigl
et al in a study of patients with hip (36%) and knee OA (64%) found
that the joint affected was not a predictor. However, females, those
without depression, taking complementary medicines and with
low comorbidities had a response with 35% improving greater than
Table 3
Clinically Significant Changes for Each Outcome Measure (Change of 5 Points or More) and Associations With These for Patient Characteristics.
OR for Worse 95% CI P value OR for Better 95% CI P value
Oxford
Unadjusted
Joints: hips compared with knees 2.21 1.15-4.24 .017 0.50 0.24-1.02 .057
Adjusteda
Sex: male compared with female 0.80 0.41-1.55 .509 0.50 0.25-1.00 .050
Age (per 5 y) 1.31 1.08-1.57 .005 0.94 0.78-1.13 .541
Age (per 5 y) for hips
Age (per 5 y) for knees
Joints: hips compared with knees 2.60 1.32-5.13 .006 0.50 0.24-1.05 .066
SF-12 PCS
Unadjusted
Joints: hips compared with knees 1.08 0.51-2.27 .835 0.58 0.28-1.19 .135
Adjusteda
Sex: male compared with female 0.71 0.33-1.54 .388 0.76 0.38-1.54 .448
Age (per 5 y) 1.35 1.09-1.68 .007 1.07 0.88-1.31 .505
Age (per 5 y) for hips
Age (per 5 y) for knees
Joints: hips compared with knees 1.24 0.58-2.68 .581 0.60 0.29-1.24 .168
SF-12 MCS
Unadjusted
Joints: hips compared with knees 1.07 0.56-2.05 .837 0.54 0.23-1.24 .146
Adjusteda
Sex: male compared with female 1.15 0.59-2.24 .680 0.90 0.39-2.07 .800
Age (per 5 y) 1.24 1.03-1.49 .021 1.13 0.89-1.42 .312
Age (per 5 y) for hips
Age (per 5 y) for knees
Joints: hips compared with knees 1.17 0.60-2.28 .646 0.57 0.25-1.34 .199
All results are from multinomial logistic regression models adjusting for baseline values and other variables as indicated. Bold text denotes statistical significance (P value <
.05).
CI, confidence interval; OR, odds ratio.
a Adjusted for all other variables in the model.
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(WOMAC) at 6 months [14]. Angst et al [13] reported on patients
with hip and knee OA who were admitted for 3 weeks of inpatient
rehabilitation and found no difference between hip and kneewith a
significant improvement of 10 points on WOMAC score for each at
discharge. The improvements seen on SF-12 for both hip and knee
were small with only PCS knee (2.7 points) reaching statistical
significance. In our study, we saw a similar improvement in PCS for
patients with knee OA, whereas those with hip OA deteriorated
significantly on both PCS and MCS.
Eyles et al [15] reported their results using a similar chronic
diseasemanagement program at 6months, in a setting inwhich the
majority of patients (90%) came from surgical waiting lists. Twenty-
eight percent of the whole group was classified as responders (an
improvement of minimum 9 points and 18% from baseline
WOMAC). Patients with knee OA were more likely to respond than
those with hip OA (OR 1.9), while males were less likely to respond
than females (OR 0.55). Age and BMI were not predictors of a
response in their study. However, in a further study, they concluded
that variables that predict worsening of OA following a chronic
disease management program remain largely unknown [32]. We
found very similar ORs for response for joint affected and gender in
our study but at longer follow-up of 1 year. The relationship with
gender did not quite reach significance, however.
Our response rate of 26% is similar to these reports despite there
being a higher proportion of patients with hip OA (44%) in this
study than in others (15%-36%) [13e15,32]. Our response rate for
patients with OA knee was 35%. We did not see improvements in
mean scores reported in previous studies. The follow-up periodwas
for 1 year on average, and initial improvements may have been lost
as the disease progressed. The patients all had radiologically proven
OA and had been referred for assessment of surgery which may
explain the relatively low responder rate. We believe that the10difference demonstrated between hip and knee OA bears out our
clinical impression that patients with knee OA can improve with
nonoperative treatment such as a muscle strengthening program
and weight loss, while those with established hip OA tend to
progress. We found changes with the condition-specific Oxford
score tended to be greater than the more generic SF-12. As ex-
pected, the PCS tended to mirror the changes in Oxford score for
both the hip and knee groups. The higher proportion deteriorating
and lower proportion improving on MCS for those with knee OA
suggests that while there may be some improvement in physical
function, patients may not be satisfied.
We have problems with access to both surgical consultation
and joint arthroplasty. The joint clinic was developed to help
improve access by prioritizing those patients most in need of
surgical assessment and to optimize nonoperative management
of those with less severe symptoms. It is effective at triaging
patients with 93% of patients referred on to a specialist being
recommended surgery [20]. The clinical threshold score for sur-
gery may vary in different centers and countries [33]. During the
same period, in our center, the average preoperative OKS was 11.1
and postoperative OKS was 39.8 [34]. The patients in our study
were assessed as not requiring or qualifying for surgery at their
initial appointment and are at the milder end of the spectrum of
symptoms that we see. However, they may have been recom-
mended surgery elsewhere if access was better. Had they been
able to access surgery the potential improvement of 15-20 points
from their baseline score is significantly more than the relatively
small changes seen as a result of the joint clinic interventions.
While we believe that the joint clinic helped prepare patients for
surgery, it was outside the scope of this study to look at out-
comes following subsequent surgery.
Up to 20% patients are dissatisfied or unsure following TKA [7].
Clementet al [35] reported thatmeetingpatient expectations andan4
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 33 (2018) 2780e2786 2785increase in OKS of more than 12 points or a postoperative score of
>31 was associated with satisfaction. Scott et al [7] reported that
poorer preoperativeMCS scores have been shown to be predictive of
poor outcomes after TKA with a mean drop of 2 points in the
dissatisfied group with an increase of 1.9 points in the satisfied pa-
tients. In this study, we saw no significant change on MCS for those
with knee OA, but patients with hip OA showed a mean drop of 3.3
points. Forty percent of all patients deteriorated by 5 points ormore
on the MCS which is likely to be a clinically relevant amount.
This is an observational study investigating the effectiveness of
and potential associations with patient characteristics and
response to an individualized multidisciplinary chronic disease
management program for hip and knee OA. A strength of the study
is that both a condition-specific PROM and a general health PROM
were collected, including a mental component score. There were
similar proportions of patients with hip and knee OA who were
well matched with respect to age, gender, and baseline scores.
Other studies have relatively low numbers of patients with hip OA
which may have led to inadequate power to detect the differences
we found. Follow-up was at an average of 1 year rather than 6
months or less, and patients were not taken from the surgical
waiting lists which might influence patient expectations. The joint
clinic was set in a real-world clinical setting and thus is potentially
generalizable and may offer benefit for other health-care systems
that face increasing demand.
A weakness of the study is that there was no single intervention
offered, as treatment was individualized. Our BMI data were incom-
plete, and we did not record weight change. There was no control
group to assess the effectiveness of the program. We may, therefore,
be reporting the natural history of hip and knee OA. However, we
believe that these results are still relevant. Theymight help to identify
patients who are likely to respond or deteriorate following nonop-
erative treatment at 1 year. It is desirable to concentrate efforts on
those patients in whom there is a reasonable expectation that
nonoperative treatmentwill lead toaclinically relevant improvement
that may postpone or even avoid the need for surgery. Conversely,
there is little point in prolonged nonoperative treatment that delays
surgery for patients who are most likely to deteriorate.
Conclusion
Nonsurgical management for patients with hip and knee OA
with an individualized chronic disease management program can
result in a clinically significant improvement in 26% of patients
while 32% deteriorate. Factors associated with a response were
patients with knee OA and younger patients. Increasing age and
patients with hip OA were associated with an increased risk of
deteriorating with over half the patients with hip OA progressing to
surgery compared with 24% of patients with knee OA. This suggests
that programs such as this may be better directed toward younger
patients and those with knee OA. This model may work better for
patients with less severe osteoarthritis.
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Background: The purpose of this study is to determine outcomes of a nonoperative treatment service for
hip and knee osteoarthritis (OA), the “Joint Clinic,” at minimum 5-year follow-up, and investigate factors
that may influence progression to joint replacement surgery.
Methods: This is an observational cohort study of 337 patients with hip (n ¼ 151, 45%) or knee OA (n ¼
186, 55%) seen at the Joint Clinic, at 5-7 years of follow-up. Kaplan-Meier survival curves were used to
determine survivorship of the affected joint and Cox regression used to determine factors associated
with time to surgery.
Results: At mean 6-year follow up, 188 (56%) patients had undergone or were awaiting total joint
arthroplasty, 127 (38%) were still being managed nonoperatively, and 22 (7%) had died without having
surgery. Patients with hip OAwere more likely to have required surgery (111/151, 74%) than patients with
knee OA (77/186, 41%) (chi-square ¼ 33.6, P < .001). The 7-year surgery-free survival for hip OA was
23.7% and knee OA 55.9% (P < .001). Factors associated with increased likelihood of surgery were joint
affected (hip, hazard ratio [HR] 2.80), Kellgren-Lawrence (KL) grade (KL 3, HR 2.02; KL 4, 4.79), and
Oxford Hip/Knee Score (HR 1.34 for each 5 points worse at baseline).
Conclusion: More than 50% of the patients referred to secondary care with mild-moderate knee OA may
not need surgery at 7 years. Patients with hip OA and those with severe radiographic changes are more
likely to require surgery and should not be delayed if there is not an adequate response to conservative
measures.
© 2020 Elsevier Inc. All rights reserved.Total hip arthroplasty (THA) and total knee arthroplasty (TKA)
are highly effective interventions for advanced stage osteoarthritis
(OA). The demand for arthroplasty is increasing which is putting
pressure on hospital services, and despite the success of THA andclosed potential or pertinent
ent, either direct or indirect,
the biomedical field which
rest with this work. For full
j.arth.2020.01.086.
BCh, FRACS (Orth), Depart-
strict Health Board, Dunedin,
107TKA not all patients are satisfied and the complications of surgery
may be major [1,2]. Therefore it is important that nonoperative
options should be exhausted before surgery [3,4].
There is strong evidence to suggest that nonoperative treatment
can be beneficial in patients with OA and may reduce or delay the
need for surgery [5e7]. A multidisciplinary chronic disease man-
agement approach has been recommended [3,4]. However, many of
these studies have relatively short-term follow-up and it is less
clear what the long-term results are of nonoperative treatment.
Studies have shown that the time to surgery may be delayed [7] or
need for surgery reduced, with 54% of patients not progressing to
surgery at 6 years after initial consultation [8]. However, these re-
ports are from countries with different healthcare systems and the
Table 1
Descriptive Statistics of the Sample.
Knee OA Hip OA Hip OA vs Knee
OA Comparison
P-Value
Total, n 186 151
Age (y) 68.1 (9.2) 66.4 (11.6) .134
Gender (female), n (%) 102 (54.8%) 85 (56.3%) .875
BMI (kg/m2) 31.5 (6.1) 28.8 (5.3) <.001
Healthy weight, n (%) 11 (10.4%) 28 (25.5%) <.001
Overweight, n (%) 40 (37.7%) 44 (40.0%) .129
Obese, n (%) 55 (51.9%) 38 (34.5%) .388
K-L grade, n (%) .231
Grade 1 18 (9.7%) 7 (4.6%) .096
Grade 2 50 (26.9%) 35 (23.2%) .452
Grade 3 88 (47.3%) 80 (53.0%) .381
Grade 4 30 (16.1%) 29 (19.2%) .388
Health-related quality
of life scales
Oxford Hip/Knee Score 19.5 (7.8) 20.3 (8.7) .356
SF-12 PCS 31.9 (8.0) 33.2 (9.2) .184
SF-12 MCS 48.4 (11.9) 48.8 (11.9) .778
Time to final follow-up (y) 6.1 (0.6) 6.1 (0.6) .809
Death prior to surgery 11 (5.9%) 11 (7.3%) .661
Cells are reported as mean (SD) unless otherwise specified.
OA, osteoarthritis; BMI, body mass index; K-L grade, Kellgren-Lawrence radio-
graphic OA grade; SF-12, Short Form 12; PCS, Physical Component Summary; MCS,
Mental Component Summary.
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threshold to access THA and TKA may vary. If these results can be
reproduced in other public health systems that have capacity
constraints, there would be important benefits.
In New Zealand (NZ), as in other countries, the incidence of hip
and knee OA has been rising due to the aging and growing popu-
lation, and increasing prevalence of obesity [9,10]. Consequently,
there is an increasing demand for both orthopedic outpatient ap-
pointments (the initial of which, for each patient, is termed the First
Specialist Assessment [FSA] in our health service) and THA and TKA
in the public sector [11,12]. The expectation from the NZMinistry of
Health is that a patient should be seen within 4 months of accep-
tance of a referral. Breaches of this target are monitored with the
potential for financial penalties to the District Health Board (DHB).
However, if there is insufficient capacity to meet this target, the
DHB is allowed to decline the referral to prevent breaches. Simi-
larly, if a patient is recommended surgery but it cannot be per-
formedwithin 4 months, then they can be declined and returned to
their general practitioner (GP) for ongoing care. This has led to the
development of scoring systems designed to prioritize patients and
the concept of a “financial threshold” score for surgery [13]. The
Joint Clinic (JC) was set up in 2012 to improve access to specialist
consultation and maximize nonoperative treatment by meeting
unmet demand through a multidisciplinary chronic disease man-
agement approach [14]. An audit of the first 2 years of patients seen
at the JC showed that 69% of patients were still being managed
nonoperatively [15]. Patients with hip OA were more likely to have
undergone surgery than thosewith knee OA and patients with knee
OA were more likely to have a clinically significant improvement
[15,16].
The purpose of this study is to determine long-term outcomes
following nonoperative treatment coordinated through the JC. If
the early results are maintained at 5 years this would be clinically
important both for patients and for an over-stretched public health
service. The primary outcome of our study is to determine the
proportion of patients that are still beingmanaged without surgery.
Secondary outcomes are to determine what factors may be asso-
ciated with requiring surgery or not at minimum 5-year follow-up.
Methods
This is an observational study of 339 patients seen at the JC
between June 2012 and May 2014, with a mean follow-up period of
6.1 years. Patients with hip or knee OA referred by their GP to the
orthopedic department were triaged to JC for evaluation. An indi-
vidualized management program was developed which included
advice on their condition, optimization of analgesia, and referral for
an outpatient physiotherapy OA program, occupational therapy,
dietitian advice, or orthotic management where indicated [14].
Patients could be referred for FSA if their presentation was severe
enough. Patients were reviewed every 6 months until they were
discharged back to GP if their symptoms were stable, or they had
deteriorated to the extent that they needed referral for surgical
assessment. Patients with bilateral diseasewere included and those
referred with both hip and knee OA were classified by the most
symptomatic joint at baseline. Two patients of the 339 had been
referred with painful joint replacements and were excluded. This
left 337 eligible patients with hip OA (n ¼ 151, 45%) and knee OA
(n ¼ 186, 55%) seen at the JC during its first 2 years of operation.
Baseline data including age, gender, body mass index (BMI), and
joint affected were collected at initial assessment. Radiographic
stage at presentation was assessed using the Kellgren-Lawrence
(KL) system [17]. Patient-reported outcome measures (PROMs)
were gathered at initial assessment and at subsequent follow-up
visits. The Oxford Hip and Knee Scores (OHS, OKS) include 1210questions on activities of daily living designed to assess pain and
function of the hip or knee. The scores are graded from 0 being
most severe to 48 being no problems with the joint [18]. The Short
Form 12 (SF-12) was also collected which allowed calculation of the
physical component score (PCS) and mental component score
(MCS) [19].
Subsequent patient outcomes including PROMs were deter-
mined by accessing a combination of Orthopedic Department da-
tabases, electronic patient records, and radiology systems to
provide details of any completed surgery. This was cross-referenced
with the NZ National Joint Registry to find details of surgery per-
formed elsewhere in NZ [20]. A questionnaire was also sent out to
patients to confirm their current status with 213 of 308 (69%)
surviving patients responding. The final outcome with respect to
surgery was determined for all patients.
Kaplan-Meier curves were calculated to determine survivorship
of the affected joint with the end point of joint replacement. Uni-
variate andmultivariate Cox regression analyses were performed to
investigate the relationship among baseline variables including
joint affected, radiographic grade, age, gender, BMI, and PROMs,
and time to surgery. Statistical analysis was performed using R
version 3.6.0 [21]. Statistical significance was taken as P < .05.Results
The hip and knee cohorts were very similar in baseline char-
acteristics with the only statistically significant difference being a
higher BMI in patients with knee OA (Table 1). There were fewer
patients of healthy weight (BMI <25 kg/m2) with knee OA. In total,
188 (56%) of the 337 patients either had surgery (186) or were
waitlisted for surgery (2 patients). Twenty-two patients (7%) had
died without having surgery, of which 2 patients (1 hip, 1 knee)
were waitlisted but died before surgery. Seven patients who had
undergone THA (4) or TKA (3) had died. One hundred twenty-seven
(38%) of all patients were still being managed nonoperatively.
A higher proportion of patients initially presenting with hip OA
have had or are awaiting surgery (111 of 151; 74%) compared with
patients with knee OA (77 of 186; 41%, P < .001). This includes 18
J.H. Gwynne-Jones et al. / The Journal of Arthroplasty 35 (2020) 1497e1503 1499patient awaiting surgery in each group. Two patients initially seen
with knee OA have subsequently developed hip OA and undergone
THA.
Of the 127 surviving patients that have not had surgery (29 hip
OA, 98 knee OA), 25 have had an FSA. Nine were advised surgery
but scored below the financial threshold and returned to GP care
and 16 were not recommended surgery. Eight patients who had
been discharged from JC were re-referred but assessed as being
below the threshold for surgery and therefore not referred for FSA.
The remaining 94 patients (24 hips, 70 knees) have either been
discharged back to their GP (71) or self-discharged from JC due to
self-managing the disease at the time of review (20). Three patients
were too ill to consider surgery (Fig. 1). Follow-up PROMs were
available for 101 of the 127 (80%) patients in the nonoperative
group. For patients with hip OA, the mean OHS (change from
baseline) was 25.3 (0.2), SF-12 PCS 35.2 (0.2), and MCS 43.9
(2.9). For patients with knee OA, the corresponding scores were
OKS 24.8 (þ3.1), SF-12 PCS 35.0 (þ2.1), and MCS 48.7 (1.9). For
patients with hip OA, 25% had improved and 36% deteriorated by 5
points or more on OHS/OKS at latest review. The corresponding
figures for patients with knee OA were 42% improved and 24%
worse.
A Kaplan-Meier survival curve censoring patients when they
underwent surgery or died showed that 46% of all patients at 5
years and 41.6% at 7 years had not undergone surgery. There was a
significantly higher chance of not requiring surgery in patients with
knee OA (55.9% at 7 years) than thosewith hip OA (23.7% at 7 years)
(Fig. 2). The radiographic grade of OA was associated with the106 surviving 
pa ents with 
THA
1 on wait list
29 non-
opera ve
4 FSA (2 below threshold, 
2 not for surgery)












Fig. 1. Flow chart showing outcomes of patients seen at Joint Clinic. OA, osteoarthritis; JC, Jo
arthroplasty.
109likelihood of undergoing surgery with a statistically significantly
greater risk of surgery with increasing K-L grade (Fig. 3). When the
THA and TKA groups were analyzed separately (Fig. 4), there was
little difference in survival for K-L grade 3 and 4 for hip OA, with
similar proportions surviving without surgery at 7 years (grade 3,
14.3%; grade 4, 11.6%). However, for knee OA there was a strong
association with K-L gradedthose with grade 4 at baseline had
progression rates close to those of patients with advanced hip OA
(20% survival at 7 years), but those with grade 2 or 3 had a lower
rate of progression to TKA.
Univariate and multivariate Cox regression (Table 2) revealed
that patients with hip OAwere significantly more likely to undergo
surgery than those with knee OA (multivariate hazard ratio [HR]
2.80, P < .01). K-L radiographic grade was strongly associated with
likelihood of surgery on both univariate and multivariate Cox
regression (Fig. 3, Table 2) with a HR of 2.02 for K-L grade 3 and 4.79
for grade 4 (multivariate model). Age was significant in the uni-
variate model only, with an 8% increase in risk of progressing to
surgery for each additional 5 years of age at baseline. Gender and
BMI were not significant predictors of the likelihood of surgery. The
OHS/OKS was significant on both univariate and multivariate
models with a 34% increase in risk for each 5 points worse at
baseline. SF-12 PCS score was significant only in the univariate
model, with an increase in risk of 16% for each 5 points worse at
baseline.
When patients with hip and knee OA were analyzed separately,
in the multivariate model, patients with knee OA K-L grade 3 and 4
and worse SF-12 PCS were significantly more likely to undergo73 surviving 
pa ents with 
TKA





21 FSA (14 not for 
surgery, 7 below 
threshold)












int Clinic; FSA, First Specialist Assessment; THA, total hip arthroplasty; TKA, total knee
Fig. 2. Kaplan-Meier curve showing survival of joints not requiring surgery compared to patients with hip and knee osteoarthritis. Survival (%, 95% confidence intervals) at 5 years:
knee ¼ 61.5% (54.8-69.0), hip ¼ 26.5% (20.1-34.9); 6 years: knee ¼ 58.6% (51.7-66.4), hip ¼ 23.7% (17.5-32.1); and 7 years: knee ¼ 55.9% (48.5-64.4), hip ¼ 23.7% (17.5-32.1).
J.H. Gwynne-Jones et al. / The Journal of Arthroplasty 35 (2020) 1497e15031500surgery. For patients with hip OA, K-L grade 4, a worse OHS or a
higher SF-12 MCS were significant (Table 3).
Discussion
To our knowledge, this is the largest longitudinal cohort study of
nonoperative treatment of hip and knee OA with minimum 5-year
follow-up. We have shown that 44% of the patients initially seen at
the JC have not undergone surgery at 5-7 years of follow-up. Pa-
tients with knee OA (59%) were more likely to have not undergone
surgery than those with hip OA (26%). As expected, compared with
the 2-year results [15], a greater proportion of patients have pro-
gressed to surgery, but the differences between hip and knee are
maintained. The baseline factors associated with requiring surgery
were joint affected, that is, hip rather than knee, more advancedFig. 3. Kaplan-Meier survival curve for proportion not requiring surgery by Kellgren-Lawren
(100.0-100.0), grade 2 ¼ 62.9% (53.4-74.2), grade 3 ¼ 38.8% (32.0-47.1), grade 4 ¼ 18.3% (10
35.1% (28.4-43.5), grade 4 ¼ 15.6% (8.2-29.7); and 7 years: grade 1 ¼ 95.0% (85.9-100.0), gr
11radiographic grade, and worse baseline OHS/OKS. The group of
patients with knee OA who were still being managed non-
operatively had small gains in mean OKS and SF-12 PCS compared
with baseline which may not be clinically relevant, while the group
with hip OA who were still being managed nonoperatively, had no
change.
A similar Australian study from Dabare et al [8] of 247 patients
reported 54% of patients not requiring surgery at 6 years. The pa-
tient characteristics are comparable between the studies, but their
cohort included only 80 patients (30%) with hip OA compared to
151 (45%) in this study. Patients in the Australian study were
referred either from orthopedic outpatients or the community
because they were not in need of surgery and there was ready ac-
cess to surgery for patients that needed it as soon as nonoperative
treatment was determined to not be providing an improvement. Ince grade at baseline. Survival (%, 95% confidence intervals) at 5 years: grade 1 ¼ 100.0%
.4-32.1); 6 years: grade 1 ¼ 95.0% (85.9-100.0), grade 2 ¼ 62.9% (53.4-74.2), grade 3 ¼
ade 2 ¼ 59.0% (47.9-72.6), grade 3 ¼ 33.9% (27.1-42.4), grade 4 ¼ 15.6% (8.2-29.7).
0
Fig. 4. Kaplan-Meier survival curve for proportion not requiring surgery by Kellgren-Lawrence grade at baseline by affected joint. Survival at 5 years (95% CIs): knee: grade 1 ¼
100.0% (100.0-100.0), grade 2 ¼ 78.0% (67.3-90.4), grade 3 ¼ 58.7% (49.1-70.2), grade 4 ¼ 20.0% (9.8-40.9); hip: grade 1 ¼ 100.0% (100.0-100.0), grade 2 ¼ 40.4% (26.7-61.3), grade
3 ¼ 17.3% (10.6-28.3), grade 4 ¼ 17.4% (7.4-41.2); 6 years: knee: grade 1 ¼ 93.3% (81.5-100.0), grade 2 ¼ 78.0% (67.3-90.4), grade 3 ¼ 54.4% (44.6-66.4), grade 4 ¼ 20.0% (9.8-40.9);
hip: grade 1 ¼ 100.0% (100.0-100.0), grade 2 ¼ 40.4% (26.7-61.3), grade 3 ¼ 14.3% (8.1-25.0), grade 4 ¼ 11.6% (3.6-37.6); and 7 years: knee: grade 1 ¼ 93.3% (81.5-100.0), grade 2 ¼
71.5% (57.1-89.6), grade 3 ¼ 52.2% (42.1-64.7), grade 4 ¼ 20.0% (9.8-40.9); hip: grade 1 ¼ 100.0% (100.0-100.0), grade 2 ¼ 40.4% (26.7-61.3), grade 3 ¼ 14.3% (8.1-25.0), grade 4 ¼
11.6% (3.6-37.6).
J.H. Gwynne-Jones et al. / The Journal of Arthroplasty 35 (2020) 1497e1503 1501contrast, our study cohort consists of patients that were referred to
the orthopedic department by their GP for consideration of surgery
and triaged to the JC. If the 29 patients who were referred for
surgery at their initial JC appointment were excluded then 149 on
308 patients (48%) had not progressed to surgerywhich gives a very
similar result to the Australian study where there were no access
barriers to surgery.
Like us, Dabare et al [8] found that patients with hip OA (60%)
were more likely to have undergone surgery than those with knee
OA (33%) at 6 years. They reported that the rate of progression to
surgery declines after 3 years for both hip and knee cohorts. Our
results show a similar trend with patients with hip OA requiring
surgery earlier than knees, but a flattening of the curves after the 3-
year mark and roughly equal rates thereafter (Fig. 2). This may be
because patients fit enough for surgery will have it early while less
medically fit patients will remain. Svege et al [7], in a randomizedTable 2
Relationship Between Baseline Variables and Time-to-Surgery.






Hip 2.63 (1.95-3.53)a 2.80 (2.05-3.83)a
Age (y) 1.08 (1.00-1.16)b 1.03 (0.96-1.11)
Gender
Male Reference
Female 0.87 (0.65-1.16) 0.91 (0.67-1.23)
BMI 0.92 (0.80-1.06) e
K-L grade
Grade 1-2 Reference
Grade 3 2.70 (1.82-3.99)a 2.02 (1.33-3.07)a
Grade 4 5.43 (3.46-8.51)a 4.79 (2.96-7.77)a
Health-related quality of life scales
Oxford Hip/Knee Score 0.74 (0.67-0.82)a 0.74 (0.66-0.85)a
SF-12 PCS score 0.86 (0.79-0.94)a 0.96 (0.86-1.06)
SF-12 MCS score 0.97 (0.91-1.04) 1.08 (1.00-1.16)
All cells report hazard ratio (95% confidence interval). Hazard ratios for continuous
variables (age, BMI, health-related quality of life scales) are reported for a 5-point
change in the continuous scale. BMI was dropped due to the proportion of
missing values.
BMI, body mass index; K-L grade, Kellgren-Lawrence radiographic osteoarthritis
grade; SF-12, Short Form 12; PCS, Physical Component Summary; MCS, Mental
Component Summary.
a P < .01.
b P < .05.
111control trial of 109 patients with hip OA that compared usual care
with an exercise program, reported 75% patients progressing to
surgery with usual care, compared to 59% in the group provided an
exercise therapy program. The slope of the Kaplan-Meier curve in
their study did not appear to vary over the 6-year period.
It is not surprising that we found a strong association with K-L
grade and progression to surgery. At baseline, 227 of 337 patients
(67%) had advanced changes (K-L stage 3 and 4). The odds of a
patient with K-L grade 3 progressing to surgery was twice that of a
patient with K-L grade 1 or 2 OA, and the odds of patients with K-L
grade 4 OA progressing to surgery were 4.79 times those with K-L
grade 1 or 2 disease. Patients with knee OA showing K-L grade 4
changes had a rate of progression to surgery that was comparable
with stage 3 and 4 hip OA but a better prognosis for other grades.
Dabare et al [8] reported very similar HRs for K-L stage 3 (HR 2.62,
not significant) and 4 (HR 4.96, P ¼ .001) changes compared with
grade 1 and 2. Radiographic changes do not always correlate with
symptoms; Skou et al [22], in a large series of 1414 patients with
knee OA (82% K-L stage 3 and 4) at 1-5 years of follow up, reported
that nonoperative treatment improved pain regardless ofTable 3
Relationship Between Baseline Variables and Time-to-Surgery, Stratified by Affected
Joint.
Baseline Variable Knee Hip
Age (y) 1.14 (0.97-1.33) 1.01 (0.93-1.10)
Gender
Male Reference
Female 0.69 (0.42-1.11) 0.97 (0.64-1.47)
K-L grade
Grade 1-2 Reference
Grade 3 2.52 (1.29-4.95)a 1.65 (0.96-2.83)
Grade 4 8.27 (3.91-17.47)a 3.14 (1.65-5.98)a
Health-related quality of life scales
Oxford Hip/Knee Score 0.77 (0.58-1.01) 0.74 (0.63-0.86)a
SF-12 PCS score 0.79 (0.64-0.98)b 1.01 (0.89-1.15)
SF-12 MCS score 0.98 (0.85-1.13) 1.14 (1.03-1.26)b
All cells report hazard ratio (95% confidence interval), from a multivariate model
including all other covariates. Hazard ratios for continuous variables (age, BMI,
health-related quality of life scales) are reported for a 5-point change in the
continuous scale.
BMI, body mass index; K-L grade, Kellgren-Lawrence radiographic osteoarthritis
grade; SF-12, SF-12, Short Form 12; PCS, Physical Component Summary; MCS,
Mental Component Summary.
a P < .01.
b P < .05.
J.H. Gwynne-Jones et al. / The Journal of Arthroplasty 35 (2020) 1497e15031502radiographic severity. Dowsey et al [23,24] reported poorer out-
comes after THA and TKA in patients with less severe radiographic
changes, suggesting that caution should be exercised before rec-
ommending surgery in patients with less severe radiographic
disease.
The baseline OHS or OKS was a significant determinant of pro-
gression to surgery with a 34% increase in risk of surgery for each 5
point lower OHS/OKS at baseline. When patients with knee OA
were analyzed separately, the baseline OKS had a similar trend but
just failed to reach significance due to wide confidence intervals;
however, the SF-12 PCS was significantly associated with progres-
sion to surgery. This suggests that both condition-specific PROMs
such as the OHS/OKS and general scores such as the SF-12 are useful
in prioritizing healthcare decisions. These results are consistent
with those of Dabare et al [8] in their univariate model; however, in
the multivariate model only pain scores remained significant. This
difference may be explained by our use of a prioritization tool
during the time of this study which has been shown to correlate
well with the OHS/OKS [13], whereas the study of Debare et al was
in a setting in which there was ready access to surgery and no
surgical prioritization was used.
We found no significant association between age and progres-
sion to surgery. The relationship with age is complex. A surgeon
may be less likely to offer surgery to a younger patient because of
the increased risk of requiring a revision procedure or to an older
patient because of elevated surgical risk due to comorbidities. An
older patient may be less able to participate in an exercise program
or may tolerate pain and loss of function less well, but conversely
may have lower demands than a younger patient. Dabare et al [8]
found that the influence of age followed an inverted U appearance
(a quadratic function), with the largest hazard of surgery at 67
years, which may reflect these competing influences.
Dabare et al [8] concluded that a larger proportion of patients
with hip OA present with worse symptoms, and require earlier
arthroplasty than those with knee OA. However, as the progression
to surgery slows down after 3 years there is a major role for con-
servative treatment of both hip and knee OA patients in the long
term. They advocated persistence with conservative treatment
regardless of stage of disease at presentation. Those needing surgery
will become apparent but a large proportion will not need surgery
within 5 years which will have a great effect on the health budget.
In contrast, we found no difference in baseline presentation
between patients with hip and knee OA. Our healthcare system has
more limited access to surgery, there is explicit rationing and pa-
tients need to deteriorate significantly to qualify for publicly funded
surgery.
Our experience has been that patients with hip OA progress
more rapidly, are more disabled, and therefore more likely to
qualify for surgery than patients with knee OA [12,15,16]. Therewas
no improvement with nonoperative treatment in the group with
hip OA and a greater proportion had deteriorated than improved by
a clinically relevant amount. However, there was a modest
improvement in OKS in the groupwith knee OA still beingmanaged
nonoperatively with a greater proportion improving rather than
deteriorating. This suggests for patients with knee OA that while
nonoperative treatment had limited gains, there was no significant
deterioration in the group that had not undergone surgery.
We agree that good nonoperative treatment should be trialed.
However, our data suggest that 80% patients with hip OA with KL
grades 3 and4will deteriorate and require THAwithin 3-5 years. This
should be reflected in surgical prioritization as there is little point in
delaying surgery for these patients. A high proportion of patients
with knee OA especially with less severe radiographic changes may
not require surgery at 5 years with good nonoperative management
and we recommend efforts be directed toward this group.11The strength of this study is that it used prospectively gathered
data of a large cohort over 5 years. All patients were referred for
orthopedic assessment by their GP with an expectation that sur-
gery should be considered. We were able to access patient records
and the New Zealand Joint Registry to collect surgical information,
and JC appointment details for all patients. Two-thirds had
advanced (KL grade 3 or 4) radiographic changes. Therefore we are
reporting a real-world situation and believe that this study is
generalizable to similar healthcare systems.
The principal limitation of this study is the observational design,
fromwhich we cannot distinguish between the effect of the JC and
the natural history of the disease. In OA symptoms can fluctuate,
though typically slowly deteriorate. We believe that we are
reporting the results of good nonoperative treatment through an
individualized program [14,16]. We have used the hard end point of
arthroplasty surgery, acknowledging however that the intervention
rate for THA and TKA varies between countries. The decision to
offer surgery is complex and the indications and threshold to offer
surgery vary between healthcare systems. We are obliged to pri-
oritize (ration) surgery using prioritization tools. Therefore the low
surgical rate may be in part due to access barriers resulting in pa-
tients having to accept their pain and disability. Although only 9
patients were advised surgery but failed to qualify due to the
financial threshold, it is possible that other patients had learned to
live with their problem and did not request re-referral, or were not
referred back for surgery by their GP, because of the known capacity
constraints. This may be true for those with hip OA as there was no
improvement and a greater proportion had deteriorated than
improved by a clinically relevant amount. However for the group
with knee OA that had not undergone surgery, there was a modest
improvement in OKS with a greater proportion improving rather
than deteriorating. It was beyond the scope of this study to do a full
cost-effectiveness analysis. However, we have previously reported
that the marginal cost of delivering the JC was NZ$550 (year 1) and
NZ$384 (year 2) per patient [14]. This compares with an average
cost to the DHB of approximately NZ$16,000 for a THA or TKA. By
delaying or avoiding surgery in even a small proportion of patients
for 5 years, it has proven to be both an economic and clinical
success.
The results of this study have shown that nonoperative treat-
mentmay delay or even prevent the need for surgery at 5-7 years in
more than 50% of patients with knee OA, especially in those with K-
L stage 3 or less. Patients with hip OA, especially with more severe
radiographic changes and those with K-L grade 4 knee OA, are
significantly more likely to require surgery and should not be
delayed if there is not an adequate response to conservative mea-
sures. Poorer patient-reported scores were also predictive of the
need for surgery and should be considered as part of the prioriti-
zation process.
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Background: Nonoperative management of patients with knee osteoarthritis (OA) through multidisci-
plinary programs may delay or reduce the need for total knee arthroplasty (TKA). However, avoidance of
surgery may not represent success for the patient.
Methods: A cohort of 120 patients with knee OA managed with at least 6 months of supervised
nonoperative treatment coordinated through the Joint Clinic were reviewed at 5 years. Outcomes
including Oxford knee score (OKS), Short Form 12 (SF-12), and SF-6D and other measures including
analgesia use, global change, and perception of need for surgery were collected and compared with those
from the cohort who had undergone TKA.
Results: Seventy (62.5%) surviving patients were still being managed nonoperatively. There was no
significant change in any outcome score (OKS, SF-12 physical component score, SF-12 mental component
score, SF-6D) (P ¼ .26 to .84). Forty-two patients had undergone TKA with mean time to surgery 29.0
months (range, 9-69 months). In this group, the mean OKS fell from 17.9 at baseline to 10.3 (range, 3-21)
preoperatively (P < .0001) and at 5 years there was a significant improvement from baseline in OKS, SF-
12 physical component score, and SF-6D scores (P < .0001). All outcome scores and change in scores were
significantly higher for the surgical group (all P < .001).
Conclusion: Although a high proportion of patients with knee OA have avoided surgery at 5 years, their
outcomes show no improvement from baseline and are poorer than those who have undergone TKA.
Avoidance of surgery should not necessarily be regarded as an indicator of success of nonoperative
treatment for the patient.
© 2020 Elsevier Inc. All rights reserved.There is a rapidly increasing demand for total knee arthroplasty
(TKA) which is challenging publicly funded health services [1e4].
There has been much debate about the appropriate level of symp-
toms for surgery with large variations between different healthcare
systems [5,6]. Increasingly, in New Zealand (NZ) and elsewhere,closed potential or pertinent
ent, either direct or indirect,
the biomedical field which
rest with this work. For full
j.arth.2020.04.087.
BCh, FRACS (Orth), Depart-
istrict Health Board/Dunedin
11there is a need for rationing of procedures such as TKA [7,8]. Surgery
at the right time is highly effective with case series and registry
reports showing large improvements in pain and function and
excellent long-term revision-free survival. However, up to 20% of
patients may be dissatisfied with the results of TKA and complica-
tions of surgery may be severe [9,10]. In this environment, it is
important that nonoperative treatment of patients is optimal.
Nonoperative management of patients with knee osteoarthritis
(OA) through an individualized multidisciplinary program is rec-
ommended in American College of Rheumatology, European League
against Rheumatism, Osteoarthritis Research Society International,
and National Institute of Clinical Excellence guidelines [11e14]. It
has been shown tobe effective andmaydelayor even avoid theneed
for TKA [15e17].4
Table 1




All Patients Nonoperative Surgery Difference Between
Groups P Value
Total, n 120 78 42
Age (y) 68.7 (9.0) 67.8 (9.8) 70.3 (7.1) .15
Gender .58
Male 53 (44%) 33 (42%) 20 (48%)
Female 67 (56%) 45 (58%) 22 (52%)
BMI (kg/m2) 31.0 (5.6) 31.0 (6.3) 31.0 (4.6) .99
K-L grade <.0001
Grade 1 10 (8%) 10 (13%) 0 (0%)
Grade 2 32 (27%) 26 (33%) 6 (14%)
Grade 3 59 (49%) 37 (47%) 22 (52%)
Grade 4 19 (16%) 5 (6%) 14 (33%)
OKS 20.3 (7.3) 22.1 (7.6) 17.1 (5.4) .0003
SF-12 PCS 32.1 (8.3) 33.2 (8.9) 29.9 (6.5) .04
SF-12 MCS 49.2 (12.3) 50.3 (12.4) 46.9 (12.0) .16
SF-6D utility 0.61 (0.12) 0.63 (0.13) 0.57 (0.09) .03
BMI, bodymass index; K-L, Kellgren-Lawrence grade; OKS, Oxford knee score; SF-12
PCS, Short Form 12 physical component score; MCS, mental component score.
Values are given as mean (standard deviation) or number (%).
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 35 (2020) 2350e2356 2351We developed the Joint Clinic (JC), a physiotherapist and
nurseeled clinic to improve access for patients with hip and knee
OA. Patients referred to the orthopedic department for consider-
ation of surgery and triaged to the clinic receive an individualized
nonoperative management program [18]. The JC has been shown to
be an effective triage tool [19]. Patients with knee OA and those
with milder symptoms were more likely to respond to nonopera-
tive treatment than those with hip OA and we recommended that
nonoperative management was best directed toward these patients
[19,20]. This was confirmed in our 5-year results where over 50% of
patients with knee OA were still being managed nonoperatively at
5- to 7-year follow-up. Patients with hip OA, more advanced
Kellgren-Lawrence (K-L) grade, and worse Oxford hip/knee score
(OHS/OKS) were predictive of the likelihood of undergoing surgery
[17]. However, while surgical avoidance may be seen as a safe and
desirable outcome for patients and overstretched health services, it
may not represent treatment success to the patient. There are little
data on the outcomes of patients treated nonoperatively at long-
term follow-up and how they compare with patients who have
undergone surgery.
The aim of this study is to report the patient-reported functional
outcomes of patients with knee OA managed nonoperatively
through the JC at 5-year follow-up after their initial assessment.
The secondary aim is to compare those patients who underwent
surgery after their initial period of nonoperative treatment with
those who have continued with nonoperative treatment.
Patients and Methods
The JC was set up to improve access and nonoperative man-
agement for patients referred to the orthopedic department of our
Public Hospital with hip and knee OA. Patients were triaged to the
clinic by a consultant orthopedic surgeon and assessed by an
experienced physiotherapist and orthopedic nurse. An individual-
ized management program was developed which included advice
on their condition, optimization of analgesia, and referral for an
outpatient physiotherapy OA program, occupational therapy, die-
tician advice, or orthotic management where indicated [18]. Pa-
tients were reviewed every 6 months until they were discharged
back to general practitioner if their symptoms were stable, or they
had deteriorated to the extent that they needed referral for surgical
assessment. Radiological assessment was only repeated as needed.
In New Zealand, patients only qualify for publicly funded sur-
gery if there is capacity for the procedure to be done within 4
months. If a surgeon recommends surgery, the patient is scored
using a prioritization tool [8]. If the patient scores below the
threshold score, they are declined surgery and returned to the care
of their general practitioner for nonoperative management. How-
ever, there is the option for clinical override in special cases.
This is a prospective observational cohort study comprising 120
patients with knee OA who were assessed in the JC between June
2012 and May 2014 and were treated with a minimum 6-month
trial of individualized nonoperative treatment. Inclusion criteria
for the initial study were all patients seen and subsequently
reviewed at JC with a diagnosis of knee OA (unilateral or bilateral).
Exclusions were patients referred for surgical assessment at their
initial JC appointment, self-discharge, or failure to attend a follow-
up appointment at 6 months. We have previously reported the
outcomes of this cohort at 12-month follow-up [20]. By the time of
this review at 5 years, 8 patients (7%) had died without surgery, 70
(58%) were still being managed nonoperatively, and 42 patients
(35%) had undergone TKA with the mean time to surgery from
initial assessment 29.0 months (range, 9-69 months).
Patient-reported outcome measures (PROMs) including OKS
[21] and Short Form 12 (SF-12) [22] were collected at the initial JC115appointment and subsequent appointments. All baseline radio-
graphs were assessed and graded according to the K-L classification
by 2 observers [23]. A questionnaire was sent out to all surviving
patients including the OKS and SF-12. This allowed calculation of
OKS, SF-12 physical and mental component scores (PCS, MCS), and
SF-6D utility [24]. The 5-year OKSwas also categorized according to
the classification of Kalairajah et al [25]. The minimum important
difference (MID) in OKS was taken as 5 points as used in our pre-
vious article [20,26]. There were further questions including their
use of walking aids, analgesia, and use of physical therapy exercises.
They were also asked to indicate their global change from baseline
using a global impact of change question and their satisfactionwith
JC. Patients who had not undergone surgery were asked how they
currently rated their need for surgery. Surgical patients were asked
about any complications and a full chart review performed of all
surgical patients for any adverse effects. The preoperative OKS was
also collected in these patients. The NZ Joint Registry (NZJR) was
used to check whether any patients had undergone either primary
or revision surgery elsewhere [27].
Statistical analysis was performed using R version 3.6.0 (R Core
Team) [28]. Chi-squared tests were used for categorical variables
and t-test for continuous variables. Statistical significance was
taken as P < .05.
Ethics approval was given by the University of Otago Ethics
Committee (Health). All patients gave written consent to be
included in the study.Results
The mean follow-up period was 5.5 years (range, 4.5-6.5 years).
Of 112 surviving patients, 77 (69%) responded to the questionnaire
with no difference in proportion responding between surgical (28
of 42, 67%) and nonoperative groups (49 of 70, 70%) (P¼ .87). There
was no significant difference between respondents and non-
respondents with respect to gender, K-L grade, or baseline OKS, SF-
12 PCS, or SF-6D utility scores. However, respondents were younger
(P ¼ .040) and had lower baseline body mass index (BMI) (P ¼ .048)
and higher SF-12 MCS scores (P ¼ .010) than nonrespondents
(Table S1). The nonoperative and surgical groups at baseline were
similar with respect to age, gender, BMI, and SF-12 MCS (Table 1).
The OKS, SF-12 PCS, and SF-6D utility were lower and the K-L grade
was more advanced in the surgical group at baseline.
Table 2
Patient-Reported Outcome Scores for Respondents at Baseline and 5 Years.
Outcome Score Nonoperative Surgery
5-y Follow-Up Change From Baseline P Value 5-y Follow-Up Change From Baseline P Value
OKS 23.3 (8 to 48) 1.2 (24 to 22) .38 38.4 (20 to 48) 19.6 (5 to 36) <.0001
SF-12 PCS 30.7 (14.0 to 56.7) 1.9 (26.0 to 24.1) .26 46.1 (17.7 to 60.8) 15.6 (29.9 to 37.9) <.0001
SF-12 MCS 51.5 (20.1 to 68.5) 1.0 (28.0 to 35.8) .60 51.2 (12.5 to 64.0) 2.8 (33.9 to 25.4) .32
SF-6D utility 0.633 (0.345 to 0.922) 0.006 (0.544 to 0.371) .84 0.787 (0.567 to 1.000) 0.201 (0.032 to 0.416) <.0001
The values are given as mean (range).
The 5-y scores for the surgical group were significantly higher than the nonoperative group for all scores and change in scores (P < .001) with the exception of MCS (P ¼ .76)
and change in MCS (P ¼ .24).
OKS, Oxford knee score; SF-12 PCS, Short Form 12 physical component score; MCS, mental component score.
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 35 (2020) 2350e23562352Of the 49 respondents still being managed nonoperatively, 18
(36%) patients had improved and14 (28%) deteriorated by OKS  5
points. Of all 77 respondents (surgery and nonoperative), 42 (55%)
had deteriorated by OKS  5 points or had undergone surgery and
only 18 (23%) had improved by OKS  5 points with nonoperative
treatment at 5 years. In patients still being managed non-
operatively, there was no statistically significant change in any of
the 4 outcome scores (OKS, SF-12 PCS, SF-12 MCS, and SF-6D) at 5
years compared with baseline (P value range, .26-.84) (Table 2).
At 5-year follow-up, 10 (20%) of the nonoperative group rated
themselves as verymuch or quite a lot better and 27 (55%) as quite a
lot or very much worse. Thirty-two (65%) patients were taking pain
relief daily or on most days, and 19 (39%) were using walking aids
(stick, frame crutches) (Table 3). Most patients reported their
experience of JC to be good or excellent (33, 67%). Almost half (24 of
49, 49%) were still performing regular physical therapy exercises.
Five patients (10%) indicated that they either were on a wait-list
or wanted surgery but did not qualify due to the prioritization
process. All showed clinically meaningful deterioration on all or
most outcome scores. A further 13 patients (27%)were getting to the
stage of wanting something done. Their mean scores had deterio-
rated by a clinically significant margin, although there was wide
variability and some patients showed significant improvements. SixTable 3




None 36 (72%) 16 (57%)
1 crutch 1 (2%) 5 (18%)
2 crutches 0 (0%) 0 (0%)
Stick 10 (20%) 7 (25%)
Stick þ2 crutches 0 (0%) 0 (0%)
Frame 2 (4%) 0 (0%)
Frame þ stick/crutches 0 (0%) 0 (0)%
Did not answer
Pain medications
Rarely/never 11 (22%) 2 (7%)
Occasionally 4 (8%) 3 (11%)
Once or twice a week 7 (14%) 0 (0)%
Most days 8 (16%) 3 (11%)








Quite a bit worse
Very much worse
Did not answer
Values are given as number (%).
11patients (12%) said they did not need or want surgery. Their PROMs
were the highest and all showed improvements in OKS and most
other scores. The largest group of patients (24, 49%) had learned to
live with the problem. Their mean scores were intermediate with
improvements in OKS, MCS, and SF-6D although the range was
wide. The patient perception of their requirement for surgery (ie,
increasing dissatisfaction with nonoperative treatment) was asso-
ciated with a decrease in all PROMs (Table 4).
Of the 42 patients who had undergone TKA, there were 5 pa-
tients (12%) with adverse events related to their surgical procedure.
One patient had anaphylaxis on anesthetic induction and the pro-
cedure was abandoned. She subsequently had an uneventful TKA.
There were 3 thromboembolic complications: 2 patients developed
small soleal sinus deep vein thromboses and one a small right
upper lobe segmental pulmonary embolus, all of which resolved
with treatment. A 71-year-old man developed an acute kidney
injury requiring dialysis and a subsequent hematemesis but made a
complete recovery. At mean 3.9-year follow-up (0.8-6.0 years)
postsurgery, there have been no revisions or reoperations and none
of the surgical group had died.
The mean OKS in the surgery group had fallen from 17.9 at
baseline to 10.3 preoperatively (P < .0001) (Fig. 1). At 5 years, there
were statistically significant improvements from baseline on OKSrom Baseline for Nonoperative and Surgical Respondents at 5 Years.
Final Review Difference Between Groups
at Final Review P Value
Nonoperative Surgery
25 (51%) 16 (57%) .67
2 (4%) 2 (7%)
1 (2%) 0 (0%)
13 (27%) 6 (21%)
0 (0%) 2 (7%)
1 (2%) 1 (4%)
2 (4%) 1 (4%)
5 (10%) 0 (0%)
7 (14%) 11 (39%) .02
9 (18%) 5 (18%)
1 (2%) 2 (7%)
7 (14%) 4 (14%)
25 (51%) 5 (18%)
0 (0%) 1 (4%)
6 (12%) 17 (61%) <.0001
4 (8%) 4 (14%)
3 (6%) 2 (7%)
3 (6%) 3 (11%)
5 (10%) 0 (0%)
20 (41%) 0 (0%)
7 (14%) 1 (4%)
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117(þ19.6), SF-12 PCS (þ15.6), and SF-6D utility (þ0.201) (all P <
.0001), and no significant change in MCS scores (P ¼ .32) (Table 2).
Nineteen patients (73%) had good or excellent OKS scores (34).
Four patients (15%) in the surgery group had an OKS <27 (poor). All
had improvements in OKS of 5 to 8 points and reported an
improvement from baseline. Twenty-one (75%) rated themselves as
very much or quite a lot better, while 1 (4%) rated themselves as
quite a lot or very much worse (Table 3). He had a good early result
after TKA but developed loosening of an ipsilateral total hip
arthroplasty which is thought to be a significant contributor to his
symptoms. Most patients in the surgery group were taking pain
medication rarely (11, 39%) or occasionally (5, 18%), and 12 (43%)
were using walking aids (Table 3). Most reported their JC experi-
ence to be good or excellent (20, 71%), and all respondents had
improved by 5 points on OKS. Half were still performing regular
physical therapy exercises.
All outcome scores and change in scores from baseline were
significantly higher for the surgical group than the nonoperative
group (P < .001) (Table 2, Fig. 1). Patients in the surgical group were
less likely to take pain relief regularly (P ¼ .02) and a significantly
higher proportion of patients rated themselves as very much or
quite a bit better after surgery (P < .0001). There were a signifi-
cantly higher proportion of patients with a good and excellent OKS
in the surgical group (76% vs 18%) and a lower proportion with a
poor OKS (12% vs 69%) (chi-squared, P < .001) (Table 5).
There was no significant difference in the use of walking aids,
the proportion still performing regular physical therapy exercises,
and the satisfactionwith their experience of JC between the surgery
and nonoperative groups.
Discussion
This study has shown that 62.5% of surviving patients with knee
OA seen at the JC were still beingmanaged nonoperatively at 5-year
follow-up with no significant change from baseline in any patient-
reported outcome measures (OKS, SF-12, SF-6D). Also, 23% of re-
spondents had improved by a clinically relevant amount while 55%
had deteriorated or undergone surgery. The nonoperative group
had statistically significant and clinically relevant poorer outcomes
at 5 years than those patients who had undergone TKA. In the
surgical group, there were few adverse effects of surgery and no
reoperations.
The patients seen at JC represent those at the milder end of the
spectrum that we are referred. Patients in this cohort were all
referred for consideration of surgery but were felt at initial
assessment to be below the threshold to qualify for surgery. They
had aminimum of 6 months of supervised nonoperative treatment.
In our previous study of this cohort at mean 1-year follow-up, 35%
patients with knee OA improved by 5 points on OKS while 21%
had deteriorated by 5 points. In total, 29 patients (24%) had un-
dergone TKA [20]. At 5 years, the number who had undergone TKA
had risen to 42 (35%). Many of the patients still being managed
nonoperatively had not had any clinically relevant deterioration
over 5 years despite the usual progressive nature of OA. However,
the results of nonoperative treatment for the group as a whole
showed a decrease in OKS, if the preoperative scores of the surgical
group who failed nonoperative management are included.
Similar clinics have been developed in other centerswhich show
that gains can be made even in patients referred with advanced
disease [15,16,29,30]. Skou et al in a randomized, controlled trial of
patients eligible for TKA showed that 68% of the nonoperative
group had avoided surgery at 2 years [16]. This has been used to
promote large-scale programs such as Good Life with osteoarthritis
in Denmark (GLA:D)) which has been introduced to other countries
including Canada and Australia [31]. It is hoped that these programs
Fig. 1. Box and whisker plot showing changes in Oxford knee score (OKS) from baseline for nonoperative and surgical groups.
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are only to 2 years and it is not clear whether the need for TKA is
merely being delayed [16].
We have previously reported that surgery can be avoided in 56%
of patients with knee OA and 24% of those with hip OA at 5 years in
our healthcare setting where there is explicit rationing of surgery
[17]. In this cohort, where we included only those that were
compliant with treatment for at least 6 months, 76% had avoided
surgery at 1 year and 65% at 5 years. Similarly, Dabare et al [15]
using a multidisciplinary clinic with ready access to surgery when
required showed that 67% of patients with knee OA and 40% of
patients with hip OA had avoided surgery at 6 years. However, few
details were reported in their study on the status of these patients
who had “successful” nonoperative management with 77% of pa-
tients giving “an improvement with conservative treatment” as the
reason for not having surgery.
In our study, there were clinically relevant improvements in
scores in the small group (12%) of patients who felt they did not
need or want surgery. There were also smaller improvements seen
in the larger group of respondents (49%) who had learned to live
with the problem. The group (27%) that were “getting to the stage
of wanting something done” had an average deterioration on all
outcomes but had a wide range of scores with some improving and
others deteriorating by clinically relevant amounts. Only 5 patients
(10% of respondents) have been advised or wait-listed for surgery
but have not qualified. Their scores were poor and showedTable 5
Number of Patients by OKS Category at 5 Years (Kalairajah et al [25]).
Category OKS Nonoperative Surgery
Poor <27 31 (69%) 3 (12%)
Fair 27-33 6 (13%) 3 (12%)
Good 34-41 7 (16%) 6 (24%)
Excellent 42-48 1 (2%) 13 (52%)
Chi-squared 31.5, P < .0001.
Values are given as number (%).
OKS, Oxford knee score.
11deterioration from baseline on all scores. All patients were initially
referred for consideration of surgery and many of these patients
may have undergone surgery elsewhere or if there was better ac-
cess to surgery in our institution. The JC has been very successful at
reducing the surgical burden but this study suggests that this
reduction is not so much due to the success of nonoperative
management but rather our environment has altered the expec-
tation of patients regarding surgery.
It is well known that TKA is a highly effective intervention for
end-stage OA. However, the literature suggests that 15%-20% of
patients may be dissatisfied with TKA and complications of surgery
may be serious [9,10]. In a randomized, controlled trial comparing
nonsurgical treatment alone with TKA and nonsurgical treatment,
there was improved pain relief and functional outcomes in the TKA
group at 2 years but an increased risk of serious adverse events
[16,32]. They reported 24 serious adverse events in 50 patients who
underwent TKA with 8 involving the index knee: 3 knees requiring
manipulation under anesthesia, 1 deep infection, 1 supracondylar
fracture femur, and 3 deep vein thromboses [32]. In contrast, we
saw only 5 complications in 42 patients (12%) with no knees
requiring manipulation under anesthesia and no subsequent revi-
sion procedures or reoperations at a mean follow-up of 3.2 years.
While surgery is a major intervention with risks, with modern
techniques including enhanced recovery programs these can be
minimized [33].
In this study, the postoperative mean OKS of 38.4 in those who
underwent TKA compares favorably with the NZJR (OKS 37.7 at 6
months), despite the low mean preoperative OKS [27]. In the sur-
gical group, only 3 patients (12%) had a poor result with OKS <27
but all had a gain of OKS of 6-8 points and reported an improve-
ment from baseline. In contrast, 69% of those managed non-
operatively had a poor result using the same OKS criteria.
We have compared outcomes of patients treated surgically and
those who continued with nonoperative treatment from a cohort
where the intention was to treat nonoperatively. The baseline
characteristics of patients in these groups were reasonably well
matched with respect to age, gender, and BMI but patients who
underwent surgery had poorer PROMs and radiographic changes at8
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significantly higher for the surgical group compared to those still
being managed nonoperatively and at or above the MID reported
for all scores [26,34,35]. Health-related quality of life (HRQoL) as
measured by the SF-6D showed a gain of 0.201 with surgery which
is well above the MID of 0.041 [35]. The difference in SF-6D be-
tween the surgical and nonoperative groups of 0.129 at 5 years
gives an indication of the potential loss of quality-adjusted life
years for patients continuing with nonoperative treatment rather
than having a TKA.
A significant limitation is our response rate. It is particularly
difficult to follow up patients who have not had a surgical pro-
cedure and may not even remember their JC appointment 5 years
earlier. Most patients are elderly and we had more success with
paper-based than web-based questionnaires while telephone sur-
veys were of limited value. There may be recall bias in the re-
sponses to the more subjective questions especially regarding their
perception of global change from baseline. However, the patient-
reported scores, which were our primary outcome measure, were
collected prospectively. A further limitation is that this study is
observational. We are likely to be reporting the natural history of
knee OA in patients who have had good nonoperative management
rather than the results of a specific intervention. The study focusses
on functional outcomes and radiological reviewwas not included in
the protocol. Radiographs were only repeated as necessary such as
preoperatively for the surgical group so many in the nonoperative
group did not have radiographs at final review. It is possible that
booster doses of nonoperative treatment including physiotherapy
may have improved the results. However, equal proportions of
those that improved had either continued or stopped physio-
therapy, suggesting that this is unlikely to have a major bearing.
There were no standardized criteria for surgery in our study and
not all patients may have wanted, needed, or been suitable candi-
dates for surgery. Although thresholds for surgery vary across health
systems, there is likely to be little debate about the need for surgery
in suitable patients with amean preoperative OKS of 10.3. However,
it likely those patients with a higher OKS would be considered for
TKA in many other healthcare systems. In the United Kingdom,
Dakin et al [36] suggested that, basedonHRQoLgains, themost cost-
effective preoperativeOKSwas 12-15 points but TKA remained cost-
effective even in patients with an OKS up to 35-40 points. In the
United States, Ferket et al [37] suggested that TKA would be more
effective if restricted to patients with SF-12 PCS <50 and was most
attractive from an economic viewpoint in patients with a score <35
points. However, we do not believe that scores such as OKS or PCS
should be used to determine access to TKA alone. The decision to
offer surgery is complex and should involve clinical and radiological
assessment of the patient by an orthopedic surgeon.
Strengths of this study are the detailed outcomes including
patient-reported scores and length of follow-up for a nonoperative
cohort. We are confident that we have identified all those who have
undergone TKA and any surgical complications through our elec-
tronic records, audit database, and cross-referencing to the NZJR.
Conclusions
Good nonoperative management coordinated through a dedi-
cated JC has resulted in a high proportion of patients with knee OA
avoiding surgery at 5 years. However, many have learned to live
with their problem and showed little to no improvement in
patient-reported outcomes. Their outcomes were poorer than
those in the cohort who have undergone TKA. Patients who un-
derwent TKA had low complication rates and significant improve-
ments in HRQoL. When reporting the results of nonoperative
management, avoidance of surgery alone should not be regarded as119an indicator of success for the patient. TKA should not be withheld
or delayed in suitable patients.Acknowledgments
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Baseline Characteristics of Respondents and Nonrespondents to 5-Year Questionnaire.
Baseline Characteristic All Patients Respondents Nonrespondents Difference Between
Groups P Value
Total, n 120 77 43
Age (y) 68.7 (9.0) 69.2 (7.9) 67.8 (10.7) .43
Gender .45
Male 53 (44%) 36 (47%) 17 (40%)
Female 67 (56%) 41 (53%) 26 (60%)
BMI (kg/m2) 31.0 (5.6) 30.3 (5.1) 32.9 (6.6) .05
K-L grade .71
Grade 1 10 (8%) 5 (6%) 5 (12%)
Grade 2 32 (27%) 23 (30%) 9 (21%)
Grade 3 59 (49%) 38 (49%) 21 (49%)
Grade 4 19 (16%) 11 (14%) 8 (19%)
OKS 20.3 (7.3) 20.6 (6.9) 19.9 (8.0) .63
SF-12 PCS 32.1 (8.3) 31.5 (8.3) 33.1 (8.4) .32
SF-12 MCS 49.2 (12.3) 51.1 (12.8) 45.5 (10.5) .02
SF-6D utility 0.61 (0.12) 0.62 (0.13) 0.59 (0.11) .29
Subsequent TKA 42 (35%) 28 (36%) 14 (33%) .68
BMI, body mass index; K-L, Kellgren-Lawrence radiographic stage; OKS, Oxford knee score; SF-12 PCS, Short Form 12 physical component summary, MCS, mental component
summary; TKA, total knee arthroplasty.
Values are given as mean (standard deviation).121
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Epidemiology and Outcomes of Acute Achilles Tendon Rupture with Operative
or Nonoperative Treatment Using an Identical Functional Bracing Protocol
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ABSTRACT
Background: This study reports on the demographics of acute
Achilles tendon rupture in our region and compares the results
of a selective approach to operative and nonoperative treat-
ment using an identical rehabilitation program with func-
tional bracing. Materials and Methods: A consecutive series of
363 patients, aged 15 to 60 years, treated over 8.5 years by
either open operative repair (143) or nonoperatively (220) were
compared with respect to demographics, re-rupture rate, and
major wound complication. Results: There was an almost equal
number of males (159) and females (152) up to age 50 years but
males comprised 73% of patients aged 51 to 60 years. Netball
was the most common cause of injury and explains the rela-
tively high incidence in females. In the 143 patients treated
surgically there were two re-ruptures (1.4%) and two reop-
erations for wound complications (1.4%). In the 220 patients
treated nonoperatively there were 19 re-ruptures (8.6%), 13 of
113 males (11.5%) and six of 107 females (5.6%). There was a
significantly lower re-rupture rate, and reoperation rate in the
surgical group (p < 0.05). In the nonoperative group there was
a significantly lower rate of re-rupture in patients over 40 (six
of 119) (4.1%) compared with those 40 years and under (13 of
99, 13.1%) and between females over 40 when compared with
males 40 years and under. Conclusion: In our region there is
a high incidence of Achilles tendon rupture among women due
to netball and results in a younger age of injury than previ-
ously reported. Our results support surgery in patients less
than 40 years, particularly males, if there are no contraindi-
cations. Functional bracing as part of nonoperative treatment
can result in low re-rupture rates in patients over 40, especially
in females.
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INTRODUCTION
Achilles tendon rupture is a relatively common injury
in the adult population and its incidence appears to be
increasing.16,21,22 It is three to four times more common
in males.10,25 The incidence rises rapidly after 25 years of
age with a peak around 42 years.10,21 Females sustaining the
injury tend to be 2 to 3 years older than males.10,16,21 Despite
several meta-analyses1,14 and randomized controlled trials
(RCT)3,18,20 the treatment remains controversial. Operative
treatment is generally accepted as having a lower re-rupture
rate but a higher rate of wound complications which may
be devastating.1,14,31 Variables in the rehabilitation phase
such as duration of casting and weightbearing status make it
difficult to compare treatments. Recent trends in management
have focused on early motion and functional treatment both
after surgery and with nonsurgical management.5,27,29 This
may improve the functional outcome in surgically treated
patients5,13,19,26 and reduce re-rupture rates in patients treated
nonoperatively.11,29
In 1999 we developed a standardized program for all
patients with an Achilles tendon rupture based on the
literature available at the time (Table 1). Functional bracing
commenced at 4 weeks post-injury whether the patient had
been treated surgically or nonoperatively. This study reports
on the demographics of acute Achilles tendon rupture in
our region and compares the results of a selective approach
to operative and nonoperative treatment using an identical
rehabilitation program with functional bracing from 4 weeks
after injury.
PATIENTS AND METHODS
This study reports on 363 consecutive patients treated for
acute traumatic closed rupture of the Achilles tendon over 8.5
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Table 1: The Rehabilitation Protocol Used by our
Physiotherapy Department Following Surgical Repair or
Nonoperative Treatment




• Active only range of motion
with knee bent and straight
• Gait re-education in CAM
walker increase from partial
to full weightbearing







• Passive stretches / lying /
sitting
• Bilateral calf raises
nonweightbearing (ie: sitting)
• Cycling with heel flat.






• Single leg raises.
• Progress concentric/eccentric
• Jogging








years between July 1999 and February 2008 following intro-
duction of the rehabilitation program. Patients were identified
from our emergency department database, in patient coding,
surgical audit system, and physiotherapy department records.
Case note review was performed to confirm the diagnosis
of complete rupture and identify complications. Inclusion
criteria were a complete, traumatic closed rupture of the
Achilles tendon in skeletally mature patients aged 60 years
and younger. Patients were excluded if they lived out of
our region as we had no control over their subsequent reha-
bilitation. Chronic ruptures, partial ruptures, tendinosis, and
gastrocnemius tears were also excluded. Treatment was indi-
vidualized based on patient factors including age, activity
level and co-morbidities, and surgeon preference. Relative
contraindications to surgery were diabetes, tobacco or steroid
use or peripheral vascular disease. A younger, high-demand
patient or delayed presentation over 24 hours was a relative
indication for surgery. We believe that delayed presentation
may lead to more retraction of the tendon ends and
predispose to re-rupture. If there was a large gap on clinical
examination despite full equinus, we usually operated. Ultra-
sound or MRI was not routinely used to assess gap size. Our
department has eight consultant orthopaedic surgeons who
have a range of preference from those who treat most patients
nonoperatively to those who favor surgery in most cases
Rehabilitation in patients treated operatively or nonopera-
tively was under the supervision of a physiotherapist either at
our institution, at peripheral clinics or by community phys-
iotherapists. The guidelines were circulated to these physio-
therapists though no formal education occurred.
Surgery was performed under general or spinal anaesthesia
with the patient prone with a single perioperative dose of
antibiotic. Tourniquets or self retaining retractors were not
routinely used. A short posteromedial incision was made
over the defect. A Kessler type two strand absorbable
No. 1 core suture was usually used. Multiple interrupted
3/0 absorbable sutures were used to braid the periphery
together. Some surgeons preferred to only use 3/0 absorbable
peripheral sutures. The paratenon was carefully closed with
an absorbable suture and skin closed either with interrupted
nylon skin sutures or a subcuticular absorbable suture. The
foot was then placed in a relaxed equinus cast for 2 weeks
when sutures were removed and the wound checked. A
fibreglass cast was then applied in relaxed equinus and
removed at 4 weeks post-surgery.
Patients in the nonoperative group were placed in a below-
knee cast with the hindfoot in full gravity assisted equinus.
The patients in both groups were kept nonweightbearing in
a cast.
In both groups the cast was removed at 4 weeks and
the affected leg placed in a CAM walker (Tukwila, WA)
locked at 20 degrees equinus and worn day and night. Physio-
therapy treatment then commenced with the equinus progres-
sively decreased to neutral by 6 to 8 weeks following injury
dependent on patient progression. Weightbearing progressed
from partial to full as patient tolerance and range of
motion allowed. This was usually once the equinus was
reduced to 10 degrees or less. The orthosis was removed
by 8 weeks. Progression through the program was deter-
mined by the physiotherapist in discussion with the surgeon,
if required. Clinical assessment was performed by the
orthopaedic surgeon at 8 weeks to assess tendon continuity.
No imaging studies were routinely performed. Phase two
from 8 to 12 weeks included active and passive stretches,
concentric and eccentric muscle strengthening and proprio-
ception. Aquajogging, increasing weightbearing, and cycling
with heel flat was allowed.
After 3 months, gentle jogging and single limb heel raises
were commenced. By 4 to 6 months, running was introduced
and strength and distance activities progressed (Table 1).
Our University hospital is the only hospital in our region
which serves approximately 177,000 people spread over a
large geographical area. All patients diagnosed with this
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injury are seen in our department. Major complications such
as deep wound infection or re-rupture would therefore return
to our institution. It is possible that some patients may
have presented elsewhere with complications after their final
clinical review. However, the major complications of re-
rupture and wound complications typically present within
the first 3 to 6 months of injury.
Statistical analysis was performed with the help of a
biostatistician. Two sample t-tests or a contingency table chi
square test were used for statistical analysis. This study has
been given ethical approval by our regional ethics committee.
RESULTS
There were 363 patients in the 8.5-year period giving an
approximate incidence of the injury of 24 per 100,000. There
were 197 males (54%) and 166 females (46%). This gives
an incidence of approximately 26 per 100,000 males and 22
per 100,000 females. There was an equal sex distribution
up to age 50 but there were significantly more males (73%,
p = 0.0007) in the age group 51 to 60 years. The mean age
of males was significantly higher than females [41.2 years
(SD, 9.6) v 37.6 years (SD, 9.3), p = 0.0004] (Table 2).
Details of the mechanism of injury are given in Table 3. A
total of 285 (78.5%) of the injuries occurred during sporting
activities. The incidence of sport related injury at 94% was
significantly higher in the 15-to-30-year group than all other
groups (all p values less than 0.031). In the group aged 51 to
60 years sports only accounted for 43% of injuries which was
significantly lower than the other age groups (p < 0.0001).
Netball was the most common mechanism accounting for
24% of all injuries, 31% of sporting injuries, and 54% of
women aged 15 to 40 years. Only two ruptures in the entire
group (0.6%) were considered work related injuries; one in
a nurse restraining a patient and one in a farmer.
Of the 363 patients, 143 (39%) were treated operatively
and 220 (61%) nonoperatively. The operative group was
significantly younger than the nonoperative group (mean age
37.4 years versus 40.9 years, p = 0.0011). There was no
significant difference in the proportion of males and females
treated operatively (p = 0.168).
The mean operative time was 52 minutes. There was a
mean delay of 0.7 days between admission and operation and
a mean stay of 2.4 days. Orthopaedic registrars (surgeons in
training) performed the procedure in 114 of 143 cases (80%).
There were two major wound complications requiring
repeat surgery. A 36-year-old man had a chronic discharging
sinus requiring debridement 16 months after repair. A
47-year-old man required debridement for recurrent infec-
tion also at 16 months post-surgery. Both these patients
had been repaired using a large non-absorbable core suture
in error by registrars contrary to our usual practice. Four
patients had minor wound complications. A 57-year-old
male required oral antibiotics for a superficial wound infec-
tion which healed without further problems. Two patients
had minor stitch reactions which healed without antibiotic
therapy and a 26-year-old male had an erythematous wound
with delayed healing until 8 weeks.
There were 21 re-ruptures (14 male, 7 female) in the
363 patients (5.8%) at a mean time of 70 days (Table 4).
In the surgical group there were two re-ruptures of 143
patients (1.4%). A 20-year-old female medical student re-
ruptured after 72 days while dancing on a table. A No. 1
absorbable core suture had been used. The other occurred in
a 45-year-old man who was jumping into the physiotherapy
pool unsupervised at 89 days post-repair. No core suture had
been used. There were 19 re-ruptures of 220 patients treated
nonoperatively (8.6%). Nine occurred within 8 weeks and
typically involved a minor injury. Two occurred around 10
weeks and six occurred between 12 and 14 weeks with a
more significant force including three who had returned to
sport despite advice. However, two occurred at 4 to 5 months
with more minor trauma. Compliance with the rehabilitation
guidelines was generally good but worse in males. Twelve re-
ruptures occurred in the 144 patients treated nonoperatively
by community physiotherapists (8.3%) while six occurred
in the 76 nonoperative patients seen in our hospital phys-
iotherapy department (7.9%, no significant difference). All
re-ruptures were treated operatively. A 35-year-old male re-
ruptured at 28 days following nonoperative treatment and
sustained a second re-rupture 68 days following operative
repair. A 31-year-old man had a deep infection 10 days
following repair of a re-rupture at 20 weeks. This required
debridement and a subsequent late reconstruction with a
gastrocnemius fascia turndown.
The reoperation rate in the surgical group (four of 143,
2.8%) was significantly lower than in the nonoperative group
(19 of 220, 8.6%) (p = 0.026). The difference between re-
rupture rates in the surgically treated patients and nonoper-
ative patients is significant (p = 0.004). This was also the
case for male patients (p = 0.005). However, in females the
difference did not reach significance with the numbers avail-
able (p = 0.23).
Details of re-ruptures in nonoperatively treated patients
are given in Table 5. The re-rupture rate for nonoperatively
treated injuries was significantly higher in patients less than
40 years old (13 of 199, 13.1%) compared with those over
40 years (six of 119) (4.1%) (p = 0.035). There was also
a significantly higher rate of re-rupture in males 40 years
and under treated nonoperatively (eight of 44) (18.1%) when
compared to females over 40 treated nonoperatively (one of
50) (2%) (p = 0.008).
DISCUSSION
The incidence of Achilles tendon rupture varies in different
countries but appears to be increasing.10,16,22,25 The inci-
dence in our region is approximately 24 per 100,000 which
compares with reported rates from 9.9/100,000 in Canada,25
19.0 per 100,000 in Finland22 and 37.3 per 100,000 in
Copyright  2011 by the American Orthopaedic Foot & Ankle Society
124









































































































































































































































































































































Copyright  2011 by the American Orthopaedic Foot & Ankle Society
125
Foot & Ankle International/Vol. 32, No. 4/April 2011 ACUTE ACHILLES TENDON RUPTURE 341




Netball 88 24% Falls, slips 23 6.3%
Squash 32 8.8% Pushing car 11 3.0%
Tennis 20 5.5% Hopping, jumping 10 2.75%
Rugby 19 5.2% Shifting furniture 3 1%
Soccer 19 5.2% Walking 3 1%
Dancing 19 5.2% Lifting 3 1%
Basketball 18 5.0% Other 5 1.4%
Touch rugby 17 4.7% Work related 2 0.6%
Badminton 11 3.0% Total non-sports 60 16.5%
Running 11 3.0% Not recorded 18 5%
Sports (other) 31 8.5%
Total Sports 285 78.5%
Table 4: Details of Patients Who Sustained a Rerupture
Gender Age
Original
Treatment Method of rerupture
Days to
rerupture Complications
Female 28 Nonoperative Vacuuming in CAM walker 42 Sural nerve entrapment
Female 32 Nonoperative Fall into hole 53
Female 38 Nonoperative Foot in gutter 47
Female 38 Nonoperative Pushing off 86
Female 40 Nonoperative Hopped off bed 72
Female 42 Nonoperative Tripped on bedclothes 113
Male 21 Nonoperative Walking 50
Male 25 Nonoperative Running 83
Male 30 Nonoperative Touch rugby 96
Male 31 Nonoperative Tripped 140 Deep infection following repair,
late reconstruction
Male 35 Nonoperative Fall into hole 56
Male 35 Nonoperative Walking in CAM walker 28 Second rerupture following
operative repair at 68 days
Male 37 Nonoperative Pushed in street 55
Male 37 Nonoperative Not recorded 85
Male 41 Nonoperative Hockey 87
Male 47 Nonoperative Shifting sheep 90
Male 49 Nonoperative Tripped 26
Male 55 Nonoperative Gentle dorsiflexion 34
Male 57 Nonoperative Climbing onto truck 70
Female 20 Surgical Dancing 72
Male 45 Surgical Jumping into pool 89
Denmark.10 Sporting activities are the cause of the injury in
73 to 83% of cases in most series4,10,25 with ball or racquet
sports most common. The rise in incidence appears to reflect
the increased participation in sports in recent decades.10 We
found a decreasing rate of sports related ruptures with age
with less than half of those aged over 50 sustaining the injury
with sporting activity.
The mean age of 40.6 years for our patients is similar
to other series which range from a mean of 37 to 45
years.3,10,18,20,21,28,29 However in our series females were, at
Copyright  2011 by the American Orthopaedic Foot & Ankle Society
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Table 5: Details of Patients Treated Nonoperatively
Who Sustained a Rerupture, Sub-divided by Age and
Gender
≤40 years >40 years Total
Male 8/44 (18.1%) 5/69 (7.2%) 13/113 (11.5%)
Female 5/57 (8.8%) 1/50 (2%) 6/107 (5.6%)
Total 13/99 (13.1%) 6/119 (4.1%) 19/220 (8.6%)
There is a significantly higher rerupture rate in patients less than 40
years old compared with those over 40 years old (chi square 4.44,
p = 0.035). Females less than 40 years old have a lower rerupture rate
than males less than 40 years old (chi square 7.08, p = 0.008). No
other differences reached significance.
37.6 years, on average significantly younger than males by
3.6 years. Previous studies from Canada,25 Scotland,16 and
Finland21 have reported that women who sustained ruptures
were on average 2 to 3 years older than men.
In most epidemiological studies there are 75% to 80%
males10,21,25 with treatment studies comprising 79% to 94%
males.3,6,15,18,20 Our series is unusual in that there were equal
numbers of males and females up to age 50. The incidence
in women was at least three to four times that reported
in Denmark, Canada, and Scotland.10,21,25 This difference
is explained by netball which is played widely and almost
exclusively by women at a competitive level although there
are mixed social leagues. In netball players jump to catch the
ball but are not allowed to step after landing. In Australia a
study of injuries in netballers and basketball players showed
that TA rupture was common in women with an average age
of 35.2 years.7
TA rupture is very unusual in under-20-year-olds both
in the general population10,21 and in netballers.9 Secondary
school age netballers make up approximately half of our
netball playing population yet there were only two ruptures
in that age group. The average age suggests that it occurs in
those players returning to the sport after a lay off.
The treatment of Achilles tendon rupture has always
been contentious. It is unclear whether functional outcomes
are improved after surgery.3,17,18,20,27,30 Operative treatment
usually has a lower re-rupture rate than nonoperative treat-
ment but may have significant wound complications which
tend to offset the complication rate.3,20,28
Meta-analyses have shown that the re-rupture rate follow-
ing surgical repair was 3.1% to 3.5% with an infection rate of
4% to 4.7%. The re-rupture rate with nonoperative treatment
was significantly higher at 12.6% to 13%.1,14
Despite careful technique, more recent papers continue to
show re-rupture rates in surgically treated patients from 4.5
to 5.6%22,23,24 and infection rates of 2.2 to 6%.22,24 Younger
patients may be more prone to re-rupture with Rettig et al.23
reporting four re-ruptures of 24 (16.6%) in patients less than
30 years of age treated surgically.
Bruggeman et al. reported a wound complication rate of
10.4% in 167 consecutive open repairs with tobacco and
steroid use, diabetes and female sex being significant risk
factors.2 We are cautious in operating on older patients,
diabetics, smokers and patients on corticosteroids which may
help explain the low rate of major wound problems (1.4%) in
our operative group. We believe that our operative technique
of no tourniquet or self-retaining retractors, absorbable
sutures, and perioperative antibiotics also contribute to our
low rate of wound complications. Our rerupture rate in
surgically treated patients was also low with the use of
absorbable sutures whether or not a core suture was used.
Percutaneous techniques may reduce wound infection rates
to 0% to 1.8%.6,8,15 However, re-rupture rates of 2.5% to
7.1% may be higher than with open techniques.6,8,15,17 Other
problems such as palpable knots8 and sural nerve injury rates
up to 10.5% have also been reported.6,8
With traditional nonoperative treatment of 8 to 12 weeks
in an equinus cast, re-rupture rates as high as 17 to 20.8%
have been reported.18,31 However, this may be reduced
to 7% using 8 weeks casting but allowing immediate
weightbearing.12
In recent years there has been a trend towards functional
bracing both following surgery5,13,19 and in nonoperative
treatment.11,29 This may increase patient satisfaction, lower
re-rupture rates and decrease postoperative complications.26
Our program was designed to be used consistently and
balance early mobilization with protection from patient non-
compliance. We only commence weightbearing as tolerated
at 4 weeks. Our re-rupture rate of 8.6% in nonoperatively
treated patients is comparable to the published results of
functional nonoperative treatment. Wallace et al. reported
complete (three) or partial (five) re-ruptures in eight of 140
(5.7%) using a nonoperative protocol similar to ours with a
custom orthosis from 4 weeks.29 Hufner et al. reported re-
ruptures in eight of 125 (6.4%) with functional nonoperative
treatment using ultrasound to determine whether there was
a gap of less than 10 mm.11 The highest rates of re-rupture
in our series were seen in males under 40 years. This may
reflect the higher demand, greater muscle bulk or lack of
compliance likely in this age group. Despite the relatively
good results of nonoperative treatment we still found a
significantly decreased rate of re-rupture and of reoperation
for all causes in our surgical group. There was, however, no
significant difference in re-rupture rates for women due to
the low rates of re-rupture with nonoperative treatment in
women over 40 years old.
There are weaknesses to our study. It is a retrospective
audit with no randomization and focused on the end-points of
re-rupture and deep infection. Minor complications in either
group may be under-reported. However, over the period
surgical techniques did not change and the rehabilitation
protocol was the same for both groups. It is simplistic to
believe that one treatment, either operative or nonoperative,
should be used for all patients with this injury. Our selective
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approach has resulted in a low rate of surgical complications
and a total re-rupture rate of 5.8%. Our series is one of the
larger reported yet it may still be underpowered to detect
significant differences in risk factors for re-rupture such as
age and sex. A future study based on these results with 80%
power to detect a difference in re-rupture rates between sexes
would require over 600 patients per group.
CONCLUSION
Contrary to previous studies we found an equal number of
men and women with an acute Achilles tendon rupture up to
age 50 years and a mean age in women of 37.6 years which
is 3.7 years younger than men. The unusually high incidence
in women appears to be due to the popularity of netball.
With our functional bracing protocol there was a significantly
lower re-rupture rate in operatively treated patients and a low
major surgical complication rate. Our results support surgery
in patients less than 40 years of age, in particular males, if
there are no contraindications. However, functional bracing,
as part of nonoperative treatment can result in low re-rupture
rates in patients over 40 especially in females.
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Article
Acute rupture of the Achilles tendon is a relatively common 
injury. The mechanism of Achilles tendon rupture is usually 
traumatic injury during a sporting event.6,7,31 It is more 
common in men, most commonly around 40 years of age. 
The incidence may be increasing as aging adults continue 
their participation in high-demand sports.6,11,20
There is much debate on the best management of acute 
Achilles tendon ruptures. Historically, studies have shown 
increased rerupture rates with nonoperative management, 
which are typically 9% to 12%15 and may be as high as 
21%.21 However, there are increased wound-healing prob-
lems with operative treatment, which can be catastrophic.10,32 
Proponents of surgery cite improved outcomes with sur-
gery, and it is recommended for elite athletes.17,19,31 
However, this may be as a result of an accelerated rehabili-
tation program, which can also be incorporated into a non-
operative functional bracing protocol.8 These programs 
have improved early functional outcomes and are safe and 
have improved patient satisfaction.18,19,28,30 Recent prospec-
tive, randomized studies have failed to show significant 
clinical differences in functional outcome but continue to 
show increased wound complications with operative man-
agement.14,33 Regardless of treatment choice, long-term 
functional deficits may persist in the injured limb.16,24,27
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Abstract
Background: The purpose of this study was to compare the functional results of operative and nonoperative treatment 
of acute Achilles tendon rupture using an identical rehabilitation program of functional bracing.
Methods: Over a 10-year period, 200 patients (99 operative, 101 nonoperative) aged between 18 and 65 years were 
treated at our institution’s physiotherapy department after acute Achilles tendon rupture. There were 132 patients (62 
operative, 70 nonoperative) available for a minimum 2-year follow-up (average 6.5 years; range, 2-13 years). Functional 
outcome was assessed using the Achilles tendon total rupture score (ATRS).
Results: With the numbers available, no significant difference could be detected in ATRS between operative (mean 84.8, 
median 90) and nonoperative groups (mean 85.3, median 91; P = 0.55). No significant difference could be detected in ATRS 
between male and female patients however treated (P = 0.30) or between patients younger and older than 40 years at time 
of injury (P = 0.68). There was no correlation between ATRS score and age at injury in all patients (ρ = −0.0168, P = 0.85). In 
male patients, there was a weak trend with older patients at follow-up having better scores (ρ = 0.21, P = 0.069). However, 
among female patients, there was a significant negative correlation between ATRS scores and increasing age (ρ = −0.29, P = 
0.03). Logistic regression analysis failed to show any significant effect of age at rupture, gender, or mode of treatment on ATRS.
Conclusions: This study showed no significant difference detectable in ATRS between operative and nonoperative patients 
in the treatment of acute Achilles tendon ruptures using an identical rehabilitation program with functional bracing.
Level of Evidence: Level II, prospective comparative study.
Keywords: ATRS, Achilles tendon rupture treatment, functional bracing
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Our hypothesis was that there would be no significant 
difference in patient-reported functional outcomes between 
patients treated operatively or nonoperatively when using 
an identical functional bracing protocol. The purpose of the 
study was to measure patient-reported outcomes using the 
Achilles tendon total rupture score (ATRS)4,23 between 2 
cohorts of patients with acute Achilles tendon rupture 
receiving either operative or nonoperative treatment using 
the same functional bracing protocol.
Methods
This was a cohort study comparing patient-reported out-
comes between operative and nonoperative treatment using 
an identical functional rehabilitation program. Our regional 
ethics committee gave approval for the study. Operative or 
nonoperative treatment was individualized based on patient 
factors including age, activity level and comorbidities, and 
surgeon preference. Relative contraindications to surgery 
were diabetes, tobacco or steroid use, or peripheral vascular 
disease. A younger, high-demand patient or delayed presen-
tation over 24 hours were relative indications for surgery.
A total of 200 patients met the inclusion criteria of a 
complete, traumatic closed rupture of the Achilles tendon in 
patients aged between 18 and 65 years. Ninety-nine patients 
were treated operatively, and 101 patients were treated non-
operatively. Sixty-eight patients were lost to follow-up 
because of change of contact number, they moved, or they 
were not available for the study, leaving 132 patients avail-
able for a minimum 2-year follow-up (average 6.5 years, 
range, 2-13 years; Figure 1). Sixty-two patients (47%) had 
been treated operatively and 70 patients (53%) nonopera-
tively. In the study group, of the 132 patients evaluated, the 
mean age at injury was 41.1 years. There were 79 men 
(60%) and 53 women (40%). The mean age of women was 
significantly lower than males by 4 years (P = 0.044).
Only patients who were treated in our physiotherapy 
department were included to ensure consistency of the use 
of the rehabilitation protocol (Table 1). Patients were 
excluded if their rehabilitation occurred outside our institu-
tion. Chronic ruptures, partial ruptures, tendinosis, and gas-
trocnemius tears were also excluded. The diagnosis was 
based on clinical examination. We did not routinely use 
ultrasound or magnetic resonance imaging (MRI) in the 
diagnosis or management of acute ruptures.
Operative Technique and Treatment Protocol
Surgery was performed with the patient prone with a single 
preoperative dose of intravenous 2 g cefazolin. Tourniquets 
or self-retaining retractors were not routinely used. A short 
posteromedial incision was made over the defect. A Kessler 
type 1 core suturing technique with absorbable No. 1 suture 
and multiple interrupted 3/0 absorbable sutures was used to 
braid the periphery together. The paratenon was closed with 
an absorbable suture and skin closed either with interrupted 
nylon skin sutures or a subcuticular absorbable suture. 
Postoperatively, the ankle was placed in an equinus cast. 
Patients in the nonoperative group were placed in a below-
knee cast with ankle in full gravity-assisted equinus.
The patients in both groups were kept non–weight bear-
ing in a cast for 4 weeks and then placed in a controlled 
ankle movement walker boot (Tukwila, WA) locked at 20 
degrees equinus and worn day and night. Physiotherapy 
treatment then commenced with the equinus progressively 
decreased to neutral by 6 to 8 weeks. Weight bearing pro-
gressed from partial to full as patient tolerance and range of 
motion allowed. This was usually once the equinus was 
reduced to 10 degrees or less. The orthotic was removed by 
Figure 1. Diagram showing identification of the study 
population, inclusion and exclusion criteria, and the study 
groups.
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8 weeks. Phase 2 from 8 to 12 weeks included active and 
passive stretches, concentric and eccentric muscle strength-
ening, and proprioception. Aqua jogging, increasing weight 
bearing, and cycling with heel flat were allowed. After 3 
months, gentle jogging and single-limb heel raises were 
commenced. By 4 to 6 months, running was introduced and 
strength and distance activities progressed (Table 1).
Prospectively gathered data included demographic 
details including age and gender. Chart review was per-
formed, and our audit database was checked for details of 
complications, reruptures, and reoperations. Patients were 
contacted for review by mail, telephone, and online sur-
veys, which included the ATRS. The ATRS is a validated 
patient-reported outcome score published in 2007 by 
Nilsson-Helander et al.23 It consists of 10 questions in 
which the patient self-reports the amount of limitations on 
each particular aspect of the function of the Achilles tendon 
giving a 0 to 100-point linear score, with 100 being a nor-
mal functional Achilles tendon. A 7 to 10-point difference is 
considered clinically relevant.3,4,23
The primary outcome of this study was to compare the 
patient-reported functional outcome using the ATRS 
between the operative and nonoperative groups. Subgroup 
analysis was performed comparing gender and age of 
patients within and between the 2 groups.
Statistical Methods
All statistical data were calculated using the statistical soft-
ware Stata (StataCorp, www.stata.com). An intention-to-
treat analysis was performed. Therefore, patients initially 
treated nonoperatively who reruptured and required surgery 
were analyzed as nonoperative treatment. Statistical signifi-
cance of the functional scores between the 2 groups was 
analyzed with the use of a 2-sample Wilcoxon rank-sum 
(Mann-Whitney) test. A χ2 test was used to compare rerup-
ture rates. Spearman’s ρ was used to investigate the associa-
tion between ATRS and age and follow-up duration. A 
logistic regression analysis was performed to explore the 
effect of age at rupture, gender, and mode of treatment on 
ATRS.
Results
Of the 99 patients treated operatively, there were 2 rerup-
tures (2%). Of the 101 patients treated nonoperatively, there 
were 6 reruptures (6%). There was no statistically signifi-
cant difference in rerupture rates between treatment groups 
(χ2 = 2, P = 0.157). There was no significant difference in 
age between the operative and nonoperative groups (P = 
0.3; Table 2).
There was no significant difference in ATRS functional 
scores between operative (mean 84.8, median 90) and non-
operative groups (mean 85.3, median 91; P = 0.55) with the 
numbers available. There was no significant difference in 
scores between the two treatment groups seen for either 
men or women (Table 2) There was no significant differ-
ence in mean ATRS between men and women however 
treated (P = 0.30) or between patients younger and older 
than 40 years at time of injury (P = 0.68; Table 2).
There was no correlation between ATRS score and age at 
injury in all patients (ρ = −0.0168, P = 0.85). In male 
patients, there was a weak trend with older patients at fol-
low-up having better scores (ρ = 0.21, P = 0.069). However, 
among female patients, there was a significant negative cor-
relation between ATRS scores and age at follow-up, with 
older patients tending to have poorer scores (ρ = −0.29, P = 
0.03). These trends were also seen when comparing age at 
rupture: men (ρ = 0.18, P = 0.11), female (ρ = −0.35, P = 
0.011). The duration of follow-up had no relationship to 
ATRS (ρ = 0.14, P = 0.1). Logistic regression analysis 
failed to show any significant effect of age at rupture, gen-
der, or mode of treatment on ATRS.
Discussion
The use of accelerated functional rehabilitation in operative 
or nonoperative treatment of Achilles ruptures is increas-
ingly common. The protocols usually combine both early 
weight bearing and early motion in an orthotic rather than 
Table 1. Rehabilitation Protocol Used by Our Physiotherapy 
Department Following Operative Repair or Nonoperative 
Treatment.
0-4 wk •• Relaxed equinus cast non–weight bearing
Phase 1
4-8 wk
•• Active only range of motion with knee bent
and straight
•• Gait reeducation in controlled ankle
movement walker increase from partial to
full weight-bearing







•• Bilateral calf raises
10-12 wk •• Bilateral calf raises non–weight-bearing
(ie, sitting)
•• Cycling with heel flat
















1334 Foot & Ankle International 38(12)
conventional casting. These may result in lower rerupture 
rates and earlier functional gains compared with the results 
with traditional casts.7,18,26,28,29,33 A recent meta-analysis by 
Soroceanu et al29 concluded that functional outcome scores 
did not differ significantly between the 2 groups. However, 
variability in treatment protocols and in the use of validated 
and nonvalidated scores means results need to be treated 
with caution.10 We sought to minimize this variation by 
using identical casting, bracing, and rehabilitation guide-
lines with all patients followed in our physiotherapy depart-
ment. The protocol was developed in 2001 to try to balance 
early motion with protection from noncompliant patients 
and is not as aggressive as many published studies.
This study uses the ATRS as it has been identified as the 
only outcome measure that has demonstrated multiple facets 
of validity for use in this patient group.13 Healthy patients 
have scores close to 100, and a score of 85 points and above is 
considered a good or excellent result.3,23 Most studies have 
reported mean ATRS scores of 80 to 90 at 12 months, with 
median scores around 90 regardless of treatment.12,25 
However, Barfod et al1 in a randomized controlled trial (RCT) 
comparing the effect of early weight bearing in patients man-
aged nonoperatively reported a mean ATRS of 73 and 74 at 12 
months. It is not clear why their scores were lower. The mean 
age of their patients was similar to ours, although there were 
only 16% women. The largest study we are aware of using the 
ATRS surveyed 487 patients at mean 3.6 years postinjury.2 
There was no significant difference in ATRS between opera-
tive treatment at one hospital (81.7) and nonoperative treat-
ment at another (78.9). The mean age of their cohort was 46 
years, which is 5 years older than our study.
To our knowledge, there have been only 2 RCTs compar-
ing functional outcome scores of operative versus nonopera-
tive treatment using the ATRS.22,25 Neither showed any 
significant difference in ATRS at 12-month follow-up. In an 
RCT of 97 patients, all underwent an identical bracing and 
mobilization program.22 The mean 12-month ATRS and 
rerupture rates were 88 points and 4% for the operative and 
86 points and 12% for the nonoperative group. Olsson et al25 
reported the mean 12-month ATRS was 82 in the operative 
group and 80 in the nonoperative group. Our results are 
comparable to these studies22,25 but at a longer-term mean 
follow-up of 6.5 years. The mean and median ATRS results 
suggest a good or excellent result in most patients regardless 
of treatment. Our rerupture rates of 2% in the operative 
group and 6% in the nonoperative group are lower than 
those reported in meta-analyses.10,29,32 The difference in 
rerupture rate failed to reach statistical significance, which is 
probably due to small numbers. We identified no significant 
functional benefit from operative treatment in any subgroup 
of age or gender with the numbers available.
In other RCTs comparing operative and nonoperative 
treatment, Keating and Will14 found no functional differences 
at 1 year using a traditional casting approach but had rerup-
ture rates of 5% and 10%, respectively. Moller et al21 had an 
unacceptably high rerupture rate of 20.8% with nonoperative 
treatment but had equally good functional results if compli-
cations were avoided. Metz et al19 compared minimally inva-
sive surgery with nonoperative treatment but used differing 
rehabilitation protocols and braces. There was an earlier 
return to work in the surgery group, but no other differences 
reached significance. Willits et al33 used an identical bracing 
and rehabilitation program in an RCT of 144 patients. 
Rerupture rates were not statistically significant (2.8% opera-
tive, 4.2% nonoperative), and there were no functional differ-
ences using both objective measures and the Leppilahti score.
Hutchison et al9 have recently reported a large series of a 
dedicated management programs using ultrasound to deter-
mine treatment, functional bracing, early weight bearing, 
and an accelerated exercise program. Their rerupture rate is 
the lowest we are aware of in a large series, with only 3 of 
273 (1.1%) overall and 2 of 211 (1%) treated nonopera-
tively. Their ATRS scores were collected only to 9 months 
in 43 patients and so were relatively low at 72.4. The ATRS 
typically improves to 12 months and may improve with 
nonoperative management until 2 years.24 The program 
resulted in a significant reduction in surgery and health care 
costs, with satisfactory outcomes.
It is not clear why there was a negative association 
between age and ATRS in female patients with the opposite 
Table 2. Details of Patients, Treatment, and Achilles Tendon Rupture Score (ATRS).
Number Mean Age, y ATRS Mean ATRS Median Interquartile Range
All patients 132 41.1 85.1 91 78, 98
 Male 79 42.7 87.7 91 82, 98
 Female 53 38.9 81.2 91 71-97
Operative 62 40.1 84.8 90 78, 98
 Male 41 41.5 85.5 89 78, 98
 Female 21 37.3 83.5 91 77, 97
Nonoperative 70 42.0 85.3 91 80, 98
 Male 38 43.9 90.1 93 87, 99
 Female 32 39.8 79.6 87 60, 99
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trend in male patients in our study. Women in our study 
tended to have lower scores than men, particularly with 
nonoperative treatment, where the difference in mean score 
was 10 points. While this did not reach statistical signifi-
cance, it may be clinically relevant. Grävare Silbernagel 
et al5 also noted lower scores in women, but the differences 
did not reach significance. Bergkvist et al2 reported a sig-
nificant worsening of ATRS with increasing age in nonop-
eratively managed female patients. The demographics of 
our study population were unusual in that there were a high 
proportion of women (40%) compared with studies from 
other countries, and the female patients were typically 4 
years younger at the time of injury than male patients. The 
gender difference should be recognized in future studies.
Limitations of the Study
There are limitations to our study. It is a cohort study with 
no randomization and focused on the ATRS score as the pri-
mary outcome. However, the 2 groups were well matched 
with respect to numbers, age, and gender. We did not use 
other objective tests of strength or record return to work or 
sport; however, these objective deficits would be expected 
to show up in a patient-reported score such as ATRS. Other 
studies have reported objective functional deficits despite 
good or excellent patient-reported scores.16,24,27 A strength 
is that despite a large loss to follow-up, because of a rela-
tively young and mobile population and the long-term fol-
low-up period, the numbers at final follow-up were still 
larger than most of the studies cited above.1,14,21,22,25,33 We 
did not perform a power study prior to commencing the 
study, but as the ATRS scores were identical in the 2 groups, 
we believe that the numbers were sufficient to conclude that 
there was no clinically relevant difference. Strengths of the 
study were the standardization of the rehabilitation program 
between the operative and nonoperative groups. It is the 
longest follow-up study using the ATRS, suggesting that 
results do not deteriorate with time following injury.
Conclusion
With the numbers available, this study found that there was 
no statistically significant difference and no clinically rele-
vant difference in patient-reported functional outcomes at 
minimum 2-year follow-up using the ATRS between opera-
tive and nonoperative treatment of Achilles tendon rupture 
with an identical functional rehabilitation program. It does 
not support operative treatment of an acute Achilles tendon 
rupture to improve a patient’s functional outcome.
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Chapter 5 
Scoring, prioritisation and effects of rationing with respect to total 
joint replacement. 
a) Scoring Tools: Implementation & Validation
In publicly funded health care systems there will never be sufficient capacity for all the 
elective orthopaedic surgery that could be done. How this is managed will vary between 
health care systems. In New Zealand, Elective Surgery Performance Indicators (ESPIs) have 
driven the need for scoring or prioritisation tools. If a patient cannot be seen within 4 
months of acceptance of a referral, or undergo surgery within 4 months of the decision to 
offer surgery then they cannot be given certainty and are allowed to be declined. While the 
Ministry of Health uses the term prioritisation, we have termed this ‘explicit rationing’ 
which has achieved a degree of acceptance in the media. A variety of scoring tools for 
surgical prioritisation have been used in NZ since the introduction of Clinical Priority Access 
Criteria (CPAC). It is expected that these prioritisation tools are used in all DHBs. However, 
threshold scores, which may allow comparison between DHBs, are not publicised and are 
not released by the Ministry of Health. The lack of consistency in scoring within and 
between DHBs is cited as a reason for this. There has been limited validation of these tools 
and little comparison with widely used condition-specific patient reported outcome scores. 
As part of the Orthopaedic Patient Programme we implemented independent nurse led 
scoring for hip and knee replacement due to concerns regarding the impartiality of surgeon 
scoring. In ‘Rationing for Total Hip and Knee Arthroplasty Using the New Zealand 
Orthopaedic Association Score: Effectiveness and Comparison with Patient-Reported Scores’ 
we report on the NZ Orthopaedic Association score for hip and knee replacement and its 
comparison with established validated condition-specific patient-reported scores such as 
the Oxford Hip and knee score. We found the score to be effective tool for rationing joint 
replacement but had concerns about its ability to discrimate around the threshold score. In 
‘The ShortMAC: Minimum important change of a reduced version of the WOMAC 
osteoarthritis index’ we investigate the minimum important clinical change in a shortened 
version of the Western Ontario MacMaster (WOMAC) osteoarthritis Index. We conclude 
that it is valid and responsive and a patient friendly alternative to the traditional tool.  
Some centres match their acceptances for FSA to their likely surgical capacity rather than 
using surgical prioritisation. This has led to the development of a new tool, the National 
Referral prioritisation tool (NRPT), to prioritise referrals so that the rationing is performed at 
an earlier stage before a patient is even seen at FSA. It has been designed to be a generic 
tool that can be used for all specialities. We have been the first to pilot the NRPT in Dunedin 
where it was introduced to try to reduce the acceptance rate of referrals by 50%. 
In ‘The National Referral Prioritization Tool for First Specialist Assessment: Results of the 
Pilot Study in Orthopaedic Surgery” we report the results of the pilot implementation of the 
new NRPT in orthopaedic surgery in Dunedin. We conclude that it is more discriminating 
than the clinical priority categories used previously and potentially allows fine-tuning of a 
threshold score to balance acceptances and capacity. 
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b) Consequences of rationing
While it has been accepted that there will never be enough capacity for everyone who may 
benefit from surgery, it has not been documented what the consequences are of explicit 
rationing both for individual patients who have been declined surgery and for the service.  
‘Rationing of hip and knee replacement: Effect on the severity of patient-reported symptoms 
and the demand for surgery in Otago’ showed that the demand for THR/TKR had increased 
by 19% from my original study. Patients qualifying for surgery were more disabled and many 
of those that were declined would have qualified for surgery previously.  
‘The Outcomes of patients returned to General Practitioner after being declined hip and knee 
replacement’ reports on what happen to those patients who are recommended THR or TKR 
but fail to qualify due to their prioritisation score.  There is little else that the GP has to offer 
so many are re-referred. The majority subsequently undergo surgery with patients with hip 
OA more likely to qualify than those with knee OA. This merely delays surgery by an average 
of 15 months while the patient deteriorates. The patients are more likely to be 
deconditioned which may have an effect on their outcome after surgery. 
c) Health Related Quality of Life
The final two papers in this chapter introduce general health related quality of life (HRQoL) 
scores rather than condition-specific scores. In ‘The relationship between preoperative 
Oxford hip and knee score and change in health-related quality of life following total hip and 
total knee arthroplasty: Can it help inform rationing decisions?’ we showed that patients 
with poorer preoperative Oxford hip and knee scores will end up with a poorer post-
operative Oxford score and general health related quality of life (HRQoL), as measured by 
SF-6D utility, but will have a greater gain in HRQoL. The inference is that making a patient 
wait until they have declined to a threshold score will have a negative impact on their final 
outcome. 
In ‘Total Hip and Knee Arthroplasties Are Highly Cost-Effective Procedures: The Importance 
of Duration of Follow-Up’ we use the SF-6D utility to model cost-effectiveness of hip and 
knee replacement out to 15 years including long term revision rates and mortality. This 
shows that both procedures are highly cost-effective by 3 years with the cost/QALY reducing 
out to 15 years. They are more cost-effective in those with poorer preoperative scores and 
younger patients but remain highly cost-effective even in older patients and those with 
better preoperative scores.   
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Background: There is increasing interest in scoring systems to prioritize patients for hip and knee
arthroplasty. The purpose of this study was to determine the effectiveness of the New Zealand Ortho-
paedic Association (NZOA) score and compare it with patient-reported scores of patients listed for hip
and knee arthroplasty.
Methods: Over a 1-year period, all patients listed for primary hip and knee arthroplasty were scored by a
prioritization nurse. The NZOA score, outcome, preoperative Oxford hip or knee score (OHKS) and
reduced Western Ontario McMaster osteoarthritis index (WOMAC) score (RWS) were collected.
Results: Overall, 608 patients were listed for hip (319) or knee (289) arthroplasty. The mean scores for
knees were all better than hips (P < .001). On initial scoring, 324 patients (53%) were given certainty
(mean NZOA, 80.5; OHKS, 10.0; RWS, 35.1), 90 (15%) given clinical over-ride (NZOA, 69.6; OHKS, 12.0;
RWS, 33.2), and 194 (32%) returned to general practitioner (NZOA, 64; OHKS, 14.2; RWS, 30.8). Knees
(38%) were more likely to be returned than hips (26%; P ¼ .002). Fifty (26%) were re-referred during the
study period (mean, 5 months) and given certainty or over-ride. The difference at final outcome between
patients with certainty and clinical over-ride was NZOA, 10.3 points; Oxford, 1.6 points; and RWS, 1.4
points. The difference between clinical over-ride and returned to general practitioner was NZOA, 7.2;
Oxford, 4.4; RWS, 5.3.
Conclusion: The NZOA score is an effective tool for rationing for joint arthroplasty. Patients around the
threshold score of 70 may not have a clinically important difference compared with those above
threshold.
© 2016 Elsevier Inc. All rights reserved.Hip and knee arthroplasty are 2 of the most successful and cost-
effective interventions in orthopedic surgery. However, public
health systems are under significant funding constraints, and in our
country, it is recognized that there is a need for explicit rationing of
publicly-funded total joint arthroplasty. Several scoring systems
have been used in the last 15 years in our country: the Clinicalclosed potential or pertinent
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137Prioritisation Access Criteria score [1], the priority scoring system
for major joint arthroplasty (also known as the New Zealand score)
[2-4] and the New Zealand Orthopaedic Association Hip and Knee
priority score (NZOA score) introduced in 2008 [5,6] (Fig. 1).
As the demand for major joint arthroplasty continues to rise,
other countries have developed priotitization scores [7-9]. In the
United Kingdom, it has been proposed that the widely used Oxford
and Western Ontario McMaster osteoarthritis index (WOMAC)
scores should be used to ration access to joint arthroplasty with
varying thresholds suggested [10]. However, several authors have
reported that these scores do not predict satisfaction post-
operatively and should not be used for prioritization [10-13].
The NZOA score has been widely used in our country since its
introduction. It has sections on pain, personal functional limitation,
Fig. 1. New Zealand Orthopaedic Association Hip and Knee Prioritisation Tool (NZOA score) including local criteria for determining score for consequence of delay.
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 31 (2016) 957e962958social limitation function, ability to benefit, and consequence of
delay and is scored 0 (best) to 100 (worst). There has been little
published on it and no validation studies. Recently, a study [6]
compared the NZOA scores between 2 District Health Boards and
showed significantly higher scores at one hospital with 36% of pa-
tients declined surgery due to threshold. It was unclear if this rep-
resented scoring practice or a true difference in pain and disability.
In our district, we have had significant problems with excess de-
mand over capacity [14]. We have used the NZOA score since its
introduction. Scoring was originally done by the supervising
consultant via a form in the patient’s electronic record. Within a
short time, the financial threshold score rose from below 70 to 79
points and the numbers of patients failing tomeet threshold rapidly13increased. When the threshold rose to 80 points, the system broke
down as it was almost impossible to score patients above threshold
without “gaming” the system. This typically involved the indis-
criminate use of 24 points for the question 5 (consequence of delay).
As part of a programme, funded by the National Health Board, to
address patient flow, it was decided that all scoring for joint
arthroplasty surgery in our hospital would be by a single experi-
enced orthopedic nurse to ensure consistency, using theNZOA score.
The purpose of this study was to determine the effectiveness of
the first 12-month use of the NZOA score as scored by the priori-
tization nurse (PN) and to compare the score against validated
patient-reported scores for all patients listed for hip and knee
arthroplasty whether qualifying for surgery or not.8
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In October 2013, before the programme commencing, the
threshold for hip and knee arthroplasty in our hospital was 80
points using the NZOA score. As an inter-rater reliability exercise,
103 consecutive patients listed for hip or knee arthroplasty were
scored both by a consultant at the time of first specialist assessment
and by the PN. Comparisons of the first 4 questions of the NZOA
score were made. The inter-rater reliability, or degree of agreement
between the consultant and nurse (for each of the 4 questions
separately and also the threshold score outcome), was assessed
using weighted Kappas (using linear weights).
After analysis of the waiting list figures, capacity, contracted
volumes, and Elective Services Performance Indicator compliance,
the threshold was set at 71 points commencing November 1, 2013.
All patients falling below threshold would be returned to general
practitioner (GP) although clinical over-ride could be used. Criteria
for the use of 24 points for question 5 were developed after dis-
cussion with all surgeons. (Fig. 1)
The letters of patients referred to the Orthopaedic Department
by GPs are triaged by a surgeon. Patients with severe symptoms or
radiologic changes will be offered an appointment. Others may be
referred to a nurse and physiotherapy led clinic, the “Joint Clinic” to
maximize nonoperative treatment. Those in need of surgery can
then be referred for a specialist appointment. The decision to wait-
list a patient is at the surgeon’s discretion after assessing the risk-
to-benefit ratio for an individual patient. We have no formal
policy on patients with increased body mass index. Dietitian advice
is offered at joint clinic or at outpatient appointment. The average
body mass index of our patients undergoing hip or knee arthro-
plasty is 31.7kg/M2. Details of all patients seen and listed for pri-
mary hip or knee arthroplasty surgery were collected from
November 1, 2013, to October 31, 2014. The patient completed an
Oxford hip or knee score (OHKS) and a reduced WOMAC score
(RWS). The modified Oxford score (0-48 where 0 is worst and 48
best) was used. [15] The RWS is a shortened version of the original
WOMAC score [16] and uses 5 pain questions and 7 function
questions (scored 0-4, where 0 is best) giving a worst score of
48 [17].
Patients were phoned by the PN within 2 weeks and scored
using the NZOA tool. A decision onwhether the patient qualified for
publicly funded surgery was made and communicated inwriting to
the patient. Patients were categorized as: certainty (NZOA score 71
or greater), clinical over-ride (NZOA <71 points), or return to GP
(NZOA score <71).
The decision on qualification was deferred if active medical
problems such as poorly controlled diabetes, cardiovascular dis-
ease, or smoking required addressing first. Reasons for clinical over-
ride were collected. Details and scores of patients returned to GP
care were collected including their subsequent outcome.
Independent samples t-tests were used to compare means, and
the test for a difference in proportions was used to estimate the
differences between hip and knee patients in outcome (certainty,
clinical over-ride, and return to GP). Pearson’s correlation coeffi-
cient (r) was calculated to examine the correlations between the 3
different scoring methods. The 2-sided significance level a ¼ 0.05
was specified for all statistical tests. Stata software, version 13.1,
was for all statistical analyses.
Ethics approval was given by the local institutional review board
for this study.
Results
In the inter-rater reliability investigation there were 103
patients scored by both the PN and a consultant. The agreement139between the consultant and nurse on the 4 individual questions
varied from “fair” to “almost perfect”with weighted k of 0.55, 0.69,
0.27, and 0.89 for questions 1-4, respectively [18]. The mean
(standard deviation [SD]) NZOA score by the consultant was 75.6
(9.7) compared with 75.1 (10.60) by the nurse. With a threshold
score of 80 points at that time for surgery, the consultant and nurse
agreed on 91 (88.3%) of the patients. The consultant scored 7 above
threshold where the nurse scored them below and the consultant
scored 5 below threshold where the nurse scored them above. The
weighted k assessing the agreement on certainty categorization
was 0.71 suggesting “substantial” inter-rater reliability of the NZOA
score [18].
During the 12-month period, November 1, 2013, to October 31,
2014, 608 patients were wait-listed for either hip or knee arthro-
plasty and scored by the PN. These patients had a mean age of 68.3
years (SD 10.5) and 342 (56.2%) were women. Of these, 414 (68.1%)
initially qualified for surgery (324 with certainty and 90 patients
with clinical over-ride), with the remaining 194 (31.9%) patients
returned to GP care (Table 1).
The mean NZOA score for patients with certainty was 80.5
points, which was significantly higher than those on clinical over-
ride (69.6) which in turn was significantly higher than those
returned to GP care (64 points; P < .001). The Oxford score for each
category was also statistically significantly different (P values
< .001-.019) although the difference in mean score was only 2
points between certainty and clinical over-ride and 2.2 points
between clinical over-ride and GP care. The difference in mean
RWS between certainty and clinical over-ride (P ¼ .048) or GP care
(P < .001) were both statistically significant.
There were 319 patients listed for hip arthroplasty (52.5%) and
289 (47.5%) listed for knee arthroplasty (Table 2). The mean age of
patients listed for hip arthroplasty was significantly lower than
knees by 2 years (67.3 years [SD 11.6] vs 69.4 (9.1) years; diff: 2.1; CI:
0.4-3.7; P ¼ .0157), and similar proportions of each were female
(56%). Hip patients were statistically significantly more likely than
knee patients to qualify for surgery at initial assessment either
through meeting the threshold (60.8% vs 45.0%; diff: 15.8; CI: 8.0-
23.7; P < .001) or when those with clinical over-ride are included
(73.7% vs 61.9%; P ¼ .002). Therefore, knees were significantly more
likely to be returned to GP (38% vs 26%; diff: 11.7; CI: 4.3-19.1; P ¼
.002; Table 2).
Themean NZOA, Oxford, and RWS scores of all patients listed for
joint arthroplasty were significantly worse for hips than knees.
Hips given certainty initially had significantly higher mean NZOA
scores and RWS than knees with certainty. There was no significant
difference between hips and knees in the clinical over-ride and
return to GP categories for any of the 3 scores.
The NZOA score as expected showed a significant difference
(P < .001) between each of the 3 outcome categories for both hips
and knees There was a statistically significant difference in mean
Oxford and RWS between the certainty and return to GP categories
for both hips (Oxford 3.3 points P < .001, RWS 4.2 points, P ¼ .001)
and knees (Oxford 4.5 P < .001, RWS 3.7 points, P ¼ .01). For knees,
the difference in mean Oxford score between certainty and clinical
over-ride (1.9 points, P ¼ .030) and between clinical over-ride and
GP care (2.6 points, P ¼ .033) reached significance although the
actual differences are small.
The RWS and Oxford scores had very high correlation with each
other(r ¼ 0.8058, P < .001), whereas there was a poorer correla-
tion between NZOA and either Oxford (r ¼ 0.4309; P < .001) or
RWS (r ¼ 0.3391, P < .001).
Of those initially returned to GP, 50 patients (25 hips and 25
knees; 25.8%) were referred back within the study period and
subsequently scored above threshold (13) or given clinical over-ride
(37). The mean time to the new decision after rescoring was 5
Table 1
Outcomes and Mean Scores of All Patients Waitlisted for Hip or Knee Arthroplasty, After Initial Categorization and After Final Outcome.
Outcome Category All Patients After Initial Prioritization All Patients Final Outcome
N ¼ 608 NZOA Score (SD) Oxford/48 (SD) RWS/48 (SD) N ¼ 608 NZOA Score (SD) Oxford/48 (SD) RWS/48 (SD)
Certainty (NZOA 71 points) 324 (53.3%) 80.5 (6.2)a,b 10.0 (4.5)a,b 35.1 (6.6) a,b 337 (55.4%) 79.9 (6.8)a,b 10.0 (4.5)a,b 35.2 (6.6)a
Clinical over-ride
(NZOA <71 points)
90 (14.8%) 69.6 (1.8)a,c 12.0 (4.7)a,c 33.2 (6.5)c 127 (20.9%) 69.6 (1.8)a,c 11.6 (4.6)a,c 33.8 (6.5)a
GP care 194 (31.9%) 64.0 (6.8)b,c 14.2 (6.1)b,c 30.8 (8.4)c 144 (23.7%) 62.4 (7.0)b,c 16.0 (6.0)b,c 28.5 (8.1)b,c
NZOA, New Zealand Orthopaedic Association; RWS, reduced WOMAC score; SD, standard deviation; GP, general practitioner.
a Statistically significantly different from the corresponding GP care score.
b Statistically significantly different from the corresponding clinical over-ride score.
c Statistically significantly different from the corresponding certainty score.
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 31 (2016) 957e962960months with only 11 patients in this group re-referred after 6
months. The RWS and Oxford sores of these patients were not
significantly different from those patients initially given certainty
(P¼ .316 and P¼ .966, respectively). The NZOA (diff: 6.2; CI: 4.2-8.2;
P < .001), Oxford (diff 6.0; CI 8.4 to 3.6; P < .001) and RWS (diff
7.9; CI 4.6-11.3; P < .001) scores of these 50 patients were signifi-
cantly worse than the 144 who remained in GP care.
In total, 464 patients (260 hips and 204 knees) were given
certainty for surgery during the 12-month period, and of these,
clinical over-ride was invoked for 127 (21%) patients. There was no
significant difference in the use of clinical over-ride between hips
and knees either at initial scoring (hip: 12.9% vs knee: 17.0%; P ¼
.155) or final outcome (18.8% vs 23.1%, P ¼ .185). The most common
reasons for clinical over-ride were for patients who had been on
long-term active review, those with very poor Oxford or RWS
scores, employment or social issues, second side surgery, or pa-
tients with significant medical conditions such as rheumatoid
arthritis and hematologic and renal disorders.
At final outcome, the difference in mean scores between the
certainty and clinical over-ride categories was 10.4 points on NZOA
(P < .001) but only 1.6 points on Oxford (P ¼ .007) and 1.4 points on
RWS (P ¼ .100). The corresponding differences in the mean scores
between clinical over-ride and GP carewere 7.2 points on NZOA, 4.4
points on Oxford, and 5.3 RWS (all P < .001; Table 1, Fig. 2).
Discussion
Hip and knee arthroplasty surgery are highly successful and
cost-effective interventions but with an aging population the de-
mand is increasing [19]. Funding constraints are likely to become an
increasingly widespread problem, both in our country and world-
wide, as the population ages and demand outstrips supply. There
has been much debate in countries with public health systems
about the use of scoring tools to prioritize and ration joint arthro-
plasty surgery. Should surgery be for those most in need [1], those
most likely to be satisfied or have the best outcome [11,13], or those
who will gain the most or be the most cost-effective? [10,20,21].
Oxford and WOMAC scores have been widely used as patient-
reported scores, but they were not designed to prioritize patients
[15]. Despite this, it has been proposed that the Oxford score should
be used to ration access to TKR with a threshold OKS ranging from
18 to 32 points [10]. However, neither score has been shown to be
predictive of satisfaction mainly because postoperative satisfaction
is so high [10,11,13]. Similarly, cost effectiveness studies have shown
that the vast majority of hip or knee arthroplasties are cost-
effective [10,20] even with Oxford scores up to 35 or 40 if healthy
[10]. Hossain et al concluded that the decision to implement knee
arthroplasty for a patient should be undertaken individually
without reliance on preoperative patient-reported outcome mea-
sures [12]. This traditional approach, however, does not appear to
accept the need for explicit rationing.14The NZOA score was developed using a process described by
Hansen et al [5] and is a development of the previously used Clinical
Prioritisation Access Criteria and New Zealand tools [1-4]. There are
5 sections with scores given relative weightings developed during
the validation process. It does not include patient-reported scores
but has sections on pain, personal functional limitation, social lim-
itation function, ability to benefit, and consequence of delay.
Although used by about half of the 20 District Health Boards in NZ
there have been no validation studies. The only publication we are
aware of using the score is by Blackett et al [6] who compared 2
centers. In Hawkes Bay 41% and in Northland 33% of patients were
declined due to threshold. The average NZOA score for patients in
Hawkes Bay qualifying for surgery was 76.9 points and for those
declined was 64.7 points, whereas in Northland, the scores were
70.6 and 55.4 points. They do not directly state their treatment
threshold or use of clinical over-ride. As no other outcome scorewas
used and multiple consultants scored the patients, it is not clear
whether the differences seen in their study are true differences in
the incidence and severity of disease, surgical capacity, or reflect
different interpretations and use of the tool. By using a single nurse
to score all patients and also collecting patient-reported outcome
measures, we hoped to address these issues.
TheWOMAC score has beenwidely used and has 5 questions for
pain, 17 for function, and 2 for stiffness [16]. It may be reported as a
total score out of 100 or scored for each domain separately
(particularly pain and function). The RWS we have used has 5 pain
questions and 7 function questions to give a score of 48 points and
more equal weighting of pain and function [17]. We found that the
NZOA tool has reasonably good agreement with RWS (correlation
coefficient r¼ 0.34) and Oxford scores (r¼ 0.43). The older NZ score
was found to have correlations with WOMAC between 0.26 [3] and
0.5 for pain and 0.54 for function [4]. Other scoring systems have
correlations with WOMAC between 0.39 and 0.79 [7-9].
The group of patients returned to GP after initial scoring and
especially at final outcome scored significantly lower than the
certainty group. The difference of 4-6 points on both RWS and
Oxford is greater than theminimum clinical difference of 2-5 points
reported for the OHKS [15,22] and the 12% change from baseline
WOMAC [23] and therefore is likely to be clinically significant.
A concern is the number of patients who were given clinical
over-ride either after initial scoring or after return to GP and early
re-referral. These patients almost invariably scored 70 points on the
NZOA tool. The Oxford and RWS of these patients were less than 2
points different from the certainty group and therefore unlikely to
have a clinically important difference.
There is no recognized value of either Oxford or WOMAC score
that indicates the need for surgery. In clinical series, authors have
reported mean WOMAC scores of 51%-60% [13,24-26]. Gossec et al
[27] found WOMAC pain and function scores were predictive of a
recommendation of hip (pain 59.8%, function 63.3%) or knee


























































































































































































































































































































































































































































































































































































































































































































































Fig. 2. Box plot comparing initial scores with final outcome category. NZOA (New
Zealand Orthopaedic Association) score (0 best to 100 worst), Oxford (Oxford hip or
knee score 0 worst to 48 best), RWS (reduced WOMAC score 0 best to 48 worst). GP,
general practitioner.
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14128 for knee and 30 for hipwhich is similar to our return to GP group.
In other articles, validating scoring tools, aWOMAC from39% to 65%
for pain and 43% to 58.8% for function qualified for surgery [4,7,9].
Our patients who qualified for surgery would have fallen into the
urgent category of Escobar et al (pain 65%, function 74%) [9]. Pub-
lished series from our country have reported mean WOMAC scores
of 56-76 [3,26,28] and Oxford scores in the range 10-18 [28,29].
Hip scores are typically a little worse than knee scores. Gossec
reported a difference of 3%-4% in WOMAC pain and function scores
between hip and knee patients. Large series from the United
Kingdomshowan average preoperativeOxford score of 18-20points
for knee arthroplasty [10,11,21,30,31]. The scores for hip arthroplasty
are a little lower (worse) at 16-19 points [11,20,21,24,32,33] with
public hospital patients scoring worse than private [32].
We found that each of the 3 scores of patients awaiting hip
arthroplasty were 4%-5% worse than those waiting for knee arthro-
plasty. This resulted in significantly more knees than hips being
returned to GP. This suggests that patients awaiting knee arthro-
plasty are disadvantaged relative to those needing hip arthroplasty.
However, the gains are usually greater for hip arthroplasty, and it has
been suggested that for an equal gain in quality-adjusted life years
knee arthroplasties should score 8 points higher than hips on pre-
operative Oxford score.[21] Both hip and knee arthroplasty are
highly cost effective for patients with scores in the range of our pa-
tients currently returned to GP [21]. Rationing is delaying surgery for
these patients which has significant cost implications for the patient
and society, even if not directly to the health system [10,26,34].
A strength of this study is that patient-derived scores were
obtained and a single person scored all patients. However, it is
possible that patients may have inflated their OHKS and RWS as
they realized that honest scoring may result in them not qualifying
for surgery. A further weakness is that because of the size of our
district and the number of rural clinics, the PN conducted in-
terviews by telephone. However, nurse scoring did correlate well
with the surgeon in the pilot study. This study reports on a popu-
lation that may be skewed by the severity of disease in our region.
The average Oxford and RWS scores of those returned to GP were
above the mean scores of most series. Therefore, our findings may
not be generalizable. Further validation work should look at the
effectiveness of the NZOA tool across a wider range of scores.
Many surgeons may find the idea of explicit rationing unac-
ceptable. It is difficult to deny patients surgery that is often life
D.P. Gwynne-Jones et al. / The Journal of Arthroplasty 31 (2016) 957e962962transforming. However, the unpalatable truth is that there are
limits to public health funding and elective surgery is the easiest for
funders to ration. Explicit rationing is likely to become increasingly
common in other public health systems. We have continued to
lobby for improved access but are obliged to prioritize patients.
The NZOA score does appear to be an effective scoring tool. Its
purpose is to ration access to hip and knee arthroplasty rather than
determine whether surgery is indicated. The threshold in place at
any institution is not fixed but will depend on the balance of supply
and demand. In our institution, it would be rare to contemplate
surgery in a patient who scored less than 50 points (10 of 608 in this
series). The tool appears to be successful at distinguishing between
patients below 70 points and those with higher scores with respect
to severity of symptoms from patient-reported scores. The problem
is around the threshold of 70. If our threshold had dropped to 70
points, the number qualifying for surgery without the use of clinical
over-ride would have increased by 50% from 324 to 494. This limits
its effectiveness as a discriminatory tool. Similar bottlenecks may
occur at other scores depending on the threshold in place in any
hospital (scores of 79, 66, and 62 are commonly seen). Using a single
nurse to score all patients has removed some of the variability
inherent in a subjective scoring system. Before this, there were
legitimate concerns about the consistency of scoring. Meaningful
comparison of access thresholds across the country needs the use of
validated patient-derived scores in addition to the NZOA tool.References
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UU STUDY DESIGN: Clinical measurement study; 
secondary analysis of randomized clinical trial 
data.
UU BACKGROUND: A 12-item shortened version 
(ShortMAC) of the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOMAC), a 
condition-specific, patient-reported osteoarthritis 
index, has been derived, published, and validated. 
The minimum important change (MIC) of the 
ShortMAC has not been reported or compared 
with the traditional 24-item WOMAC.
UU OBJECTIVES: To investigate the MIC of the 
12-item ShortMAC and the traditional 24-item 
WOMAC across 3 levels of patient-perceived global 
change.
UU METHODS: The Management of OsteoArthritis 
Trial cohort of 206 consecutive patients with knee 
or hip osteoarthritis was assessed at the initial vis-
it and after 9 weeks of physical therapy (n = 155) 
or usual medical care (n = 51). The global rating of 
change instrument, assessed at the 9-week visit, 
provided the anchor. The MIC was calculated using 
receiver operating characteristic curve methodol-
ogy for the ShortMAC and the traditional WOMAC, 
across 3 levels of patient-perceived change (small, 
medium, and large change) defined by the global 
rating of change.
UU RESULTS: The MICs for the ShortMAC and tra-
ditional WOMAC (both transformed to a scale from 
0 to 100) were 7.9 and 9.8 points for small change, 
8.4 and 9.8 points for medium change, and 12.1 
and 10.1 points for large change, respectively. The 
MICs of the pain and function subscales are also 
reported for small, medium, and large changes.
UU CONCLUSION: The lower point estimates for 
the MIC of the ShortMAC compared with that of 
the traditional WOMAC, using conventional defini-
tions of MIC and half the number of items, indicate 
greater efficiency for use in clinical trials and 
reduced patient burden. J Orthop Sports Phys Ther 
2018;48(2):81-86. Epub 21 Oct 2017. doi:10.2519/
jospt.2018.7676
UU KEY WORDS: minimum clinically important 
difference, minimum important difference, osteo-
arthritis, responsiveness
1Centre for Musculoskeletal Outcomes Research, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. The Management of OsteoArthritis (MOA) Trial was 
approved by the Lower South Regional Ethics Committee of the New Zealand Ministry of Health (ethics reference LRS/07/11/044). The MOA Trial was funded by the Health Research 
Council of New Zealand (07/200) and the New Zealand Lottery Grants Board (MR212664). Neither the Health Research Council nor the Lottery Grants Board had any role in 
study design, data collection, analysis, interpretation or reporting, or the decision to write and submit the paper. The authors certify that they have no affiliations with or financial 
involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article. Address correspondence to Dr Haxby Abbott, Centre
for Musculoskeletal Outcomes Research, Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin 9054 New Zealand. E-mail: haxby.abbott@otago.ac.nz UUCopyright
©2018 Journal of Orthopaedic & Sports Physical Therapy®
J. HAXBY ABBOTT, DPT, PhD, FNZCP1 • CATHERINE HOBBS, PhD1 • DAVID GWYNNE-JONES, MA, BM BCh, FRACS1
ON BEHALF OF THE MOA TRIAL TEAM
P
erceived respondent burden, data completeness, and response 
rate are important considerations when designing outcome 
measure instruments for research and selecting appropriate 
questionnaires for use in clinical practice. Respondent burden
The most widely accepted condition-
specific patient-reported outcome in-
strument for assessing pain and physical 
function in people with osteoarthritis 
(OA) of the lower limbs is the Western On-
tario and McMaster Universities Osteoar-
thritis Index (WOMAC).6,8 The WOMAC 
consists of 24 questions that measure pain 
(5 items), stiffness (2 items), and function 
(17 items) (TABLE 1). Whitehouse et al29 
recognized the necessity and benefits of 
shortening the WOMAC10,22 and proposed 
an abridged version of the WOMAC. The 
resulting reduced WOMAC kept the 
WOMAC pain subscale (WOMAC-P) un-
changed, eliminated the 2-item WOMAC 
stiffness subscale, and removed 10 items 
from the WOMAC physical function sub-
scale (WOMAC-F) that were found to be 
differentially applicable to sex or cultural 
groups, redundant  in the same construct 
(eg, eliminating 1 of 2 stair items), open to 
misinterpretation, a poor model fit, or as-
sociated with a high proportion of missing 
responses (TABLE 1).10,22 Whitehouse et al29 
demonstrated the reliability, validity, and 
responsiveness (in terms of standardized 
response means) of the reduced WOMAC-
F in a clinical cohort of patients with hip 
or knee OA undergoing total joint replace-
ment surgery. Subsequently, Yang and 
The ShortMAC: Minimum Important 
Change of a Reduced Version of  
the Western Ontario and McMaster 
Universities Osteoarthritis Index
ensuring the questions are relevant to 
the patient’s condition, sex, and cul-
ture; and keeping instructions clear and 
concise.20,25,29
may be reduced by reducing question-
naire length (and therefore the time 
required to complete the question-
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colleagues32 validated the internal con-
sistency, reliability, and responsiveness of 
the reduced WOMAC-F in a nonsurgical 
cohort, thus showing its generalizability 
beyond patients undergoing total joint 
replacement, and recommended its use 
during nonsurgical interventions.
In clinical practice and research, it is 
crucial to be able to interpret the mean-
ingfulness of change in the score of an 
outcome measure over time.15 The most 
important clinimetric property for in-
terpreting responsiveness to change is 
the minimum important change (MIC). 
The MIC of the shortened version of the 
Western Ontario and McMaster Univer-
sities Osteoarthritis Index (ShortMAC) 
or its subscales has not been reported. 
The aim of this study was, therefore, to 
investigate the MIC of the ShortMAC 
(7-item reduced WOMAC-F plus 5-item 
WOMAC-P: a 12-item questionnaire) 
alongside the full, traditional version 




total of 206 patients from the 
Management of OsteoArthritis 
(MOA) Trial, a randomized con-
trolled trial of nonsurgical interventions 
in patients with hip or knee OA, were 
evaluated at recruitment and again after 
9 weeks of physical therapy interven-
tions (n = 155) or usual medical care (n = 
51).1 Participating patients were referred 
to the trial by their general practitioner, 
or referred by their general practitioner 
to the Department of Orthopaedic Sur-
gery (Outpatient Clinic, Dunedin Public 
Hospital, New Zealand) for an ortho-
paedic outpatient consultation, but did 
not meet the priority criteria to be wait-
listed for hip or knee joint replacement 
surgery. Inclusion in this study required 
participants to meet the clinical criteria 
of knee or hip OA diagnosis as outlined 
by the American College of Rheumatol-
ogy.3,4 People with previous surgical in-
tervention, recent analgesic initiation, 
and physical or mental impairment that 
would prevent participation were exclud-
ed, as previously described.1
All of the participants completed 
questionnaires, including the tradition-
al 24-item WOMAC (0-240 scale), at 
their initial assessment and again after 
9 weeks of therapy or usual care. To aid 
in comparisons across studies, we report 
WOMAC scores both on the original 
scale and normalized to a 0-to-100 scale. 
At the 9-week assessment, participants 
also completed the 15-point global rat-
ing of functional change (GROC) instru-
ment.16 Global change instruments are 
the recommended reference anchor for 
MIC studies.2,16,27
Three levels of change on the external 
anchor, the GROC instrument, were de-
fined, as previously described.2 These lev-
els represented small, medium, or large 
patient-perceived change. The MICs were 
calculated for the traditional WOMAC and 
the ShortMAC, as well as for subscales (the 
WOMAC-P, the full WOMAC-F, and the 
reduced WOMAC-F), across the 3 levels 
of change, using receiver operating char-
acteristic curve methodology,11 and cross-
checked with the sum-of-squares method 
TABLE 1
Items Included in the Traditional  
WOMAC and ShortMAC Instruments
Dimension Assessed/Item Traditional WOMAC ShortMAC
Pain
1. While walking on a flat surface X X
2. Ascending or descending stairs X X
3. At night while in bed X X
4. Sitting or lying X X
5. Standing upright X X
Stiffness
1. On first waking in the morning X
2. Later in the day X
Function
1. Descending stairs X
2. Ascending stairs X X
3. Rising from sitting X X
4. Standing X
5. Bending to floor X
6. Walking on flat surface X X
7. Getting in/out of car X X
8. Going shopping X
9. Putting on socks X X
10. Rising from bed X X
11. Taking off socks X
12. Lying in bed X
13. Getting in/out of bed X
14. Sitting X X
15. Getting on/off the toilet X
16. Heavy domestic duties X
17. Light domestic duties X
Total number of items 24 12
Instrument range* 0-240 0-120
Abbreviations: ShortMAC, shortened version of the Western Ontario and McMaster Universities  
Osteoarthritis Index; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
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using the Youden approach, wherein sen-
sitivity and specificity are equally weight-
ed.13,14 Using the GROC as the reference 
standard for change,11 responsiveness was 
assessed first by using the area under the 
curve (AUC) to assess the ability of the 
scale to differentiate those patients who 
improved from those who did not11 and, 
second, by assessing correlation with the 
GROC.11 An AUC above 0.7011 and a cor-
relation of 0.50 or greater were considered 
acceptable responsiveness,11 and a differ-
ence of 0.10 was considered significant.11 
Standard error of measurement (SEM) 
was calculated, and minimum detectable 
change (MDC) was defined at the 90% 
confidence level (MDC90) as SDchange × 
1.645, where SDchange is change in score in 
the group defined as no change (ie, GROC 
scores of 6 to 10) and 1.645 is the z-score 
for 2-sided 90% confidence limits.11 In ad-
dition, internal consistency was assessed 
through calculation of Cronbach’s alpha. 
We considered a coefficient over .7 ac-
ceptable and hypothesized reduced Cron-
bach’s alpha in the ShortMAC, toward a 
desired upper limit of .95,26 as evidence of 
reduced redundancy among instrument 
items.27,29,32 The floor and ceiling effects 
were also investigated, where a maximum 
of 15% of participants reporting the worst 
or best possible score, respectively, across 
the instrument of interest was deemed ac-
ceptable.17 Calculations were performed 
using IBM SPSS Statistics Version 24.0 
(IBM Corporation, Armonk, NY).
RESULTS
T
he baseline characteristics of 
the 206 recruited participants are 
presented in TABLE 2, along with the 
self-reported scores from the 24-item 
WOMAC questionnaire and the 12-item 
reduced form at the initial and 9-week 
visits, the Cronbach alpha for each time 
point, numbers at each analysis level of 
the GROC, and correlations with the 
GROC at 9-week follow-up.
TABLE 3 reports the SEM, MDC90, MIC, 
and AUC results. The point estimate of 
the MIC for the ShortMAC was lower 
than that for the traditional WOMAC at 
small and medium, but not large, levels of 
change; however, responsiveness did not 
significantly differ by AUC or correlation 
(TABLES 2 and 3). The lower bound of the 
95% confidence interval of the AUC ex-
ceeded 0.70 for all scales and subscales 
at each level investigated. TABLE 4 reports 
the proportion of minimum score (floor) 
or maximum score (ceiling) totals report-
ed for the full WOMAC and ShortMAC. 
There was no evidence of significant floor 
or ceiling effects at either time point 




ith the increased prominence 
of patient-reported outcomes in 
clinical practice and research, 
interpreting the meaning of outcome 
measure change is essential. To our knowl-
edge, this is the first study to report the 
MIC for both the traditional WOMAC 
and a reduced-item form of the WOMAC 
instrument. Within this same sample of 
patients with a wide spectrum of hip or 
knee OA, receiving physical therapy in-
terventions or usual medical care, we have 
shown that the ShortMAC was similarly 
responsive to change. While the Short-
MAC has a lower point estimate for the 
MIC compared with that of the traditional 
WOMAC at the small and medium levels, 
responsiveness was not significantly dif-
ferent in any analysis. The ShortMAC’s 
fewer number of items and slightly lower 
MIC have favorable implications both for 
the efficiency of questionnaire administra-
tion and for the efficiency of sample-size 
requirements for clinical trials.
TABLE 2
Characteristics of Participants and 
Description of Data at Initial and Final Visits*
Abbreviations: F, function; GROC, global rating of change; NA, not applicable; P, pain; ShortMAC, 
shortened version of the Western Ontario and McMaster Universities Osteoarthritis Index; WOMAC, 
Western Ontario and McMaster Universities Osteoarthritis Index.
*Values are mean ± SD or mean ± SD (range) unless otherwise indicated.
†Cronbach alpha is an indicator of internal consistency.
‡P<.001.
Baseline At 9 Weeks




Traditional WOMAC (0-240) 101.00 ± 54.21 (2-223) 82.53 ± 54.30 (2-206)
Cronbach alpha† .974 .977
ShortMAC (0-120) 50.02 ± 27.54 (1-110) 40.51 ± 27.31 (0-108)
Cronbach alpha† .954 .955
GROC (1-15) NA
Large change (13+) … 50
Medium change (12+) … 66
Small change (11+) … 87
No change (6-10) … 86
Worse (1-5) … 33
Correlations with GROC NA
Traditional WOMAC … 0.59‡
ShortMAC … 0.57‡
WOMAC-P subscale … 0.53‡
Traditional WOMAC-F … 0.57‡
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The baseline WOMAC values and the 
extent of change are consistent with those 
reported previously in studies looking at 
nonsurgical treatment of OA of the lower 
extremity,5,30,32 supporting the external 
validity of our MIC estimates. Williams et 
al30 reported the MIC for the WOMAC at 
2 months to be 4.0 (0-100 scale) using the 
Youden index to identify the MIC estimate 
(sensitivity and specificity equally weight-
ed), or 8.8 when using a specificity value of 
0.80. Those MIC values, and those found 
in the current study, are lower than the 14 
to 22 points reported by Escobar et al12 
(0-100 scale) in individuals undergoing 
TABLE 3
MIC and AUC for the Traditional  
and Reduced WOMAC Instruments and Subscales
Abbreviations: AUC, area under the receiver operating characteristic curve; F, function; GROC, global rating of change; MIC, minimum important change;  
P, pain; SDC90, smallest detectable change at upper bound of 90% confidence limits; SEM, standard error of measurement; ShortMAC, shortened version of  
the Western Ontario and McMaster Universities Osteoarthritis Index; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
*Small, greater than or equal to “somewhat better” on the GROC; medium, greater than or equal to “moderately better” on the GROC; large, greater than or
equal to “quite a bit better” on the GROC, as rated by participants.
†Original scale.
‡Transformed scale (0-100).
§Values in parentheses are 95% confidence interval.
Outcome Measure
No Change 
(n = 86) MIC† MIC‡ AUC§ MIC† MIC‡ AUC§ MIC† MIC‡ AUC§
Traditional WOMAC (0-240) 23.5 9.8 0.802 (0.738, 0.865) 23.5 9.8 0.822 (0.756, 0.888) 24.125 10.1 0.838 (0.774, 0.901)
SEM 7.6
SDC90 17.7
ShortMAC (0-120) 9.5 7.9 0.788 (0.724, 0.851) 10.125 8.4 0.819 (0.754, 0.885) 14.5 12.1 0.835 (0.769, 0.902)
SEM 7.6
SDC90 17.7
WOMAC-P subscale (0-50) 2.5 5.0 0.779  (0.715, 0.843) 4.5 9.0 0.814 (0.751, 0.877) 5.5 11.0 0.808 (0.736, 0.880)
SEM 9.7
SDC90 22.6
WOMAC-F subscale (0-170) 5.5 3.2 0.798 (0.732, 0.863) 5.5 3.2 0.826 (0.759, 0.894) 5.5 3.2 0.840 (0.776, 0.903)
SEM 8.0
SDC90 18.6
ShortMAC-F subscale (0-70) 6.5 9.3 0.774 (0.708, 0.841) 5.5 7.9 0.806 (0.736, 0.877) 8.5 12.1 0.831 (0.764, 0.899)
SEM 7.6
SDC90 17.7
Small Change (GROC 11+) (n = 87)* Medium Change (GROC 12+) (n = 66)* Large Change (GROC 13+) (n = 50)*
TABLE 4
Floor and Ceiling Effects of the Traditional and 
Reduced WOMAC Instruments and Subscales
Abbreviations: F, function; P, pain; S, stiffness; ShortMAC, shortened version of the Western Ontario and McMaster Universities Osteoarthritis Index; 
WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Outcome Measure Relevant Measure
Floor Effect  
(Worst Outcome)
Ceiling Effect  
(Best Outcome)
Floor Effect  
(Worst Outcome)
Ceiling Effect  
(Best Outcome)
Traditional WOMAC (0-240) Traditional WOMAC 0% 0% 0% 0%
ShortMAC (0-120) ShortMAC 0% 0% 0% 1/206, 0.5%
Subscales
WOMAC-P subscale (0-50) Traditional WOMAC, ShortMAC 0% 2/206, 1% 0% 6/206, 2.9%
WOMAC-S subscale (0-20) Traditional WOMAC 1/206, 0.5% 8/206, 3.9% 1/206, 0.5% 11/206, 5.3%
WOMAC-F subscale (0-170) Traditional WOMAC 0% 2/206, 1% 0% 1/206, 0.5%
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total joint replacement and, therefore, in 
whom larger changes would be expected. 
They also used a different anchor question 
with larger steps.
The MICs corresponding to small, me-
dium, and large self-perceived changes 
were remarkably stable for both instru-
ments. The ShortMAC demonstrated ap-
propriate stepwise increases in the MIC 
for increasing levels of the GROC, which 
were less evident for the full WOMAC 
version. This is likely due to reduced 
item redundancy and can be interpret-
ed as evidence of greater sensitivity to 
change of the ShortMAC. Because we 
used a 15-point scale in the GROC, the 
numbers of respondents per scale point 
were relatively small (eg, only 12 of 206 
participants reported feeling “moderately 
better”); however, categorizing the GROC 
responses into 3 levels of change ensured 
sufficient numbers at each level (TABLE 2), 
giving us the ability to show the extent 
of MIC improvement across levels of pa-
tient-perceived change.
One of the limitations of this research 
that must be considered is the anchor 
used in the present study, the GROC in-
strument, which asked participants to 
compare the current impact of OA on 
their overall health status to its impact 9 
weeks earlier and at baseline. Although 
the GROC has been shown to reflect a 
bias toward current status rather than 
equally weighting both current and 
baseline components of “change,”18,23,24 
it is still the recommended reference 
anchor for MIC studies.2,11,16,27 Also, it 
captures more domains of health status 
than merely pain and physical function, 
so it does not correlate exactly with the 
WOMAC. Also, as with any self-reported 
questionnaire, the GROC is limited by 
the accuracy of patients’ recall, so it is not 
recommended for use in clinical practice 
or for other applications with differing 
periods of recall.23,24 In this study, the re-
call time was consistent between the 2 in-
struments, and a 9-week recall period is 
short enough to not be considered prob-
lematic.26 The MIC estimates were lower 
than the MDC90, limiting the interpreta-
tion of the MIC for individual patients.11 
However, the test-retest scores used to 
calculate the SEM and MDC90 were con-
ducted 9 weeks apart and, while ideal for 
estimating the MIC, were likely to bias 
MDC upward. Other sources recommend 
SEM or 0.5 × SDchange as another way to 
estimate real change over measurement 
variability, the latter of which, in this 
case, would be 5.4 to 6.9 points.11,15 Find-
ing the true MDC would require further 
research specifically assessing test-retest 
reliability of the instruments in un-
changed participants.
As noted previously,29,32 Cronbach’s 
alpha was particularly high in the tradi-
tional WOMAC, highlighting the appar-
ent redundancy present in the instrument. 
Reducing the questionnaire decreased this 
value toward the desired upper limit of 
.95,26 thereby producing more favorable 
internal consistency, but to a lesser extent 
than had been previously reported.29,32 A 
ceiling effect in the traditional WOMAC 
has been reported following surgical inter-
vention.9,12,19,21 In the current study, where 
nonsurgical intervention was applied, the 
traditional and reduced-form WOMAC 
instruments and subscales demonstrated 
an absence of any floor effects, and mini-
mal ceiling effects well within acceptable 
levels. This is consistent with earlier re-
search, Yang et al32 also having reported 
minimal overall floor and ceiling effects 
after “conservative” treatment.
The patients included in the current 
study were involved in a trial of nonop-
erative therapy for OA of the lower limb. 
While the type of therapy and its efficacy 
are of little relevance to the objectives of 
the current study, at the time of recruit-
ment, these participants were deemed to 
have a wide spectrum of symptom severity, 
from mild to significantly impaired by OA, 
but were not on the waiting list for total 
joint replacement surgery. As such, their 
disease burden would be expected to cover 
a broader range but average less than that 
of patients referred for surgery, and their 
treatment effects to be less marked than 
those in patients scheduled for total joint 
replacement. Both the traditional WOM-
AC and the ShortMAC have the sensitivity 
to detect change with nonoperative ther-
apy, thereby expanding their applicability 
beyond surgical intervention studies.29,32
Also with regard to generalizability, 
to aid in comparisons across studies, we 
reported both the raw scores and results 
normalized to a 0-to-100 scale. The tra-
ditional WOMAC instrument is available 
in 3 formats: 5-point Likert scale (range, 
0-96), 100-mm visual analog scale (range, 
0-240), and, as in the current study, 
11-point numeric rating scale (range, 
0-240).7 While no systematic differences 
have been reported between the scales, giv-
en these modifications and others adopted 
in the literature, it is essential that the scale 
and the score range be clearly defined.31
Other studies have proposed short-
form versions of the WOMAC, includ-
ing reducing the number of items in the 
WOMAC-P subscale, but no consensus 
has been reached.10,22,28 This ShortMAC, 
a reduced version of the WOMAC, is the 
only reduced version to have been in-
dependently tested in both surgical and 
nonsurgical patient populations, and for 
which MIC estimates are available.29,32
CONCLUSION
T
he results of this study support 
recommendation of the reduced-
form WOMAC as a patient-friendly 
alternative to the traditional WOMAC 
instrument to assess the impact of OA on 
a patient’s daily life, and as a valid and 
responsive means of assessing change in 
status following surgical or nonsurgical 
intervention. U
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Abstract
Background: Most public hospitals are receiving more referrals for first specialist assess-
ment than they have capacity to see. Traditional priority categories are too broad for effec-
tive discrimination. In New Zealand (NZ) explicit prioritization is required by legislation
and supported by the Medical Council of NZ. A new generic National Referral Prioritization
tool (NRPT) has been developed which includes a patient impact on life score. This study
reports its trial implementation in orthopaedic surgery in a single centre.
Methods: Four months of referrals to the orthopaedic department were prioritized using the
new NRPT and traditional clinical priority categories. Scores and acceptances were com-
pared across conditions, surgeons and against the traditional categories.
Results: The mean NRPT was 60.1 (range 23–99). The correlation with impact on life was
0.59. There was good consistency of scores between surgeons. The NRPT score was signifi-
cantly different across clinical priority categories (urgent, semi-urgent, routine). A total of
305 referrals (49%) were accepted using the NRPT compared with 493 (79%) if the tradi-
tional tool had been used. Patients with foot and ankle, carpal tunnel syndrome and upper
limb conditions had the lowest scores and were more likely to be declined.
Conclusions: The NRPT is the first tool designed to prioritize referral letters. It is more dis-
criminating than the clinical priority categories used previously. It allows fine-tuning of a
threshold score to balance acceptances and capacity.
Introduction
There is increasing demand for first specialist assessment (FSA)
and elective orthopaedic surgery. In New Zealand (NZ), a patient
must be seen within 4 months of referral by their general practi-
tioner (GP) as legislated in the National Waiting Time Policy
(1999) and subsequent review by the Office of the Auditor General
(2011).1 If the District Health Board (DHB) does not have the
capacity to see a patient within this time period they can be
declined and returned to the GP with some form of management
plan. Similarly, if a patient is offered surgery, then it must be per-
formed within 4 months of the certainty decision.1 This has resulted
in the need for triage, prioritization and varying degrees of
rationing.
Triage is defined as ordering a queue based on urgency while pri-
oritization is the ordering of a queue by multiple criteria. Rationing
occurs when capacity is limited and can be applied to a queue,
however, ordered. Explicit prioritization is required under the legis-
lation and is supported by the Health and Disability Commissioner
and the Medical Council of New Zealand.2 This has led to the
development of various scoring tools for the prioritization of
patients for surgical treatment.3–7 However, to date, we are unaware
of any scoring systems that have been used to prioritize requests for
FSA. Triage categories, such as urgent, semi-urgent and routine
lack discrimination when demand exceeds capacity.8,9 Condition-
specific scores such as the Oxford hip or knee score or Western
Ontario MacMaster Osteoarthritis index have been used to set
thresholds for referral for total hip or knee replacement despite not
being designed for that purpose.10,11 A systematic review has
highlighted the need for the use of standardized tools and proce-
dures for triage.12
The National Referral Prioritization tool (NRPT) is a generic tool
designed to be used across both surgical and non-surgical speciali-
ties. It is similar to the surgical prioritization tools used in
© 2020 Royal Australasian College of SurgeonsANZ J Surg 90 (2020) 1738–1742
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orthopaedic and general surgery and includes a patient impact on
life (IOL) score.7,13 It assesses the severity of symptoms, risk and
impact of deterioration, and ability to benefit from a specialist
appointment.
It was decided that the new NRPT should be piloted in our
department as part of a recovery programme to reduce the number
of patients waiting more than 4 months for their FSA as required
by Ministry of Health guidelines.1
The purpose of this study is to report on the implementation and
results of the pilot trial of the NRPT in orthopaedic surgery in our
hospital.
Development and design
The NRPT includes a patient IOL score based on six questions
scored by the patient on a scale of 1–6 points (Document S1).
The surgeon completes five questions on the severity of symp-
toms, the functional impact of the condition, the likelihood of
deterioration within 6 months, the consequence of deterioration
and factors that may affect the ability of the patient to benefit
(Document S2). The weighting of these questions was developed
using the PAPRIKA methodology and the 1000minds software
where clinicians are asked to make multiple pair-wise rankings
of alternatives.14,15 This resulted in weightings of: 23.1% conse-
quence of deterioration; 20.5% clinician derived symptom sever-
ity; 17.9% clinician function severity; 12.8% for each of Patient
IOL, risk of deterioration and other factors. After completing all
questions on the web-based system, a priority score is automati-
cally generated out of a maximum 100 points (Document S3).
The determination of the threshold score for access is a joint
management and clinician decision based on the capacity of a
service and forecast demand.
If the score is below the threshold set by the DHB a patient can
be given a clinical override if special factors exist that are not cap-
tured by the tool. There is an option for automatic priority for spe-
cial cases such as a patient with malignancy or a sub-acute
presentation with a high likelihood of catastrophic consequences.
There is no reference in the tool for inability to work because in
NZ being in paid employment cannot be ethically used to
discriminate.
Methods
Prior to the introduction of the prioritization tool all referrals to the
orthopaedic department were triaged by consultant orthopaedic sur-
geons based on their area of sub-specialization using the categories
– Immediate, Urgent, Semi-urgent, Routine and Low Priority.
Patients with hip or knee osteoarthritis could also be triaged to the
Joint Clinic (JC), a physiotherapist- and nurse-led clinic, for non-
operative treatment.16,17 Approximately, 30% of referrals were
declined, which included most routine and low priority patients.16
Referrals with a triage category of semi-urgent and above were usu-
ally accepted. However, there was no mechanism to match accep-
tances with future capacity.
All GP referral letters received in the first 4 months of the trial
(May to August 2019) were triaged using the traditional tool and
scored with the new prioritization tool. The surgeons had access to
the GP letter, the patient IOL score, all relevant investigations and
hospital electronic records to help inform the scoring. Referrals for
paediatric conditions and acute referrals better seen in Fracture
Clinic were excluded. Patient IOL scores were collected by mail,
email or phone by an administration clerk during the pilot period.
The threshold score was adjusted weekly based on the predicted
capacity of the service. During this phase, surgeons were blinded to
the final acceptance/decline decision but could use clinical override
if they felt it justified based on the final score.
Statistical analysis was performed using R v3.5.1 (R-Foundation,
Vienna, Austria, http://www.R-project.org/) and included compari-
son of patient IOL scores and total score using correlation coeffi-
cients. Means and standard deviations were calculated to describe
the distribution of scores for each condition. Scores were compared
across conditions and across the traditional clinical priority catego-
ries using pairwise t-tests. Consistency between surgeons was
analysed by pairwise t-tests, within conditions to allow for variations
in symptoms and scoring across conditions. All pairwise t-tests were
adjusted for multiple comparisons using the methods of Holm.18
Ethics approval was given by University of Otago Ethics Com-
mittee (Health) HD19/043.
Results
A total of 673 referrals were received of which 45 (6.7%) were ret-
urned due to missing information (e.g. recent X-ray, height and
weight, neurophysiological studies). Of the remaining 628 referrals,
three were triaged as special case with automatic priority. Details of
referrals by condition are given in Table 1. The NRPT returned
scores ranging from 23 to 99 out of 100. No banding or clustering
was observed and the distribution of the scores had a relatively nor-
mal distribution (Fig. 1). The patient IOL score ranged from the
minimum of 6 with significant clustering only at the maximum
score of 36. (Fig. 1) There was reasonably strong correlation
between the NRTP score and the patient IOL score (r = 0.59).
There was generally good consistency between the 11 surgeons
with one surgeon scoring consistently lower for most conditions.
One of three spine surgeons scored significantly lower but was only
involved in scoring for the first 2 months of the project.
The mean scores were highest for patients with hip, spine and
shoulder conditions and lowest for carpal tunnel syndrome (CTS),
foot and ankle and upper limb problems. (Table 1). The NRPT
score generally mirrored the patient IOL score, but spine conditions
and CTS were scored more highly by clinicians than patients rela-
tive to the other conditions (Fig. S1). The distribution of scores by
condition for acceptances and declines are shown in Figure 2.
The mean NRPT score increased by only 4 points to 65 over the
17 weeks (0.3 points per week, 95% confidence interval 0.06–0.53,
P = 0.012). The threshold score increased for the first 13 weeks
from 52 points in week 1 and has stabilized at 71 points. There was
increasing use of clinical override from Week 13 onward.
There were statistically significant differences between the aver-
age NRPT scores for the traditional clinical priority categories
(P < 0.0001) (Fig. S2). The difference in scores between patients
accepted and declined with the NRPT for semi-urgent (P < 0.0001)
National Referral Prioritization tool 1739
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and routine (P < 0.003) was also significant. Under the old system
493 patients would have been accepted for an FSA (79% of refer-
rals). With the NRPT, 305 (49%) patients were accepted including
33 with clinical override (5.3% of all referrals).
Discussion
While many systems have been used to prioritize patients for sur-
gery this is the first tool we are aware of that has been used to prior-
itize GP referral letters. The NRPT gives a wide range of scores
and is more discriminating than the traditional triage categories.
There is good correlation between the patient IOL score and the
NRPT score and good consistency between clinicians. The NRPT
meets its goal of being a fair and consistent method of prioritizing
referrals and allows fine-tuning of an access threshold to match
acceptances with capacity. The main disadvantage of the tool is that
it is time consuming with delays in triaging referrals and some
resistance from surgeons.
A feature of the tool is that it includes a patient IOL score that
has been validated when used in the orthopaedic surgical prioritiza-
tion tool.7 In this study it correlated reasonably well with the total
score, unlike in the General Surgery pilot study.13 This may be
because of clinicians giving higher scores for the ‘likelihood of
deterioration’ and ‘consequences of delay’ questions in General
Surgery, as we saw for CTS and spine conditions. An administra-
tion assistant collected the patient IOL during the study. In future it
is hoped that the patient IOL scores will be collected and included
in an electronic referral.
In our hospital, the goal of DHB management was to reduce
the number of referral acceptances to 50% in order to improve
compliance with Ministry of Health performance indicators.
This required an improved prioritization system. The surgeons
agreed to pilot the NRPT on condition that it was formally eval-
uated. The threshold score was set by the DHB to reflect this
need for rationing. Explicit prioritization and associated ration-
ing, while distasteful to surgeons, is part of the NZ public health
care system and required by legislation. The Medical Council of
New Zealand allows clinicians to advocate for patients but they
have a duty to responsibly use resources and must be a party to
any rationing decisions.2
During this pilot we saw minimal score creep and low use of
clinical override. However it is likely that surgeon behaviour will
change leading to further creep, gaming and increased use of over-
ride as the threshold becomes widely known. All scoring systems
while initially effective tend to fail if the balance between demand
and capacity is too unequal.6,19,20
Fig 1. Distribution of scores: National Referral Prioritization tool and patient impact on life score.
Table 1 National Referral Prioritization tool and patient impact scores, by condition with proportions accepted, over-ridden and declined
Condition n Prioritization tool score
(range)








Hip 109 68.2 (13.5) (24–99) 28.8 (6.8) (9–36) 66 (60.6) 4 (3.7) 39 (35.8)
Spine 129 66.2 (13.1) (33–89) 24.4 (8.6) (6–36) 68 (52.7) 3 (2.3) 58 (45.0)
Shoulder 43 66.0 (10.3) (48–83) 27.2 (7.9) (8–36) 20 (46.5) 0 (0.0) 23 (53.5)
Dupuytrens 16 65.4 (11.0) (48–83) 25.6 (8.3) (9–36) 7 (43.8) 1 (6.2) 8 (50.0)
Knee 138 62.6 (11.3) (29–84) 27.3 (6.4) (7–36) 62 (44.9) 8 (5.8) 68 (49.3)
Carpal
tunnel (CTS)
57 60.1 (11.7) (26–82) 21.3 (8.3) (6–36) 19 (33.3) 8 (14) 30 (52.6)
Foot/ankle 80 59.3 (12.2) (23–88) 23.2 (7.5) (6–36) 29 (36.2) 3 (3.8) 48 (60.0)
Upper limb 44 56.1 (15.2) (27–89) 23.0 (9.0) (6–36) 11 (25.0) 4 (9.1) 29 (65.9)
Other 12 53.2 (14.3) (23–68) 21.0 (9.8) (6–36) 2 (16.7) 1 (8.3) 9 (75.0)
Total 628 63.3 (13.0) (23–99) 25.3 (8.2)(6–36) 284 (45.2) 32 (5.1) 312 (49.7)
The following were statistically significant differences (P < 0.05): National Referral Prioritization score: hip > knee, CTS, foot and ankle, other. Spine > foot and
ankle, upper limb, other. Shoulder > upper limb, other. Patient impact on life score: hip > spine, foot and ankle, upper limb, CTS, other. Knee > foot and ankle,
upper limb, CTS. Shoulder > CTS.
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In New Zealand there have been a number of different
approaches to managing referrals. Canterbury DHB introduced
Health Pathways which include guidelines to GPs on when to refer
patients to avoid inappropriate referrals.21 Inglis et al. reported
using two experienced surgeons to triage all referrals with hip and
knee problems, which effectively became a virtual FSA.8 50% of
referrals were declined but 97% patients who were seen were given
certainty for surgery.8 A similar system was used for spine refer-
rals.9 While this is efficient and effective we do not believe it is true
prioritization. In contrast we have focused on surgical prioritization
using a standardized tool after a patient has been assessed in person
resulting in 32% of patients being declined total hip or knee
replacement due to inadequate surgical capacity.6,20
In other health-care systems, it may not be permissible to
decline referrals and many use some form of triaging or alter-
nate care pathways, summarized in two recent systematic
reviews.12,22 A common strategy uses non-medical staff such as
extended scope physiotherapists to triage referrals using stan-
dardized protocols and to see patients in multidisciplinary
clinics.12 We have used this successfully for patients with hip
and knee OA with the Joint Clinic.16 While designed to maxi-
mize non-operative treatment it also worked well as a triage
tool ensuring appropriate patients in need of surgery were seen
by orthopaedic surgeons.17
The person triaging is dependent on the information given in the
referral letter. This is important in specialities where patients may
have a serious underlying condition or malignancy. Scoring tools
have been developed to improve and assess the quality of refer-
rals.23 In this study only 6.7% referrals were returned prior to scor-
ing due to missing information. Access to electronic records and X-
ray systems helped to fill any gaps.
The NRPT allows for automatic priority if there is a high suspi-
cion of cancer or likelihood of catastrophic consequences but was
only used in three cases (0.5%) in this study. Automatic priority
can and should be used more frequently in other specialities to
avoid the risk of missing a malignancy or similar. The NRPT can
prioritize the remaining patients with benign conditions if capacity
to see these patients is limited.
Strength of this study is that the NRPT was used to prioritize all
orthopaedic referrals during the 4 month study period. A patient
IOL score was used and correlated well with the total score. The
surgeons were familiar with triaging and the use of the national
orthopaedic surgical prioritization tool. A limitation is that the
threshold score varied during the pilot period, which meant that
some patients may have qualified 1 week but not the next. However
the threshold stabilized as anticipated after 3 months. We did not
sub divide sub-speciality areas into specific diagnosis because the
groups would become too small. We have only included orthopae-
dic referrals so cannot assess whether the NRPT is generalisable
across other specialties.
Conclusion
The NRPT is the first tool designed specifically to prioritize referral
letters. It generates a wide range of possible scores and avoids clus-
tering and so provides advantages over triaging using clinical prior-
ity. In orthopaedics, some conditions may have a low mean score
but the most severely affected of patients with those conditions will
still be accepted.
The tool was designed for the NZ system where there is a
requirement for a service to see patients within 4 months of accep-
tance of the referral but allows a referral to be declined. It may be
less applicable to other health care systems where it is expected that
all referrals are seen.
An important outcome of the study has been to identify the
unmet demand for orthopaedic FSA. If introduced widely, the
NRPT may allow comparison of the threshold scores and demand
between specialities within a DHB or between different DHBs. This
may help funding decisions and resource allocation.
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Rationing of hip and knee 
replacement: effect on the 
severity of patient-reported 
symptoms and the demand 
for surgery in Otago 
David Gwynne-Jones, Ella Iosua
ABSTRACT
AIM: A key Government health target has been to increase access to elective surgery. Despite this, there is 
a growing concern about unmet demand and increasing numbers of patients are being declined elective 
surgery. This study aims to determine whether there has been an increase in the severity of osteoarthritis 
of the hip and knee in patients undergoing publicly-funded elective total joint replacement (TJR) and any 
increase in demand for TJR in Otago.
METHOD: Demographic details and preoperative patient reported outcome scores (Oxford hip or knee 
score (OHS,OKS) and a reduced Western Ontario and McMaster Osteoarthritis Index (WOMAC) score (RWS) 
were collected prospectively in an historical cohort of patients undergoing total hip and knee replacement 
(THR, TKR) between 2006–2010. These were compared with all patients undergoing THR and TKR in the 
12-month period commencing 1 November 2013, and all patients waitlisted during this period but returned 
to GP due to capacity issues. An estimate of current demand was made by adding all waitlisted public
patients from the 12-month period to surgical numbers from private and those funded by ACC. 
RESULTS: In the 2006–2010 group of 613 patients, the mean OHS was 13.6 (SD 6.7) and OKS 15.4 (SD 
6.5) and RWS 30.5 (SD 8.0). Three hundred and sixty-seven patients who underwent surgery in 2013/4 
had significantly poorer scores (OHS 9.9 (SD 4.9), OKS 10.6 (SD 3.8), RWS 34.8 (SD 6.7)). The scores of 194 
patients returned to GP in 2013/4 were the same as the historical surgical group (OHS13.0 (SD 6.2, OKS 
15.2 (SD 5.9), RWS 30.8 (SD 8.4)). Six hundred and eight patients were wait-listed for public surgery and 
356 joints were performed in private or under ACC in the 12-month period. The current intervention rate in 
Otago is 371/100,000 per year, while the demand has risen from 417/100000 in 2010–12 to 494/100,000 per 
year. In 2014, the shortfall was 241 joints per year.
CONCLUSION: Patients undergoing primary elective total hip and knee replacement in Otago in 2014 are 
more severely disabled than between 2006–2010. Patients currently being returned to GP would have 
qualified for publicly funded surgery during that period. The demand for elective TJR in Otago has increased 
by 19% since 2012.
Hip and knee replacement are two of the most successful interventions in orthopaedic surgery. The 
population of New Zealand is both ageing 
and growing, and it is predicted that there 
will need to be a large increase in the 
numbers of joint replacements over the 
next 10 years.1,2 The public health system is 
under significant funding constraints, and 
joint replacements are relatively expensive 
to provide. However, in the long term they 
are highly cost effective.3-5 In New Zealand, 
the ‘Joint Initiative’ ran from 2004 to 2008, 
which led to a significant increase in the 
number of joint replacements performed 
nationally. From 2008 onwards, the 
funding was no longer ringfenced and was 
included in the orthopaedic volumes of 
District Health Boards (DHBs). An increase 
in funding for orthopaedic procedures 
including joint replacement was signalled 
in the 2015 budget.
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DHBs are required to prioritise patients 
and operate on the most in need. However, 
they are also obliged to meet Elective 
Surgical Performance Indicators (ESPIs). 
These include ESPI 5 (time to surgery from a 
certainty decision). This target was initially 
6 months but reduced to 5 months in June 
2013, and to 4 months in December 2014. 
This target has resulted in the so called 
‘financial threshold’ score. If a patient is 
judged to benefit from surgery but capacity 
constraints mean that they cannot have 
surgery within the ESPI target, then they 
can be placed on Active Review if just 
below the threshold or returned to General 
Practitioner (GP).
In our district we have had significant 
problems with excess demand over 
capacity. The problems are longstanding, 
and in 2006 there was a well-publicised 
‘cull’ of patients who had waited too long 
for surgery. Between 2010 and 2012 we 
estimated that the demand for elective hip 
and knee replacement was 41.7/10,000 per 
year.6 The main drivers were the age of the 
population and a backlog of cases due to 
under-provision relative to demand.6 
Despite using each new scoring system,6-9 
we found that the mismatch between 
supply and demand drove the financial 
threshold up in order to ensure ESPI 
compliance.6 Increasingly, this is being seen 
in other centres in New Zealand.10 The drive 
for shorter wait times for elective surgery 
has not been matched by any significant 
increase in joint replacement numbers in 
our region. In turn, we have noticed an 
increase in the severity of disease of those 
patients who do qualify for surgery.
In response to concerns around capacity 
and unmet demand, a programme 
funded by the National Health Board 
was developed to address patient flow. 
It was decided that all scoring for joint 
replacement surgery in our hospital would 
be by a single experienced orthopaedic 
nurse, the prioritisation nurse (PN), to 
ensure consistency and avoid accusations of 
surgeons ‘gaming the system’. 
The purpose of this study is to compare 
patient reported scores from a historical 
cohort of patients undergoing primary 
elective THR or TKR from 2006–2010 with 
patients undergoing surgery in 2013–2014, 
and those waitlisted but returned to GP 
for being below the financial threshold 
during the same period. A secondary goal 
was to determine whether the current 
level of demand in our local population for 
elective THR and TKR had increased since 
our previous report looking at the years 
2010–2012. 
Methods
In October 2013, prior to the programme 
commencing, the threshold for hip 
and knee replacement in our hospital 
was 80 points using the New Zealand 
Orthopaedic Association hip and knee 
prioritisation tool (NZOA score).6 This 
tool was developed by the Orthopaedic 
Working Group of the National Waiting 
Times Project and introduced in 2008. 
There were 106 patients with certainty, 83 
on active review and 181 other patients 
had been listed for joint replacement 
but returned to GP. After analysis of the 
waiting list figures, capacity, contracted 
volumes, and ESPI compliance, the 
financial threshold was set at 71 points 
commencing 1 November 2013. Active 
review would no longer be used and all 
patients falling below threshold would be 
returned to their GP. All patients were to 
be scored by the prioritisation nurse using 
the NZOA tool. Criteria for the use of the 
five components of the score, especially 
the consequence of delay, were agreed 
and policed.11 
Data were retrieved from our department 
database of patients who had undergone 
primary hip or knee replacement (including 
unicompartmental knee replacement (UKR)) 
between 2006 and 2010. Patient details, 
including pre-operative scores, had been 
prospectively recorded in our departmental 
database. The patient completed a pre-oper-
ative Oxford hip or knee score (OHKS) and 
a reduced Western Ontario and McMaster 
Osteoarthritis Index (WOMAC) score (RWS). 
The modified Oxford score (0–48, where 0 is 
worst and 48 best) was used.12 The reduced 
WOMAC score (RWS) uses 5 pain questions 
and 7 function questions (scored 0–4, where 
0 is best) giving a worst score of 48.13,14 
Preoperative scores were available on 613 
of 945 patients on the database. 
Details of all patients undergoing elective 
primary total hip or knee replacement 
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(including UKR) between1 November 2013 
to 31 October 2014 were collected. This 
included age, gender, NZOA score, OHKS 
and RWS scores. Numbers and scores of 
patients waitlisted for surgery during the 
same period and their outcomes were also 
collected prospectively. This included details 
and scores of patients returned to GP care.
The historical group, study group and 
return to GP group were then compared by 
age, gender, OHKS and RWS. Independent 
sample t-tests were used to compare means, 
and the test for a difference in proportions 
was used to estimate differences between 
the 3 cohorts (2006–2010, 2013/2014 
Surgery, and 2013/2014 Return to GP). 
The two-sided significance level α=0.05 
was specified for all statistical tests. Stata 
software version 13.1 was used for all 
statistical analyses.
Demand was calculated as in our previous 
paper by including all publicly funded 
patients listed for the 12-month study period 
and adding those performed under ACC, 
plus all primary joints performed at Mercy 
Hospital, Dunedin.6 Hip replacements for 
fracture were excluded. Unicompartmental 
knee replacement was included. Bilateral 
simultaneous procedures were counted 
as two joints. The population of Otago less 
Queenstown was taken as 194,800 at June 
2013.15 The New Zealand intervention rate 
was calculated from Joint Registry data using 
the New Zealand population as 4,442,100, 
based on 2013 census data.15,16
Unicompartmental knee replacements 
comprised only 5–9% of knee replacements 
across the whole study period and so were 
not analysed separately.
Ethics approval was given by the 
University of Otago Ethics Committee 
(Health) for this study.
Results
Demographics 
The historical cohort from 2006–10 
comprised 613 patients (355 hips (58%) and 
258 knees (42%)). It was well matched with 
respect to age, gender and proportion of hips 
to knees with the study period (Table 1).
During the study period in 2013/4, 367 
primary elective hip and knee replace-
ments were performed. There were 204 hip 
(56%) and 163 knee (44%) replacements. 
The mean age was 69.3 years, with hips a 
little younger than knees (68.5 years vs 70.3 
years). The mean NZOA score was 78.8 (hip 
79.8, knee 77.7).
A consultant scored 137 patients (37%) who 
had been given certainty before the start of 
nurse prioritisation. The PN had scored 230 
(63%). There were no significant differences 
between those scored by nurse or surgeon 
with respect to age, gender, proportion of hips 
or knees, NZOA score, Oxford or RWS. 


























Combined n= 613 n= 367 n=194
Male (%) 260 (42.4) 166 (45.2) 91 (46.9) -2.8 (-9.2, 3.6) 0.389 -4.5 (-12.5, 3.5) 0.271 -1.7 (-10.3, 7.0) 0.705
Age (SD) 69.3 (10.1) 69.3 (10.4) 67.3 (9.0) -0.0 (-1.3, 1.3) 0.979 1.9 (0.4, 3.5) 0.016 2.0 (0.2, 3.7) 0.027
Hips n= 355 n= 204 n=84
Hips % 57.9 55.6 43.3 2.3 (-4.1,8.7) 0.477 14.6 (6.6,22.6) <0.001 12.3 (3.7,20.9) 0.006
Male (%) 153 (43.1) 90 (44.1) 39 (46.4) -1.0 (-9.6, 7.5) 0.815 -3.3 (-15.2, 8.5) 0.580 -2.3 (-15.0, 10.3) 0.720
Age (SD) 68.1 (10.8) 68.5 (10.9) 66.0 (10.6) -0.4 (-2.3, 1.5) 0.668 2.1 (-0.5, 4.7) 0.107 2.5 (-0.2, 5.3) 0.073
Knees n= 258 n= 163 n= 110
Knees % 42.1 44.4 56.7
Male (%) 107 (41.5) 76 (46.6) 52 (47.3) -5.2 (-14.9, 4.6) 0.299 -5.8 (-16.9, 5.3) 0.304 -0.6 (-12.7, 11.4) 0.916
Age (SD) 70.9 (8.6) 70.3 (9.6) 68.4 (7.4) 0.6 (-1.1, 2.4) 0.487 2.5 (0.7, 4.4) 0.007 1.9 (-0.2, 4.0) 0.078
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During the study period, 608 patients 
were waitlisted for primary THR or TKR. 
Four hundred and fourteen (68%) were 
given certainty for surgery and 194 (32%) 
were returned to GP care. The return to GP 
group was younger by 2 years (p=0.027) 
and had a significantly higher proportion 
of knee (57%) than the two surgical groups 
(Table 1). Of the 194 returned to GP, 50 were 
re-referred and given certainty within the 
12-month study period (mean 5 months).
Patient-reported scores
The Oxford scores and RWS scores 
were significantly worse for both hips 
and knees in 2013/4 compared with the 
historical cohort. The difference in Oxford 
score of 3.7 for hips and 4.7 for knees and 
RWS (hip 3.4, 11% change from baseline, 
and knee 5.4, 19% change from baseline) 
is likely to reflect a clinically important 
difference.12,17,18
The Oxford and RWS scores of those 
patients returned to GP in 2013/4 were 
the same as for those receiving surgery in 
2006-10 (Table 2).
Demand
During the 12-month study period, 608 
patients were waitlisted, 464 patients 
were given certainty and 367 patients 
had undergone surgery. The number 
of patients waiting with certainty had 
increased from 106 to 164 and the numbers 
on Active Review had fallen from 83 to 23. 
Demand was 241 (67%) in excess of supply. 
Even after sending back 194 patients, the 
imbalance was 47 joints (13% excess), which 
rose to 97 (26% excess) when those re-re-
ferred and given certainty were included. 
During the same period, an additional 
8 hip replacements were performed in 
the hospital under ACC, and 348 hip and 
knee replacements were performed in the 
private sector, giving a total of 723 joints 
performed during the year. The current 
intervention rate for primary hip and 
knee replacement in Otago is 371/100,000. 
The demand, assuming no unmet need in 
private, is now approximately 495/100,000. 
In New Zealand, 16,104 hip and knee 
replacements, including unicompartmental 
replacement of knee, were performed 
in 2014, after excluding those for acute 
fracture.16 This gives a New Zealand inter-
vention rate of 363/100,000 for 2014.
Discussion
There will always be excess demand in 
the public sector leading to the need for 
some form of prioritisation or rationing. 
This paper shows that prioritisation is being 
implemented effectively. Patients under-
going surgery have mean scores that are 
poorer than those returned to GP. We have 
previously reported that nurse scoring is as 
effective as consultant scoring.11 It removes 
inconsistencies and accusations of attempts 
to ‘game’ the system. However, there are 
problems around the threshold score.11
The patient-derived scores were signifi-
cantly worse for the study period when 
Table 2: Comparison of preoperative Oxford and reduced WOMAC scores (RWS) between surgery 2006-10, surgery 2013/4 and 



























Oxford 13.6 (6.7) 9.9 (4.9) 13.0 (6.2) 3.7 (2.4, 4.9) <0.001 0.6 (-1.5, 2.7) 0.577 -3.1 (-4.9, 1.2) 0.001
RWS 31.7 (7.9) 35.2 (6.9) 31.7 (8.5) 3.4 (4.9, 1.9) <0.001 0.0 (-2.5, 2.5) 0.982 3.4 (0.9, 6.0) 0.008
Knees
Oxford 15.4 (6.5) 10.6 (3.8) 15.2 (5.9) 4.7 (3.4, 6.1) <0.001 0.2 (-1.7, 2.1) 0.855 -4.6 (-6.1, -3.0) <0.001
RWS 28.9 (7.8) 34.3 (6.3) 30.1 (8.2) 5.4 (7.1, 3.6) <0.001 -1.3 (-3.6, 1.1) 0.290 4.1 (1.7, 6.5) <0.001
Combined
Oxford 14.3 (6.7) 10.2 (4.5) 14.2 (6.1) 4.1 (3.2, 5.0) <0.001 0.1 (-1.3, 1.5) 0.862 -4.0 (-5.2, -2.8) <0.001
RWS 30.5 (8.0) 34.8 (6.7) 30.8 (8.4) 4.3 (5.4, 3.1) <0.001 -0.3 (-2.0, 1.4) 0.735 4.0 (2.2, 5.7) <0.001
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compared with the historical cohort. The 
return to GP group were similar to those 
qualifying for surgery in the historical 
group. Knees were more likely to be 
returned to GP than hips. This reverses 
the ratio seen for those qualifying for 
surgery in both the historical and study 
group. In general, patients with hip OA are 
more disabled than knees.11,19 Knees in the 
historical group had better scores than hips, 
but that difference is now less.
The difference on Oxford score of 4.1 
points (hips 3.7, knees 4.7) is comparable 
with the minimum clinical difference 
of 2 to 5 points reported for the Oxford 
score.12,17 Similarly, the change in RWS of 
4.3 points (hips 3.4 , knees 5.4) is greater 
than 6% of maximum (2.9 points) and the 
12% change from baseline WOMAC (3.7 
points), and therefore is likely to be clini-
cally significant.18
There is no absolute value of RWS or 
Oxford score that indicates the need for 
surgery. Large series from the UK show 
an average preoperative Oxford score of 
18–20 points for knee replacement .4,5,20-22 
A recent study on unicompartmental 
replacement showed a mean preoperative 
OKS of 24 points.23 
The Oxford scores for hip replacement 
are a little lower (worse) at 16–19 
points,3,4,20,24-26 with public hospital patients 
scoring worse than private.25 In Canterbury, 
the mean preoperative OHS was 18 in a 
prospective observational study between 
2009 and 2011 of 726 hips.27
The mean scores seen in all three groups 
in this paper are all significantly worse 
than these studies. They fall into the bottom 
three deciles for hip, and bottom two deciles 
for knee, by Oxford score.12 However, 
Singleton et al reported similar scores in 
both Māori (OHKS 10.1, WOMAC 76.2%) 
and non-Māori (11.26, 73.5%) in the Bay of 
Plenty between 2005 and 2009.28
It has been reported that worse preop-
erative Oxford scores lead to poorer 
postoperative scores, though the 
improvement is greater.4,12,25 We have not 
collected postoperative scores on the study 
group, but have reported postoperative 
scores similar to New Zealand Joint Registry 
averages in other studies, especially since 
introduction of ERAS protocols.29 We esti-
mated the demand for primary THR and 
TKR in Otago to be 41.7/10,000 between 
2010 and 2012, with 55% of TJR publicly 
funded.6 Using the same methodology, the 
demand in 2014 increased by 18.5% to 
49.5/10,000, while both the total number 
of joint replacements and the intervention 
rate have fallen slightly. 
This figure may still be an underestimate 
of the need in the community. Behaviour of 
both GPs and surgeons may have changed, 
and patients with less severe disease may 
be less likely to be referred or offered 
surgery. We introduced a physiotherapy 
and nurse-led clinic (Joint Clinic) in 2012 in 
which patients with less severe disease are 
managed nonoperatively.30 Approximately 
50 patients with Oxford scores less than 20 
points were under Joint Clinic care during 
the study period.
Nationally, the overall intervention rate 
(all funders) has climbed from 330/100,000 
in 2011 to 363/100,000 in 2014.6 The raw 
overall intervention rate in Otago of 
371/100,000 is similar to the national rate. 
However, population demographics mean 
that after age and ethnicity standardisation 
it is likely to be lower.31 
New Zealand has a relatively high rate of 
provision compared with other developed 
countries. It is predicted to rise to around 
600/100,000 by 2026.1 The increase in 
demand is less than anticipated in the US 
and it has been suggested that rather than 
reflecting over-servicing in New Zealand, 
it demonstrates a response by the health 
service to an identified area of high need.1 
Since our original report there has been a 
lot more publicity about unmet demand for 
orthopaedic surgery across New Zealand.10 
Nationally, increased numbers of TJR have 
been performed over this period, but age 
and ethnicity standardised rates of TJR 
vary widely across DHBs.31 We do not think 
that the situation in Otago is necessarily 
different from the rest of New Zealand, but 
we do appear to be several years ahead for 
a number of reasons. New Zealand has an 
ageing population, and Otago has a higher 
proportion of older patients than the New 
Zealand average.2,6 We have previously 
identified the backlog of patients awaiting 
surgery due to under-provision in previous 
years as a factor.6 Despite this, there 
has been no increase in publicly-funded 
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surgery in Otago between 2010 and 2014. 
We estimate 61–65% of TJR are publicly 
funded based on the National Minimum 
Data Set (NMDS) and Joint Registry figures. 
In contrast, only 51% of TJRs in Otago were 
publicly funded in 2014. This has fallen 
from 55% in 2010–12. We believe that this 
difference is due to under-provision in the 
public sector in Otago rather than over-
servicing in private. Many of these patients 
have chosen to self-fund their procedure due 
to problems with access to the public sector. 
Other centres in New Zealand have 
reported on unmet demand, with 33% of 
patients listed for TJR in Northland and 41% 
in Hawkes Bay declined due to threshold.10 
The average NZOA score in Hawkes Bay for 
patients qualifying for surgery was 76.9 
points, which is similar to ours (78.8), while 
in Northland it was 70.6 points. However, 
as no other outcome score was used and 
multiple consultants scored the patients, it 
is not clear whether the differences seen in 
their study are true differences in the inci-
dence and severity of disease, or whether 
they reflect surgical capacity or different 
interpretations and use of the scoring tool. 
A strength of this study is that all patients 
in the return to GP group had been priori-
tised by a single nurse to ensure consistency 
using the NZOA tool. Criteria for its use 
were agreed and policed. We have used 
patient-reported outcome scores to assess 
the severity of patient symptoms. These are 
validated scores in common usage. They 
were not designed as prioritisation tools 
and it is possible that patients have inflated 
their scores in an attempt to qualify for 
surgery.11,12 However, the Oxford or RWS 
does not directly influence the NZOA score 
which was used to determine qualification 
for surgery. There were still problems with 
access to TJR in 2006–2010 when we started 
using these scores and we had no reason 
to believe that patients were consistently 
attempting to game the system. 
A weakness is that the historical cohort 
does not include all cases performed 
between 2006 and 2010. This may result in 
some bias. However, the historical cohort 
was well matched with respect to age, 
gender and proportion of hip to knee with 
the study period. 
It has been predicted that the demand 
and projected numbers of hip and knee 
replacement will rise significantly.1,2 It is 
unclear how this can be funded. While 
the budget announcement of increased 
numbers of TJR from 2016 onward is 
welcome, the numbers are inadequate to 
match demand. The indicative increase 
of Southern DHB (including Southland) 
is provisionally for only 62 extra joints 
spread over 3 years. The onus therefore is 
on individual DHBs to decide the allocation 
of their scarce resources. If orthopaedic 
volumes are not increased, then other 
orthopaedic procedures will need to be cut 
if additional joint replacements are to be 
done. The alternative is to raise thresholds 
for TJR to an unacceptable level to achieve 
ESPI compliance.
Prioritisation and process change may 
help efficiency and allow more timely 
surgery. However, the 4-month target 
is artificial and by itself does nothing to 
increase capacity. The worst patients may 
be getting their surgery sooner, but there 
is no sign that the numbers of severely 
affected patients is decreasing.
The public needs to be given realistic 
expectations. There is explicit rationing 
and, although cost effective, public funding 
for hip and knee replacement will soon only 
be for the most severely affected. Others 
need to consider private insurance, or self-
funding their surgery. 
Conclusion
Patients undergoing primary elective 
total hip and knee replacement in Otago 
in 2014 are more severely disabled than 
between 2006–2010. Patients currently 
being returned to GP would have qualified 
for publicly-funded surgery during that 
period. The unmet demand for TJR in Otago 
has increased by 19% since 2012. 
This paper confirms that the increasing 
demand that is not matched by an increase 
in supply leads to a recognisable and 
measurable increase in the severity of 
disease using validated patient-reported 
measures in patients qualifying for surgery. 
The problems we describe are likely to 
become increasingly widespread across 
New Zealand.
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The outcomes of patients 
returned to general 
practitioner a er being 
declined hip and knee 
replacement
Toni Anitelea, Ella Iosua, Ayaaz Ebramjee, David Gwynne-Jones
In New Zealand it is recognised that the public sector is not able to fully cope with the demand for publicly-funded elective 
surgery. District health boards (DHBs) are 
required to prioritise patients and operate 
on those most in need. However, they are 
also obliged to meet Elective Surgery Perfor-
mance Indicators (ESPIs). One of these (ESPI 
5) stipulates that no patient should wait lon-
ger than four months once given certainty
for surgery by the DHB. The original target
of six months was reduced to fi ve months
in June 2013 and four months in December
2014. If there is insuffi  cient capacity for
the operation to be completed within this
timeframe then a patient cannot be given
certainty. If they fall just below this ‘fi nan-
cial threshold’ and are likely to deteriorate
and meet the threshold within the foresee-
able future they can be classed as Active
Review (AR). This requires regular follow-up 
by the service. Otherwise they are declined 
and returned to their general practitioner 
(GP) for ongoing care. 
Total hip and knee replacement (THR, 
TKR) are two of the most widely performed 
and cost-effective elective surgical proce-
dures with approximately 10,000 procedures 
performed per year in New Zealand.1 
Despite increases in numbers of public-
ly-funded procedures, the rate has had a 
minimal increase between 2007 and 2013.2 
This has resulted in demand outstripping 
capacity and the need for explicit rationing 
with up to 32–41% of patients being declined 
total joint replacement (TJR) and returned 
to GP.3–6 The outcome of these patients 
returned to GP is currently not known. 
Anecdotal experience suggests that more 
patients are choosing to self-fund their 
ABSTRACT
AIM: To determine the outcome of patients waitlisted for hip and knee replacement surgery who were 
returned to GP due to resource constraints.
METHODS: Prospectively gathered data of all patients returned to GP was analysed, including 
demographics, clinical prioritisation scores and patient-reported scores. Subsequent outcome was 
collected from departmental records and the National Joint Registry. 
RESULTS: Between November 2013 and December 2015, 374 patients were returned to GP care. At minimum 
12-month follow-up, 215 (57.5%) had undergone or had certainty for surgery, 36 patients (9.6%) had been
re-referred and again declined surgery and 123 (32.9%) remained in GP care. The factors influencing the
likelihood of a patient subsequently qualifying for surgery were need for hip rather than knee replacement, 
time from initial FSA and initial NZOA score. The mean waiting time for those patients who underwent
publicly-funded surgery was 14.7 months.
CONCLUSION: Returning patients to GP delays treatment rather than reducing the need for surgery. This 
delay results in waste, added costs to the patient, healthcare system and society, and may reduce the 
benefit of surgery. There needs to be a significant increase in capacity to meet this demand. 
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procedures in the private sector. Prelim-
inary research fi ndings suggests that at least 
25% of patients returned to GP are re-re-
ferred soon after being declined.3,4 
The primary aim of this study was to 
determine the outcome of the return to 
GP group at minimum 12-month follow up 
after their initial orthopaedic outpatient 
appointment. Secondary outcome measures 
were to determine predictors of re-referral 
and the time from initial clinic appointment 
until surgery if subsequently undertaken. 
Methods
In November 2013 we commenced a 
system whereby all patients waitlisted for 
hip or knee replacement by an orthopaedic 
surgeon at a fi rst specialist assessment 
(FSA) were independently scored by a single 
prioritisation nurse using the New Zealand 
Orthopaedic Association hip and knee 
priority scoring tool (NZOA score).3 Details 
of the tool and process have been previ-
ously described.3,4 The threshold score was 
set at 71 points (0 best to 100 worst) based 
on the expected capacity of the orthopaedic 
service. Any patients who scored above 
the threshold would be given certainty for 
surgery with an expectation that the surgery 
would be completed within four months. If 
a patient scored below the threshold score 
they could be given a clinical over-ride by 
their surgeon, or were returned to GP for 
ongoing care. A decision had been made 
that no patients were to be classed as active 
review. The NZOA score has been compared 
with patient-reported outcome scores and 
found to be an effective tool, though patients 
just below the threshold score may not have 
a clinically important difference from those 
above threshold.3 
Pre-operative patient-reported outcome 
scores (Oxford Hip or Knee Score (OHS, 
OKS)7 and a Reduced Western Ontario and 
McMaster Osteoarthritis Index (WOMAC) 
score (RWS)8,9 were collected prospectively 
as part of the prioritisation process. The 
Oxford score has 12 questions and is scored 
0 to 48 where 0 is worst, The RWS has 5 pain 
and 7 function questions and is scored 0 to 
48 where 48 is worst. 
The cohort of patients returned to GP 
between November 2013 and December 
2015 was identifi ed via a record kept 
prospectively by the prioritisation nurse. 
Their subsequent outcome was determined 
from this database with further infor-
mation, including gender and ethnicity 
collected from Southern District Health 
Board’s (SDHB) patient record software 
and clinical notes. There was a minimum 
12-month follow-up period after the date of
their FSA. Patient details were cross refer-
enced with the New Zealand Joint Registry,
which has 98% compliance in New Zealand
to check whether TJR was performed in
other hospitals.1
The outcomes of these patients were cate-
gorised to one of four categories: remain 
with GP, below threshold, private or surgery. 
Patients classifi ed as remain with GP were 
those that had been declined surgery and 
had not been re-referred by their GP for 
reassessment. Those classifi ed as below 
threshold were those that had been re-re-
ferred but still did not meet the threshold 
for elective surgery and were again returned 
to GP. The private group were those who had 
been declined through the public system, 
and self-funded surgery in the private 
sector. Patients classifi ed as surgery were 
those that had received publicly-funded 
surgery after being returned to their GP. 
The wait times of the surgery group 
from their initial FSA to eventual certainty 
decision, and from FSA to surgery, were 
collected. Comparisons were made between 
the fi rst and second year of the study period, 
and between hips and knees. 
Statistical analysis was performed with 
the help of a biostatistician. Associations of 
sex and age with the outcome group were 
assessed using the chi-square test for inde-
pendence and Analysis of Variance (ANOVA) 
respectively. ANOVA was also used to inves-
tigate associations between the outcome 
group and each of the NZOA, OHS or OKS 
score and WOMAC scores. Chi square tests 
were used to compare outcomes between 
sub-groups. 
Ethics approval was obtained from the 
University of Otago Ethics committee 
(Health).
Results 
During the period covered by this study, 
374 patients were returned to GP after being 
waitlisted for THR or TKR and scored by the 
prioritisation nurse. Demographic details 
are given in Table 1. The mean age across 
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all groups was 67.5 years with patients 
requiring THR on average almost four 
years younger than those requiring TKR. 
The mean time from FSA to the time of this 
review was 24.2 months (12 to 37 months). 
The same number of patients (187) had been 
returned in each of the two years of the 
study. During the same period, 832 primary 
elective hip and knee replacements were 
performed at our institution. 
Of the 374 patients, 122 (32.6%) remained 
in the community without any further 
contact. A further 36 (9.6%) patients had 
been re-referred by their GP to see the 
specialist for another clinical assessment 
and had again failed to meet the fi nancial 
threshold for elective surgery. Two patients 
had died: one in each of the above groups. 
Over half of the sample had received or 
were awaiting surgery across either public 
or private sectors. One hundred and nine-
ty-four patients (51.9%) had undergone 
or were awaiting public elective surgery 
with 22 patients (5.9%) electing to self-fund 
private surgery (Table 2).
Patients awaiting hip replacement were 
signifi cantly more likely than those awaiting 
knee replacement to have subsequently 
qualifi ed for public surgery [100 of 156 
(64%) vs 94 of 218 (43%) (Chi square 19.7, 
p<0.0001)]. Conversely, knees were more 
likely than hips to remain in GP care without 
re-referral: [87 of 218 (39.9%) vs 35 of 156 
(22.2%) chi square 12.6, p<0.0001)]. An equal 
number of hips and knees had their surgery 
in the private sector (Table 2).
Patients in the surgery group had 
follow-up of 26.4 months compared to 
20.7 months in the remain with GP group. 
Patients seen in year 1 were more likely to 
have certainty for surgery (121/187, 64.7%) 
than those in year 2 (73/187, 39%) (chi 
square 24.7, p<0.0001). Conversely, signifi -
cantly more patients remained in GP care 
from year 2 (86 of 187 (46%) compared 
with year 1 (36 of 187, 19.3% chi square 
30.4, p<0.0001). There was no signifi cant 
association between sex and patient fi nal 
outcome (p=0.31) nor age and patient fi nal 
outcome (p=0.77).
The surgery group had the highest mean 
initial NZOA score, as well as the worst 
mean Oxford and reduced WOMAC (RWS) 
scores. There was a signifi cant association 
between mean patient NZOA score and 
Table 1: Demographic details of the 374 patients 
returned to general practitioner (GP). 
Number 374







Scores at initial FSA
NZOA (0–100) 63.1 (6.5)
OKS (0–48) 14.5 (5.5)
OHS (0–48) 14.0 (5.3)
RWS (0–48) 31.2 (7.2)
Duration of 





Year 1 (n, 
mean, range,)
187 30.7 (25–37 months)
Year 2 (n, 
mean, range,)
187 17.6 (12–24 months)
FSA; First specialist assessment, NZOA; New Zealand 
Orthopaedic Association hip and knee prioritisation 
score, OHS; Oxford hip score, OKS; Oxford knee score, 
RWS; Reduced WOMAC score.
Table 2: Outcomes of patients initially returned to 
general practitioner (GP) at minimum 12-month 
follow up. 





























Total 374 156 218
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patient fi nal outcome (p<0.01). Any associ-
ation between patient outcome and mean 
Oxford (p=0.10) or RWS (p=0.08) did not 
reach signifi cance (Table 3).
Of the 115 patients with an initial NZOA 
score of 70 points (a common score just 
below the threshold), 76 (66%) subsequently 
gained certainty compared with 88 of 201 
(44%) with a lower score (chi square 14.6, 
p<0.0001).
The mean waiting time from initial FSA 
to certainty date was 11 months (sd 6.6, 
median 10 months) (range 1–30 months). 
The mean time from FSA to surgery was 
14.7 months (sd 6.9, median 14) (range 4–33 
months). Thirteen people had received 
certainty but were yet to undergo the 
proposed surgery. The mean time from the 
certainty decision to surgery was 3.7 months 
(sd 3.3, range 1–23 months) (Figure 1).
Discussion
In this study over a two year period, 374 
patients who were recommended TJR by 
their surgeon were declined for surgery 
due to capacity constraints in the public 
health system and therefore returned to 
GP care. This equates to approximately 
31% of patients waitlisted for surgery and 
has not changed from our previous paper.3 
This is supposed to give patients certainty 
and allow them to make choices. These are 
essentially limited to: wait until they dete-
riorate, go private or request reassessment. 
Only 22 (5.9% of all patients returned) 
elected to self-fund in the private sector, 
which refl ects the demographic of this popu-
lation with few patients having the funds 
for a private operation. Those who can 
afford to self-fund tend to bypass the public 
system altogether. Two hundred and thirty 
(61.5%) were re-referred during the study 
period of which 194 (51.9% of all returns) 
went on to receive surgery and 36 (9.6%) 
again failed to meet the fi nancial threshold 
Table 3: Scores at time of initial fi rst specialist 
assessment (FSA). 






































NZOA; New Zealand Orthopaedic Association hip and 
knee prioritisation score, OHS; Oxford hip score, OKS; 
Oxford knee score, RWS; Reduced WOMAC score.
Figure 1: Time from fi rst specialist assessment (FSA) to certainty decision and to surgery.
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for elective surgery. Only a third (122, 
32.6%) remained in the community without 
any further referral. 
The factors that had the greatest infl uence 
on the likelihood of a patient subsequently 
qualifying for surgery were initial NZOA 
score, hip rather than knee disease and the 
length of time from initial FSA. This is not 
surprising and refl ects the natural history of 
these conditions, which is to slowly dete-
riorate. Patients with hip osteoarthritis 
are typically more disabled than those 
with knee osteoarthritis and less likely to 
respond to non-operative interventions.3,10 
The surgery group had the worst patient-re-
ported scores (OHS,OKS and RWS) at initial 
assessment but the trend did not reach 
statistical signifi cance. The patient-reported 
scores of the patients (OHS 14.0, OKS 14.5, 
RWS 31.2) are a level similar to those who 
had received surgery between 2006 and 
2010 in our institution4 and worse than the 
average scores reported in the literature for 
primary hip and knee replacement in other 
centres in New Zealand or overseas.11–20 
However, during the period of the study 
the mean scores of patients undergoing 
surgery in our institution were OHS 9.9, OKS 
10.6 and RWS 34.8.4 This demonstrates that 
those patients returned to GP were a slightly 
less severe group than those qualifying for 
surgery, confi rming that the prioritisation 
was robust. 
Prior to this study we had used active 
review (AR) widely with 162 patients 
waiting for TJR on AR in August 2012.5 
Patients remained within the system and 
could be assessed by use of experienced 
nurses and patient-reported question-
naires. This created an increasing amount 
of work for the service and their visi-
bility was a potential embarrassment for 
DHB management, the Ministry of Health 
and politicians. It was decided when we 
commenced nurse prioritisation that 
active review was no longer to be used. 
As two-thirds of patients scoring 70 points 
subsequently qualifi ed for surgery the 
continued use of AR would have been 
justifi ed and it would have avoided the 
additional delay, costs and administration 
of re-referral from a GP. The majority of 
patients (63%) in the surgery group got 
certainty for surgery within 12 months 
of initial FSA. Most of these patients will 
have waited until their initial decline 
decision, waited and paid for a further GP 
appointment and potentially waited 4–6 
months for a further FSA.
The demand for TJR is increasing in New 
Zealand and around the world.21,22 However, 
between 2007 and 2013 there was there was 
no increase in the rate of publicly funded 
elective primary hip and knee replacement 
in New Zealand although the total numbers 
of joint replacements increased.2 The 
demand for TJR in our area appears to be 
higher than the New Zealand average but the 
problems we are seeing are not unique.3–6 
The reduction of the Ministry of Health’s 
target from six months to four months 
does little to facilitate patient care.4 While 
those accepted onto the waitlist will get 
their surgery sooner, it does not increase 
the numbers of procedures done. Because 
failure to meet the target may be asso-
ciated with fi nancial penalties to the DHB, 
the unintended consequence is that more 
patients are being returned to GP purely to 
meet the target.6,21,23 They do not show up on 
waiting lists so are invisible.
In this study the mean time from certainty 
to surgery was 3.7 months. However, the 
real wait time for those patients initially 
returned to GP who ended up qualifying 
for public surgery was 14.7 months. The 
remaining patients are still waiting at 
an average of 21 months following FSA. 
Waiting for surgery has an adverse effect 
on outcomes. Studies have consistently 
shown that worse pre-operative scores 
are associated with poorer post-operative 
results, though the improvement in score 
may be greater.7,11,16,17 Waiting longer than 
six months can cause a 50% decrease in the 
odds of achieving a better than expected 
functional outcome compared with those 
who waited less than six months.24 It is not 
clear if this is happening in our practice as 
we have no comparable controls. Following 
introduction of an enhanced recovery 
programme, our post-operative Oxford 
hip scores compared to the New Zealand 
average are worse (38.8 vs 40.4) but the OKS 
is a little better (39.8 vs 37.5) despite poor 
pre-operative scores (11.1).1,25 
Total hip replacement and total knee 
replacement are two of the most cost-ef-
fective procedures in orthopaedic 
surgery.11,15 By returning patients back to 
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the care of their GP rather than operating, 
there is a substantial and avoidable loss of 
quality-adjusted life years.16 There may be 
increased medical costs for non-operative 
treatment and its complications, such as 
gastro-intestinal bleeds from non-steroidal 
anti-infl ammatory use, and increased in-pa-
tient costs due to increased complexity of 
surgery, length of stay and risk of complica-
tions. In addition there are personal costs 
to the patient and societal costs, which are 
harder to quantify.26,27 
Rolfson et al estimated the cost of waiting 
for hip replacement in Sweden as US$7,666 
per patient per year.26 Fielden et al calcu-
lated the mean cost was NZ$1,030 (US$688) 
per person per month waiting (2005 
fi gures).27 Societal costs made up over 70% 
of this even in those who were not in paid 
employment. If we extrapolate these fi gures 
(but still using 2005 values and exchange 
rates) to our cohort then the additional 
cost of waiting more than six months for 
surgery in those who were initially returned 
but who subsequently underwent publicly 
funded surgery was NZ$1.6 million (US$1.1 
million). The cost of those still waiting is 
a further NZ$2.6 million (US$1.7 million). 
Index-linking would increase these fi gures 
by 26% to NZ$2 million and NZ$3.25 
million.28 As the current costing for an 
uncomplicated publicly funded hip or knee 
replacement is approximately $16,000 using 
WIESNZ15 cost-weights, this could have 
funded an additional 328 joint replacements 
at 2015 values.29
A limitation of this study is that it is 
not clear what has happened to the third 
of patients who remain in primary care 
without re-referral or surgery. The natural 
history of the condition is a slow deterio-
ration. They may have given up, modifi ed 
their expectations or developed inter-
current medical problems that preclude 
surgery. Only two patients had died. Further 
research would be helpful in this area but 
was outside the initial scope of this project. 
We had hoped to look at outcomes among 
Māori and Pacifi c patients. However, only 
three of the 374 were of Pacifi c ethnicity, 
and six were Māori, meaning ethnic specifi c 
analyses were not possible. We have previ-
ously shown higher rates of publicly funded 
TJR provision in Māori than New Zealand 
European and slightly lower rates in Pacifi c 
people.2 It appears that Māori and Pacifi c 
people are not over-represented in the 
return to GP group. Finally, the NZOA hip 
and knee prioritisation score used in this 
study has recently been superseded by a 
new generic score that includes a patient 
impact on life score. Patients with hip and 
knee OA will now be scored directly against 
patients with other orthopaedic condi-
tions. This is likely to have an effect on the 
numbers and mix of patients returned to GP. 
Conclusion
In our district and across New Zealand, 
the demand for TJR has increased, there 
has not been a corresponding increase 
in service provision and the target time 
allowed by the Ministry of Health for 
surgery has decreased. This has resulted 
in many patients being declined surgery 
despite reaching the clinical threshold for 
joint replacement. Those qualifying for 
surgery are more severely affected than in 
past years. Returning patients to GP delays 
treatment rather than reducing the need 
for surgery. Over half of patients returned 
to GP care in order to meet the four-month 
target will end up qualifying for surgery 
with a mean waiting time of 14.7 months 
from initial FSA. This delay results in waste, 
added costs to the patient, healthcare system 
and society and may reduce the benefi t of 
surgery. Only 5.9% of patients returned to 
GP elected to pay for private surgery. Less 
than a third of patients remain in primary 
care without further referral or surgery. 
Further work is required to determine the 
fate of this group. There needs to be a signif-
icant increase in capacity in our district to 
meet this demand. 
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Background: In countries with publicly funded health care, there is an increasing need for explicit ra-
tioning for total joint arthroplasty (TJA). The Oxford Hip and Knee Scores (OHS/OKS) have been used to
set access thresholds for TJA despite not being developed for that purpose. The aim of this study was to
determine whether preoperative OHS/OKS can aid rationing decisions by investigating the changes in
general health-related quality of life after TJA.
Methods: OHS/OKS, Short Form-12, and Short Form-6D (SF-6D) scores were collected preoperatively and
at 1 year postoperatively in a cohort of patients undergoing total hip arthroplasty (THA; n ¼ 713) and
total knee arthroplasty (TKA; n ¼ 520). The association between preoperative OHS/OKS and post-
operative score and the change in OHS/OKS and SF-6D was investigated, adjusting for age and gender.
Results: The mean Oxford scores improved from 13.9 to 40.7 (OHS) and 15.6 to 37.4 (OKS). The mean SF-
6D improved after THA (0.53 to 0.80) and TKA (0.56 to 0.78) (all P < .0001). Poorer preoperative Oxford
scores were associated with poorer postoperative OHS/OKS and SF-6D but larger improvements. For
every 5 points lower preoperative OHS/OKS, the postoperative SF-6D score was worse by a margin of
0.019 (THA) and 0.023 (TKA).
Conclusions: Preoperative OHS/OKS can help inform rationing decisions. A lower preoperative OHS/OKS
will result in greater gains but a lower final outcome score in general health-related quality of life.
© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Total hip arthroplasty (THA) and total knee arthroplasty (TKA)
are very successful interventions for end-stage osteoarthritis (OA).
With an aging population and rising rates of obesity, the demand for
THA and TKA is increasing [1,2]. In countries with limited publicly
funded health care, there is an increasing need for explicit rationing
[3,4]. Almost half of National Health Service trusts in the United
Kingdom are now rationing THA and TKA [5]. There are concerns
that delaying surgery until a patient has deteriorated to a thresholdics, Dunedin Hospital, Great
999x58618.
Inc. on behalf of The American As
y-nc-nd/4.0/).
mous User (n/a) at University of Otag
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171scoremayhave a deleterious effect on theirfinal outcome [6], which
could be seen as an unintended consequence of rationing.
In New Zealand,Ministry of Health policy requires District Health
Boards to complete surgery within 4 months of a decision to offer
publicly funded surgery. Those patients who cannot, due to capacity
constraints, beoperatedonwithin4monthsaredeclinedsurgeryand
returned to the care of their general practitioner (GP). Since 2000,
various tools or scoring systems have been used to help prioritize
patientswith theemphasis onoffering surgery to thosepatientswith
the worst symptoms. These tools have been validated and shown to
be effective but lack discrimination around the threshold score [4].
They are not designed to assess outcomes after surgery.
Condition-specific scores such as the Oxford Hip Score (OHS)
and Oxford Knee Score (OKS) were originally developed to assess
outcomes after joint replacement [7]. They have been used in some
regions in the United Kingdom to determine eligibility for surgerysociation of Hip and Knee Surgeons. This is an open access article under the CC BY-
o from ClinicalKey.com.au by Elsevier on April 01, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
Table 1
Patient-reported outcome measures before and 1 y after joint arthroplasty surgery.
Outcome measure Preoperative Postoperative 1 y Changed
Mean (SD) Mean (SD)
Total hip arthroplasty (THA)
Total Oxford score 13.9 (6.6)b 40.7 (7.3)b 26.8 (9.2)b
SF-12 PCS 28.1 (5.3) 43.5 (11.0)a 15.4 (10.9)a
SF-12 MCS 43.0 (12.0) 54.4 (9.4) 11.4 (12.8)c
SF-6D utility value 0.53 (0.11)b 0.80 (0.15) 0.27 (0.17)b
EQ-5D from SF-12 0.383(0.22)a 0.775 (0.20) 0.392 (0.25)b
Total knee arthroplasty (TKA)
Total Oxford score 15.6 (6.1)b 37.4 (8.2)b 21.8 (9.3)b
SF-12 PCS 28.3 (5.3) 41.3 (10.4)a 13.0 (10.3)a
SF-12 MCS 44.7 (11.4) 53.8 (9.6) 9.2 (11.8)c
SF-6D utility value 0.56 (0.10)b 0.78 (0.15) 0.22 (0.15)b
EQ-5D from SF-12 0.433 (0.20)a 0.747 (0.19) 0.314 (0.25)b
a Indicates difference between the THA and TKA groups is statistically significant
P < .01.
b Indicates difference between the THA and TKA groups is statistically significant
P < .001.
c Indicates difference between the THA and TKA groups is statistically significant
P ¼ .02.
d All changes (preoperative to postoperative) are highly statistically significant (P
< .0001).
D.P. Gwynne-Jones et al. / Arthroplasty Today 6 (2020) 585e589586despite not having been designed for that purpose and not shown
to be predictive of patient satisfaction after THA and TKA [8].
In addition to condition-specific scores, generic health-related
quality of life (HRQoL) measures such as the Short Form-12 (SF-
12) [9], the Short Form-6D (SF-6D) [10], and the Euroquol-5D [11]
can be used to assess outcomes. The SF-12 [9] has 12 questions
covering 8 domains: physical functioning, role participation
(physical and emotional), social functioning, bodily pain, mental
health, general health, and vitality. It is usually reported as a
physical component score (PCS) and a mental component score
(MCS). The SF-6D [10] is a preference-based single-index measure
of health, derived from the SF-12, which can be used to calculate
quality-adjusted life years for use in cost-utility analysis. The SF-6D
focuses on 7 of the 8 health domains covered by the SF-12, with
only the general health domain not included. The EQ-5D [11] is a
preference-based HRQoL measure that describes health across 5
dimensionsdmobility, self-care, usual activities, pain/discomfort,
and anxiety/depression and is also commonly used in cost-utility
analysis.
An advantage of generic HRQoL measures is they can be used to
compare outcomes of procedures within orthopaedics or with
other specialties, which may help inform resource allocation in a
publicly funded health system.
The aim of this study was to determine whether preoperative
OHS/OKS can help inform rationing decisions by investigating the
changes in general HRQoL after THA and TKA.
Material and methods
Data Set
This cohort study comprises 1233 patients who underwent THA
(n ¼ 713) or TKA (n ¼ 520) at our institution between 2006 and
2010. Patient demographic data including the age, sex, and joint
replaced were collected. Patient-reported scores (OHS/OKS and the
SF-12) were collected preoperatively and postoperatively (at
approximately 1 year) using an arthroplasty audit database
(OrthoWave, Stryker, Sydney, Australia). SF-12 PCS andMCS and SF-
6D scores were calculated using responses to individual questions
from the SF-12 [9,10]. To enable comparability with results from
other studies, we also report EQ-5D-3L scores that were mapped
from the SF-12 scores [EQ-5D(SF-12)] using a published crossover
algorithm [12]. The SF-6D has half the range of the EQ-5D-3L and a
correspondingly lower minimum important difference (MID)
(0.041) than the EQ-5D (0.074) [13]. The MID for OHS and OKS was
taken as 5 points [14]. The MID for SF-12 PCS and MCS was also
taken as 5 points [15].
Statistical Analysis
Patients were grouped into 5 bands based on their preoperative
Oxford score: <10, 10-14, 15-19, 20-24, and over 25 points. For both
THA and TKA, preoperative and postoperative mean and standard
deviation were calculated for each patient-reported outcome
measure. The change in scores (postoperative minus preoperative)
was tested using a paired t test.
The association between preoperative Oxford scores and post-
operative Oxford, SF-12 PCS and MCS, and SF-6D scores was
assessed graphically by plotting the postoperative score and the
change in score, for each outcome measure, against preoperative
Oxford scores. Curves were fitted using robust locally weighted
regression smoothing to visualize the relationship between pre-
operative and postoperative outcomes [16]. Linear regression,
adjusted for age and sex, was used to estimate postoperative
outcome scores and change in scores, conditional on preoperativeDownloaded for Anonymous User (n/a) at University of O
2021. For personal use only. No other uses without permis
17Oxford score, for the THA and TKA cohorts. All statistical analyses
were conducted using R version 3.5.1 [17].Results
Baseline data were collected from patients who underwent a
THA (n ¼ 713) or a TKA (n ¼ 520). Follow-up surveys were
completed at a mean of 13 months postoperatively by 945 patients
(THA [n ¼ 569]; TKA [n ¼ 375]), a completion rate of 77%. There
were no significant differences in age, sex, or baseline measures
between those completing and those not completing the follow-up
survey. Most patients were female, with no significant difference in
gender mix between THA and TKA patients (P ¼ .18). Patients with
hip OA were approximately 3 years younger and had poorer pre-
operative Oxford (P ¼ .0001) and SF-6D scores (P ¼ .0006) than
patients with knee OA but had no significant difference in SF-12
PCS (P ¼ .64) or MCS (P ¼ .08).
After surgery, there was a significant improvement in all mean
unadjusted outcome scores for both THA and TKA (P < .0001)
(Table 1). Unadjusted mean scores after THA were significantly
better than those after TKA for Oxford scores (3.3, P < .0001) and
SF-12 PCS (2.2, P ¼ .009). There was no significant difference in the
postoperative score between THA and TKA cohorts for SF-12 MCS
(0.6, P¼ .4), SF-6D (0.02, P¼ .063), or EQ5D (SF-12) (0.028, P¼ .067).
The mean improvement was greater for THA than TKA on all scores
including OHS/OKS (5, P < .001), SF-6D (0.05, P < .001), and EQ-
5D(SF-12) (0.078, P < .001) (Table 1).
Patientswith a lower preoperativeOxford score achieveda lower
mean postoperative Oxford score, SF-12 PCS, SF-12 MCS, and SF-6D
than thosewith higher preoperative scores, after both THA and TKA.
The improvement (gain in scores) was greater in those with lower
preoperative scores on all outcome scores (Fig. 1, Table A1).
In adjusted regression models, age was a significant (but
nonlinear) predictor of postsurgery improvement in outcome
scores for Oxford, SF-12 PCS, and SF-6D for both hips (P < .001) and
knees (P < .04) but not for SF-12 MCS (P > .15). (Figure A1). The
improvement in OHS was greatest in patients aged 60 years and in
OKS for patients aged 70 years. The gain in SF-6D utility was greater
in younger patients and declined with increasing age especially
after 70 years. Men had significantly smaller improvements than
women in Oxford scores for hips (P¼ .007) but not knees. Therewastago from ClinicalKey.com.au by Elsevier on April 01, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
2
Figure 1. Postsurgery and improvement in total Oxford Hip or Knee Score and SF-6D utility 1 y after surgery, by presurgery total Oxford score (unadjusted with 95% confidence
intervals).
D.P. Gwynne-Jones et al. / Arthroplasty Today 6 (2020) 585e589 587no significant difference between men and women for SF-12 or SF-
6D outcomes.
After adjusting for age and gender, the mean postoperative
Oxford, SF-12 PCS, and SF-6D scores for both THA and TKA were
significantly lower for those with poorer Oxford scores at baseline
(Table A1). The difference in mean scores between the poorest
preoperative group (OHS/OKS<10) and the best preoperative group
(OHS/OKS>25) was OHS 3.9, OKS 4.6 points, SF-12 PCS 5.0 (THA),
5.4 (TKA), SF-6D 0.08 (THA), and 0.10 (TKA).
In the continuous regression model, the postoperative OHS was
0.8 points and OKS 1.2 points poorer for every 5-point difference in
preoperative OHS/OKS (Fig. 2a). Similarly, for SF-6D, the post-
operative scorewas worse by 0.018 (THA) and 0.023 (TKA) for every
5-point decrease in preoperative OHS/OKS (Fig. 2c). The difference
in change in the Oxford score between THA and TKA was statisti-
cally significant for all preoperative OHS/OKS <28 points (Fig. 2b). A
similar pattern was seen for the gains in SF-6D score according to
preoperative OHS/OKS but was not statistically significant because
of wide confidence intervals (Fig. 2d).
Discussion
Our results show significant improvement in HRQoL at 1 year
after THA and TKA. The postoperative SF-6D and EQ-5D(SF-12)
scores after THA and TKA are comparable; however, there is a
significantly larger gain after THA than TKA on all outcome scores. A
poorer preoperative OHS/OKS is associated with a lower HRQoLDownloaded for Anonymous User (n/a) at University of Otag
2021. For personal use only. No other uses without permission
173score at 1 year, compared with higher preoperative scores. There
was a clinically important difference in postoperative SF-6D scores
between the groups with the lowest and highest preoperative
Oxford scores, after adjusting for age and gender, that is, more than
the MID reported for SF-6D [13]. This suggests that a clinically
relevant poorer HRQoL outcome may result from rationing access
to arthroplasty on the basis of lower Oxford scores. However, larger
HRQoL gains were associated with lower preoperative Oxford
scores. These findings are relevant to health services such as ours,
in which the use of explicit rationing over recent years has led to
themean preoperative OHS/OKS score falling to around 10 points in
our institution [3,4].
It is well established that, for both THA and TKA, lower preop-
erative Oxford scores are associated with a lower postoperative
Oxford score and a higher change in score [7,18-20]. Less has been
published on generic HRQoLmeasures, withmost studies reporting
EQ-5D scores. Our results show that the mean improvement in SF-
6D in our patients after both THA (0.27) and TKA (0.22) is well
above the MID of 0.041. This is higher than that previously reported
[21-23], mainly due to lower preoperative SF-6D in our cohort. The
mean EQ-5D(SF-12) score also improved significantly from 0.383 to
0.775 (a gain of 0.392) after THA and from 0.433 to 0.747 (þ0.314)
after TKA. These scores and changes were similar or greater than
results reported in other studies using the EQ-5D [18,24-26].
Dakin et al reported an improvement in the mean EQ-5D score
from 0.39 to 0.71 (þ0.32) after TKA, with the greatest gains in those
with an OKS in the lowest quintile (OKS <12) [18]. Subsequently,o from ClinicalKey.com.au by Elsevier on April 01, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
Figure 2. Postsurgery and improvement in total Oxford Hip or Knee Score and SF-6D utility 1 y after surgery, by presurgery total Oxford score (adjusted for age and gender).
D.P. Gwynne-Jones et al. / Arthroplasty Today 6 (2020) 585e589588Eibich et al. [19] reported similar findings after THA and TKA, also
demonstrating that gains in HRQoL (as measured by the EQ-5D)
were still evident in patients with preoperative OHS >46 and OKS
>44 [19]. Gordon et al. [27], using data from the Swedish hip reg-
istry, also reported lower preoperative scores were associated with
poorer postoperative EQ-5D scores. Our results, in a sample with
poorer mean preoperative scores confirm that a larger gain in
HRQoL results in patients with poorer preoperative OHS/OKS, but at
a lower final EQ-5D score.
These findings have implications on the cost-effectiveness of
total joint arthroplasty in relation to preoperative status. Dakin
et al. [18] suggested that if TKAs were to be rationed based on the
magnitude of HRQoL gains, OKS would be a reasonable tool to use
to set the threshold. They suggested that the most cost-effective
preoperative OKS was 12-15 points, but TKA remained cost-
effective even in patients with an OKS up to 35-40 points,
depending on the American Society of Anesthesiologists grade.
Schilling et al concluded that TKAwas likely to be cost-effective for
most patients except those with an unusually high HRQoL [26].
Ferket et al. [28] found only small improvements in SF-12 PCS
(þ1.7) and SF-6D HRQoL scores after TKA (þ0.008). They suggested
that TKAwould bemore effective if restricted to patients with SF-12
PCS <50 and was most attractive from an economic viewpoint in
patients with a score <35 points. In contrast, themean preoperative
PCS in our studywas 28.3, with a clinically relevant improvement of
13 points.Downloaded for Anonymous User (n/a) at University of O
2021. For personal use only. No other uses without permis
17Consistent with other reports [19,25], we found greater
improvement in OHS/OKS after THA than TKA. The differences in
change in OHS/OKS (5 points), SF-6D (0.050), and EQ-5D(SF-12)
(0.078) are at or above the reported MID for these scores [13,14].
Our results suggest that to achieve a similar gain in both Oxford
score and HRQoL at 1 year, a patient with knee OA should have an
Oxford score 3-4 points worse than a patient with hip OA. This was
statistically significant for the Oxford score but did not reach sta-
tistical significance for SF-6D utility despite showing the same
pattern. Jenkins et al reported similar findings with patients un-
dergoing TKA needing an OKS 8 points lower than for a patient
undergoing THA to offer the same value for money over a patient’s
lifetime [25]. This gives some limited support to prioritizing THA
over TKA.
Oxford scores alone should not be used to determine access to
THA and TKA. Patient-reported scores such as the Oxford score may
be open to “gaming” by a patient or referring GP if it becomes
known that they are being used to determine whether a patient
qualifies for surgery. The decision to offer surgery is complex and
should involve clinical and radiological assessment of the patient
by an orthopaedic surgeon. Increasingly, however, some form of
gate-keeping is required, which may be by surgeons, managers,
commissioners, or GPs. This study shows that preoperative Oxford
score can help inform these rationing decisions. A patient with a
poorer preoperative score will gain more than a patient with a
higher score, which may be seen as cost-effective. However, atago from ClinicalKey.com.au by Elsevier on April 01, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
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to a poorer score may prejudice their final outcome and increase
indirect costs. The results are a reflection of the New Zealand health
care system where patients are prioritized by severity. We used
data from 2006 to 2010 before rationing became so severe. Oxford
scores were not used to determine access during this period, and
therefore, we do not believe that patients inflated their scores.
Despite the lack of explicit rationing, there were relatively few
patients with Oxford scores over 25 points, and the mean preop-
erative scores are lower than those reported in the National Joint
Registry of England, Wales , Northern Ireland and the Isle of Man
[29] and by other authors [8,15,18,19,25]. However, the results
should be generalizable to other public health systems that are
under financial pressure. Although a total joint arthroplasty may be
cost-effective in patients with a preoperative Oxford score of >35
points as reported by others [18,19], there is a more limited gain in
HRQoL. It is likely that, increasingly, publicly funded services will
not be able to routinely offer surgery to these patients.
Strengths of this study are that we used prospectively gathered
data and were able to compare the SF-6D measure with the
condition-specific Oxford scores that have been widely used else-
where. Although the OHS/OKS were not designed to be used for
rationing, in practice, they have been widely used to dictate
thresholds. Therefore, we believe this study is relevant to the cur-
rent debate on rationing and gives some support for their use.
Limitations to this study include the observational design and
the absence of comorbidity data, which may influence both pre-
operative and postoperative HRQoL scores. As patients did not
complete an EQ-5D questionnaire, the EQ-5D-3L scores used in this
study were derived from the SF-12 scores. They were calculated to
enable comparisons with published studies and showed similar
changes. Because the algorithm was based on UK preference
weights and full cost data were unavailable, quality-adjusted life
years were not calculated. The 1-year response rate of 77% is not
uncommon in large observational studies but may lead to some
bias. However, we found no difference in baseline variables be-
tween responders and nonresponders. The maximal benefit may
occur after 12 months, so these results may not be fully represen-
tative of the maximal outcome. However, the use of 1-year data is
consistent with other reports and therefore allows comparison. A
longer follow-up increases the chances of other conditions devel-
oping that may impact the more general HRQoL scores.Conclusions
Rationing for joint replacement, while unpalatable to many
surgeons, is inevitable in publicly funded systems where demand
exceeds capacity. This study shows that, despite not being designed
for the purpose, OHS/OKS can help inform these decisions. Delaying
access to a patient until they have deteriorated to a level where they
have a greater gain after surgery may come at the expense of not
achieving the same outcome as patients with less severe symptoms.Conflict of interest
The authors declare there are no conflicts of interest. Dunedin
Hospital receives an educational grant from DePuy Synthes to
support an Arthroplasty Fellow. The authors do not believe that this
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Figure A1. Improvement in Oxford score and SF-6D utility by age of the patient (unadjusted with 95% confidence intervals).
Table A1
Adjusted outcomes after joint arthroplasty surgery, by presurgery Oxford score.
Outcome measure Presurgery Oxford score
<10 10-14 15-19 20-24 25þ
Postoperative scores 1 y
Oxford
Hip 39.9 (38.5 to 41.2) 40.6 (39.4 to 41.9) 42.4 (41.0 to 43.7)b 42.2 (40.3 to 44.2)a 43.8 (41.3 to 46.4)b
Knee 37.1 (35.1 to 41.2) 37.3 (35.7 to 41.9) 38.7 (37.1 to 43.7) 39.5 (37.5 to 44.2) 41.7 (39.0 to 46.4)b
^ ^̂ ^ ^̂ ^ ^
PCS
Hip 41.7 (39.6 to 45.2) 42.5 (40.5 to 44.5) 46.5 (44.3 to 48.8)c 47.2 (44.3 to 50.1)b 46.7 (42.7 to 51.6)a
Knee 42.1 (38.9 to 45.2) 41.9 (39.4 to 44.5) 41.9 (39.2 to 48.8) 43.5 (40.1 to 50.1) 47.5 (43.5 to 51.6)a
^̂
MCS
Hip 53.0 (51.1 to 56.8) 54.8 (52.9 to 56.6) 55.1 (53.0 to 57.5) 54.3 (51.6 to 60.1) 56.3 (52.5 to 62.0)
Knee 53.9 (51.0 to 56.8) 52.9 (50.6 to 56.6) 55.1 (52.6 to 57.5) 57.0 (53.8 to 60.1) 58.2 (54.5 to 62.0)
SF-6D
Hip 0.77 (0.74 to 0.83) 0.80 (0.77 to 0.83) 0.83 (0.79 to 0.86)a 0.83 (0.79 to 0.88)a 0.85 (0.79 to 0.94)a
Knee 0.78 (0.74 to 0.83) 0.78 (0.75 to 0.83) 0.79 (0.76 to 0.86) 0.83 (0.78 to 0.88) 0.88 (0.82 to 0.94)b
Average improvement in outcome scores after surgery
Oxford
Hip 33.4 (32.0 to 34.7) 28.6 (27.3 to 29.8)c 25.7 (24.3 to 27.1)c 20.5 (18.5 to 22.5)c 14.4 (11.8 to 17.0)c
Knee 29.8 (27.7 to 34.7) 25.2 (23.6 to 29.8)c 21.7 (20.1 to 27.1)c 17.9 (16.0 to 22.5)c 14.2 (11.4 to 17.0)c
^̂ ^̂ ^̂ ^
PCS
Hip 14.9 (12.8 to 18.0) 15.3 (13.3 to 17.3) 18.6 (16.3 to 20.9)a 18.3 (15.4 to 21.2) 11.5 (7.4 to 19.8)
Knee 14.9 (11.7 to 18.0) 13.8 (11.3 to 17.3) 13.7 (11.1 to 20.9) 13.5 (10.1 to 21.2) 15.7 (11.6 to 19.8)
^̂ ^
MCS
Hip 17.1 (14.7 to 20.8) 12.3 (10.0 to 14.6)b 7.0 (4.4 to 11.2)c 5.7 (2.4 to 12.0)c 6.2 (1.6 to 10.9)c
Knee 17.2 (13.6 to 20.8) 10.9 (8.1 to 14.6)b 8.2 (5.1 to 11.2)c 8.1 (4.3 to 12.0)c 4.7 (0.0 to 10.9)c
SF-6D
Hip 0.32 (0.29 to 0.37) 0.28 (0.25 to 0.31)a 0.26 (0.23 to 0.30)b 0.24 (0.20 to 0.29)b 0.15 (0.09 to 0.24)c
Knee 0.32 (0.27 to 0.37) 0.25 (0.21 to 0.31)a 0.22 (0.18 to 0.30)c 0.22 (0.17 to 0.29)b 0.18 (0.12 to 0.24)c
Adjusted outcome for the presurgery category significantly different to the reference (Oxford <10) category: aP < .05; bP < .01; cP < .001.
Adjusted outcome for the knee arthroplasty cohort significantly different to the hip arthroplasty cohort: ^P < .05; ^̂ P < .01; ^̂ ^^P < .001.
No patients with a presurgery Oxford score of 25þ had a postsurgery score <27.
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Background: Total hip and knee arthroplasties (THA/TKA) are clinically effective but high cost proced-
ures. The aim of this study is to perform a cost-effectiveness analysis of THA and TKA in the New Zealand
(NZ) healthcare system.
Methods: Data were collected from 713 patients undergoing THA and 520 patients undergoing TKA at
our local public hospital. SF-6D utility values were obtained from participants preoperatively and 1-year
postoperatively, and deaths and any revision surgeries from patient records and the New Zealand Joint
Registry at minimum 8-year follow-up. A continuous-time state-transition simulation model was used to
estimate costs and health gains to 15 years. Quality-adjusted life years (QALYs), treatment costs, and
incremental cost-effectiveness ratios (ICERs) were calculated to determine cost effectiveness. ICERs
below NZ gross domestic product (GDP; NZ$60 600) and 0.5 times GDP per capita were considered “cost
effective” and “highly cost effective” respectively.
Results: Cumulative health gains were 2.8 QALYs (THA) and 2.3 QALYs (TKA) over 15 years. Cost effec-
tiveness improved from ICERs of NZ$74,400 (THA) and NZ$93,000 (TKA) at 1 year to NZ$6000 (THA) and
NZ$7500 (TKA) at 15 years. THA and TKA were cost effective after 2 years and highly cost effective after 3
years. QALY gains and cost effectiveness were greater in patients with worse preoperative functional
status and younger age.
Conclusion: THA and TKA are highly cost-effective procedures over longer term horizons. Although
preoperative status and age were associated with cost effectiveness, both THA and TKA remained cost
effective in patients with less severe preoperative scores and older ages.
© 2021 Elsevier Inc. All rights reserved.Total hip and total knee arthroplasties (THA/TKA) are clinically Systematic reviews of the cost effectiveness of total joint
very effective procedures and are being performed in increasing
numbers. They are high cost and high volume procedures and
consume a large amount of the budget for elective orthopedic
surgery. With increasing financial pressures in most healthcare
systems it is important that procedures are cost effective as well as
clinically effective.project grant from the Health
any potential or pertinent
conflict with this work. For
016/j.arth.2021.01.038.
tre for Musculoskeletal Out-
iversity of Otago, PO Box 56,
177arthroplasty (TJA) have concluded that THA and TKA are both
highly cost-effective procedures, although noted a paucity of evi-
dence in regard to THA [1e3]. Patients with more severe symptoms
have been shown to have larger health-related quality of life
(HRQoL) gains for similar costs and hence are more cost effective;
however, studies have also shown lower final HRQoL for these
patients, suggesting there is loss of HRQoL both before and after
surgery if it is delayed due to rationing [4,5].
Nonoperative treatment of knee OA can also be clinically effective
and has lower costs, so has also been shown to be cost-effective.
Skou et al [6] recently concluded from randomized controlled trial
data that TKA plus nonoperative treatment is not cost-effective over
a 2-year horizon compared with nonoperative treatment with the
option of later TKA. In contrast, a recent systematic reviewconcluded
that delaying surgery may result in short-term savings but the
HRQoL losses were greater than the savings [3].
R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e92Generic instruments such as the EQ-5D and SF-6D measure
HRQoL and, in combination with utility weights, allow quality-
adjusted life years (QALYs) to be calculated for cost-effectiveness
analysis. Varying methods have been used to calculate QALYs at
different time horizons following TJA. Some studies have collected
detailed data for periods out to 2 or 5 years [6e8]. Others have used
the change at 1 year in cohort studies and extrapolated over a pa-
tient’s lifetime or have used hypothetical Markov modeling. A long
time horizon is desirable, as the upfront cost of a TJA is high but the
benefits usually last formany years. However, if an implant fails and
requires revision there are further costs as well as health impacts,
so it is important that long-term analysis includes revision and
mortality data.
The focus of this study is publicly funded THA and TKA in the
southern region of New Zealand (covering a population of
approximately 330,000 people). The New Zealand healthcare sys-
tem is largely publicly funded and publicly provided, although
approximately 19% of total healthcare expenditure comes from
private spending including private health insurance and out-of-
pocket payments [9]. Patients referred for orthopedic assessment
at our local public hospital are prioritised using scoring tools with
the aim that the most severely affected patients are guaranteed
surgery within 4 months. However, due to limited funding those
who are less severely affectedwill be declined surgery and returned
to their general practitioner for ongoing care [10,11]. This has led to
poorer preoperative status than has been reported elsewhere,
which would be expected to result in greater gains in HRQoL
postoperatively [4]. Assuming revision and complication rates are
low, we hypothesise that contemporary TJA is likely to be highly
cost effective. The aim of this study is to perform a cost-
effectiveness analysis for THA and TKA using local data at various
time intervals to 15 years, including actual revision and mortality
rates. Secondary outcomes include the effect of age, gender and
preoperative status on cost effectiveness.
Methods
Data Sources
Data were collected from our departmental arthroplasty audit
database on a consecutive series of 713 patients undergoing pri-
mary THA and 520 patients undergoing primary TKA at our local
public hospital between January 2004 and April 2011. Follow-up
surveys were completed at a median of 13 months (interquartile
range 12 to 14 months) postoperatively by 565 THA patients (a
completion rate of 79%) and 376 TKA patients (72%).
The New Zealand Joint Registry (NZJR) collects operative details
on all primary arthroplasties performed in New Zealand and details
of any subsequent revision surgery wherever performed in the
country. It is mandatory for arthroplasty surgeons to participate
and has 98% compliance. The local cohort was linked to NZJR data to
determine any deaths or revision surgeries performed up to the end
of September 2019 (ie, between 8.4 and 15.8 years of follow-up for
all patients). Longer-term patient-reported Oxford Hip or Knee
Scores (OHS/OKS) [12,13] are also collected by the NZJR for a
random 20% sample of patients at 5 and 10 years post-surgery.
Outcome Measures
Demographic data including age and sex were collected from
patient records for all participants. Patient-reported outcomes were
collected pre- and postoperatively using the OHS/OKS and the SF-12
HRQoL questionnaire [14]. SF-6D health utility values were calcu-
lated from SF-12 responses to allow the calculation of QALYs for cost-
effectiveness analysis [15]. As a sensitivity analysis and to compare17with previous reports of cost-effectiveness of TJA, EQ-5D health
utility values [16,17] were also calculated from the OHS and OKS,
based on previously-published mapping algorithms [18,19].
The cost-effectiveness analysis was conducted from a payer
perspective. Hospital costs, including all associated inpatient costs
during the hospital stay, were calculated using public hospital cost
weights published by the NZ Ministry of Health [20]. The costs of
THA and TKA were $16,502 and $16,903, respectively. We assumed
that non-surgical costs would be the same with and without TJA;
this assumption was tested in sensitivity analyses. All costs are
reported in 2018 NZ dollars (NZ$1 z US$0.69 in 2018).
Preliminary Statistical Analysis
Analyses were conducted separately for the THA and TKA co-
horts. We first calculated descriptive statistics for the two cohorts,
including participant baseline characteristics and the patient-
reported outcomes at the preoperative and postoperative time
points. Summary statistics were calculated as count (percent) for
discrete measures and mean (standard deviation) for continuous
measures. Kaplan-Meier survival curves were calculated for both
(all-cause) revision surgeries and (all-cause) mortality.
To evaluate the assumption that short-term gains from THA and
TKA would be maintained over the long-term, we examined OHS/
OKS scores at 5- and 10-year follow-up from the NZJR along with
pre- and 1-year postoperative outcomes reported in our cohort. To
check for possible selection bias, given the small proportion of
participants with long-term follow-up data, outcomes were
compared at each available time point between the subset of par-
ticipants with complete outcome data at all time points (preoper-
ative and 1-, 5-, and 10-years postoperative; n ¼ 66) and the full
sample of all participants with data recorded at that time point.
Cost-effectiveness Model
The cost effectiveness of THA and TKA was estimated using a
continuous-time state transition model to capture the initial health
gains and costs of surgery, the continued accrual of health gains
over time, and the costs and health impacts of subsequent revision
surgeries (Fig. C1). The model consisted of an initial simulated
sample of 1000 patients, drawn by bootstrap sampling with
replacement from the observed cohort; models of revision and
mortality derived from the observed cohort data; trajectories of
health utility values after surgery derived from the cohort data and
published literature; and the costs of surgery calculated from
health system cost weights.
For each individual in the simulated sample, a time-to-revision,
time-to-mortality, and trajectory of health gains was drawn from
the corresponding observed input parameter distributions. The
cumulative health and cost outcomes of the cohort were then
calculated out to each specified time horizon e 1, 2, 3, 4, 5, 10, and
15 yearseand compared with outcomes for the same cohort
assuming no change from baseline (representing optimised non-
operative management in the observed setting) [21,22]. The
model was repeated for 100 sets of randomly-drawn parameter
values to derive uncertainty estimates around each outcome.
Future costs and QALYs were discounted at a rate of 3.5% per
annum, as recommended for cost-effectiveness analyses in NZ [23].
All analyses were conducted using R version 3.6.0 [24], with the
‘hesim’ package (v0.3.1) for health-economic simulation [25].
Estimating Inputs for the Cost-effectiveness Model
Time-to-revision, time-to-mortality, and SF-6D health utility
inputs for the cost-effectiveness model were estimated from the8
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mates were adjusted for patients’ age, sex, and preoperative OHS/
OKS, to allow estimates of cost effectiveness to be derived for
different patient subgroups based on these baseline variables.
Time-to-revision was not adjusted for baseline covariates, as there
were too few revisions observed to estimate these associations.
Time-to-revision and time-to-mortality models were estimated
using survival analysis. Time-to-revision was assumed to follow an
exponential distribution and time-to-mortality a log-logistic dis-
tribution, following visual inspection of the empirical survival
curves and comparison of the Akaike Information Criterion for
alternative models (see Appendix B).
Improvement in SF-6D health utility between baseline and 1-
year follow-up was estimated using linear regression. Based on
published reports of the trajectory of HRQoL gains after THA and
TKA [26e30], we assumed a rapid recovery in the first 6 weeks
(reaching 65% of the estimated 12-month health utility gain), fol-
lowed by a slowing pace of improvement to 85% of the total gain at
3 months, 95% at 6 months, and maximal improvement at 12
months postoperatively and thereafter. Revisions were assumed to
have a slower recovery reaching 90% at 6 months (and maximal
improvement at 12 months).
Cost-effectiveness Analysis
The incremental per-patient QALY gains and treatment costs of
TJA compared to no TJA were obtained from each simulation run,
and used to calculate the incremental cost-effectiveness ratio
(ICER), expressed as cost per QALY gained. Cost-effectiveness re-
sults were calculated for the entire cohort for each intervention
(THA/TKA), as well as for subgroups defined by age (5-year age
groups: Under 65 years, 65e69, 70e74, 75e79, 80 years and over),
sex, and preoperative OHS/OKS scores (5-point bands: Under 10,
10e14, 15e19, 20e24, 25 and over).
A cost-effectiveness threshold equivalent to NZ GDP per capita
(NZ$60 600 in 2018) was used, with ICERs below this threshold
considered to be cost effective; we further considered ICERs below
half this level ($30 300) to be highly cost effective.While there is no
consensus on appropriate cost-effectiveness thresholds or how
these should be determined [31], and NZ has no explicit threshold
for funding decisions [32], the GDP/capita threshold has been rec-
ommended by the World Health Organisation [33,34] and is
consistent with explicit and implicit thresholds in several compa-
rable countries [35]. However, it is becoming increasingly recog-
nised that ‘opportunity cost’-based thresholdserepresenting the
health gains foregone by funding one intervention rather than
anothereare generally lower than GDP-based thresholds [31,36],
motivating our consideration of the lower threshold to identify
more highly cost-effective scenarios. The half-GDP/capita threshold
is similar to opportunity-based cost-effectiveness thresholds
recently estimated for the UK [37] and Australia [38].
Sensitivity Analyses
The construction of the cost-effectiveness model and the deri-
vation of input data required several assumptions which were tested
in sensitivity analyses. First, it is recommended to consider alter-
native time-to-event distributions in survival analyses [39]. We
therefore re-ran the cost-effectiveness simulation with alternative
time-to-mortality models using several standard distributions rec-
ommended for survival models: exponential, Weibull, Gompertz,
and log-normal. There were insufficient revisions observed to esti-
matemeaningful alternativemodels for time-to-revision. (With very
few revisions observed, the potential impact of different distribu-
tional assumptions would be negligible in any case.)179Second, we adjusted the time-to-revision models to include
previously-published estimates of the relative hazard for baseline
covariates (age and sex) [40,41], as there were too few revisions
observed in our dataset to estimate these directly. No previous
estimates were available to model the association of preoperative
Oxford scores with revision rates.
For several uncertain input parameters, we conducted one-way
sensitivity analyses. This involves varying these input parameters
to upper and lower ‘plausible’ ranges, determined by review of the
literature, and examining whether these plausible ranges of input
values would change any of our cost-effectiveness findings. The
assumption of no ongoing net costs (ie, post-surgery costs the same
as ongoing nonoperative management costs) was varied to include
ongoing costs of $500 per year for post-surgery care or nonopera-
tive management costs of $500 per year (ie, an ongoing net cost
saving for surgery), based on experience from an optimised
nonoperative management pathway [42]. The assumption that
health utility values would remain constant at baseline levels, on
average, for the nonoperative management group was varied to
account for either regression to the mean in patient outcomes
(potentially accounting for some of the improvement in outcomes
observed in the TJA cohort) [43] or further deterioration in health
status over time, at an average rate of 0.03 (on the 0e1 utility scale)
per year. The recovery trajectory of health utility values over the
first year post-surgery was varied to be either faster than our base
case assumption (rapid recovery to achieve 85% of the health gain
by 6 weeks, and the remainder by 6 months) or slower (90% of the
health gain reached gradually by 6 months, with the remainder by
1 year). As no data were available on surgical complications or
readmissions for our cohort, we used previously published esti-
mates of readmission rates in our local system [44] to evaluate the
potential impact on costs and cost-effectiveness of TJA. No data on
the cost of readmissions were available; we assumed a cost of
$20,000 per readmission for our sensitivity analysis. Lastly, the
discount rate applied to future costs and health gains was varied to
0% and 5% per year, as has been recommended for cost-
effectiveness analyses in NZ [23].
Results
Descriptive Analysis
Demographic characteristics and patient-reported outcome
scores are shown in Table 1. THA patients were slightly younger, on
average, than TKA patients. The majority of both cohorts were fe-
male. Baseline patient-reported outcome scores were poor, and
slightly worse on all scores for THA compared to TKA patients. All
outcome scores showed clinically and statistically significant im-
provements at 1-year follow-up.
Postoperative health gains, as measured by OHS and OKS, per-
sisted with very little change (on average) through both 5- and 10-
year follow-up (Fig. A1). There were no meaningful differences at
any time point between the subsample of participants with com-
plete follow-up data to 10 years and the full sample of all partici-
pants at each follow-up point, suggesting that thosewith long-term
follow-up were a representative sample of the cohort (at least with
respect to OHS and OKS) and selection bias is unlikely to be an issue
in evaluating long-term health gains (Fig. A2).
Over the observed follow-up period, 13 THA and 5 TKA patients
underwent revision surgery. Revision-free rates at 15 yearswere 97.0%
(95% CI: 95.2 to 98.8) for THA and 98.1% (96.3 to 99.8) for TKA (Fig.1A).
At the date of final follow-up (September 2019), 105 THA pa-
tients and 81 TKA patients had died. The 15-year survival rateswere
77.4% (95% CI: 73.3 to 81.8) for THA patients and 74.6% (69.6 to 80.0)
for TKA patients (Fig. 1B).
Table 1
Baseline Characteristics and Patient-Reported Outcome Scores.
Patient Characteristic THA TKA
Age; mean(SD) 68.1 (11.0) 70.9 (8.8)
Gender; n(%)
Male 254 (45%) 151 (40%)
Female 311 (55%) 224 (60%)
Patient-reported health outcomes; mean(SD)
Oxford Score
Preoperative baseline 14.0 (6.6) 15.6 (6.1)
Postoperative follow-up 40.7 (7.3) 37.4 (8.2)
Change (95% CI) 26.8 (26.0 to 27.6) 21.8 (20.9 to 22.8)
SF-12 PCS score
Preoperative baseline 28.1 (5.4) 28.3 (5.3)
Postoperative follow-up 43.5 (11.0) 41.3 (10.4)
Change (95% CI) 15.4 (14.3 to 16.4) 13.0 (11.7 to 14.3)
SF-12 MCS score
Preoperative baseline 43.1 (12.0) 44.7 (11.4)
Postoperative follow-up 54.5 (9.4) 53.8 (9.6)
Change (95% CI) 11.4 (10.2 to 12.6) 9.2 (7.7 to 10.6)
SF-6D utility
Preoperative baseline 0.53 (0.11) 0.56 (0.10)
Postoperative follow-up 0.80 (0.15) 0.77 (0.15)
Change (95% CI) 0.27 (0.25 to 0.29) 0.22 (0.20 to 0.24)
EQ-5D utilitya
Preoperative baseline 0.24 0.31
Postoperative follow-up 0.83 0.80
Change (95% CI) 0.59 (0.55 to 0.64) 0.49 (0.46 to 0.52)
SD, standard deviation; CI, confidence interval; PCS, SF-12 Physical Component Summary score; MCS, SF-12 Mental Component Summary score; THA, total hip arthroplasty;
TKA, total knee arthroplasty.
a EQ-5D scores are calculated from group mean Oxford scores; individual-level EQ-5D values are not available to calculate SDs.
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Modeled revision rates, from the survival model, were close to
observed rates over the 15-year period, although uncertainty in-
tervals were wide, particularly for TKA patients, due to the small
number of observed revisions (Fig. A3).
HRQoL gains were smaller for older patients and for patients
with better preoperative OHS and OKS scores, for both THA and
TKA (Table C1). There was no significant difference in HRQoL gains
between men and women for either procedure.A B
Fig. 1. Revision and mortality rates. (A) Revision-free survival rates, censored at the time of d
follow-up (September 2019). THA, total hip arthroplasty; TKA, total knee arthroplasty.
18All model input parameters and distributions are reported in the
Appendix (Tables C1-C3).
Cost-effectiveness Findings
Cumulative health gains increased steadily over the modeled
time period, reaching 2.8 QALYs (95% uncertainty interval: 2.7 to
3.0) per THA patient and 2.2 QALYs (2.1 to 2.4) per TKA patient over
15 years (Fig. 2A). Surgery costs were high in the first year ($16 549





Fig. 2. Cumulative QALY gains (A), costs (B), and incremental cost-effectiveness ratios
(C), THA and TKA. Dashed lines in panel C indicate the 0.5-times and 1-times GDP/
capita willingness-to-pay thresholds; all points below these lines are considered cost
effective at the corresponding level. GDP, gross domestic product; ICER, incremental
cost-effectiveness ratio; QALY, quality-adjusted life years; THA, total hip arthroplasty;
TKA, total knee arthroplasty.
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(Fig. 2B). The projected cost effectiveness therefore improved
throughout the modeled time period (Fig. 2C).
Neither THA nor TKA were cost effective over a 1-year horizon
(ICER¼ $73 900 for THA; $94100 for TKA), due to the high up-front
costs of surgery. Both were cost effective over a 2-year horizon and
highly cost effective over a 3-year and longer time horizon. Over 15
years, ICERs were $6 000 for THA and $7 700 for TKA.
Using the EQ-5D values derived from Oxford scores, there were
QALYgains of 0.49 at 1 year and 6.21 at 15 years for hips, and 0.40 at
1 year and 4.99 at 15 years for knees (Fig. A4, Panel A). The ICERs
ranged from $33 500 at 1 year to $2 700 at 15 years for THA and181$42 000 at 1 year to $3 500 at 15 years for TKA (Fig. A4, Panel C), and
were therefore considered cost effective over all time horizons (and
highly cost effective after 2 years).
Sub-group Analyses
QALY gains and cost effectiveness were greater in patients with
worse preoperative OHS and OKS scores and younger age, for both
THA and TKA, while there was little difference in any outcomes
between men and women (Fig. 3; Figs. A5 and A6).
Sensitivity Analyses
Alternative parametric models for time-to-mortality made very
little difference to any of the results (Fig. A7); nor did adjusting
revision risk for baseline patient characteristics (Fig. A8).
The results of the one-way sensitivity analyses are presented in
the tornado plots in Figure 4. Over a 1-year horizon (Panel A), the
assumptions with the largest potential impact on estimated cost
effectiveness were the extent of possible regression to the mean in
health utility for patients continuing to bemanaged nonoperatively
and the short-term recovery trajectory of health utility following
TJA. None of the one-way sensitivity analyses changed the main
findings over a 1-year horizon.
Over the medium-term 3-year horizon (Panel B), the largest
potential impacts on cost effectiveness came from regression to the
mean in health utility for nonoperativemanagement. Both THA and
TKA remained cost effective in all analyses at the 3-year horizon,
with THA highly cost effective in all scenarios except regression to
the mean in nonoperative health utility.
Over the long-term 15-year horizon (Panel C), ongoing treat-
ment costs and nonoperative health utility trajectories had the
largest impacts on cost effectiveness, but both THA and TKA
remained highly cost effective in all scenarios.
Discussion
The cost effectiveness of THA and TKA improves rapidly over
longer follow-up. We found that THA and TKA are cost effective
after 2 years and highly cost effective after 3 years. THA was more
cost effective than TKA, due to larger health gains for similar costs.
Greater health gains and improved cost effectiveness were seen in
younger patients and those with poorer preoperative Oxford hip or
knee scores.
The average SF-6D scores at 12 months for THA (0.80;
change þ0.27) and TKA (0.77; þ0.22) were consistent with other
studies using the SF-6D, which have reported scores ranging from
0.72 to 0.799 (THA) and 0.71 to 0.80 (TKA), and gain in scores from
0.168 to 0.185 (THA) and 0.114 to 0.15 (TKA) [7,26,27,30,45,46].
Greater gains in the current study were due to poorer preoperative
scores in our patients.
These greater HRQoL gains were also seen in our long-term
QALY estimates compared to other studies. Previous studies have
reported longer-term (15 years to lifetime) health gains of 1.39 to
2.35 QALYs after THA and 1.34 to 2.144 QALYs after TKA [26,27,46].
Our gains were 2.8 QALYs (THA) and 2.3 QALYs (TKA) over 15 years.
Patient survival in our models was 78% for THA patients and 75% for
TKA patients suggesting that the 15-year horizon we used un-
derestimates total lifetime QALY gains.
Elmallah et al. calculated an ICER at 1 year of US$39 453/QALY
for THA and US$43 107/QALY for TKA, although it is unclear how
they derived these figures. [27]. It appears from their reported
QALYs and costs that 1-year ICERs should be US$101 000 and
US$119 000 respectively. Our ICER at 1 year was $73 900




Fig. 3. Cost-effectiveness ratios for THA and TKA, by baseline covariates. Dashed lines indicate the 0.5- and 1-times GDP/capita willingness-to-pay thresholds; all points below these
lines are considered cost effective at the corresponding level. GDP, Gross domestic product; OHS, Oxford Hip Score; OKS, Oxford Knee Score; QALY, quality-adjusted life years; THA,
total hip arthroplasty; TKA, total knee arthroplasty.
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[7], consistent with our 5-year ICER of $14 200 (z£7 400) for THA.
Other studies have used the EQ-5D to calculate QALY gains from
TJA. The EQ-5D has approximately twice the range of utility values
of the SF-6D and therefore gives a higher estimate of health utility
gains. In published studies, these range from 0.358 to 0.470
following THA and from 0.267 to 0.332 following TKA [5,8,47,48]. In
order to compare our results with these reports, we mapped OHS
and OKS to EQ-5D utility values and found utility gains of 0.59 after
THA and 0.49 after TKA, with 15-year gains of 6.2 QALYs for THA
and 5.0 QALYs for TKA. These gains were greater than those pre-
viously reported, due to worse preoperative status in our patients;
the use of mapping algorithms to estimate EQ-5D utility values in
our study may also have introduced uncertainty in comparisons18with previous studies. Jenkins et al. calculated lifetime cost/QALY,
using a discount rate of 3.5%, of £2 852 (THA) and £3 738 (TKA) [47].
At 15 years, using the same utility instrument and discount rate, our
ICER was $2 700 (z£1 400) for THA and $3 500 (z£1 800) for TKA.
In the KAT trial, Dakin et al. reported an ICER of £5 623/QALY [8].
Our comparable ICER at 5 years was $8 100 (z£4 200) for TKA. All
of these estimates are well within the highly cost-effective range.
Similar to other studies, we showed greater gains in HRQoL in
younger patients [7,45]. This was evident at 1 year, indicating that
the gains were independent of mortality, but became greater over
the 15-year horizon as a larger proportion of older patients died.
We saw no difference in gains by gender.
It has previously been shown that 1-year outcome scores are




Fig. 4. “Tornado plot” of one-way sensitivity analyses on key model input parameters/assumptions. Bars show the range of estimated ICERs when varying assumptions on input
parameters to their most favorable (lowest ICER estimate) and least favorable (highest ICER estimate) “plausible” values, one-at-a-time. For parameter ranges considered, see
‘Sensitivity analyses’ in the Methods in the text. Dashed lines indicate the 0.5- and 1-times GDP/capita willingness-to-pay thresholds; solid vertical line indicates the ICER from
primary analyses. GDP, Gross domestic product; HRQoL, health-related quality of life; THA, total hip arthroplasty; TKA, total knee arthroplasty.
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that the preoperative Oxford score was systematically associated
with costs and quality of life, with increased costs for patients with
poorer preoperative scores [5]. From US cohort data, Ferket et al.
found a mean increase in SF-6D of only 0.008 after TKA and
concluded that there were minimal gains in health utility in pa-
tients with good physical function as determined by the SF-12 PCS
[49]. They calculated that, at a threshold of US$100 000/QALY, TKA
was only cost effective if performed on patients with significant loss
of function indicated by a preoperative SF-12 PCS below 20 points.
In contrast, Dakin et al. concluded that while the benefits varied
with preoperative OKS, TKAwas cost effective even in patients with
a preoperative OKS over 35 or 40 depending on ASA status [8]. In
our study, TKAwas cost effective in patients with preoperative OKS
over 25 points after 3 years and highly cost effective after 5 years.
A systematic review found that non-operative treatment
involving exercise interventions was cost-saving [50]. The Man-
agement of Osteoarthritis (MOA) trial showed gains in QALYs of
0.19 at 2 years with exercise therapy over usual care, and lower total
health system costs [51]. Skou et al [6] found that providing TKA in
addition to non-surgical treatment resulted in greater health utility
compared with non-surgical treatment only, but did not find it to
be cost-effective at the 2 year horizon. In their study the addition of
non-surgical treatment and a high reoperation and complication
rate increased the cost of the TKA group, while 32% of the non-
surgical group had a subsequent TKA. They noted the need for
studies with a longer time horizon but questioned whether the
results of TKA would be maintained at longer follow-up. Our study
and the NZJR data suggest that these gains are maintained to at
least 10 years, resulting in improving cost effectiveness over time.
However, we have assumed no QALY gain from non-operative183treatment in our model, as evidence suggests that even with a
coordinated multidisciplinary approach there is no significant
improvement in this setting over both short- and longer-term
follow-up to 5 years [21,22].
In New Zealand the costs of publicly-funded THA and TKA
($16,502 and $16,903) are relatively high compared with other
common orthopedic procedures such as knee arthroscopy ($5743)
and rotator cuff repair ($7154), although they are lower than for
spinal decompression and fusion (one-level) ($27,631) and total
ankle replacement ($21,620) [20]. Comparative data on the cost-
effectiveness of these procedures are not available. In an environ-
ment where health systems have limited resources, similar data on
the cost-effectiveness of other procedures both within orthopedics
and across other specialties should be considered to aid prioriti-
sation and rationing decisions.
Strengths of this study are that this is a reasonably large
prospectively-gathered dataset that includes all revision proced-
ures performed anywhere in NZ. Our modeling is consistent with
the observed data and we believe gives a generalisable estimate of
cost effectiveness in a population with poor preoperative status.
Unlike other studies we have not extrapolated to lifetime gains. Our
results are consistent with previous work, with differing outcomes
likely attributable to poorer baseline scoresemeaning that post-
operative gains were greater without a major difference in provi-
sion costs [4,5]. We have included real revision rates and factored in
the costs of revision surgery whereas other studies have not
included revision surgery or used an estimate.
We assumed that the majority of the improvement occurs
within the first 6 weeks, meaning greater health utility gains in the
first year than if an average of the gain at 12 months is used.
Conversely, we did not assume that the full utility gain accrued for
R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e98the whole of the first year (and thereafter) as some authors have
done. We used SF-6D as our primary health utility measure rather
than EQ-5D as this can be directly derived from the SF-12 data we
collected prospectively.
Limitations of the study are that we had incomplete follow-up
scores at 12 months and only 20% of the cohort were sampled by
the NZJR at 5 and 10 years. However, we found no differences be-
tween those sampled and the remainder of the group. There was
wide uncertainty in revision rates by 15 years postoperatively due
to the small number of observed revisions (especially for TKA);
however, the very low number of observed revisions means that
even (proportionally) wide confidence intervals had little impact
on our cost-effectiveness findings. We did not collect complication
data including readmissions which would have increased health
care costs. We did not collect EQ-5D so used published algorithms
to convert OHS/OKS into EQ-5D for secondary analyses to allow
comparison with other studies.
Our modeling assumes no change in health utility state with
non-operative treatment over the 15-year horizon. While there
may have been some small gains with non-operative treatment
many will have deteriorated therefore we consider our results a
conservative estimate of the net gains from surgery. We also
included only direct hospital costs and did not include GP visits,
drug costs or other societal costs which are likely to be greater in
patients treated non-operatively [22]. We had relatively few pa-
tients with milder preoperative scores, but TJA was cost effective
even in these patients. We also had a pleasingly low revision rate
which may be not be representative of outcomes elsewhere,
potentially limiting generalisability.
Conclusion
We have shown that both THA and TKA are cost-effective pro-
cedures after 2 years and highly cost effective from 3 years on-
wards, with decreasing ICERs with longer follow-up. THA was
consistentlymore cost effective than TKA at every time point.While
preoperative status had the strongest influence on cost effective-
ness, THA and TKA remained cost effective in those with less severe
preoperative scores, but only became highly cost effective at 4-5
years. Similarly the procedures were also highly cost effective in
older patients after 3-4 years.
References
[1] Daigle ME, Weinstein AM, Katz JN, Losina E. The cost-effectiveness of total
joint arthroplasty: a systematic review of published literature. Best Pract Res
Clin Rheum 2012;26:649e58.
[2] Nwachukwu BU, Bozic KJ, Schairer WW, Bernstein JL, Jevsevar DS, Marx RG,
et al. Current status of cost utility analyses in total joint arthroplasty: a sys-
tematic review. Clin Orthop Relat Res 2015;473:1815e27.
[3] Kamaruzaman H, Kinghorn P, Oppong R. Cost-effectiveness of surgical in-
terventions for the management of osteoarthritis: a systematic review of the
literature. BMC Musculoskelet Disord 2017;18:183.
[4] Gwynne-Jones DP, Sullivan T, Wilson R, Abbott JH. The relationship between
preoperative Oxford hip and knee score and change in health-related quality
of life following total hip and total knee arthroplasty: can it help inform ra-
tioning decisions? Arthroplasty Today 2020;6:585e9.
[5] Eibich P, Dakin HA, Price AJ, Beard D, Arden NK, Gray AM. Associations be-
tween preoperative Oxford hip and knee scores and costs and quality of life of
patients undergoing primary total joint replacement in the NHS England: an
observational study. BMJ Open 2018;8:e019477.
[6] Skou ST, Roos E, Laursen M, Arendt-Nielsen L, Rasmussen S, Simonsen O, et al.
Cost-effectiveness of total knee replacement in addition to non-surgical
treatment: a 2-year outcome from a randomised trial in secondary care in
Denmark. BMJ Open 2020;10:e033495.
[7] Fordham R, Skinner J, Wang X, Nolan J, The Exeter Primary Outcome Study
Group. The economic benefit of hip replacement: a 5-year follow-up of costs and
outcomes in the Exeter Primary Outcomes Study. BMJ Open 2012;2:e000752.
[8] Dakin H, Gray A, Fitzpatrick R, MacLennan G, Murray David, The KAT Trial
Group. Rationing of total knee replacement: a cost-effectiveness analysis on a
large trial data set. BMJ Open 2012;2:e000332.18[9] Health and Disability System Review. Health and disability system review e
final report e purongo whakamutunga. Wellington, New Zealand: HDSR; 2020.
[10] Gwynne-Jones D. Quantifying the demand for hip and knee replacement in
Otago, New Zealand. NZ Med J 2013;126:7e17.
[11] Gwynne-Jones D, Iosua E. Rationing of hip and knee replacement: effect on
the severity of patient-reported symptoms and the demand for surgery in
Otago. NZ Med J 2016;129:59e66.
[12] Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of
patients about total hip replacement. J Bone Joint Surg [Br] 1996;78-B:185e90.
[13] Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of
patients about total knee replacement. J Bone Joint Surg [Br] 1998;80-B:63e9.
[14] Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to score version 2 of
the SF-12 health survey (with a supplement documenting version 1). Lincoln,
RI: QualityMetric Incorporated; 2002.
[15] Brazier JE, Roberts J. The estimation of a preference-based measure of health
from the SF-12. Med Care 2004;42:851e9.
[16] EuroQol Group. EuroQol e a new facility for the measurement of health-
related quality of life. Health Policy 1990;16:199e208.
[17] Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:
1095e108.
[18] Pinedo-Villanueva RA, Turner D, Judge A, Raftery JP, Arden NK. Mapping the
Oxford hip score onto the EQ-5D utility index. Qual Life Res 2013;22:665e75.
[19] Dakin H, Gray A, Murray D. Mapping analyses to estimate EQ-5D utilities and
responses based on Oxford Knee Score. Qual Life Res 2013;22:683e94.
[20] NCCPP Casemix e Cost Weights Project Group. New Zealand casemix
framework for publicly funded hospitals, including WIESNZ18 methodology
and casemix purchase unit allocation for the 2018/18 financial year.
Wellington, New Zealand: Ministry of Health; 2018.
[21] Gwynne-Jones JH, Wilson RA, Wong JMY, Abbott JH, Gwynne-Jones DP. The
outcomes of nonoperative management of patients with hip and knee osteoar-
thritis triaged to a physiotherapy-led clinic at minimum 5-year follow-up and
factors associated with progression to surgery. J Arthroplasty 2020;35:1497e503.
[22] Gwynne-Jones DP, Gwynne-Jones JH, Wilson RA. The functional outcomes of
patients with knee osteoarthritis managed nonoperatively at the Joint Clinic
at 5-year follow-up: does surgical avoidance mean success? J Arthroplasty
2020;35:2350e2356.e1.
[23] Phamaceutical Management Agency (PHARMAC). Prescription for pharmacoe-
conomic analyses: Methods for cost-utility analysis, version 2.2. Wellington, New
Zealand: PHARMAC; 2015.
[24] R Core Team. R. A language and environment for statistical computing
[Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2019.
https://www.R-project.org/ [accessed 17.12.20].
[25] Incerti D, Jansen JP. Hesim: Health-economic simulation modeling and deci-
sion analysis [Internet]. 2020. https://CRAN.R-project.org/package¼hesim
[accessed 17.12.20].
[26] Liebs TR, Herzberg W, Rüther W, Russlies M, Hassenpflug J, For the Multi-
center Arthroplasty Aftercare Project. Quality-adjusted life years gained by
hip and knee replacement surgery and its aftercare. Arch Phys Med Rehabil
2016;97:691e700.
[27] Elmallah RK, Chughtai M, Adib F, Bozic KJ, Kurtz SM, Mont MA. Determining
health-related quality-of-life outcomes using the SF-6D following total hip
arthroplasty. J Bone Joint Surg Am 2017;99:494e8.
[28] Kennedy DM, Stratford PW, Riddle DL, Hanna SE, Gollish JD. Assessing re-
covery and establishing prognosis following total knee arthroplasty. Phys Ther
2008;88:22e32.
[29] O’Brien S, Bennett D, Doran E, Beverland DE. Comparison of hip and knee
arthroplasty outcomes at early and intermediate follow-up. Orthopedics
2009;32:170e6.
[30] Schilling C, Dowsey MM, Clarke PM, Choong PF. Using patient-reported out-
comes for economic evaluation: getting the timing right. Value Health
2016;19:945e50.
[31] Cubi-Molla P, Errea M, Zhang K, Garau M. Are cost-effectiveness thresholds fit for
purpose for real-world decision making? [Internet]. London, UK: Office of Health
Economics; 2020. https://www.ohe.org/publications/are-cost-effectiveness-thre
sholds-fit-for-purpose-real-world-decision-making [accessed 17.12.20].
[32] Metcalfe S, Rodgers A, Werner R, Schousboe C. PHARMAC has no cost-
effectiveness threshold. NZ Med J. 125:99e101.
[33] Sachs JD. Macroeconomics and health: investing in health for economic
development. Geneva, Switzerland: World Health Organisation; 2001.
[34] Hutubessy R, Chisholm D, Tan-Torres Edejer T, WHO-CHOICE. Generalized
cost-effectiveness analysis for national-level priority-setting in the health
sector. Cost Eff Resour Alloc 2003;1.
[35] Zhang K, Garau M. International cost-effectiveness thresholds and modifiers
for HTA decision making [Internet]. London, UK: Office of Health Economics;
2020. https://www.ohe.org/publications/international-cost-effectiveness-
thresholds-and-modifiers-hta-decision-making [accessed 17.12.20].
[36] Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness
thresholds: initial estimates and the need for further research. Value Health
2016;19:929e35.
[37] Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, et al. Methods for
the estimation of the National Institute for Health and Care Excellence cost-
effectiveness threshold. Health Technol Assess 2015;19.
[38] Edney LC, Haji Ali Afzali H, Cheng TC, Karnon J. Estimating the reference in-
cremental cost-effectiveness ratio for the Australian health system. Pharma-
coEconomics 2018;36:239e52.4
R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e9 9[39] Latimer NR. Survival analysis for economic evaluations alongside clinical tri-
alsdextrapolation with patient-level data: inconsistencies, limitations, and a
practical guide. Med Decis Making 2013;33:743e54.
[40] Hailer NP, Garellick G, K€arrholm J. Uncemented and cemented primary total
hip arthroplasty in the Swedish Hip Arthroplasty Register: evaluation of
170,413 operations. Acta Orthop 2010;81:34e41.
[41] Namba RS, Cafri G, KhatodM, Inacio MCS, Brox T, Paxton EW. Risk factors for total
knee arthroplasty aseptic revision. J Arthroplasty 2013;28(Suppl. 1):122e7.
[42] Abbott JH, Ward AL, Crane C, Chapple CM, Stout K, Hutton L, et al. Imple-
mentation of a ‘Joint Clinic’ to resolve unmet need for orthopaedic services in
patients with hip and knee osteoarthritis: a program evaluation. BMC Mus-
culoskelet Disord 2019;20:324.
[43] Schilling C, Petrie D, Dowsey MM, Choong PF, Clarke P. The impact of
regression to the mean on economic evaluation in quasi-experimental pre-
post studies: the example of total knee replacement using data from the
Osteoarthritis Initiative. Health Econ 2017;26:e35e51.
[44] Gwynne-Jones DP, Martin G, Crane C. Enhanced recovery after surgery for hip
and knee replacements. Orthop Nurs 2017;36:203e10.
[45] Konopka JF, Lee Y-y, Su EP, McLawhorn AS. Quality-adjusted life years after
hip and knee arthroplasty: health-related quality of life after 12,782 joint
replacements. JB JS Open Access 2018;3:e0007.185[46] Hamilton DF, Clement ND, Burnett R, Patton JT, Moran M, Howie CR, et al. Do
modern total knee replacements offer better value for money? A health
economic analysis. Int Orthop 2013;37:2141e52.
[47] Jenkins PJ, Clement ND, Hamilton DF, Gaston P, Patton JT, Howie CR. Pre-
dicting the cost-effectiveness of total hip and knee replacement. Bone Joint J
2013;95-B:115e21.
[48] Pennington M, Grieve R, Sekhon JS, Gregg P, Black N, van der Meulen JH.
Cemented, cementless, and hybrid prostheses for total hip replacement: cost
effectiveness analysis. BMJ 2013;346:f1026.
[49] Ferket BS, Feldman Z, Zhou J, Oei EH, Bierma-Zeinstra SMA, Mazumbdar M.
Impact of total knee replacement practice: cost effectiveness analysis of data
from the Osteoarthritis Initiative. BMJ 2017;356:j1131.
[50] Pinto D, Robertson MC, Hansen P, Abbott JH. Cost-effectiveness of non-
pharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis:
systematic review. Value Health 2012;15:1e12.
[51] Abbott JH, Wilson R, Pinto D, Chapple CM, Wright AA, the MOA Trial
team. Incremental clinical effectiveness and cost effectiveness of
providing supervised physiotherapy in addition to usual medical care in
patients with osteoarthritis of the hip or knee: 2-year results of the
MOA randomised controlled trial. Osteoarthritis Cartilage 2019;27:
424e34.
R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e99.e1Appendix
Appendix A. Supplementary ResultsFigure A1. Change in Oxford Hip and Knee Scores from preoperative baseline, at 1-, 5-, and 10-year follow-up. Error bars show 95% confidence intervals. All available observations
used at each time point (THA: n ¼ 542 at 1-year follow-up, n ¼ 58 at 5-year follow-up, and n ¼ 29 at 10-year follow-up; TKA: n ¼ 371, n ¼ 58, and n ¼ 38, respectively); see
Figure A2 for evaluation of potential selection bias at 5- and 10-year follow-up. THA, total hip arthroplasty; TKA, total knee arthroplasty.Figure A2. Oxford Hip and Knee Scores, preoperative baseline to 10-year follow-up, by follow-up completion status. THA, total hip arthroplasty; TKA, total knee arthroplasty.
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Figure A3. Revision-free survival rates, modeled and observed. THA, total hip arthroplasty; TKA, total knee arthroplasty.
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Figure A4. Cumulative QALY gains, costs, and incremental cost-effectiveness ratios,
THA and TKA, using EQ-5D utility values mapped from Oxford hip and knee scores,
Dashed lines in Panel C indicate the 0.5- and 1-times GDP/capita willingness-to-pay
thresholds; all points below these lines are considered cost effective at the corre-
sponding level. GDP, gross domestic product; ICER, incremental cost-effectiveness
ratio; QALY, quality-adjusted life years; THA, total hip arthroplasty; TKA, total knee
arthroplasty.
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Figure A5. Cumulative QALY gains following THA and TKA, by baseline covariates. OHS, Oxford Hip Score; OKS, Oxford Knee Score; QALY, quality-adjusted life years; THA, total hip
arthroplasty; TKA, total knee arthroplasty.
R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e9 9.e4
189
Figure A6. Cumulative surgery costs (incl. revisions) for THA and TKA, by baseline covariates. OHS, Oxford Hip Score; OKS, Oxford Knee Score; THA, total hip arthroplasty; TKA, total
knee arthroplasty.
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Figure A7. Cost-effectiveness ratios for THA and TKA, under different assumptions on survival distributions. Dashed lines indicate the 0.5- and 1-times GDP/capita willingness-to-
pay thresholds; all points below these lines are considered cost effective at the corresponding level. GDP, gross domestic product; THA, total hip arthroplasty; TKA, total knee
arthroplasty.
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Figure A8. Cost-effectiveness ratios for THA and TKA, with revision rates adjusted for
baseline patient characteristics. Dashed lines in Panel C indicate the 0.5- and 1-times
GDP/capita willingness-to-pay thresholds; all points below these lines are considered
cost effective at the corresponding level. GDP, gross domestic product; ICER, incre-
mental cost-effectiveness ratio; QALY, quality-adjusted life years; THA, total hip
arthroplasty; TKA, total knee arthroplasty.
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R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e9 9.e8Appendix B: Survival Distribution Preliminary ModelingFigure B1. Empirical and fitted survival curves, time-to-mortality. THA: Total hip arthroplasty; TKA: Total knee arthroplasty.
Table B1













R.A. Wilson et al. / The Journal of Arthroplasty xxx (2021) 1e99.e9The empirical survival curves and the fitted distributions for alternative time-to-mortality distributions were examined to determine the
preferred distribution for survival modeling. All fitted distributions except the exponential distribution fit the observed survival curves
closely, with little difference between the log-logistic, log-normal, and Weibull distribution fitted curves (Figure B1).
Akaike’s Information Criterion (AIC) was compared betweenmodels to find the optimal model (with lower AIC values indicating a ‘better’
model for the observed data). The AIC values were lowest for the log-logistic and log-normal models for both THA and TKA, with very little
difference between these two (Table B1).
Therewere insufficient data to estimate alternative survival distributions for revision-free survival, with only 13 THA and 5 TKA revisions
observed over the 15-year follow-up period. Given these very small numbers of revisions, we considered the likely impact of alternative
survival distributions on cost-effectiveness results to be negligible.
Appendix C: Model Input Parametersgure C1. State-transition model structure. All patients start in state ‘Primary TJA’ and may progress to ‘Revision TJA’ and/or ‘Dead’ based on individual time-to-event simulation
erived from observed survival rates). Costs and utilities are accrued to the specified time horizon (1, 2, 3, 4, 5, 10, or 15 years), with a discount rate of 3.5% per year. Input pa-
meters are derived and the simulation model is run separately for THA and TKA. TJA, total joint arthroplasty; THA, total hip arthroplasty; TKA, total knee arthroplasty.Table C1
Gain in SF-6D Health Utility Scores.
Variable THA TKA
Constant 0.586 (0.054) 0.512 (0.079)
Age (years) 0.00343 (0.00077) 0.00257 (0.00107)
Sex (female) 0.014 (0.016) 0.021 (0.018)
Oxford score 0.00655 (0.00118) 0.00626 (0.00140)
Cells report coefficients (std. error) from the regression models for change in SF-6D
health utility values (SF  6DPostoperative  SF  6DPreoperative).
THA, total hip arthroplasty; TKA, total knee arthroplasty.
Table C2










Shape 1.84 (1.54 to 2.20) 1.75 (1.43 to 2.14)
Scale 1 527 (379 to 6 161) 1 001 (179 to 5 599)
Age (years) 0.940 (0.923 to 0.958) 0.948 (0.928 to 0.969)
Sex (female) 1.255 (0.966 to 1.629) 1.195 (0.887 to 1.611)
Oxford score 1.020 (0.999 to 1.041) 1.007 (0.983 to 1.032)
Cells report (exponentiated) coefficients (95% confidence interval) of the time-to-
revision and time-to-mortality survival models. Time-to-revision censored at death.





Primary TJA $16 502 $16 903
Revision TJA $23 876 $22 156
Cells report mean surgery costs (weighted average of procedures coded as with and
without serious complications). Surgery costs were treated as fixed (no stochastic
parameter distribution).
TJA, total joint arthroplasty; THA, total hip arthroplasty; TKA, total knee
arthroplasty.
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Chapter 6 
Improving perioperative management. 
Perioperative management of patients is constantly evolving and improving. It is driven 
both by a desire for quality but also the need for beds and cost saving. In an early paper 
‘Clinical pathways in total knee arthroplasty: a New Zealand Experience’ we reported on 
the introduction of clinical pathways in 1997 to help streamline care. It showed a 
reduction in length of stay (LOS) from 12.9 days to 10.3 days without an increase in 
complications or readmissions. More recently, there has been significant interest in 
enhanced recovery programmes in joint replacement. [1] I was fortunate to attend a 
presentation by Tom Wainwright and Mr Rob Middleton Middleton in 2012 on 
enhanced recovery techniques as used in Bournemouth, UK. Ward staff including the 
Charge Nurse and lead physiotherapist also attended. We were inspired and introduced 
many of their techniques as part of the Orthopaedic Patient Pathway. ‘Enhanced 
recovery after surgery for hip and knee replacements’ reports on our experience and 
showed a decrease in LOS, no increased risk of complications and 98% discharged home. 
This was despite the fact that the mean Body Mass Index (BMI) was over 30 and the 
proportion of sick and very sick patients (American Association of Anaesthesiologists 
(ASA) grade 3 and 4) increased from 23% to 32%. 
Sicker patients have led to an increased interest in perioperative medicine. 
Cardiopulmonary exercise testing (CPET) is a relatively new technique to assess a 
patient’s fitness for surgery. An issue with patients with lower limb disease is that 
conventional treadmill testing may not be possible. Our paper ‘Cardiopulmonary 
exercise testing in severe osteoarthritis: A crossover comparison of four exercise 
modalities’ compares different exercise modalities in patients with hip and knee OA.  It 
concludes that arm ergometry is not an appropriate substitute for CPET modalities 
utilising the lower limbs in patients affected by osteoarthritis as it underestimates peak 
 ̇O2 and anaerobic threshold.  
Complications are an important cause of morbidity and potential costly returns to 
theatre. Intraoperative imaging can play an important role in avoiding complications 
during surgery but has the potential to be hazardous to both patient and surgeon. It is 
commonly used in fracture management including hip fractures.  
Our first study ‘Radiation use in the orthopaedic theatre: a prospective study’ audited 
the use of radiation, predominantly in the trauma theatre. It highlighted the increased 
radiation exposure to the patient from taking hard copy films with the image intensifier 
and the potential hazards to junior staff from catching their hands in the beam. 
In elective surgery an important use is to aid in the placement of pedicle screws during 
instrumented spinal surgery. Malposition can lead to nerve irritation and damage, or 
loss of fixation. Imaging also helps to prevent wrong level surgery. Our study ‘Radiation 
exposure during fluoroscopically assisted pedicle screw insertion in the lumbar spine’ has 
become a standard with 104 citations.  
Reference 
1. Wainwright, T., Middleton, R.  (2010).  An orthopaedic enhanced recovery pathway.  Current
Anaesthesia and Critical Care, 114-20.
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Clinical pathways in total knee arthroplasty:
A New Zealand experience
JM Pennington, DPG Jones, S McIntyre
Department of Orthopaedic Surgery, Dunedin Hospital, Dunedin, New Zealand
Conclusion. Clinical pathway implementation
resulted in a significant reduction in the length of stay,
and achieved a more efficient management of
hospitalised patients without compromising outcome.
Key words: arthroplasty; clinical pathway; complications;
length of stay; managed care; patient readmissions
INTRODUCTION
Total knee arthroplasty (TKA) is performed at an
increasing rate as a result of the increase of the mean
age of the population. The number of primary TKAs
performed in New Zealand during the year 2000 had
a 23% increase compared with the previous year.1
Such an increase drains the time and financial
resources of the health care providers. Clinical
pathways have been introduced in North America,
Australia, and the UK, with the expectation of
Address correspondence and reprint requests to: Dr David P Gwynne Jones, Department of Orthopaedic Surgery, Dunedin School
of Medicine, Dunedin Hospital, Dunedin, New Zealand. E-mail: david.gwynne-jones@stonebow.otago.ac.nz
ABSTRACT
Purpose. To ascertain the effects of a clinical pathway
in our institution.
Methods. This retrospective and comparative study
was performed on all patients undergoing total knee
arthroplasty over a 5-year period. This period covered
the 30 months prior to the introduction of the
pathway (group 1), and the 30 months following its
introduction (group 2).
Results. There was a significant reduction in the
duration of hospital stay of group 2 patients (p<0.0001),
with 62.8% of these patients staying less than 8
postoperative days. There was a reduction in the
number of patients with thromboembolic com-
plications (p<0.05) and no increase in overall com-
plications or readmission rate. There was a trend to
increased use of rehabilitation services among group
2 patients.
Journal of Orthopaedic Surgery 2003: 11(2): 166–173
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maintaining a high quality of care at a lower cost.
Clinical pathways are standardised protocols for the
management of patients with common conditions or
those undergoing common surgical procedures. They
are intended to cover all foreseeable aspects of care
by all members of the health care team managing the
involved patients. The objectives of implementing the
protocols include the standardisation of care and the
reduction of in-patient stay and cost without adverse
effect on patient outcomes. In the literature there is
evidence that the use of clinical pathways help
reduce the length of stay (LOS)2–9 and cost4,6,8,10
without undesirable outcomes.3,6,11 Most studies also
show that after the implementation of a pathway,
there is no significant change in postoperative
complication and readmission rate.3,4,7 We report
our experience with  a clinical pathway for TKA in a
New Zealand public hospital.
METHODS
In July 1997 we introduced a clinical pathway for
patients undergoing TKA. The pathway was
developed by a multidisciplinary team of health care
workers involved in the care of TKA patients. The team
comprised an orthopaedic surgeon, the clinical
care pathway coordinator, senior nursing staff, and
Figure 1 Day 2 total knee replacement clinical care pathway.
198
168 JM Pennington et al. Journal of Orthopaedic Surgery
Figure 2 Progress page of clinical care pathway.
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Figure 3 Discharge phase of clinical care pathway.
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physiotherapy and occupational therapy staff from
both in-patient and out-patient/preadmissions areas.
The pathway was a protocol that was translated into
the backbone of the patient’s medical chart. It
commenced at the preadmissions clinic with the
medical, anaesthetic, and physiotherapy assessment.
The nursing assessment included a pressure score and
falls risk score. The patient received an overview of
both the in-patient and out-patient programmes.
Medical, nursing, and physiotherapy tasks or goals
were set for each postadmission day (Fig. 1). The
medical chart, which was monitored daily, had points
that were signed off by the relevant professionals until
the day of discharge. Deviations from the expected
progress were also recorded. The pathway was initially
set for an 8-day postoperative LOS. An overview of
progress was recorded on the front of the pathway
chart (Fig. 2). Discharge criteria included active
knee flexion to 90Ο, ability to walk with aids on
stairs, independent showering, unaided transfers,
and dressing, etc. (Fig. 3)
A retrospective and comparative study was
performed on all patients undergoing primary TKA
over a 5-year period from 1 January 1995 to 31 De-
cember 1999 in Dunedin Hospital, Dunedin. During
the 30-month period prior to the introduction of the
pathway, 181 TKAs were performed. This group of
patients (group 1) became the control group in
this study. In the consecutive 30-month period follow-
ing its introduction, there were 261 TKAs performed.
This group of patients (group 2) underwent the
pathway. In both groups, we only studied cases of
elective primary TKAs. Acute, revisional, bilateral, and
unicompartmental procedures were excluded from
both groups. Procedures were performed by, or under
the direct supervision of, 6 consultant orthopaedic
surgeons.
All group 2 patients were assessed at the pre-
admissions clinic for suitability for introduction to the
pathway. Patients were not enrolled onto the pathway
if they had significant concomitant medical or mobility
problems that would affect a standard postoperative
stay and recovery. These problems included severe
multiple-joint involvement, severe cardiac or respira-
tory diseases, and potential intensive care or coronary
care admissions in the immediate postoperative
period. However, the patients excluded from
enrolment onto the clinical pathway were included for
data analysis in group 2 in order to prevent bias in the
study, and to allow comparison with similar patient
populations.
One group 1 patient and 2 group 2 patients died
postoperatively. The 2 groups were comparable with
respect to place of residence, age, sex, underlying
diagnosis and co-morbidities (Table 1).
Outcome examined included the LOS, admissions
on the day of surgery, complications, readmissions
within 90 days, and discharge destination. Patients’
daily performance and that at discharge were recorded
for group 2 as part of the pathway documentation.
During the period of the study, there was no change
in the type of implant, operating theatre protocol, or
physiotherapy technique used. Guidelines for referral
to rehabilitation included poor progression along the
pathway, general frailty, problems with activities of
daily living, and poor support at home. Data were
collected from the hospital’s electronic patient
administration database, the departmental audit
system, the clinical pathway system, and the patient
medical records.





























































Demographic and clinical features*
* Data shown in No. (%) except otherwise stated
±
201
Vol. 11 No. 2, December 2003 Clinical pathway in total knee arthroplasty 171
Statistical analysis
Chi squared and Fisher’s exact tests were used to assess
the differences between the groups for discrete
variables. Student’s t test was used for continuous
variables. Any p value less than 0.05 was considered
statistically significant.
RESULTS
Within group 2, 241 (92%) patients were accepted onto
the pathway, of whom 209 (87%) patients completed
the pathway satisfactorily. LOS was found to be
significantly reduced for all patients in group 2
compared with those in group 1. The mean LOS was
reduced from 12.9 days in group 1 to 10.3 days in
group 2 (p<0.0001). The percentage of patients
discharged within 8 postoperative days rose from
23.8% in group 1 to 62.8% in group 2 (p<0.0001). The
rate of admission on the day of surgery increased
from 2.2% in group 1 to 4.2% in group 2, but such
difference was not statistically significant. There was
also an insignificant increase in the rate of utilisation
of the in-patient rehabilitation unit from 6.6% in
group 1 to 11.9% in group 2. Those patients who
required rehabilitation were transferred to the
rehabilitation unit. The mean LOS for rehabilitation
was 13.4 days in group 1, compared with 10.6 days in
group 2 (p<0.05). The difference of readmission rate
(12.2% for group 1 and 10.3% for group 2) between
the 2 groups was not statistically significant either. The
results are summarised in Table 2.
The overall rate of complications dropped from
32.6% in group 1 to 25.7% in group 2. In particular, the
number of patients requiring manipulation under
anaesthesia was reduced in group 2. There were also
significantly fewer patients complicated with deep
vein thrombosis or pulmonary embolism in group 2.
Conversely, there was an insignificant increase in the
rate of reported superficial wound infection from
5.5% in group 1 to 9.2% in group 2. There was neither
a corresponding difference in the rate of deep wound
or joint infection nor a significant increase in the rate
of revision procedures between both groups. The
results are summarised in Table 3.
Review of the prospectively gathered performance
data for the patients in group 2 showed that by
postoperative day 8, 89% of these patients attained 90Ο
of knee flexion (93% of whom were further capable of
mobilising independently and safely both on the flat
and on stairs).
DISCUSSION
A care pathway integrates the routine aspects of a pa-
tient’s care. Ideally it avoids delay in identifying poten-
tial problems and streamlines care accordingly. During
the study period we accepted 92% of the patients onto
the pathway. With increased experience we now find
it extremely rare to exclude a patient from the pathway.
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Length of stay, admission day, and use of rehabilitation service*
* Data shown in No. (%) except otherwise stated
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There was a significant reduction in the LOS
for patients admitted onto our pathway. Our
reduction of 2.6 days was comparable to those of
2 days by Pearson et al.,7 1.5 days by Dowsey et al.,3
and 3.6 days by Fisher et al.4 Although Mabrey
et al.6 achieved a 6.2 days’ reduction, their patient
population had a mean age of 10 years less than that
of our study. In contrast to Pearson et al.,7 who
admitted 75.6% of their patients on the day of
surgery, our admission rate on the day of surgery was
very low in both groups (2.2% in group 1, and 4.2%
in group 2). Since 39% of our patients were from rural
abodes, further measures can be implemented to
increase the same-day admission rate, which helps
to reduce the LOS.
We propose that different care pathways for TKA
should have similar core components such as early
discharge planning and in-patient physiotherapy;
but we still have to be sensitive to institution-
specific requirements. Our pathway emphasises early
discharge planning, patient education, and early
mobilisation with out-patient physiotherapy. We did
not increase staff numbers or add services. Pearson et
al.7 set their LOS at 8 days, transferring patients
from the acute ward to a convalescent ward on day 4.
They also developed a structured approach to home
physiotherapy. Mabrey et al.6 set a 5-day stay with
different discharge criteria, such as 65Ο active knee
flexion and the ability to walk 50 feet with aids
(stair climbing was not mentioned). In-patient
rehabilitation was required for 20% of those patients
and home physiotherapy for a further 17%. Dowsey
et al.3 routinely used community nurses for 3 weeks
following discharge.
We found an insignificant increase in the rate of
transfer to an in-patient rehabilitation facility in the
pathway group. This did not account for the overall
reduction in the length of patient stay. We believe that
the increased and earlier utilisation of rehabilitation
services is largely a result of the clinical pathway. This
clinical pathway helps to identify those patients who
will benefit from rehabilitation earlier, prompting
timely referral.
While there may be concerns about the potential
for adverse outcomes with early discharge of patients,
our study shows that such concerns are not verified
by empirical data. By day 8 of the pathway, 89% of the
enrolled patients had over 90Ο of knee flexion, and 93%
of whom were mobilising satisfactorily. These patients
thus met the historical criteria for discharge, which
were also applied to the patients in group 1. In
addition, we found no increase in either postoperative
complications or readmissions after the pathway
implementation, which is consistent with other
studies.3,6,7 Furthermore, readmissions and most
complication types (especially thromboembolic
phenomenon) showed a downward trend.
There are inherent weaknesses in this retrospective
study. It is difficult to confidently conclude that the
improvements were mainly attributed to the intro-
duction of the pathway. However, since the selected
patients were from the same institution and were
well matched with respect to age, American Society
of Anesthesiologists score, sex, and diagnosis, it is
highly probable that the use of a pathway was a major
factor influencing the changes. Our tentative con-
clusion is also supported by the fact that there were
no major changes in indications, staff, surgical
technique or implants during the study period.
The pathway is also a useful audit tool. By analysing
the variations recorded, we were able to identify poten-
tial complications such as wound oozing caused by the ad-
ministration of low-molecular-weight heparin, and urin-
ary retention following spinal anaesthesia. This early
awareness can help us modify our practice accordingly.
CONCLUSION
This study adds to the growing evidence that the use
of a clinical pathway can be an aid to streamline the
care of patients with a consequent reduction in the
LOS without detrimental effect.
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 Enhanced recovery after surgery (ERAS) programs, 
also known as enhanced recovery programs (ERPs), 
fast track, or rapid recovery, are based on the work of 
Henrik Kehlet in colorectal surgery ( Kehlet, 1997 ). In 
recent years, there has been considerable interest in 
their introduction in orthopaedic surgery, especially in 
hip and knee replacements ( Ibrahim, Twaij, Giebaly, 
Nizam, & Haddad, 2013 ;  Kehlet & Thienpont, 2013 ). 
Programs are designed to prepare patients for, and re-
duce the total impact of, surgery, helping them recover 
more quickly. These programs include preoperative in-
formation and optimization of comorbidities, anes-
thetic and postoperative analgesia, surgical technique, 
perioperative blood management, early mobilization, 
rehabilitation, and discharge planning ( Kehlet & 
Thienpoint, 2013 ). Such programs take a whole-sys-
tem, evidence-based, multidisciplinary approach 
( Ibrahim et al., 2013 ; Kehlet & Thienpoint, 2013). In 
orthopaedics, they may reduce mortality, average 
length of stay (ALOS), and perioperative complications 
without an increase in complication or readmission 
rates ( Kearney, Jennrich, Lyons, Robinson, & Berger, 
2011 ;  Malviya et al., 2011 ;  McDonald, Siegmeth, 
Deakin, Kinninmonth, & Scott, 2012 ; Wainwright & 
Middleton, 2010). As there are approximately six times 
more elective hip and knee replacements performed 
per year in the United Kingdom than colorectal proce-
dures, the potential benefi ts may be greater (Wainwright 
& Middleton, 2010). 
 Despite the success of ERAS programs, there have 
been few published results in Australasia ( Keane et al., 
2012 ). We developed and implemented ERAS protocols 
as part of a wider program—the Orthopaedic Patient 
Pathway  funded by the Ministry of Health, under the 
Elective Services Productivity and Workforce Program. 
The purpose of this article is to describe the develop-
ment, implementation, and results of the fi rst 18 months 
of the program in our public hospital. The fi rst 528 pa-
tients undergoing primary hip or knee replacement fol-
lowing the introduction of the ERAS program were 
 BACKGROUND:  Enhanced recovery after surgery (ERAS) 
programs or hip and knee replacements have had a sig-
nifi cant effect on streamlining patient care with shorter 
stays, no increase in complications, and improved outcomes 
including reduced mortality. 
 PURPOSE:  To compare outcomes following the introduction 
of an ERAS program for hip and knee replacements devel-
oped at our institution with a historical cohort of patients. 
 METHODS:  ERAS protocols were developed at our institu-
tion for patients undergoing hip and knee joint replace-
ments. Key aspects were changes in preadmission, a new 
education session, improved management of perioperative 
anemia, standardized anesthetic guidelines, day of surgery 
mobilization, and improved discharge planning. The results 
of the fi rst 18 months (528 consecutive patients) were com-
pared with those of a historical cohort of 507 patients from 
the 18 months prior to their introduction. 
 RESULTS:  In the ERAS group, the mean age was 68.3 years 
for patients who underwent hip replacement and 70.4 years 
for patients who underwent knee replacement. Thirty-two 
percent of patients were ASA (American Society of Anesthe-
siologists) Grades III and IV. The average preoperative Oxford 
score was 11. The average length of stay (ALOS) fell from 
5.6 to 4.3 days for patients who underwent hip replacement 
and from 5.7 to 4.8 days for patients who underwent knee 
replacement ( p  < .001). Ninety-six percent of patients were 
discharged home. The 30-day readmission rate increased 
from 3.2% to 5.5% ( p  = .065). Six-month Oxford knee 
scores were higher in the ERAS group (39.8 vs. 36.3,  p  = 
.03). There was no increase in mortality or early revision rate. 
 CONCLUSIONS:  Substantial reductions in ALOS can be 
gained with the introduction of ERAS protocols, with high 
patient satisfaction and no increase in complications in a 
consecutive unselected group of public hospital patients. This 
requires a multidisciplinary approach and a strong clinical input. 
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compared with a historical cohort from the 18-month 
period immediately prior to their introduction.
 Methods 
 Our institution is the main hospital for a population of 
200,000, covering a sparsely populated area of 32,000 
square kilometers. There are 10 orthopaedic surgeons 
and one arthroplasty fellow who perform approximately 
400 hip and knee arthroplasties including revision sur-
gery per year. Elective patients are admitted to a single 
orthopaedic elective ward (20–24 beds). In addition to 
the normal ward nursing staff, there is one permanent 
orthopaedic physiotherapist, a rotating physiotherapist, 
and one occupational therapist. Key members of the de-
partment (including the elective ward charge nurse, the 
senior permanent physiotherapist, and the clinical 
leader) attended a 1-day workshop on the principles and 
implementation of enhanced recovery ( Wainwright & 
Middleton, 2010 ). Having been enthused by the presen-
tation, the team members resolved to introduce the tech-
niques to our institution. Over the next 6 months, all as-
pects of the patient journey were reviewed. Small-scale 
audits were conducted on cancellations at the preadmis-
sion clinic and on day of surgery, effect of preoperative 
anemia on transfusion requirements and ALOS, use of 
drains, use of femoral nerve blocks, and local anesthetic 
infi ltration techniques. New protocols were developed 
by the nursing, physiotherapy, and medical staff. An ex-
perienced former orthopaedic charge nurse was ap-
pointed to a part-time ERAS facilitator role, and the 
head orthopaedic surgeon was the  clinical champion for 
the project. 
 An audit of cancellations at the preadmission clinic 
showed the commonest reasons for cancellation of sur-
gery were poorly controlled medical conditions, need 
for dental care, and skin problems such as ulcers. This 
led to the development of a preoperative health ques-
tionnaire concentrating specifi cally on recent dental 
care, skin lesions, and chronic health conditions. This 
was mailed to patients and general practitioners (GPs) 
prior to the preadmission appointment. Problems were 
identifi ed and addressed, and surgery was delayed if 
necessary. An audit of preoperative anemia showed that 
patients who were anemic (males  < 130 g/L, females 
 < 120 g/L) stayed a mean 1.6 days longer than those pa-
tients who were not anemic (6.8 vs. 5.2 days) and 56% of 
anemic patients required transfusion compared with 
12.5% of nonanemic patients. This led to the develop-
ment, in conjunction with the Hematology Department, 
of an algorithm for the early identifi cation and manage-
ment of preoperative anemia. Facilities and arrange-
ments for intravenous iron infusion and oral iron sup-
plementation were developed for patients with 
preoperative iron-defi cient anemia. 
 Community service physiotherapists and occupa-
tional therapists had seen patients from the historical 
cohort for education and aids such as raised toilet seats 
and crutches. Although education was given, this was 
not always consistent or up to date. A new preoperative 
education class was developed for all patients who lived 
within 1-hour travel time from our hospital and run by 
members of the elective ward staff. Aids were issued, 
and patients were instructed on preoperative physio-
therapy exercises. Details of their postoperative care 
and expectations were given by the staff who would be 
looking after them, which ensured continuity. The pa-
tient information guide was rewritten to refl ect a shifting 
of responsibility onto the patient and the family in areas 
such as smoking cessation and discharge planning. 
 Standardized anesthetic and analgesia guidelines 
were developed with a consultant anesthetist (see 
 Table 1 ). The goal was for mobilization of the patient 
on the day of surgery if possible and better manage-
ment of postoperative pain. Key initiatives included 
the routine administration of tranexamic acid (if no 
contraindications) and increased use of parenteral and 
oral nonsteroidal anti-infl ammatory drugs. A rand-
omized study we conducted showed no advantages to 
postoperative continuous femoral nerve infusions over 
a single-shot femoral nerve block, so their use was dis-
couraged ( Wyatt, Wright, Locker, Stout, & Theis, 2015 ). 
In turn, femoral nerve block has been superseded 
by local infi ltration with ropivacaine, adrenaline, 
and tranexamic acid in patients undergoing knee 
replacements. 
 Discharge criteria were developed so that in a medi-
cally fi t patient the fi nal decision on discharge is made 
by the nursing and physiotherapy staff. Patients should 
be independent for transfers in and out of bed, have 
managed stairs and showering, and have satisfactory 
knee fl exion (for knee replacement patients) prior to dis-
charge. The ERAS team consulted and discussed the 
new protocols with all orthopaedic surgeons, junior 
doctors, anesthetists, nursing staff, inpatient and outpa-
tient physiotherapists, and local GPs. 
 Following discussion and small-scale trials, the new 
protocols were implemented in January 2013. Key as-
pects are summarized in  Table 2 . 
 This study compares a consecutive series of all pa-
tients undergoing primary elective total hip (THR) or 
knee replacement (TKR) from January 1, 2013, to June 
30, 2014, with a historical control cohort from the pre-
ceding 18-month period, July 1, 2011, to December 31, 
2012. Revision surgery and hip replacement for acute 
fractures were excluded. Data including age, gender, 
body mass index (BMI), ALOS, time of discharge, trans-
fusion requirements, and acute readmissions were col-
lected prospectively. 
 Baseline data collected included the American 
Society of Anesthesiologists (ASA) grade. This has fi ve 
grades, where ASA I is a healthy patient, ASA II is a pa-
tient with mild systemic disease, ASA III is a patient 
with severe systemic disease, and ASA IV is a patient 
with severe systemic disease that is a constant threat to 
life. ASA V is a moribund patient who is not expected to 
survive without the operation and is not relevant to elec-
tive joint replacement. ( ASA, 2014 ) Preoperative Oxford 
hip or knee scores (OHS, OKS), which are used in our 
prioritization process, were also collected for the ERAS 
group. The Oxford score is a 12-question patient-
reported outcome measure. There are fi ve questions on 
pain and seven on function, each of which has fi ve op-
tions and is scored 0–4, where 0 is worst and 4 is best. 
This gives a score of 0–48, where 48 is best. The score is 
validated and widely used to report the improvement 
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and outcome following hip or knee replacement surgery 
( Murray et al., 2007 ). 
 Complications and readmission data were collected 
from our institution’s patient management system, the 
department’s surgical audit system, and the surgical site 
infection (SSI) surveillance program for hip and knee 
replacements. Data were cross-referenced with the New 
Zealand (NZ) Joint Registry for revisions, deaths, and 
6-month postoperative Oxford scores. The NZ Joint 
Registry (2014) collects details of all patients undergo-
ing hip or knee replacement in the country and has 98% 
compliance. 
 T ABLE 1.  A NESTHESIA G UIDELINE FOR THJR/TKJR 
This is only a guideline. It is recognized that the attending anesthetist may fi nd it necessary to alter this in certain circumstances depending 
on the patient’s individual needs. Please contact APS early if the patient is opioid tolerant. 
 Spinal anesthesia  + intrathecal morphine 100–150  μ g 
 Sedation or  light general anesthesia 
Maintain spontaneous ventilation where possible 
Maintain  normothermia 
 Cefazolin 2 g prior to skin incision and tourniquet infl ation 
 Consider tranexamic acid 15 mg–20 mg/kg iv slowly prior to incision if excessive blood loss is expected or the patient is anemic (Hb 
 < 130 g/L, males, 120 g/L females) 
Avoid excessive  fl uids , i.e., 1–2 L in routine cases; aim for approximately 3 L in the fi rst 24 hours 
 Paracetamol 2 g as a premed or 1 g iv intraoperatively 
 Parecoxib 40 mg iv if not contraindicated, i.e., allergy, severe asthma, PUD, abnormal creatinine,  > 75-year-old. Consider continuing for 
3 days postop 
 TKJR only 
  Femoral nerve block (single shot): Bupivacaine 100 mg, or ropivacaine 150 mg  + dexamethasone 8 mg 
 OR  Peri/intra-articular local anesthetic: Ropivacaine 200–300 mg  + adrenaline 1 mg  + 1 g tranexamic  acid (in place of IV dose made 
 up to 100 mL with normal saline) 
 Postoperative analgesia to consider 
  Paracetamol 1 g qid regular 
  Ibuprofen 200–400 mg 8 hourly 3 days and then stop  + omeprazole 40 mg od while on Ibuprofen
  PCA for 1–2 days for patients who underwent knee replacement started in recovery; prn for patients who underwent hip replacement 
  Oxycontin  Knees only 10 mg bd. Start postop Day 1 for 3 days and then stop 
  Oxynorm 5–10 mg po q3h prn (not while on PCA) review on D/C 
  Clonidine patch tts1 start once mobilizing (Day 1) 
  Tramadol 50–100 mg qid/prn (avoid if SSRIs, previous intolerance, seizures) 
 Note . bd  = twice daily; D/C  = discharge; od  = once daily; Hb  = hemoglobin; iv  = intravenous; PCA  = patient-controlled analgesia; 
po  = per os or orally; prn  = as needed; PUD  = peptic ulcer disease; qid  = four times a day; q3h  = every 3 hours; SSRI  = serotonin-specifi c 
reuptake inhibitor; THJR  = total hip joint replacement; TKJR  = total knee joint replacement. 
 T ABLE 2.  K EY C OMPONENTS OF THE ERAS P ROGRAM 
Early identifi cation and treatment of preoperative anemia 
Preoperative health questionnaires to patients and GPs 
Weekly preoperative education class run by the ward nursing and allied health staff 
Rewritten patient information guide 
Streamlined preadmission process 
Day of surgery admission for all patients 
Standardized anesthetic and analgesia guidelines 
Intraoperative local anesthetic infi ltration 
Perioperative blood management algorithm 
Day of surgery mobilization 
Development of nurse- and physiotherapy-led discharge criteria 
 Note . ERAS  = enhanced recovery after surgery; GP  = general practitioner. 
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 The study was approved by the University of Otago 
Human Ethics committee (Health). Statistical analysis 
was performed using Stata v13 (College station, TX). 
Two-tailed  t tests were used for continuous variables 
and chi-square tests for categorical data. 
 Results 
 There were 507 patients who underwent primary elec-
tive hip and knee replacements in the historical control 
group and 528 in the ERAS group. The groups were well 
matched with respect to age, gender, and ASA grade (see 
 Table 3 ). The mean age for patients who underwent hip 
replacement was 68 years and for patients who under-
went knee replacement was 70 years. In both groups, 
30% of patients were ASA Grades III and IV, indicating 
the presence of severe systemic comorbidities. In the 
ERAS group, the median BMI was 31.7 kg/m 2 and the 
mean preoperative OHS was 11.1 ( SD  = 4.9) and OKS 
was 11.1 ( SD  = 4.0). These data were not available for 
the historical cohort but are likely to be very similar. 
 The day of surgery admission rate increased from 
96% in the control group to 99% in the ERAS group. 
The average ALOS for elective THR fell signifi cantly by 
1.3 days and by 0.9 days for TKR, with the main drop 
occurring almost immediately following the introduc-
tion of the new protocols, especially for THR (see 
 Figure 1 ). There was a shift to discharges later in the day 
during the course of the study. If patients were able to be 
discharged in the afternoon or evening after their physi-
otherapy, they did not have to wait for a medical ward 
round the following day. Patients who were mobilized 
on the day of surgery had an ALOS 1 day shorter than 
those who did not. Twenty-one patients (4%) were dis-
charged to a rehabilitation ward or rural hospital bed. 
The mean age of these patients was 76 years, and 17 
(81%) were patients who underwent hip replacement. 
 Following the introduction of the perioperative ane-
mia management pathway, the transfusion rate dropped 
from 26% to 17% for patients who underwent hip 
replacement ( p  = .18) and was unchanged for patients 
who underwent knee replacement at 9%. There was a 
40% reduction in the number of units of blood trans-
fused per patient. The median length of stay (LOS) for 
patients with preoperative anemia was 5 days compared 
with 4 days for nonanemic patients. 
 Two in-hospital deaths occurred in ASA Grade III pa-
tients. A 78-year-old died of aspiration pneumonia after 
prolonged hypotension following a hip replacement. An 
80-year-old developed cardiogenic shock following knee
 T ABLE 3.  C OMPARISON OF D EMOGRAPHIC D ETAILS AND O UTCOMES OF THE T WO G ROUPS P RE -  AND P OSTIMPLEMENTATION OF 
ERAS C HANGES 
2011–2012 Pre-ERAS 2013–2014 Post-ERAS  p 
Hip 314 318
Male:Female 146 (46%):168 (54%) 146 (46%):172 (54%) .88 
Age (years), mean ( SD ) 66.8 (11.8) 68.3 (11.8) .10 
ASA Grades III and IV 93 (30%) 104 (33%) .40 
Mean LOS ( SD ) 5.6 (2.1) 4.3 (1.9)  < .00001 
Median (IQR) 5 (4–6) 4 (3–5) 
Mean preop Oxford score ( SD ) Not available 11.1 (4.9) 
Mean 6-month Oxford score ( SD ) 36.6 (8.7) 38.8 (7.8) .152 
Revisions 3 (0.96%) 4 (1.26%) .7 
Knee 193 210
Male:Female 83 (43%):110 (57%) 107 (51%):103 (49%) .11 
Age (years), mean ( SD ) 69.8 (9.0) 70.4 (8.9) .54 
ASA Grades III and IV 58 (30%) 67 (32%) .52 
Mean LOS ( SD ) 5.7 (1.8) 4.8 (1.8)  < .00001 
Median (IQR) 5 (5–6) 4 (4–5) 
Mean preop Oxford score Not available 11.1 (4.0) 
Mean 6-month Oxford score ( SD ) 36.3 (7.4) 39.8 (6.6)  .03 
Revisions 2 (1.04%) 0 (0%) .139 
Hips and knee combined 507 528 
Deaths 30 days 1 (0.2%) 3 (0.57%) .336 
Deaths 90 days 2 (0.4%) 4 (0.76%) .442 
 Readmissions  < 30 days 16 (3.2%) 29 (5.5%) .065 
 Note . ASA  = American Society of Anesthesiologists; ERAS  = enhanced recovery after surgery; IQR  = interquartile range; LOS  = length 
of stay; OHS  = Oxford hip score (0–48); OKS  = Oxford knee score (0–48). The chi-square test used for categorical data; the  t test for 
continuous variables. Boldface indicates statistical signifi cance. 
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replacement and died despite acute coronary artery by-
pass grafting. Two patients (aged 86 and 79 years, ASA 
Grade IV with multiple comorbidities) died following dis-
charge to residential care at 30 and 50 days, respectively. 
The 30-day and 90-day death rates were not signifi cantly 
different from those of the historical cohort (see  Table 3 ). 
 There were fi ve confi rmed SSIs out of 528 hip and 
knee replacements (0.9%). Four patients (0.75%) re-
quired a return to the operating theater: two patients 
who underwent knee replacement for superfi cial infec-
tion and wound breakdown, and one patient for a he-
matoma following hip replacement. A 78-year-old man 
required revision of an uncemented hip at 4 days due to 
an early dislocation because of loose undersized compo-
nents. Three other patients who underwent hip replace-
ment  had revision at 28, 133, and 455 days for disloca-
tion, giving a hip revision rate of 1.3%. No patients who 
underwent knee replacement had revision. The revision 
rates were not signifi cantly different from those seen in 
the historical cohort. 
 There was an increase in the 30-day readmission rate 
from 3.2% (16 of 507) to 5.5% (29 of 528) (ns,  p  = .065). 
In the ERAS group, the commonest reasons for read-
mission were for wound problems and suspected infec-
tion ( n  = 9), pain issues ( n  = 7), and concerns regarding 
leg swelling and deep vein thrombosis ( n  = 4). Only four 
patients from the historical group were readmitted for 
these reasons. 
 Regular qualitative patient surveys were performed, 
with high satisfaction reported. The 6-month Oxford 
scores were higher in the ERAS group by 3.5 points for 
patients who underwent knee replacement ( p  = .03) and 
2.2 points for patients who underwent hip replacement 
(ns,  p  = .152) (see  Table 2 ). 
 Compared with the historical group, there was a sav-
ing of 601 bed nights over the 18-month study period or 
400 bed nights per year. This represents a theoretical 
bed night reduction of 20%. However, in practice, this 
opened up the beds for additional patients with an 
increase in elective admissions of 10.7% and 6% for 
acute admissions, resulting in no signifi cant change in 
the total number of orthopaedic bed nights. The in-
crease in readmissions led to an extra 97 nights (163 
nights vs. 68 nights in the control cohort). 
 Discussion 
 There has been a trend toward shorter LOS following 
hip and knee replacements over the last two decades. 
Day of surgery admission has become the norm in our 
unit, and only in exceptional circumstances are patients 
not admitted on the day of surgery regardless of their 
place of residence, age, or family supports. 
 Enhanced recovery initiatives have been shown 
across the world to improve patient outcomes and can 
reduce the LOS to 2–4 days for patients undergoing hip 
and knee replacements even in unselected cohort stud-
ies ( Kehlet, 2013 ). In practice, many hospitals have 
longer stays than this and may discharge patients to re-
habilitation facilities rather than home. However, in the 
United Kingdom, it appears that hospital stays of 
around 5 days are achievable with the widespread im-
plementation of ERPs in public hospitals and not just in 
dedicated specialist units ( Kehlet, 2013 ). 
 This study reports on a consecutive unselected group 
of the fi rst 528 primary hip and knee replacements per-
formed in our public hospital following the implementa-
tion of the ERAS program. No patients were excluded. 
The mean age of 68 years for patients undergoing hip 
replacement and 70 years for patients undergoing knee 
replacement was typical for public hospital patients 
( Dakin, Gray, Fitzpatrick, MacLennan, & Murray, 2012 ; 
 Jenkins et al., 2013 ;  Malviya et al., 2011 ;  McDonald et al., 
2012 ; Wainwright & Middleton, 2010). The BMI (31.7 
kg/m 2 ) was higher than NZ averages for hip (28.7 kg/m 2 ) 
and knee (31.1 kg/m 2 ) (NZ Joint Registry, 2015). The 
proportion of patients with ASA Grades III and IV 
(32.7%) was higher than that reported by  Wainwright 
 F IGURE 1.  Graph showing length of stay by month for primary elective THR and TKR before and after implementation of the ERAS 
program. ERAS  = enhanced recovery after surgery; THR  = total hip replacement; TKR  = total knee replacement. 
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and Middleton (2010 ; 8.5%) and the NZ Joint Registry 
(2015; 23%–25%). In our district, we have a population 
that is older than the national average and has had prob-
lems with access to hip and knee replacements ( Gwynne 
Jones, 2013 ;  Gwynne Jones & Iosua, 2016 ). Many pa-
tients undergoing surgery had been waiting for 
12–18 months due to fi nancial constraints. Most patients 
had severe disease and were signifi cantly deconditioned. 
This is refl ected in the average preoperative Oxford score 
of 11 points for both hip and knee replacements com-
pared with average preoperative Oxford scores of 
18–20 points reported by others ( Dakin et al., 2012 ; 
 Jenkins et al., 2013 ;  McDonald et al., 2012 ). Despite this, 
we were able to show signifi cant changes in our LOS, 
with only a small increase in readmission rates. Our me-
dian LOS dropped from 5 to 4 days for patients who un-
derwent knee or hip replacements, and the reduction in 
mean LOS is comparable with other published results 
from the United Kingdom ( Kotze, Carter, & Scally, 2012 ; 
 Malviya et al., 2011 ;  McDonald et al., 2012 ;  Robinson, 
Wagstaff, Sanghera, & Kerry, 2014 ; Wainwright & 
Middleton, 2010). Units in the United States have re-
ported decreases in LOS of 3.4–3.5 days with similar 
strategies including preoperative education classes and 
pain management ( Kearney et al., 2011 ;  Parisien, 
Valentine, Hoffman, & Penzero, 2012 ). However, LOS 
fi gures can be misleading if some patients are discharged 
to step-down facilities. Large studies from the United 
States have shown that, despite a mean LOS of 3.9–4.2 
days, 34%–48% of patients are discharged to rehabilita-
tion or skilled nursing facilities ( Schairer, Vail, & Bozic, 
2014 ;  Zmistowski et al., 2013 ). Our fi gure of 96% dis-
charged home is very similar to that of the Bournemouth 
group in England (Wainwright & Middleton, 2010). 
 It has been shown previously that transfusion is asso-
ciated with longer hospital stays and readmission rates 
( Ibrahim et al., 2013 ;  Kotze et al., 2012 ) and preoperative 
hemoglobin level predicts ALOS independent of transfu-
sion ( Kotze et al., 2012 ). In our initial audit, we noted 
that preoperative anemia was associated with an increase 
in median LOS of 1.5 days. The increase in median LOS 
is now 1 day. Our transfusion rate remains higher than 
that of other studies ( Irwin et al., 2013 ;  Kotze et al., 2012 ; 
 Malviya et al., 2011 ;  McDonald et al., 2012 ). If this can be 
further reduced, there are potential benefi ts both in 
terms of LOS and in the costs of blood transfusion. 
 The complication rate has not increased signifi cantly. 
Our SSI rate of 0.9% is similar to the NZ average of 1.2% 
( Morris, 2014 ) and at this stage no deep infections have 
been identifi ed. The return-to-theater rate of 0.75% 
compares favorably with reported rates of 1.3%–1.8% 
( Irwin et al., 2013 ;  Malviya et al., 2011 ). The 30-day read-
mission rate increased from 3.2% to 5.5%, but this is still 
similar to the 28-day readmission rates of 3.1%–8.5% 
reported by others ( Irwin et al., 2013 ;  Malviya et al., 
2011 ;  Schairer et al., 2014 ; Wainwright & Middleton, 
2010;  Zmistowski et al., 2013 ). It is concerning that the 
number of readmissions directly related to the ortho-
paedic procedure such as wound problems, pain, and 
swelling has increased. It is not clear whether this is re-
lated to the age and comorbidities of the patients or 
early discharge. 
 The 30-day and 90-day death rates of 0.57% and 
0.76% are a little higher than those reported in other 
contemporary series ( Cusick & Beverland, 2009 ;  Hunt 
et al., 2013 ;  Malviya et al., 2011 ;  Sharrock, Della Valle, 
Go, Lyman, & Salvati, 2008 ). This may refl ect the high 
proportion of patients who were ASA Grades III and IV. 
 Malviya et al. (2011) reported a reduction in mortality 
rates, with ERPs from 0.5% to 0.1% in an unselected 
group of patients of a similar age, but did not report 
ASA grade. Data from the U.K. registry have shown a 
reduction in 90-day mortality from 0.56% to 0.29% over 
the 8 years from 2003 to 2011 ( Hunt et al., 2013 ). 
 Like others, we found patient satisfaction was high 
( Jones et al., 2014 ;  Kearney et al., 2011 ;  Parisien et al., 
2012 ). The education classes were particularly well re-
ceived. The 6-month postoperative OKSs of 39.8 in the 
ERAS group were 3.5 points higher than those of the 
historical group and higher than the NZ average of 37.4 
(NZ Joint Registry, 2015). The minimum clinically im-
portant difference in Oxford score has been reported as 
5 points but may be as little as 2 points ( Beard et al., 
2013 ;  Murray et al., 2007 ). Therefore, patients in the 
ERAS had at least equivalent outcomes at 6 months to 
the historical cohort. The early revision rate (1.3% at 
minimum 18-month follow-up) for patients who under-
went hip replacement is comparable with the NZ Joint 
Registry rate of 1.1% at 1 year and 1.6% at 2 years (NZ 
Joint Registry, 2015). 
 A strength of this study is that it reports on a con-
secutive group of patients presenting to a general public 
hospital with signifi cant comorbidities and severe 
symptoms. There were multiple surgeons and anesthe-
tists of varying grade involved in the surgery, and a vari-
ety of implants were used. This suggests that the inter-
ventions are generalizable and similar results can be 
achieved in other institutions. 
 A limitation of our study is the use of a historical con-
trol group, although the patients were well matched. 
During the development of our protocols, we noted a 
small drop in ALOS. In the fi rst 6 months of the histori-
cal cohort period, the ALOS was 5.8 days for patients 
who underwent hip replacement and 6.1 days for pa-
tients who underwent knee replacement. The ALOS had 
fallen to 5.4 days for patients who underwent hip re-
placement and 5.5 days for patients who underwent 
knee replacement by the date we formally  went live. The 
dramatic drop after this date is particularly evident for 
patients who underwent hip replacement and strongly 
suggests that the gains were due to the new program. If 
we took the fi rst 6-month period of the control group as 
our baseline, then the potential benefi ts would increase 
to 500 bed nights per year. This is in part offset by the 
increased bed nights due to readmissions. 
 Some of the improvements were small and may not, 
on their own, have been shown to have a statistically 
signifi cant effect. However, a key component of pro-
grams such as these is the  aggregation of marginal gains 
( Durrand, Batterham, & Danjoux, 2014 ). The end result 
of all the small changes has resulted in signifi cant re-
ductions in key outcomes such as LOS. 
 For a project such as this to succeed, strong clinical 
input is needed. It proved critical to engage and enthuse 
the senior nursing and allied health staff on the ward. 
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Most of the changes instituted were nurse or physio-
therapist led. The change in attitudes of surgeons and 
the junior medical staff followed. Many of the changes 
can be implemented without any increase in budget. A 
key failing of the project was that there were no 
mechanisms to return any of the gains to the depart-
ment for the benefit of orthopaedic patients. 
Sustainability has been a challenge. Increasing fi nancial 
pressures, the loss of key staff, medical outliers on the 
orthopaedic ward, and nursing shortages are constant 
threats to the continuing success of the program. 
 Conclusion 
 Enhanced recovery programs for patients undergoing 
hip and knee replacements can signifi cantly reduce the 
LOS without relying on step-down or rehabilitation fa-
cilities. They are effective for an unselected public hos-
pital population with severe osteoarthritis and signifi -
cant comorbidities and have good outcomes, high 
patient satisfaction, and no increase in complications. 
Strong nursing, physiotherapy, and clinical leadership 
and a multidisciplinary approach are required. 
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Summary
Cardiopulmonary exercise testing is performed increasingly for cardiorespiratory fitness assessment and pre-
operative risk stratification. Lower limb osteoarthritis is a common comorbidity in surgical patients, meaning
traditional cycle ergometry-based cardiopulmonary exercise testing is difficult. The purpose of this study was to
compare cardiopulmonary exercise testing variables and subjective responses in four different exercise
modalities. In this crossover study, 15 patients with osteoarthritis scheduled for total hip or knee arthroplasty
(mean (SD) age 68 (7) years; bodymass index 31.4 (4.1) kg.m-2) completed cardiopulmonary exercise testing on
a treadmill, elliptical cross-trainer, cycle and arm ergometer. Mean (SD) peak oxygen consumption was 20-30%
greater on the lower limb modalities (treadmill 21.5 (4.6) (p < 0.001); elliptical cross-trainer (21.2 (4.1)
(p < 0.001); and cycle ergometer (19.4 (4.2)ml.min1.kg1 (p = 0.001), respectively) than on the armergometer
(15.7 (3.7) ml.min-1.kg-1). Anaerobic threshold was 25-50% greater on the lower limb modalities (treadmill 13.5
(3.1) (p < 0.001); elliptical cross-trainer 14.6 (3.0) (p < 0.001); and cycle ergometer 10.7 (2.9) (p = 0.003))
compared with the arm ergometer (8.4 (1.7) ml.min1.kg1). The median (95%CI) difference between pre-
exercise and peak-exercise pain scores was greater for tests on the treadmill (2.0 (0.0-5.0) (p = 0.001); elliptical
cross-trainer (3.0 (2.0-4.0) (p = 0.001); and cycle ergometer (3.0 (1.0-5.0) (p = 0.001)), compared with the arm
ergometer (0.0 (0.0-1.0) (p = 0.406)). Despite greater peak exercise pain, cardiopulmonary exercise testing
modalities utilising the lower limbs affected by osteoarthritis elicited higher peak oxygen consumption and
anaerobic threshold values comparedwith armergometry.
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Cardiopulmonary exercise testing (CPET) is considered the
gold standard tool for evaluating cardiorespiratory fitness
[1], and exercise capacity is a well-established predictor of
cardiovascular and all-cause mortality [2]. Low peak oxygen
consumption ( _VO2) and/or anaerobic threshold values can
make performing activities of daily living difficult and in the
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surgical setting are associated with an increased risk of
adverse outcomes following a range of surgical procedures
[3, 4]. Cardiopulmonary exercise testing is used as an
objective pre-operative risk assessment tool by identifying
patients who may be more vulnerable to the stress of
surgery and thereby may benefit from more intensive peri-
operative care [1, 3].
Patients presenting for major surgical procedures,
where CPET is particularly prognostically useful, often have
other comorbidities, some of which can limit their ability to
perform traditional cycle CPET. Lower limb osteoarthritis is a
condition prevalent in older adults that can significantly
impair lower limb exercise; only 60% of participants with
lower limb osteoarthritis were able to use a cycle ergometer
for exercise testing in a feasibility study [5]. Because of lower
limb impediments, arm ergometry is often used as a
substitute; however, peak _VO2 values are approximately 30%
lower than those obtained during cycle ergometry in healthy
individuals and those with coronary and peripheral artery
disease [6–9]. Comparative arm ergometry data do not exist
in the literature in patients with hip and knee osteoarthritis,
although it is feasible that arm ergometry in this cohort could
enable achievement of higher CPET values by utilising the
unaffected upper limbs. Furthermore, the elliptical cross-
trainer has been shown to evoke similar peak _VO2 values to
treadmill testing in healthy individuals [10]. It is unknown how
suitable this modality is for CPET in any clinical cohort,
particularly patients with osteoarthritis. Lastly, the treadmill is
an exercise modality readily available in hospital settings,
preferred by cardiologists due to its ability to achieve higher
work-loads (and thus higher cardiorespiratory response),
compared with cycle ergometry [11]; its practicality in an
osteoarthritis cohort is unknown. Therefore, these alternative
modalities warrant testing in this population.
The prevalence of osteoarthritis is predicted to increase
due to an ageing population and increased prevalence of
obesity [12]; these population factors are also likely to result
in more complex or high-risk surgical procedures. Risk
stratification via CPET will become more common and may
be critical in operative decision-making. It is therefore
essential to know the optimal exercise modality for
performing CPET in patients with lower limb osteoarthritis,
particularly if traditionally used cycle ergometry is not
representative or practical. The primary aim of this studywas
to compare peak _VO2 values derived from CPET using
treadmill, ellipitical cross-trainer, cycle, and arm ergometer
modalities in patients scheduled for total hip or knee
arthroplasty. Secondary aims were to compare other CPET-
derived and physiological variables and subjective
responses across the four CPETmodalities.
Methods
This study was a crossover design. Ethical approval for the
study was obtained and the trial was registered. Informed
consent was obtained and all procedures conformed to the
standards set by theDeclaration of Helsinki.
Patients with end-stage hip or knee osteoarthritis who
were scheduled for hip or knee arthroplasty at a regional
public hospital were eligible for inclusion. Patients with any
contraindication to non-physician supervised maximal
exercise testing were not studied. Contraindications
included: moderate to severe aortic and/or mitral stenosis;
hypertrophic cardiomyopathy; history of malignant or
exertional arrythmias and/or syncope; intracardiac shunt;
genetic channelopathies; New York Heart Association class-
3 heart failure; severe left ventricular dysfunction and/or
severe pulmonary arterial hypertension [13, 14];
cardiovascular event within 3 months (e.g. angina,
myocardial infarction); implantable cardioverter defibrillator
and/or pacemaker; pathology limiting upper-limb exercise
(e.g. shoulder joint osteoarthritis); and any other medical
condition deemed a significant risk to study participation.
The primary outcome measure was peak _VO2. This was
assessed by CPET utilising incremental step protocols that
had been used previously in patients with severe
osteoarthritis; it was not possible to perform ramp protocols
using the treadmill or cross-trainer, thus step protocols were
employed for all modalities. Expired gas analysis was
performed using an online gas analysis system (Quark
CPET; COSMED, Rome, Italy). Before each test, calibration
of gas and flow was conducted according to manufacturer
and published guidelines [1]. Height and body mass were
recorded before each test. All participants completed their
initial CPET on a stationary, electromagnetically braked
cycle ergometer (COSMED E200; COSMED); this ensured a
clean and reliable ECG trace could be obtained, which was
screened retrospectively by an experienced cardiologist for
undiagnosed cardiovascular disease. Immediately
following a 5-min warm-up, intensity was increased in steps
of 10–20 watts (at the researcher’s discretion) every minute
until test termination, aiming for an exercise duration of 8–
12 min [15]. Participants were asked to maintain a cadence
between 60 and 80 rev.min1.
Following the cycle CPET, the order of exercise
modality was allocated at random using a 3x3 Latin square
design for the remaining three tests. Treadmill testing was
performed using a motorised treadmill (Activate Series
Treadmill (OST); Life Fitness, Rosemont, IL, USA). A
comfortable but brisk walking speed was determined
during the 5-min warm up and this speed was maintained
for the duration of the test. Treadmill inclination was
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increased every minute by 1%. A commercially available
ergometer (Activate Series Cross-Trainer (OSX); Life Fitness)
was used for cross-trainer testing. Immediately following a
5-min warm-up, the intensity increased by 10-25 watts every
minute [10]. Arm ergometry was performed seated on an
electromagnetically-braked ergometer (COSMED E400,
COSMED). Participants completed a 3-min warm-up of arm
pedalling at 10 watts, after which exercise intensity
increased by 10 watts every 2 min; the warm-up was shorter
and intensity increased every 2 min as upper-limb exercise
uses smaller and less oxidative musculature and the extra
warm-up duration and/or more frequent increments may
cause premature volitional fatigue [16]. Participants were
requested to maintain a crank rate of between 70 and 80
rev.min-1 [17].
Expired gases and 12-lead ECG were monitored
continuously throughout all testing. Heart rate, blood
pressure and subjective measures were recorded during
exercise at regular intervals and at test termination [14]. The
test was terminated when the participant asked to stop, was
unable tomaintain the required cadence or at the discretion
of the supervising researcher if any termination criteria were
present [13]. Following test termination, exercise intensity
was lowered to facilitate a very light active recovery.
For each exercise modality, a visual analogue scale (VAS)
was used to measure pain before exercise and at peak
exercise [18]. A custom-designed questionnaire using a five-
point Likert scale (1 = strongly disagree and 5 = strongly
agree) was used to assess subjective responses to and
following each exercise modality. This was assesed by a
telephone call 24 h after the test. Questions included the
following: this test was an enjoyable experience; I would
perform the same test again; I feel more confident to exercise
after this test; I feel like I was able to give a maximal effort;
and this test impactedmy normal daily activities 24 h later.
All tests were conducted at similar times of the day for
each participant. Participants were asked to abstain from
cigarette smoking 4 h before, alcohol and caffeinated
beverages 12 h before and moderate- or high-intensity
physical activity for at least 24 h before each CPET.
Participants were reminded to continue taking their normal
medications. All tests were overseen by the same
experienced researchers and conducted in a climate-
controlled room to maintain an appropriate ambient
temperature (20–22°C) and humidity (< 60%). Tests were
conducted at least 4 days apart, to ensure adequate
washout from the previous test.
Before formal analysis, breath-by-breath data were
exported via the software package (Quark CPET v1.6.7;
COSMED) as a 20-s time average, to reduce the influence of
physiological noise [1]. All CPET data analysis was
performed independently by two researchers using Excel
(Microsoft Corporation, Redmond, WA, USA), who were
blinded to exercise modality. Peak CPET values were
determined as the maximum 20-s average value for each
variable during exercise [1]. Predicted maximal _VO2 for
cycle ergometry was estimated using an
equation developed by Jones et al. [19]. Anaerobic
threshold was determined using the V-slope method [20],
and confirmed using plots of ventilatory equivalents for
carbon dioxide ( _VE= _VCO2) and oxygen, and end-tidal
carbon dioxide and end-tidal oxygen, as functions of _VO2
[1]. The oxygen uptake efficiency slope was defined as the
_VO2 for a given ventilation (slope derived from _VO2 (y-axis)
and the log transformation of minute ventilation (x-axis))
[21]. Predictedmaximum heart rate was estimated using the
equation published by Tanaka et al. [22]. Where a
participant was prescribed a beta-adrenergic blocking
agent, an equation in patients with coronary artery disease
was used to estimate predictedmaximumheart rate [23]; no
predictive equations for healthy older adults or individuals
with osteoarthritis are available. Prism (v8.0; GraphPad
Software, CA, USA) was used for all statistical analysis. A
minimum clinical important difference of 2.0 ml.min1.kg1
was selected based on improved clinical outcomes in
prehabilitation studies [24] and its use as aminimal clinically
important difference for anaerobic threshold [25]. A sample
size of 12 was calculated (nQuerry v 8.5.1.0; Statistical
Solutions Ltd., Cork, Ireland) to provide a study power of
85% for detecting a difference of 2.0 ml.min1.kg1
between any two tests, assuming that the standard
deviation of differences was 4.0 ml.min1.kg1 (based on
pilot data) at the 5% significance level. Fifteen participants
were recruited to allow for attrition due to the unknown
tolerance of the novel exercisemodalities in this population.
A repeated-measures analysis of variance was used to
compare differences in variables across the four exercise
modalities and repeated-measures two-way analysis of
variance to compare differences in peak _VO2 by
arthroplasty site. Normality and homogeneity of variances
were assessed using the D’Agostino-Pearson and Levene’s
tests. When the assumption of sphericity was violated,
Greenhouse-Geisser’s adjustment was used. Posthoc
testing was performed to compare groups if p values
were < 0.05, using Tukey’s test to adjust for multiple
comparisons. Ordinal data were analysed using the
Friedman Test, with Wilcoxon signed rank tests to isolate
differences. Differences in within-modality pre-exercise and
peak exercise pain scores were compared using aWilcoxon
matched-pairs signed rank test. Inter-rater reliability for
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anaerobic threshold was assessed from interclass
correlation coefficient, calculated using a two-way mixed
model for absolute agreement.
Results
Between January 2019 and July 2019, 18 patients
scheduled for total hip or knee arthroplasty were screened
prospectively (Fig. 1); 15 patients were included in the
analysis and their characteristics are presented in Table 1.
No changes in medication type or dosage were reported
during the experimental period. No tests were terminated
prematurely and symptom-limited maximum values were
achieved for all tests. There were no adverse events related
to testing.
Peak _VO2 was higher on treadmill (mean difference
(95%CI) 5.8 ml.min1.kg1 (3.4–8.1); p < 0.001), cross-
trainer (mean difference (95%CI) 5.5 ml.min1.kg1 (3.9–
7.1); p < 0.001) and cycle ergometer (mean difference (95%
CI) 3.7 ml.min1.kg1 (1.8–5.6); p = 0.001) modalities,
compared with the arm ergometer (Table 2 and Fig. 2).
Eight participants recorded their highest peak _VO2 value on
the treadmill, six on the cross-trainer and one on the cycle
ergometer. No difference was apparent in peak _VO2 across
modalities between scheduled total hip and knee
arthroplasty participants (p = 0.737), although the study
was not adequately powered for this sub-group analysis.
Peak heart rate was higher on the cross-trainer
compared with arm ergometry (mean difference (95%CI) 13
beats.min-1 (6-21); p = 0.005), but not other modalities
(Table 2). Mean (SD) peak heart rates as a percentage of
predicted maximum heart rate were 90% (16) for treadmill,
96% (11) for cross-trainer, 92% (11) for cycle and 87% (11)
for arm ergometer. Peak respiratory exchange ratio was
lower during treadmill testing, compared with cross-trainer
(mean difference (95%CI)0.08 (0.15 to0.01); p = 0.034)
and cycle (0.09 (0.15 to 0.03); p = 0.003) modalities.
Respiratory exchange ratio exceeded 1.10 in one test on the
treadmill, four on the cross-trainer, six for the cycle and
three for the armergometer.
Anaerobic threshold was exceeded on all CPETs, and a
very high level of agreement for anaerobic threshold
determination was evident between the two blinded
researchers (intra-class correlation coefficient (95%CI) 0.93
(0.88-0.96)). Anaerobic threshold was up to 50% higher on
the treadmill (mean difference (95%CI) 5.1 ml.min1.kg1
(3.3–6.9); p < 0.001), cross-trainer (6.2 ml.min1.kg1 (4.8–
7.6); p < 0.001) and cycle ergometer (2.3 ml.min1.kg1
(0.8–3.8); p = 0.003), compared with the arm ergometer
(Table 2 and Fig. 3). The _VE= _VCO2 at anaerobic threshold
was higher during arm ergometry, compared with the
treadmill, cross-trainer and cycle ergometer (Table 2). The
oxygen uptake efficiency slope was higher on the treadmill,
cross-trainer and cycle ergometer compared with the arm
ergometer (Table 2).
Peak exercise pain scores increased from pre-exercise
levels for treadmill (median difference (95%CI) 2.0 (0.0–5.0);
p = 0.001), cross-trainer (3.0 (2.0–4.0); p = 0.001) and cycle
ergometry (3.0 (1.0–5.0); p = 0.001), but not arm ergometry
(0.0 (0.0–1.0); p = 0.406). Median differences in pre- and
peak-exercise pain VAS scores were greater for treadmill
(rank sum 42.0 vs. 19.5; p = 0.009), cross-trainer (43.5 vs.
19.5; p = 0.004) and cycle ergometry (45.0 vs. 19.5;
p = 0.002), compared with arm ergometry. Participants’
perceived ability to give a maximal effort was not
significantly different across modalities (Fig. 4; p = 0.072).
The cross-trainer was more likely to impact normal daily
activities in the 24 h following testing, compared with arm
ergometry (Fig. 4; p = 0.043); however, participants agreed
that they would perform the same test again (median (IQR
[range]) score 4.0 (2.0-4.0 [1.0–5.0])).
Discussion
This is the first study, to our knowledge, to directly compare
CPET variables and subjective responses across four
different exercise modalities in patients with severe lower
limb osteoarthritis. It is also the first study to describe the
physiological and subjective responses of using a cross-
trainer for CPET in a clinical population. The main finding
was that peak _VO2 was higher on modalities utilising the
osteoarthritis-affected lower limbs (treadmill, cross-trainer
and cycle), compared with arm ergometry, which used the
upper body only. Specifically, peak _VO2 values were
approximately 20–30% lower with arm ergometry
compared with the other three modalities, despite it being
the only modality that did not increase peak-exercise pain
scores from pre-exercise levels. Anaerobic threshold,
another prognostic CPET variable, was approximately 25-
50% lower on the arm ergometer compared with the other
three modalities. These findings indicate that, despite the
presence of severe lower limb osteoarthritis, CPET
modalities utilising these joints may provide more
representative peak _VO2 and anaerobic threshold values
than armergometry.
Peak _VO2 using arm ergometry is approximately 65-
80% of the leg exercise value in healthy individuals [6] and
patients with coronary artery disease [7, 8]. The results in this
study are similar: the three lower limb modalities elicited
higher peak _VO2 values than arm ergometry despite the
lower limb musculoskeletal impediments of patients
suffering severe osteoarthritis. Whereas no prior
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comparative data in lower limb osteoarthritis patients have
been published, patients with peripheral arterial disease,
another cohort characterised by lower limb dysfunction and
reduced exercise tolerance, have 25% lower peak _VO2 and
18% lower anaerobic threshold values during CPET using
arm ergometry compared with cycling [9]. One explanation
for the consistent discrepancy in peak _VO2 between
modalities is the greater volume of active skeletal muscle
Figure 1 Study flowdiagram. CPET, cardiopulmonary exercise test.
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during leg exercise, compared with arm exercise [16, 26].
Other peripheral factors such as a greater proportion and/
or earlier recruitment of type-2 muscle fibres [27], which are
more susceptible to fatigue, are also likely to contribute to
the lower peak _VO2 and anaerobic threshold values.
Arm ergometry has been shown previously to have
clinical utility for the detection of myocardial ischaemia
when conventional leg exercise was not feasible [16].
However, for determining anaerobic threshold for pre-
operative risk stratification, results from this study show that
arm ergometry underestimates anaerobic threshold, from
which risk thresholds are often derived, by approximately
25% compared with the cycle ergometer, In a study utilising
CPET data to inform postoperative care, Older et al. [28]
used an anaerobic threshold < 11 ml.min1.kg1 to assign
patients to the intensive care or high dependency unit as
opposed to the general ward. The authors reported
excellent predictive power and this threshold has been
adopted widely in clinical practice. In the current study,
14 participants had an anaerobic threshold <
11 ml.min1.kg1 during arm ergometry CPET. Conversely,
testing on a treadmill and cross-trainer yielded anaerobic
threshold below the prognostic risk threshold for only two
participants. If arm ergometry is to be used as a pre-
operative CPET risk stratification tool then ergometer-
specific thresholds must be established to avoid
underestimation of peak _VO2 and anaerobic threshold
which has the potential for additional and possibly
unnecessary occupancy in higher care units.
The oxygen uptake efficiency slope and _VE= _VCO2 at
anaerobic threshold are indices of ventilatory efficiency
derived from CPET and do not require maximal effort; this
makes them attractive for those unable to obtain maximal
cardiopulmonary stress [29]. This study showed that the
oxygen uptake efficiency slope differs by exercise modality,
with treadmill oxygen uptake efficiency slope
approximately 40% higher than with arm ergometry. The
oxygen uptake efficiency slope and peak _VO2 are well
correlated, which may explain the higher oxygen uptake
efficiency slope for treadmill and cross-trainer compared
with cycle and arm ergometry [30]. Similar to the findings of
Orr et al. [6], we found that the _VE= _VCO2 at anaerobic
threshold was up to 11% higher on the arm ergometer
compared with the other three modalities. Given that the
_VE= _VCO2 is used in clinical peri-operative risk stratification,
and the oxygen uptake efficiency slope has the potential to
be used, clinicians and future research should consider the
effect that exercise modality may have on these variables
when interpreting results.
The respiratory exchange ratio, an imperfect measure
of effort during CPET, was lowest during treadmill testing
despite eliciting the highest peak _VO2. This lower
respiratory exchange ratio should not be assumed to reflect
Table 1 Characteristics of participants (n = 15) who
completed all four cardiopulmonary exercise tests. Values
aremean (SD) or number.
Age; y 68 (7)
Sex; female 10
Height; cm 168 (8)
Bodymass; kg 88.6 (12.9)
BMI; kg.m2 31.4 (4.1)
Systolic bloodpressure;mmHg 125 (12)
Diastolic bloodpressure;mmHg 77 (8)




















Chronic kidney disease 1










Current or quit < 1 year 1
Electronic cigarette 1
_VO2, oxygen consumption; ASA, American Society of
Anaesthesiologists; ACE, angiotensin-converting-enzyme;
NSAID, non-steroidal anti-inflammatory drug.
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lack of exertion; previous studies in healthy individuals [31,
32] and patients with peripheral arterial disease [33] have
shown similar findings in part due to greater fat oxidation for
a given exercise intensity. Peak heart rate is another
measure used frequently to determine exercise effort; peak
heart rate during treadmill CPET was 90% of predicted
maximum substantiating that effort wasmaximal. Consistent
with previous literature, the lowest peak heart rate was
observed during arm ergometry compared with the other
modalities [5,6]. This is likely due to the earlier peripheral
muscle fatigue associatedwith armergometry [16].
The cross-trainer provided consistent and reliable
readings across monitored variables. Peak-exercise pain
scores and ability to give a maximal effort were not different
on the cross-trainer compared with the other lower limb
modalities. Additionally, unlike the treadmill, the cross-
trainer allows accurate quantification of work rate, making it
a viable CPETmodality in patients with severe osteoarthritis.
Figure 2 Peak oxygen consumption ( _VO2) by cardiopulmonary exercise test (CPET)modality. Results from individual
participants (each symbol represents an individual participant’s peak _VO2 across the fourmodalities) andmean (error bars
indicate SD) are presented for eachCPETmodality. *p < 0.05 vs. arm ergometer; ‡p < 0.05 vs. cycle). n = 15 for all.
Table 2 Physiological and subjectivemeasures for differentmodalities of cardiopulmonary exercise tests. Values aremean (SD)
or median (IQR [range]). Symbols represent statistically significant between modality post-hoc tests; *p < 0.05 vs. arm








n = 15 p value
Peak heart rate; beats.min-1 139 (20) 148 (19)* 143 (19) 135 (17) 0.009
Respiratory exhange ratio at peak exercise 0.98 (0.08) 1.06 (0.10)† 1.07 (0.05)† 1.04 (0.08) 0.004
Relative peak _VO2;ml.min
1.kg1 21.5 (4.6)* 21.2 (4.1)*‡; 19.4 (4.2)* 15.7 (3.7) <0.001
_VO2 at anaerobic threshold;ml.min
1.kg1 13.5 (3.1)* 14.6 (3.0)*‡; 10.7 (2.9)* † 8.4 (1.7) <0.001
_VE= _VCO2 at anaerobic threshold 33.8 (4.6)* 34.6 (4.3)* 34.9 (5.6)* 37.9 (4.6) 0.001
Oxygenuptake efficiency slope 2478 (632)* 2233 (699)*‡; 1907 (527)* † 1534 (485) <0.001


















_VO2, oxygen consumption; _VE= _VCO2, ventilatory equivelant for carbondioxide; VAS, visual analogue scale.
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A greater active skeletal muscle mass, due to the weight-
bearing nature and concurrent use of the upper body, is
likely to contribute to a higher peak _VO2 compared with
cycle ergometry. Its utility should be explored in other
clinical cohorts.
A limitation of the study design was that the initial CPET
served as screening for underlying cardiovascular disease,
so all initial testingwas performed on the cycle ergometer to
ensure a reliable ECG trace could be obtained. However,
only one participant achieved their highest peak _VO2 on the
cycle, suggesting no order effect. Despite typical age,
Kellgren-Lawrence grade and ASA physical status, the
present cohort may not be reflective of all patients
scheduled for total hip or knee arthroplasty due to mean
peak _VO2 values being higher than those reported
previously [5]. Therefore, future studies with larger sample
sizes are necessary to validate findings in this study, in order
to compare different populations with osteoarthritis, and
define risk thresholds and peri-operative prognostic criteria
for alternativeCPETmodalities.
In conclusion, despite the presence of lower limb
osteoarthritis and higher peak exercise pain scores, peak
_VO2 and anaerobic threshold values were higher during
CPET on modalities utilising these joints (treadmill, cross-
Figure 3 Anaerobic threshold by cardiopulmonary exercise test (CPET)modality. Results from individual participants (each
symbol represents an individual participant’s anaerobic threshold across the fourmodalities) andmean (error bars indicate SD)
are presented for eachCPETmodality. *p < 0.05 vs. armergometer; †p < 0.05 vs. treadmill; ‡;p < 0.05 vs. cycle). n = 15 for all.
Figure 4 Radar plot showing subjective acceptability questionnaire responses by cardiopulmonary exercise testmodality
(1 = strongly disagree, 5 = strongly agree). Data aremedian; *p < 0.05 cross-trainer vs. arm ergometer. n = 15 for all. Grey
dotted line - treadmill; dark grey dashed line - cross-trainer; grey dashed line - cycle; black solid line – armergometer.
© 2020Association of Anaesthetists 79
Roxburgh et al. | Cardiopulmonary exercise testing in osteoarthritis Anaesthesia 2021, 76, 72–81
221
trainer and cycle), compared with arm ergometry. Whereas
arm ergometry may have pre-operative utility for detecting
underlying cardiopulmonary limitation, peak _VO2 and
anaerobic threshold values should not be used for risk
stratification, unless modality specific thresholds are
created. Treadmill, cross-trainer and cycle modalities are
feasible and may provide more representative peak _VO2
and anaerobic threshold values, when compared with arm
ergometry. In a clinical setting, any one of these primarily
lower limbmodalities would be appropriate to use.
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RADIATION USE IN THE ORTHOPAEDIC THEATRE: 
A PROSPECTIVE AUDIT 
DAVID GWYNNE JONES AND JULIAN STODDART 
Palmerston North Hospital, Palmerston North, New Zealand 
Background: There is concern about the exposure of orthopaedic surgeons to radiation. The aim of this study was to monitor radiation 
use in theatre to improve practice and to attempt to quantify the radiation dose the orthopaedic surgeon may have received. 
Methods: A 6-month prospective audit of all procedures performed in the orthopaedic theatre that used fluoroscopy or radio- 
graphs was undertaken An anthropomorphic phantom was used to measure scatter and direct-skin doses. Screening times were recorded 
in a subsequent 6-month post at a tertiary trauma centre. 
Results: Fluoroscopy or radiographs were used in 378 procedures. Fluoroscopy was used in 260 procedures with a screening time of 
124 min at an average of 0.48 min per procedure. Lead aprons were worn in 99% of cases and thyroid guards in 32%. All dosimeter 
badges were negative. The surgeon’s hand was caught in the fluoroscopy beam in 15% of procedures. The phantom recordings ranged 
from 13 to 210 microGy for skin dose and 0.17-0.87 microGy for scatter dose. The calculated hand exposure was less than 5% of 
recommended levels. In the trauma post 210 min of screening was used potentially increasing the hand exposure to one-third of rec- 
ommended limits. If a printer was used to record the image, 58% of intra-operative radiographs would have been avoided. 
Conclusions: Hand exposure to radiation is the limiting factor in orthopaedics. The extremity limit will only be exceeded if the hands 
are regularly caught in the beam. Dose-reduction gloves should be considered for high-risk procedures. A printer can reduce the need 
for intraoperative plain radiographs. 
Key words: exposure, ionizing radiation, orthopaedics, radiological protection. 
INTRODUCTION 
The use of fluoroscopy has increased over the last 20 years 
especially in the orthopaedic trauma theatre. A key principle of the 
use of ionizing radiation is to keep the dose as low as reasonably 
achievable (ALARA).’ Since 1991, the risk estimates for low- 
dose radiation have been re-evaluated and increased six-fold. 
This has led to a reduction in dose limits to radiation workers 
from a 50 mSv/year to a 20 mSv/year whole-body dose.2 Studies 
have suggested that orthopaedic surgeons are not exposed to 
excessive levels of radiation unless 750 intramedullary roddings 
per year are performed.3 However, there may only be a four-fold 
safety factor for hand exposure.4 
The purpose of our study was to prospectively audit the use 
of radiation in the orthopaedic theatre, to attempt to assess the 
exposure of the operating surgeon to radiation and to identify 
methods to improve practice and reduce radiation usage. 
METHODS 
A 6-month prospective audit was conducted of all procedures 
performed by orthopaedic registrars or consultants which required the 
use of radiographs or the image intensifier in theatre. Our institution 
is a general hospital with a steady trauma workload. There are six 
consultants and four registrars. 
A form was completed at the time of surgery noting the surgeon, 
case details, what protection was worn, screening time, number of 
Correspondence: David Gwynne Jones, Department of Orthopaedic Surgery, 
Christchurch Hospital, Christchurch, New Zealand. 
Email: <ulla.david@clear.net.nz> 
Accepted for publication 9 June 1998. 
hard copies taken and the perceived need for those films and 
whether the surgeon’s hand was caught in the X-ray beam during 
the case, which was termed a critical incident. 
A series of measurements were then made using the Philips 
BV 25 image intensifier (Philips Medical Systems, Auckland, 
NZ), a Rando anthropomorphic phantom (The Phantom Lab 
Inc., Salem, NY, USA), a Capintec 192 dose meter and a Capintec 
PM-30 ionization chamber (Capintec Inc., Ramsey, NJ, USA). 
Measurements were taken with the dose meter positioned to sim- 
ulate the position of the surgeon’s hands during common pro- 
cedures. Skin and scatter doses were measured. The direct dose to 
the hands of each registrar was then calculated from the reported 
number of critical incidents multiplied by the skin dose rec- 
orded. The scatter dose was estimated by assuming that the 
hands were at the closest point to the beam throughout the 
recorded screening time. This gives a maximum possible scatter 
dose. Standard X-ray film badges were worn for 2 months of 
the study period both under the lead apron and on the dominant 
shoulder outside the apron. These were read by the New Zealand 
National Radiation Laboratory. 
For the next 6-month period the screening times of the first 
author (DGJ) were reviewed during a trauma registrar post at a ter- 
tiary trauma referral centre. 
RESULTS 
A total of 378 procedures required the use of X-rays: radiographs 
were taken during 118 procedures and fluoroscopy was used in 
260 procedures (Table 1). Four registrars performed 240 (92%) 
of these procedures.The orthopaedic experience of the registrars 
ranged from 1 to 4 years. Six consultants performed the remaining 
20 procedures. A total of 124 min screening was used during 
the 6-month period. The average total screening time for the 224
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Table 1. Operative procedures that use fluoroscopy 
Procedure No. Average screening time 
(min) 































Cases Screening time (mins) 
Average Total 
76 0.43 32.8 
63 0.61 38.2 
49 0.55 27.1 
52 0.33 17.3 
20 0.44 8.8 


















Direct Scatter (mSv) Total 
1.7 1 .0 2.7 
2.5 1.5 4 
0.3 1 .o 1.3 
0.6 0.4 1 .o 
< 0.1 0.3 < 0.1 
5.1 4.2 9.0 
Reg, registrar; Con, consultant. 
Table 3. Hand radiation exposure with fluoroscopy from anthropomorphic phantom recordings 
~~ 




Scatter : skin ratio (%) 
PA hip 30 cm 
Lateral hip 30 cm 
Distal locking 15 cm 
30 cm 

















registrars was 28.9 min (range 17.3-38.2 min) (Table 2). The 
average screening time for each procedure was 0.48 min. 
In 99% of fluoroscopy procedures a lead apron was worn. 
A thyroid guard was worn in 32% and lead gloves in 2% of 
fluoroscopy procedures. Lead glasses were not available. 
All the dosimeters worn inside and outside the lead aprons 
were negative during the trial period, which indicated levels 
lower than 0.15 mSv. 
Critical incidents were reported on 69 occasions and occurred 
in 39 procedures that used fluoroscopy (15%) (Table 1). These 
most commonly occurred during intramedullary rod fixation and 
K-wire fixation in the hand. Distal locking was the cause given for 
30% of critical incidents, carelessness or radiographer error for 30% 
and holding a hand or arm for 40%. The reported rate of procedures 
with critical incidents for individual registrars ranged from 5 to 
29% of procedures that used fluoroscopy (Table 2). 
Radiation recordings were made using the anthropomorphic 
phantom (Table 3). The highest skin dose recorded was for a PA 
of the hip (210 microGy). The lowest was for a forearm (12.9 
microGy). The scatter dose was highest during distal locking 
using a 15-cm trocar (0.87 microGy). Hand positions for the 
other procedures recorded scatter levels from 0.17 to 0.26 
microGy. The ratio of scatter to skin dose ranged from 0.09 to 
1.4%, which varied with the distance of the recorder from the 
beam. The estimated maximum possible absorbed dose to the 
hand for each registrar ranged from 2 mSv to 8 mSv per year. 
In 190 of the 260 procedures that used fluoroscopy (70%), 
plain films were also taken. In 182 of these 190 procedures 
(96%), the film was taken with the cassette placed on the image 
intensifier. In six cases (3%), intra-operative radiographs re- 
sulted in the procedure being revised. In 1 10 of these 190 pro- 
cedures (%%), the plain radiographs were felt to be unnecessary 
had there been a printer available to copy the on-screen images. 
More than two films were taken on 25 occasions; 11 were 
required because of technical errors. Two hundred and twenty-three 
films could have been avoided in the theatre. 
During the subsequent 6 months one of the authors (DGJ) per- 
formed 138 procedures using fluoroscopy with a screening time of 
210 min, giving an average screening time of 1.5 min per case. 
DISCUSSION 
A number of studies have looked at the exposure of the orthopaedic 
surgeon to radiation.2-9 All have concluded that the whole body 
dose received is well within the recommended levels but have 
emphasized caution due to the uncertainty of long-term effects of 
low-dose radiation. In the present study the finding of negative 
radiation badges supports this view. Exposure of the hands has been 225
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shown to be the limiting factor in orthopaedics,3.4.9 whereas 
in cardiological practice it is the lens of the eye.10 Fortunately 
the hand is relatively insensitive to radiation with an annual 
extremity dose limit of 150 mSv for non-radiation workers.11 
In New Zealand, orthopaedic surgeons are presumed to be radia- 
tion workers and therefore the annual extremity dose limit is 
500 mSv.12 Our results show that there is a safety factor of approxi- 
mately 20-fold for hand exposure based on the International 
Commission on Radiological Protection (IRCP) figure. How- 
ever, during a busy trauma run there may be a seven-fold 
increase in screening time, which could reduce the safety factor 
to three-fold. The authors of the present study agree with Smith 
that routine monitoring with film badges under or outside the 
apron will not adequately assess the extremity dose, which is 
the limiting factor.9 
To our knowledge, this study is the first to specifically record 
critical incidents, which depends on the surgeon reporting them, 
and we suspect that they are under-reported in our series. 
However, they are still surprisingly common and occur in an 
average of 15% of procedures using fluoroscopy. With care they 
should all be avoidable. In order to approach the ICRP limit of 
12.5 mSv per month it would take at least 240 min of scatter 
radiation or 1 min of direct exposure, i.e. 60 incidents each 
month. Our measurements suggest that direct exposure must 
have occurred in those series where thermoluminescent dosimeter 
(TLD) rings were used to record hand exposure.3.4.9 
Under the Euratom directive,l it is mandatory that radiation 
training is given to all staff who use radiation for medical pro- 
cedures. In New Zealand, this is the responsibility of the 
licensee for an institution.12 Little or no formal training is given to 
orthopaedic surgeons. Guidelines for safe use of radiation in the 
orthopaedic theatre have been published.*-5JIs The image intensi- 
fier should be positioned as close to the patient as possible to 
reduce back scatter and allow decreased doses to be used. The 
equipment should have a memory facility and be serviced regu- 
larly. Live fluoroscopy should be avoided if possible. In the 
present study, lead aprons were almost always used, and the 
surgeon retired whenever possible. Thyroid guards could be 
used more regularly. Sterile radiation reduction gloves would 
be useful especially for hand cases and distal locking of intra- 
medullary rods when the hands are very close to the beam and 
critical incidents are common. However, they will not protect 
the hands from direct exposure. A comparison of the screening 
times for similar procedures from the two study periods sug- 
gests that monitoring of screening times helps to reduce the 
amount of radiation used. 
We estimated that at least 58% of our intra-operative radiographs 
could have been avoided if a printer had been available to 
record the on-screen image. This is in agreement with Williams 
et al.,13 who found that thermal prints could replace radiographs 
in 75% of cases. Pattison et al. showed that thermal prints were 
a satisfactory and cost-effective alternative to postoperative hip 
radiographs which reduce the patient dose by 5-6 cGy.14 The 
amount of radiation used in a plain radiograph is approximately 
10 times that of a single-image intensifier flash. Therefore there 
is potential for a significant reduction in radiation dose to the 
patient. 
CONCLUSIONS 
Although radiation exposure to orthopaedic surgeons is within 
recommended levels, there should be no complacency because 
of the uncertainty in predicting the effects of low-dose radiation. 
There is no safe dose of radiation and the ALARA principle 
should be observed for both the patient and surgeon.2.15 
ACKNOWLEDGEMENTS 
The authors gratefully acknowledge the help of Mr Fergus J. 
Thomson, Physicist, Radiology Department, Auckland Hospital 
in making the radiation recordings with the anthropomorphic 
phantom. 
REFERENCES 
1. Euratom. 80/836/Euratom. Ofsicial J .  Eur. Comm. 1980; L246: 
2. Hynes DE, Conere T, Mee MB, Cashman WF. Ionising radiation 
and the orthopaedic surgeon. J.  Bone Joint Surg. Br. 1992; 74B: 
332-4. 
3. Sanders R, Koval KJ, DiPasquale T, Schmelling G, Stenzler S, 
Ross E. Exposure of the orthopaedic surgeon to radiation. 
J .  Bone Joint Surg. Am. 1993; 75A: 326-30. 
4. Smith GL, Briggs TWR, Lavy CBD, Nordeen H. Ionising radia- 
tion: Are orthopaedic surgeons at risk? Ann. R. Coll. Surg. Engl. 
5. Miller ME, Davis ML, MacLean CR, Davis JG, Smith BL, 
Humphries JR. Radiation exposure and associated risks to oper- 
ating room personnel during use of fluoroscopic guidance for 
selected orthopaedic surgical procedures. J. Bone Joint Surg. 
Am. 1983; 65A: 1-4. 
6. Barry TP. Radiation exposure to an orthopaedic surgeon. Clin. 
Orthop. 1984; 182: 160-4. 
7. Levin PE, Schoen Jr RW, Browner BD. Radiation exposure to 
the surgeon during closed interlocking intramedullary nailing. 
J. Bone Joint Sum. Am. 1987: 69A: 761-6. 
1-72. 









O’Rourke PJ, Crerand S, Hakington P, Casey M, Quinlan W. 
Risks of radiation exposure to orthopaedic surgeons. J. R. Coll. 
Edinb. 1996; 41: 40-3. 
Smith GL, Wakeman R, Briggs TWR. Radiation exposure of 
orthopaedic trainees: Quantifying the risk. J. R. Coll. Edinb. 
1996; 41: 1324. 
Jeans SP, Faulkner K. An investigation of the radiation dose to 
staff during cardiac radiological studies. Br. J .  Radiol. 1985; 
The 1990 Recommendations of the International Commission 
on Radiological Protection. ICRP, Publication 60, Vol. 21. 
Oxford: Pergammon Press, 1991. 
National Radiation Laboratory. Code of Safe Practice for  the Use 
of X-Rays in Medical Diagnosis. Christchurch, New Zealand: 
NRL C5, 1994. 
Williams RL, Clarke AJ, Haddad FS. Value of intraoperative 
image intensifier prints in trauma surgery. Ann. R. Coll. Surg. Engl. 
1996; 78: 512-14. 
Pattison RM, Koka SR, Calzada S, James SE. Postoperative 
radiographs or thermal prints after internal fixation of fractures? 
A study of DHS fixation of hip fractures. Ann. R. Coll. Surg. 
Engl. 1996; 78: 509-1 1. 
Stoker DJ. Ionising radiation and the orthopaedic patient. 








































SPINE Volume 25, Number 12, pp 1538–1541
©2000, Lippincott Williams & Wilkins, Inc.
Radiation Exposure During Fluoroscopically Assisted
Pedicle Screw Insertion in the Lumbar Spine
David P. Gwynne Jones, FRACS,* Peter A. Robertson, MD, FRACS,† Brian Lunt, Med Phys,†
and Suzanne A. Jackson, FRCS, FRACS‡
Study Design. An experimental model to assess radi-
ation exposure during lumbar pedicle screw insertion.
Objectives. To measure skin (patient) and scatter (sur-
geon) doses of radiation during lumbar spine fluoroscopy
to assess safety of the procedure for both the surgeon
and patient and determine best practice.
Summary of Background Data. Fluoroscopy assists
with accuracy of pedicle screw placement, yet the optimal
technique of C-arm use and risk to both patient and op-
erating room staff from radiation exposure are unknown.
Methods. Entry- and scatter-dose recordings were
made using a digital dosimeter while screening an an-
thropomorphic phantom prone on a radiolucent operat-
ing table. The source was positioned both superiorly and
inferiorly with the height varied in the latter orientation to
create a working space under the C-arm. The senior au-
thor’s fluoroscopy records were reviewed in 140 consec-
utive cases.
Results. In a series of 140 patients who underwent pedi-
cle screw fixation, the fluoroscopy time was 1.4 minutes per
case or 0.33 minutes per screw. In the source-superior
position, the effective dose received by the patient was
approximately 2.3 mSv per case. In the source-inferior
position with a working space of 300 mm, the effective dose
was 6.8 mSv. Scatter dose to the surgeon was higher in the
source-superior position but was still less than 10% of rec-
ommended limits for the hand, thyroid, and eyes.
Conclusions. The source-superior position is the pre-
ferred position for pedicle screw screening if a working
space is required. Patient exposure is minimized, and
surgeon dose is well within current recommendations.
[Key words: fluoroscopy, lumbosacral region, radiation
protection, spinal fusion] Spine 2000;25:1538–1541
Pedicle screws are now routinely used during instrumen-
tation of the lumbar spine. Despite their accepted advan-
tages, the potential complications from their misplace-
ment remain a serious concern. The nerve root is
particularly at risk as it passes around the pedicle. Higher
rates of reported pedicle screw misplacement have
ranged up to 40%.1,4,6,11,14 Fluoroscopy is widely used
to assist placement of the pedicle screws, yet the optimal
technique of image intensifier use and the risk of radia-
tion exposure to the patient and operating room staff are
not known.
Ionizing radiation has been increasingly used in ortho-
pedic surgery, especially in the trauma theater. In 1991
the estimate of the risk from exposure to low-dose ion-
izing radiation was increased six times.7 In a recent re-
port, the results have indicated an increased incidence of
thyroid malignancies among orthopedic surgeons.2 Re-
sults in other studies have shown that the surgeon’s hand
is most at risk.5,12
The purpose of the current study was to determine the
optimal technique of image intensifier use by measuring
skin and scatter doses of radiation during screening of
the lumbar spine and to assess the safety of this proce-
dure to both the surgeon and patient.
Methods and Materials
An anthropomorphic phantom (Rando; Radiology Support
Devices, Long Beach, CA), which is designed to simulate a
70-kg patient, was placed prone on a radiolucent operating
table with pillows under the phantom to reproduce the position
used for posterior lumbar spinal surgery.
Fluoroscopy of L4 was then performed using an image in-
tensifier (BV25 Gold; Phillips BV, Eindhoven, The Nether-
lands). The fluoroscope was positioned coaxial to the pedicles
with the source superior and the image intensifier under and as
close to the table as possible (source-superior position, beam
directed down, posteroanterior screening). Measurements of
radiation were then taken within the beam and at horizontal
positions to a distance of 1 m. Measurements were also taken at
the level of the phantom and vertically above and below the
phantom to simulate the organs of the surgeon at risk, if the
surgeon were standing adjacent to the operating table.
The fluoroscope was then reversed so that the source was
inferior (source-inferior, beam directed up, anteroposterior
screening). Readings were repeated with the image intensifier
(receiver) at various heights above the phantom, to create a
working space.
Readings were taken with a digital dosimeter (Model
35055; Keithley Instruments, Cleveland, OH) using a 15-mL
ionization chamber for primary beam measurements and a
900-mL chamber for scatter measurements.
The screening times for all pedicle screws inserted by the
senior author (PAR) during a 4-year period were used to cal-
culate relative risk estimates of radiation exposure to the hand,
eyes, and thyroid based on the guidelines of the International
Commission for Radiologic Protection (ICRP).8 The effective
dose received by the patient was calculated from the estimated
entry dose, by using tabulated results of doses to organs for
given peak kilovolts (kV), filtration, beam orientation and
body part, by the National Radiation Laboratory.
Results
The exposure factors used were 75 kV(p) and 2.7 mA
with an exposure time of approximately 1 second to
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obtain adequate images of the pedicles in the phantom,
which simulates a 70-kg man.
Radiation doses for the source-superior and source-
inferior positions at varied distances to simulate hand
positions and varied heights for radiosensitive organs are
tabulated in Table 1 and demonstrated in Figures 1A and
1B. There is an exponential decrease in scatter radiation
with increasing distance from the beam.
In the source-inferior position with the image intensi-
fier 33 cm above the back, allowing the maximum work-
ing area, the entry dose for the phantom was 1433 mGy/
image, which is almost three times higher than that in the
source-superior position. This decreased to 756 mGy
when the image intensifier was 30 cm and down to 508
mGy when the image intensifier was 20 cm above the back.
The scatter doses to the hand, thyroid, and eyes in the
source-inferior position (Image Intensifier 30 cm above)
are much lower (6–13% of the source-superior posi-
tion). The direct beam measurement is 139 times higher
in the source-superior position. The gonad dose and knee
doses are higher by a factor of 3 and 11, respectively, in
the source-inferior position.
In a 4-year period, the senior author performed 140
operations on the lumbar and lumbosacral spine involv-
ing pedicle screw fixation. Six hundred twenty-six screws
were inserted with a total screening time of 208 minutes,
with a mean screening time of 1.4 minutes per case
(range, 0.6–3.5 minutes) or 0.33 minutes per screw.
Screening was performed in the coaxial plane with the
source superior with confirmatory lateral views taken at
completion with the C-arm over the table. No record was
made of whether the hand was caught in the beam. There
was no clinical or radiographic evidence of screw mal-
position or nerve root damage due to pedicle screw
placement.9
Based on 50 minutes of screening during 34 cases a
year this gives a maximal scatter dose to the hands of 31
mSv/yr assuming that the hands are within 5 cm through-
out screening. Direct exposure would add 0.5 mSv for
each occasion the hand is caught. The thyroid dose if no
shield were used would be 2.4 mSv/yr and the eye dose
1.67 mSv/yr, based on the scatter recordings in the
source-superior position.
Based on ICRP recommendations,8 performing 50 op-
erations per year would give a safety factor of 11-fold for
hands, 117-fold for thyroid, and 63-fold for eyes.
The entry dose to the patient would average 43 mSv/
case (range, 18–107 mSv) assuming the average screen-
ing time of 1.4 minutes in the source-superior position.
The effective dose to the whole body can be calculated
from the entrance dose to the lumbar spine region by
using tabulated results of peak kilovolts, filtration, and
beam orientation. The effective dose per entry dose for
trunk irradiations is, in general, two times higher for
anteroposterior projections than for posteroanterior
projections of the same body part. For the source-
superior (posteroanterior) position, the effective dose is
2.3 mSv (range, 1–5.75 mSv). For comparison, the ap-
proximate effective dose of a single anteroposterior lum-
bar spine radiograph is 0.5–1 mSv. Extrapolating to the
source-inferior (anteroposterior) positions the average
effective dose would increase to 6.9 mSv when the C-arm
is set up with 30 cm of working space between the image
intensifier and the patient.
Discussion
Although fluoroscopy has been recommended to aid
pedicle screw placement in the lumbar spine, details of
the technique in the literature are vague. Diagrams show-
ing the image intensifier in the source-inferior position
have been published.10,13 The senior author has used the
source-superior position, because there is an approxi-
mately 46-cm space available for the instrumentation of
the spine. The source is less bulky than the image inten-
sifier. This allows use of conventional probes and drills







Source superior 508 43 2.3
Source inferior Image intensifier 33 cm above back 1433 120 12.8
30 cm 756 64 6.9
20 cm 508 43 4.6
* Calculated from 1.4 mins screening time per case.
Table 1. Dosemeter Readings Taken With Source
Superior and Source Inferior (Allowing a Working Space
of 30 cm Between the Image Intensifier/Receiver and the
Patient). Values for Organ Dosage are for Measurements
20 –25 cm From the Beam, Simulating the Surgeon
Standing Adjacent to the Operating Table
Source Superior
microGy/image




In beam 508 3.65 139
5 cm away 10 0.6 17
20 cm away 2.4 0.32 7.6
25 cm away 1.3 0.28 4.6
50 cm away 0.15 0.14 1.1
Knees 0.06 0.65 0.09
Gonads 0.49 1.4 0.35
Eyes 0.56 0.04 13
Thyroid 0.81 0.06 14
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during screw placement while having the facility to re-
peatedly spot screen throughout insertion. The entry
dose to the patient is approximately 2.5 times that of
posteroanterior hip screening during hip fracture fixa-
tion. The effective dose to the patient with the average
screening time in the source-superior position equates to
approximately three to four times that of anteroposterior
lumbar spine radiographs.
From a pure radiation protection perspective the
source-inferior position, with the image intensifier as
close to the back as possible, is the ideal. There is less
magnification of the image and most of the scatter is
directed downward, away from the operator’s trunk and
head. This would be a preferable way to check final po-
sition. However, if a working space is created, then the
patient entrance, and therefore the effective dose, in-
creases unacceptably. With 30 cm of working space, the
entrance dose is increased by half again and the effective
dose by threefold because of the anteroposterior projec-
tion.
In the source-superior position, the calculated scatter
doses to the thyroid and eye are only 0.8% and 1.6% of
recommended levels, respectively. However, care should
be taken to shield the thyroid and the eyes during screen-
ing. The hand exposure calculated using the source-
superior position is only 9% of ICRP recommendations.
There is little risk of exceeding these limits unless the
hand is regularly caught in the radiograph beam. Keep-
ing the hands at the edge of the torso reduces scatter dose
by a quarter compared with the dose within 5 cm of the
beam. Modified instrumentation may help this.
The scatter exposure to the hands, thyroid, and eyes
and direct exposure to the hands is greatly reduced in the
source-inferior position. However, optimum safe prac-
tice must take into account the dose to the patient. It is a
key principle of the safe use of ionizing radiation to keep
the radiation dose to the patient and surgeon as low as
reasonably achievable, consistent with good surgical
practice.3
Conclusions
The results in this study show that patient radiation ex-
posure is greater in the source-inferior position than in
the source-superior position when a working space is
created. Patient entry dose and magnification can be re-
duced by having the image intensifier as close to the dor-
Figure 1. A, diagrammatic representation of dosimeter readings (in microguys per image) in, and at increasing distances from, the C-arm
beam in the source-superior and source-inferior positions (30 cm working space between the image intensifier and the patient in the
source-inferior position). Note that only the source is illustrated. The image intensifier is not demonstrated in the figure. B, Readings at
the levels of the eyes, thyroid, gonads, and knees are demonstrated. These readings are taken 20 –25 cm from the beam, as though the
surgeon were adjacent to the operating table.





(50 mins screening/yr, 34 cases)
mSv/yr
Safety Factor for
34 cases/yr 50 cases/yr
Hand 500 31 16 11
Eyes 150 1.67 90 63
Thyroid* 20 (effective dose) 0.12 (effective dose) 167 117
* Thyroid limit based on assumption that thyroid is the only radiosensitive organ exposed if lead apron worn. Therefore, limit is effective dose limit multiplied by
thyroid weighting factor of 0.05.
ICRP 5 International Commission For Radiologic Protection.
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sal surface as possible in the source-inferior position.
Dosage to the surgeon is greater in the source-superior
position, yet it is well within current threshold limits if
accidental beam exposure is avoided. Current instru-
mentation could be modified to allow the hands to re-
main outside the critical 5-cm radius, and preferably out-
side 20 cm. Surgeons are advised to keep their hands as
far from the beam as possible and to limit screening time.
A lead apron must be worn, and a thyroid shield and
protective glasses should be worn.
Key Points
● Fluoroscopic screening with source superior to
the patient minimizes the patient’s effective dose.
● Scatter radiation to the surgeon is higher in the
source-superior position but is still well within rec-
ommended levels.
● The surgeon’s hands should be kept lateral to the
torso during screening to reduce scatter, and the
surgeon must avoid direct exposure to the radia-
tion beam.
● Adequate radiation protection must be worn by
the operating team.
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Chapter 7   
Results of surgical treatment: ‘Getting it right first time’ and 
improving the outcomes of surgery.  
By improving the outcomes of surgery and reducing complications there can be significant 
savings in both time and money. This is particularly relevant for THR and TKR when surgery 
is usually highly successful but complications such as deep infection and dislocation can be 
very difficult and expensive to manage. Not all implants perform equally as well at longer 
term follow up. National Joint registries have been developed that allow poorly functioning 
implants to be identified early and can also be used to identify outlier surgeons. Revision hip 
and knee surgery can be complex and have a major impact on patients. It also uses up 
precious resources that could be used for primary elective surgery. The ‘Getting it right first 
time programme (GIRFT)’ in the UK looked at all aspects of surgical management including 
appropriate implant choice. By avoiding early and late complications it improved efficiency 
and outcomes.  
This chapter includes cohort studies on the outcomes of THR and TKR that include patient 
reported functional results and long-term results. An important focus in TKR is improving 
function both through prosthesis design and surgical technique. ‘The effect of sagittal laxity 
on function following posterior cruciate retaining total knee replacement’ considers this 
issue.  
In the early 1990s we started using uncemented components for THR more frequently. Our 
two papers ‘The Morscher Press Fit acetabular component: A 9 to 13 year review’ and ‘The 
Morscher Press-Fit Acetabular Component: An Independent Long-Term Review at 18-22 
Years’ showed excellent survival of this uncemented monoblock design at long term. 
However, a desire to follow evidence coupled with a management imperative to reduce 
implant costs led to the department instituting a cement only policy in our public hospital in 
the late 1990s. We became aware that cemented cups were failing at 10-15 years while 
uncemented cups performed prior to this policy change or performed at our private 
hospital were continuing to do well. This led to two studies ‘Hybrid Fixation for Total Hip 
Arthroplasty Showed Improved Survival Over Cemented and Uncemented Fixation’ and 
‘Cemented or cementless acetabular fixation in combination with the Exeter Universal 
cemented stem.’ In these we have shown that uncemented acetabular components, 
especially those of monoblock design, and hybrid fixation in THR is associated with excellent 
long-term survivorship surpassing that of all cemented THR. This is in contrast to published 
results and registry data. Our results support the trend away from using cemented 
acetabular fixation that has occurred worldwide. These papers help inform decisions 
regarding implant choice and fixation at the time of primary surgery that may reduce the 
future revision burden. We have less evidence to support uncemented femoral fixation but 
have also used it for many years. Our case report ‘Bilateral uncemented total hip 
arthroplasty in osteopetrosis’ was the first long term report of the use of uncemented 
components in this rare condition and is regularly cited.  
Complications can occur despite good surgical technique. ‘Polyethylene liner dissociation 
with the Pinnacle acetabular component: Should we be concerned?’ is an example of an 
uncommon problem identified locally but not apparent from registry data possibly due to 
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lack of specific fields in the reporting template. The follow up paper ‘Acetabular liner 
dissociation: A comparative study of two contemporary uncemented acetabular 
components’ concludes that this is more likely to be an implant specific problem rather than 
a feature of similar 3rd generation modular systems.  
The papers in this and preceding chapters report results that match or surpass those of 
major international centres.  They highlight both the quality of our service over many years 
and the importance of local research and audit. 
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doi:10.1016/j.arthAbstract: We studied sagittal laxity using the KT1000 arthrometer in 97 total knee
arthroplasties (TKAs) in 83 patients using the porous-coated anatomic knee or
Duracon TKA (Howmedica, Rutherford, NJ) with 5.4- to 9.9-year follow-up. Two
differing tibial inserts were used: flat (group 1) and anteroposterior (AP) lipped
(group 2). Greater posterior and total laxity at 758 was seen in group 2 despite the
AP-lipped insert. No differences were seen in functional outcome scores between
groups. No significant relationship was seen between laxity and functional outcome.
Knees with more than 10 mm of AP laxity at 758 had significantly less flexion and
lower Knee Society Scores than knees with 5 to 10 mm of AP laxity. We conclude that
the optimal sagittal laxity in this cruciate-retaining TKA is between 5 and 10 mm,
although this may not hold for posterior-stabilized designs. Key words: total knee
arthroplasty, posterior cruciate retaining, sagittal laxity, KT1000 arthrometer.n 2006 Elsevier Inc. All rights reserved.It is not clear how much sagittal laxity is acceptable
after total knee arthroplasty (TKA). Moderate laxity
may give a better range of motion (ROM) and
improved functional results compared with a knee
that is too tight [1,2]. However, too much laxity
may lead to instability, poor function, pain, and
early failure [3-5]. Total anteroposterior (AP) laxity
of 5 to 10 mm appears to give satisfactory results
[1,3,6-9]. Greater than 10 mm may have worse
function [3], but less than 5 mm has an increased
risk for a fixed flexion deformity (FFD) [1]. Factors
that may influence the sagittal laxity after a719
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233cruciate-retaining TKA include the functional status
of the posterior cruciate ligament (PCL), the geom-
etry of the prosthesis, and bone cuts including the
posterior tibial slope.
The aims of the study were to determine whether
sagittal laxity has an effect on functional outcome
and ROM after posterior cruciate–retaining (PCR)
TKA and whether 2 differing PCR tibial inserts,
1 relatively flat to allow femoral brollback Q and
1 with an anterior and posterior lip to give greater
conformity, used with the same femoral component
had an effect on laxity or functional outcome.Materials and Methods
We reviewed 83 patients with 97 knee arthro-
plasties using the porous-coated anatomic (PCA) or
Duracon TKA (Howmedica, Rutherford, NJ) per-
formed between January 1992 and December 1996
at Dunedin Public Hospital. These were performed
by 7 orthopedic surgeons and supervised registrars.
The femoral component is asymmetric with a curved





No. of knees (patients) 51 (44) 46 (44)
Male knees (patients) 31 (25) 26 (25)
Female knees (patients) 20 (19) 20 (19)
Average age at
operation (SD)
71.1 (6.4) 69.1 (6.1) NS
Average duration
of follow-up (SD) (y)
8.0 (1.0) 6.1 (0.6) .0001
Average age at
follow up (SD)
79.1 (6.4) 75.2 (6.2) .0001
Average BMI (SD) 29 (4.9) 30.1 (5.8) NS
Charnley grade
A 20 18 NS
B 15 23
C 16 5
Posterior tibial slope (SD) 08 (2.8) 08 (3.1) NS
Fig. 1. Cross-sectional diagram of the PCA condylar
tibial insert (group 1) and AP-lipped insert (group 2).
720 The Journal of Arthroplasty Vol. 21 No. 5 August 2006bpatella-friendly Q intercondylar groove and curved
distal femoral condyles. There were no significant
changes made to the femoral design during the
study period. Two differing tibial insert designs were
used (Fig. 1). A relatively flat design that allows
femoral rollback was used between 1992 and 1993
in the PCA knees. An AP-lipped insert was intro-
duced in late 1993 and used for the rest of the study
period in the Duracon knees. This has an elevated
anterior and posterior lip, and more conforming
geometry. Both are designed to be implanted with
PCL retention. Patellae were replaced on an indi-
vidual basis in 36% of the knees. The minimum
follow-up was 5 years. No knee arthroplasties from
the study period were revised for instability.
Group 1 (flat insert) consisted of 51 knees in
44 patients. There were 25 males and 19 females.
The average age at operation was 71.1 F 6.4 years
with an average follow-up of 8.0 F 1.0 years (range,
6.8-9.9 years).
Group 2 (AP-lipped insert) consisted of 46 knees
in 44 patients, also 25 males and 19 females. The
average age at operation was 69.1 F 6.1 years
with an average follow-up of 6.1 F 0.6 years (range,
5.4-6.8 years).
Five patients with bilateral TKA had one of each
tibial insert. The diagnosis was osteoarthritis in
95% of cases.
Patients were followed up in clinic by indepen-
dent trained observers. Patients filled in a question-
naire that included demographic details, Charnley
grade, function of their knee using the Western
Ontario and MacMaster Universities osteoarthritis
score (WOMAC), Knee Society Score (KSS) and
Knee Society Function Score, and Short Form 12 (SF
12) questionnaire. At clinical review, weight and
height were measured, and body mass index (BMI)
was calculated. Active flexion and FFD were mea-
sured using a goniometer. Fluoroscopically aligned234AP and lateral weight-bearing radiographs of the
knees were taken. The KT1000 arthrometer (MED-
metric Corporation, San Diego, Calif) was used
according to the manufacturers’ protocol. The laxity
of the knee was measured at the quadriceps neutral
angle of approximately 758 to 808. The anterior and
posterior movements were measured when a 20-lb
push and a 20-lb pull were applied. The total laxity
was the combined total of anterior and posterior
movements. These measurements were repeated
with a quadriceps contraction to perform a quadri-
ceps active test. This allowed anterior cruciate
ligament (ACL) and PCL movements to be calculat-
ed. Anterior and posterior measurements were also
made at 308 of flexion with a 30-lb pull and a 20-lb
push, and combined for total laxity at 308 flexion.
Medial lateral stability was recorded by measur-
ing the angular displacement from maximal varus
to maximal valgus of the knee in extension.
The posterior slope of the tibial component was
measured from the lateral radiograph.
Statistical analysis was performed using Stata
version 8.1 (StataCorp L.P., College Station, TX).
Regression analysis clustered to patient with robust
SEs was performed to allow for lack of independence
arising from bilateral procedures. Correlation coef-
ficients with 2-tailed significance P values were used
to calculate any relationship between laxity and
outcome measures. Analysis of variance and post
hoc Duncan tests were used to compare groups of
differing laxity.Results
There was no significant difference between
groups for age at operation, sex, or BMI. There
was significantly longer follow-up in group 1 and
Table 2. Mean Outcome Scores and ROM Results





WOMAC total (SD) 77.5 (16) 76 (15.4) NS
KSS (SD) 71 (16.6) 74 (17.9) NS
Knee Society
Function Score (SD)
68 (23.9) 76 (23.3) NS
SF 12 physical (SD) 37.8 (10.3) 37.4 (10.9) NS
SF 12 mental (SD) 54.5 (11.3) 54.5 (10.3) NS
Active flexion (SD) 105 (13) 106 (12) NS
Flexion deformity (SD) 48 (4.3) 2.18 (2.9) .016
No. of knees
with FFD N58 (%)
16 (31) 10 (22)
Medial-lateral
stability (SD)
8.78 (3.3) 8.58 (3.0) NS
Fig. 2. Mean WOMAC scores for groups 1 (flat insert)
and 2 (AP-lipped insert).
Sagittal Laxity and Function in TKA ! Jones et al 721hence age at follow-up, as expected in a sequential
series. There were more patients who were Charn-
ley grade C in group 1 and more Charnley grade B
patients in group 2, but there was no significant
difference (see Table 1).
Functional Outcome Scores
No significant differences were seen between the
2 different tibial insert groups for WOMAC score
(total, pain, motion, or function components), KSS,
Knee Society Function Score, and SF 12 physical
and mental scores (Figs. 2 and 3, Table 2).
Range of Motion
There was no difference in active flexion between
the groups. Group 1 had an average of 1058 F 138
and group 2 averaged 1068 F 128.
There was a significant difference in FFD with
group 1 averaging 48 and group 2 averaging 28.Fig. 3. Mean KSS, Knee Society Function Scores, and
SF 12 physical and mental scores for groups 1 (flat) and
2 (AP lipped).
235In group 1, 20 knees had no FFD, 8 had 58 or less,
14 had 108 or less, and 2 had 158 and 178,
respectively. In group 2, 28 knees had no FFD,
8 were 58 or less, and 10 were 108 or less.
There was no significant difference in medial-
lateral stability between the groups.
Laxity
The results are given in Table 3. A significant
difference was seen in the total laxity at 758 and the
posterior laxity at 758 with group 2 having greater
movement despite the AP-lipped insert. No signif-
icant difference was seen between the groups for
ACL or PCL movement when a quadriceps active
test was performed. There was significantly greater
laxity at 308 than 758 for anterior, posterior, and
total laxity for both groups. Only 3 knees had total
laxity at 758 greater than 10 mm.
The groups were combined and correlations
were calculated for functional outcome, ROM,Table 3. Mean KT1000 Laxity Measurements (Groups
1 and 2 Compared Regression Analysis Clustered
to Patient)
Combined
groups Group 1 Group 2 P
Anterior laxity 758
20-lb pull (mm)
2.8 (1.8) 2.5 (1.8) 3.1 (1.8) .156
Posterior laxity 758
20-lb push (mm)
1.7 (1.7) 1.4 (0.8) 2.1 (2.2) .026
ACL movement 758 0.5 (2.1) 0.4 (2.2) 0.6 (2.0) .545
PCL movement 758 4.1 (2.6) 3.6 (2.1) 4.6 (3.0) .071
Total laxity 758 (mm) 4.6 (3.1) 3.9 (2.3) 5.3 (3.7) .037
Anterior laxity 308
30-lb pull (mm)
5.8 (3.6) 5.3 (3.3) 6.3 (3.8) .167
Posterior laxity 308
20-lb push (mm)
1.5 (0.9) 1.4 (0.6) 1.7 (1.2) .09
Combined laxity 308 7.3 (4.0) 6.7 (3.4) 8.0 (4.6) .104
Values in parentheses are SDs. Bold values indicate a
significant difference.
Table 4. Results of Knees Grouped Into Less Than
5 mm, 5 to 10 mm, and More Than
10 mm of AP Laxity at 758
AP laxity (758) 0-5 mm 5-10 mm N10 mm
No. of knees 60 32 3
KSS 70.4 (18.5) 77.0 (13.4) 55.3 (19.5)
Knee Society
Function Score
70.4 (18.5) 75.3 (23) 68.3 (20.2)
WOMAC 76.6 (16.7) 77.7 (14) 70.0 (18.7)
Flexion 1038 (12) 1128 (10) 998 (17)
FFD 48 (4) 28 (3.2) 28 (3.8)
Values in parentheses are SDs. Bold values indicate a
significant difference.
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no correlation seen between anterior, posterior, or
total laxity at either 308 or 758 and WOMAC (pain,
motion, or function), International KSS, SF 12
(mental or physical), active flexion, FFD, or medi-
al-lateral stability. Correlations with a 2-tailed
P value of less than .05 were seen for anterior laxity
at 758 and maximum flexion ( P = .018), posterior
laxity at 758 and BMI ( P = .008), and ACL
movement at 758 and tibial slope. However, it is
likely that these findings are due to chance.
The knees were grouped into those with less than
5 mm, 5 to 10 mm, and greater than 10 mm of AP
laxity at 758 (Table 4). Knees with 5 to 10 mm of
total AP laxity at 758 had significantly greater ROM
than those with more than 10 mm laxity (1128 vs
998, P = .001) and a higher KSS (77 vs 55, P = .05).
The difference in active flexion between knees with
less than 5 mm (1038) and knees with 5 to 10 mm of
laxity (1128) did not reach significance. There was a
higher mean KSS and Knee Society Function Score,
and a smaller FFD in the knees with 5 to 10 mm of
laxity compared with knees with less than 5 mm,
but these also did not reach significance.Discussion
A number of studies have attempted to relate the
laxity of a knee arthroplasty to functional outcome
or ROM [1,3,6-9]. One of the problems with
instrumented laxity testing is defining the neutral
position when measuring anterior and posterior
displacement. Most studies have therefore quoted
total AP laxity or have taken the resting point as
neutral. Warren et al [1] using electronic measur-
ing apparatus found a significant correlation be-
tween total AP laxity and passive ROM, and an
increased risk for a FFD of more than 48 if the
total AP laxity was less than 5 mm. Dejour et al
[3] compared PCR and posterior stabilised (PS)236knees at 3 to 4 years postoperative using clinical
examination and radiological laxity on weight-
bearing radiographs, and concluded that more than
10 mm of anterior translation had a worse outcome,
as shown by Knee Society Function Scores.
Yamakado et al [7] found no correlation between
laxity and ROM in 21 PCR knees at 7 years, with an
average total AP laxity of 9.7 mm on KT2000 testing
at 308 flexion. They concluded that moderate laxity
did not affect outcome.
Matsuda and Ishii [8] using the KT2000 found 9 to
10 mm of total AP laxity in well-functioning mobile-
bearing knees at 6 months and recommended this
amount of laxity. They also looked at fixed-bearing
knees and found a mean total AP displacement of
4.8 mm to 5.8 mm at 758 and 308 in cruciate-
retaining knees and concluded that 5 to 6 mm was
the suitable degree of AP laxity for that implant [9].
There was no correlation between laxity and
Hospital for Special Surgery Score or ROM.
The figures we found for anterior, posterior, and
total AP laxity were similar to these previous studies
with a mean total AP laxity of 4.6 mm (758) and
7.3 mm (308). We attempted to measure the anterior
and PCL components by asking the patient to
perform a quadriceps contraction simulating the
quadriceps active test at 758 flexion. This resulted in
greater laxity for the PCL (4.1 mm) and correspond-
ingly less anterior movement (0.5 mm). However,
we found no correlation between these results and
functional outcome. We found significantly greater
flexion in knees with 5 to 10 mm total laxity at
758 than those with more than 10 mm laxity and
better KSSs. Therefore, based on our observations,
we believe that 10 mm should be the upper limit of
laxity with this cruciate-retaining implant. This
may not necessarily hold for posterior-stabilized
designs. Knees with less than 5 mm of laxity had less
flexion but were not statistically worse than the 5 to
10 mm group.
Matsuda et al [6] considered knees with greater
total AP laxity at 758 than 308 as having a
nonfunctioning PCL and found worse KSSs in these
knees. In our series, only 7 knees had greater laxity
at 758 than 308, and none of these had significantly
worse results.
Incapacitating instability, pain, and failure can
occur both early and late in PCR knees because of
PCL deficiency [4,5]. Waslewski et al [4] described
at least 15 mm of posterior drawer in their cases that
failed because of PCL deficiency. One knee in our
series (AP-lipped insert) had 25 mm of total AP
laxity at 758 and 28 mm at 308 with a poor result.
The AP-lipped insert used in group 2 may act as a
posterior-stabilized knee because of the conforming
Sagittal Laxity and Function in TKA ! Jones et al 723design and anterior lip, and so the PCL may not be so
important. Surprisingly, however, group 2 had
greater laxity than group 1 for all measures, with
posterior laxity and total laxity at 758 reaching
significance. This group also had a significantly
smaller mean FFD. Possible explanations for these
findings are that, in group 2, the patients were
younger at follow-up and that surgical technique
and rehabilitation protocols may have changed over
the period of the study. The increased stability
afforded by the AP-lipped design may have encour-
aged a greater release of the PCL. However, Worland
et al [10] found no difference in posterior laxity
4 years after bilateral TKA whether the PCL had
been recessed or not at the time of operation. Misra
et al [11] in a prospective randomized study with the
Press-Fit Condylar (PFC) knee (De Puy Orthopae-
dics, Warsaw, Ind) found no difference in results
whether the PCL was retained or sacrificed, suggest-
ing that its role may not be as important in some PCR
knees as thought. Despite the differences in laxity
between our 2 groups, there were no significant
differences in subjective outcomes or ROM. This
may be because the WOMAC and the International
Knee Society score (KSS) scores are not discrimina-
tory enough for the end points under consideration.
In this study, we were unable to demonstrate a
significant relationship between laxity and outcome
in cruciate-retaining TKA. However, we found
greater flexion and better KSS scores in knees
with 5 to 10 mm of AP laxity at 758of flexion and
recommend that careful attention should be placed
on accurate bone cuts and soft tissue balancing
during PCR TKA to try to keep the amount of total
AP displacement within this range.Acknowledgments
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We reviewed the results at nine to 13 years of 125 total hip replacements in 113 patients 
using the monoblock uncemented Morscher press-fit acetabular component. The mean age 
at the time of operation was 56.9 years (36 to 74). The mean clinical follow-up was 11 years 
(9.7 to 13.5) and the mean radiological follow-up was 9.4 years (7.7 to 13.1). Three hips were 
revised, one immediately for instability, one for excessive wear and one for deep infection.
No revisions were required for aseptic loosening. A total of eight hips (7.0%) had 
osteolytic lesions greater than 1 cm, in four around the acetabular component (3.5%). One 
required bone grafting behind a well-fixed implant. The mean wear rate was 0.11 mm/year 
(0.06 to 0.78) and was significantly higher in components with a steeper abduction angle.
Kaplan-Meier survival curves at 13 years showed survival of 96.8% (95% confidence 
interval 90.2 to 99.0) for revision for any cause and of 95.7% (95% confidence interval 88.6 to 
98.4) for any acetabular re-operation.
Cemented acetabular components in general
have been recognised for their longevity and
predictable performance.1-3 Cementless
acetabular components may have variable
medium and longer term results.4-6 Despite
this, uncemented acetabular components are
widely used during primary total hip replace-
ment (THR), accounting for 89% of these pro-
cedures in Australia7 and 80% in New
Zealand.8 Some of the designs have been sus-
ceptible to early loosening and failure.9,10
Metal-backed modular acetabular implants
may be prone to this because of poor locking
mechanisms for their inserts, increased rates of
wear compared with all-polyethylene compon-
ents, and backside wear at the interface
between the polyethylene liner and the metal
shell.11
The Morscher acetabular component
(Sulzer Orthopaedics Ltd, Baar, Switzerland),
introduced in 1985, is a non-modular flexible
press-fit design.12,13 The polyethylene is
bonded directly to a titanium mesh shell to
eliminate the potential for backside wear.
There is no option for supplementary screw
fixation. Berli et al14 recently reported the
results at 15 years of 280 hips implanted by the
original designer quoting a survival of 97.5%
for aseptic loosening and of 95.3% overall.
However, there has been little independent evi-
dence as to whether these excellent results can
be achieved in other centres. We describe our
experience with the Morscher acetabular com-
ponent, which we have used since 1993, and
compare our results with those of the
designer’s series.
Patients and Methods
Between January 1994 and December 1997
five orthopaedic surgeons implanted 125
Morscher acetabular components in 113
patients at either of the two hospitals in our
city. The type of femoral component used, the
material of the head and the approach were at
the surgeon’s discretion.
There were 80 THRs (64%) in 71 men and
45 (36%) in 42 women. The mean age at oper-
ation was 56.9 years (36 to 74). The Charnley
grades14 by patient were as follows: grade A 84
(74.3%), grade B 24 (21.3%) and grade C five
(4.4%). The direct lateral approach was used
in 65 hips (52%) and a posterior approach in
60 (48%). Osteoarthritis was the primary
diagnosis in 106 hips (84.8%; Table I).
The acetabular component was inserted
according to the manufacturer’s instructions.
The acetabulum was reamed to the stated
diameter with the implant oversized by
1.5 mm. The inserter was aligned at an abduc-
tion angle of 30° referenced from the inferior
bevel of the implant. This was impacted to pro-
vide a primary press-fit. In women the median
size used was 52 mm (48 to 60) and in men
58 mm (48 to 62). A cemented femoral compo-
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nent was used in 67 hips (53.6%) and a cementless compo-
nent in 58 (46.4%). A ceramic head was used in 66 hips
(52.8%) and a stainless-steel head in 59 (47.2%). All the
heads were 28 mm in diameter (Table II).
The patients were invited for clinical and radiological
review or seen as part of routine follow-up. The score of
Merle d’Aubigné and Postel15 as modified by Charnley16
had been determined pre-operatively. A Harris hip score
(HHS),17 the Merle d’Aubigné and Postel score, the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) score normalised to 100,18 the short form (SF)-
12 generic health score19 and the Oxford hip score (OHS)20
were calculated at review with the results given as the mean
and SD. An anteroposterior (AP) pelvic radiograph showing
the hip with the proximal femur was obtained unless one had
been taken within the previous 12 months. Patients who
declined to travel were sent questionnaires by post or inter-
viewed by telephone. Radiographs were obtained at their
local facility and sent to our institution for assessment. All the
patients were cross-referenced to the National Joint Registry8
and to our local theatre and audit databases to ensure that no
revisions had been registered.
At the time of review two patients had died at eight and
nine years after surgery. Both had well functioning hips at the
time of death. Three hips in three patients had been revised.
Two patients (two hips) were lost to follow-up. Three
patients (three hips) could not be contacted, but had radio-
logical follow-up at a mean of 8.4 years (7.7 to 9.1). All hips
had been functioning well at the last review. The National
Joint Registry had no record of revision for any of these five
hips. We obtained clinical and radiological review of 111
hips in 99 patients including the three (three hips) who had
been revised. Seven patients were contacted by telephone and
questionnaires were completed, but they declined to attend
for radiological review (Table III). The mean age at review
was 67.9 years (46.8 to 84.6) and the mean clinical follow-
up was 11.2 years (9.7 to 13.5). Radiological follow-up was
at a mean of 9.4 years (7.7 to 13.1).
Radiological evaluation. Radiological evaluation was per-
formed using the zones described by DeLee and Charnley.21
The femoral component was assessed for evidence of
migration, subsidence and the position of the stem. Radio-
lucent lines and areas of osteolysis were categorised in the
seven zones described by Gruen, McNiece and Amstutz.22
We defined minor osteolysis as a lucency of less than 1 cm
in diameter and major osteolysis as one greater than 1 cm.
Heterotopic ossification (HO) was assessed using the clas-
sification of Brooker et al.23
Wear measurements. The Morscher acetabular component
is a flattened hemisphere with a 20° bevel. The thickness of
the polyethylene varies throughout the circumference. There-
fore the standard techniques for measuring wear as described
by Martell and Berdia24 could not be applied. A standard AP
radiograph of the hip was taken and digitised using a digital
camera of eight megapixels. The abduction angle and the
superior polyethylene thickness were measured (Fig. 1) using
E-ruler 1.1 freeware (MyCnKnow.com). The superior poly-
ethylene thickness was calculated by counting the pixels to
the edge of the titanium backing. The known head diameter
of 28 mm was used as a reference. Wear was calculated as the
difference in the superior thickness as seen on the post-
operative radiograph compared with that on the latest
follow-up radiograph. A total of 58 patients had suitable
early and late radiographs to allow accurate measurement of
the wear rate to be made. Of these, 20 randomly selected
films were re-measured by the same observer on two occa-
sions. The abduction angle was accurate to within 0.33° in
all cases with a mean difference of 0.11°. The mean differ-
ence in measurement of the thickness of the polyethylene was
Table I. Pre-operative indications for total hip replacement
Diagnosis Number of hips
Osteoarthritis 106
Developmental dysplasia     9
Previous slipped upper femoral epiphysis     3
Avascular necrosis     3
Rheumatoid arthritis     2
Paget’s disease     1
Post-traumatic arthritis     1
Table II. Details of the femoral components
used
Femoral component Number (%)
Uncemented femoral stems 58  (46.4)
CLS* 57  (45.6)
Wagner cone*   1  (0.8)
Cemented femoral stems 67  (53.6)
SLS† 52  (41.6)
Exeter‡ 11  (8.8)
MS-30*   4  (3.2)
Stainless-steel head (28 mm) 59  (47.2)
Ceramic head (28 mm) 66  (52.8)
* Zimmer, Warsaw, Indiana
† Sulzer Medica, Winterthur, Switzerland
‡ Stryker Europe, Montreaux, Switzerland
Table III. Details of the study group
Hips Patients
Start 125 113
Died   2   2
Follow-up
Clinical and radiological 108   97
Clinical only    7    7
Radiological only    3    3
Lost to follow-up   2   2
Revised*   3   3
* one hip revised in patient with bilateral THRs
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0.14 mm. The coefficient of repeatability for wear measure-
ments was 0.37 mm.25 With a mean follow-up of eight years
between radiographs this gave an accuracy of 0.05 mm/year
for the calculated wear rate.
Statistical analysis. Data were collected and recorded in a
custom-made database. Statistical analysis was performed
using Microsoft Excel (Microsoft, Redmond, Washington),
SPSS (SPSS Inc., Chicago, Illinois) and Simple Interactive Sta-
tistical Analysis (SISA, Quantitative skills, Hilversum,
Netherlands). An unpaired two-tailed Student t-test was used
for comparison of normally distributed groups of data, and for
continuous data correlation coefficients were calculated with
p-values. Statistical significance was set at a p-value of ≤ 0.05.
Kaplan-Meier survival curves with the 95% confidence
interval (CI) were calculated with the help of a biostatistician.
Results
Three hips were revised. One dislocated in the immediate
post-operative period because the acetabular component
had been inserted too steeply in a dysplastic acetabulum
and required revision at two weeks. A 40-year-old woman
with acetabular dysplasia had excessive wear of the poly-
ethylene at seven years which was attributed to a steep
abduction angle of 54° (Fig. 2). The hip was revised to a
metal-on-metal bearing. A 60-year-old man required revi-
sion for deep infection and loosening of the femoral com-
ponent at 9.3 years.
There were three other re-operations. An unrecognised
intraoperative femoral fracture in a 67-year-old man was
treated by cerclage wires around an uncemented CLS
(Zimmer, Warsaw, Indiana) femoral component. The hip
was still functioning well at 13.5 years. A 55-year-old man
sustained a traumatic periprosthetic fracture at the tip of a
CLS femoral component 11 years after operation. This was
treated successfully by a cable plate. The implant was
firmly fixed with no sign of osteolysis. One man, aged
64 years at the time of the primary THR, required re-
operation at another centre for major pelvic osteolysis at
nine years (Fig. 3). The acetabular component was firmly
fixed. Therefore allografting was carried out with good
results when seen at a follow-up of three years after grafting
and 12 years after the original procedure. In addition to the
early dislocation that was revised three other hips dislo-
cated giving a dislocation rate of 3.2%. All three stabilised
after a closed reduction with no further dislocation. 
The Kaplan-Meier survival curves at both ten and
13 years showed survival of 96.8% for revision for any
cause (95% CI 90.2 to 99.0) and of 95.7% for any acetab-
ular re-operation (95% CI 88.6 to 98.4) (Fig. 4). No
acetabular component required revision for aseptic loosen-
ing. If the two hips lost to follow-up had been classified as
failures the revision rate would be 4% for any cause at
11 years. However, neither was recorded as having been
revised in the New Zealand National Joint Registry which
is comprehensive, requires the participation of all surgeons
and enjoys 98% compliance.8
The Merle d’Aubigné and Postel score improved from a
mean pre-operative value of 9.0 (SD 3.2) (pain 2.0, mobility
Fig. 1
Anteroposterior radiograph of the hip showing the method used to cal-
culate wear and the abduction angle.
Fig. 2
Anteroposterior radiograph showing
excessive polyethylene wear as a result
of a high abduction angle requiring revi-
sion after seven years.
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2.9, function 4.1) to 16.7 (SD 1.7) (pain 5.5, mobility 5.4,
function 5.8) (Student t-test, p < 0.001). At the time of
review the mean OHS was 16.1 (SD 4.9), the mean HHS
94.0 (SD 8.5), the mean SF-12 score 75.7 (SD 17.2) and the
mean normalised WOMAC score for pain 94 (SD 9.5) and
function 90 (SD 11.6).
All the acetabular components appeared to have solid
bony ingrowth radiologically. No radiolucent lines were
seen and none of the components had migrated. The mean
initial abduction angle was 38.0° (22.9° to 60.8°). The
mean abduction angle at the time of final review was 37.8°
(23.5° to 53.8°). No significant change was seen in inclina-
tion (paired Student t-test, p = 0.6) when comparing early
and late post-operative radiographs.
Eight hips (7.0% of the 114 hips with radiological review)
had osteolytic defects greater than 1 cm in diameter. One, as
mentioned above, had major osteolysis around a well-fixed
acetabular component and required bone grafting (Fig. 3).
Three others had osteolysis ranging from 1 cm to 3 cm in
diameter in zone I of the acetabulum. One further hip had an
osteolytic area of less than 1 cm in diameter in zone I giving a
rate of any acetabular osteolysis of 4.4% of those hips with
radiological review. In four hips major osteolysis was observed
around the femoral component. A 60-year-old woman had
osteolysis in all zones around a cementless CLS femoral
component but was asymptomatic and under regular
review. Another patient had osteolysis in Gruen zones 5
and 6 around a cemented MS30 (Zimmer) femoral compo-
nent but this was also asymptomatic. Two patients had
osteolytic defects in zone 7 (1 cm, 1.5 cm × 3 cm as
measured on the AP radiograph). Minor osteolysis (less
than 1 cm) was seen in zones 1 or 7 in seven hips. Two
cemented femoral components (SLS, Sulzer Medica,
Winterthur, Switzerland) had subsided 2 mm and 4 mm,
respectively, but were asymptomatic.
The overall rate of HO was 33% (38 of 114) (Brooker grade
1, 14, grade 2, 13, and grade 3, 11). All the patients were
asymptomatic. There was a statistically significant association
between a posterior approach and a higher mean score of HO
(mean scores, posterior 0.81, lateral 0.43; p = 0.04). There was
no association between the use of cemented or uncemented fem-
oral components and the incidence of HO (p = 0.086).
The mean linear wear rate was 0.11 mm/year (0.06 to
0.78). The wear rate was significantly higher in patients with
a steeper acetabular abduction angle (r = 0.3, p = 0.019). The
one hip revised for excessive wear had an inclination of 54°
and a wear rate of 0.78 mm/yr.
There was no statistically significant correlation between the
wear rate and the type of material of the head (p = 0.6), gender
(p = 0.98), Charnley grade (p = 0.45), approach (p = 0.99), the
age at the time of operation (p = 0.36), the body mass index
(p = 0.52) or the size of the acetabular component (p = 0.21).
No statistically significant correlation was found
between the wear rate and osteolysis (p = 0.93), or a high
abduction angle and osteolysis (p = 0.8). However, in the
subgroup of seven patients with major osteolysis or reoper-
ation, who had suitable radiographs for accurate measure-
ments there was a mean wear rate of 0.26 mm/year (0.5 to
0.78). By contrast, the group with minor osteolysis or radio-
lucent lines showed a mean annual wear rate of 0.08 mm/year
(0.05 to 0.16) and that with no radiological changes had a
mean rate of 0.10 mm/year (0.0 to 0.46).
Discussion
The rationale of the design of the Morscher acetabular com-
ponent includes the achievement of three-dimensional bony
Fig. 3
Post-operative radiograph at nine years
showing major pelvic osteolysis (arrows)
in zones I and II which was treated by
bone grafting.
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Kaplan-Meier survival curve with 95% confidence intervals (CI) for revi-
sion for any reason.
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ingrowth to the titanium mesh, the production of an implant
with relatively low stiffness to avoid stress shielding, the
avoidance of the complications inherent in a modular system
such as dissociation, the achievement of primary press-fit sta-
bility without supplementary screw fixation and the avoid-
ance of impingement by the use of the inferior bevel.12-14
There have been a number of reports from the originator’s
centre on the acetabular component alone or with a primary
focus on the femoral components used with this
implant.12,14,26 However, to our knowledge, there have been
no published results on the performance of the Morscher
implant from other centres.
In the original series, 280 hips in 261 patients underwent
THR using the press-fit component. Only one revision for
aseptic loosening was reported giving a survival rate with
aseptic loosening as the endpoint of 99.6% at a mean of
6.3 years.13 Berli et al14 reviewed the same series of patients
ten years later and reported four acetabular revisions (1.4%)
at a mean of 9.8 years and 13 (4.6%) at 15 years. The reasons
for revision included aseptic loosening in seven, excessive
polyethylene wear in three, osteolysis in one, late infection in
one and malposition of the component in one. One acetabu-
lar component was radiologically loose and another had sig-
nificant ischial osteolysis, but both were asymptomatic and
unrevised. In addition, there were seven isolated femoral revi-
sions giving a total revision rate of 7.1% (20 of 280), at
15 years. No figures were reported for femoral osteolysis.
The mean age of the original series was 71 years at operation
and 123 of the 261 patients (47%) had died at the time of the
15-year follow-up. By contrast, the mean age of our patients
was 56.9 years at the time of surgery with 64% being men.
Only two (1.7%) had died at the time of follow-up. Our total
revision rate was 2.4% at a mean of 11 years with none
undertaken for aseptic loosening.
Berli et al26 also described a separate series of patients
with a mean age of 67 years using the Morscher acetabular
component with a matt finish MS30 femoral component.
There was survival of 100% of both components at ten
years. No acetabular osteolysis was seen, but three acetab-
ular components had radiolucent lines in zone I or zone II.
In addition, 6.8% of the femoral components showed oste-
olysis and 22% had radiolucent lines.
Most cementless acetabular components are modular.
The results with first-generation components such as the
Harris-Galante acetabular component (Zimmer) have been
reasonably good with revision rates ranging from 4% to
6% at 14.9 to 16 years.4,27,28 However, if all reasons for
acetabular revision including dissociation and liner
exchanges for wear are considered the re-operation rate
increases to between 8.1% and 19%.4,28 Udomkiat et al5
reported survival rates at 12 years of 99.1% for failure of fix-
ation of the Anatomic Porous Replacement acetabular com-
ponent implanted without screws, but this rose to 79% when
liner exchange was included. Recently, Utting et al29 recorded
the 12- to 16-year results of the Harris-Galante acetabular
component in patients under 50 years of age. There was a
survival of 94% for the shell, of 84% for the shell and liner
and of 55.3% for impending revision at 16 years.
Osteolysis is often seen after THR and is thought to
be initiated by wear particles. The literature records
rates of osteolysis from 2.2% to 31% with various
metal-backed acetabular components at follow-up of up
to 18 years.4-6,27,28,30-34 Wear between the femoral head
and polyethylene liner is inevitable but backside wear
between the liner and shell may also occur in modular
components. This latter problem is considered to be due
to micromovement between the liner and the metal shell,
poor conformity between the liner and the shell and the
presence of screw holes.11,35 A non-modular acetabular
component has the theoretical advantage of increased
thickness of the liner, improved conformity and reduced
micromovement, which may reduce wear and osteolysis.
Young et al35 reported less wear and a rate of osteolysis of
2% in non-modular acetabular components compared with
22% in a matched group using a modular device after a
mean follow-up of five years. Despite this there are few
non-modular cementless acetabular components in current
use. A recent report on the titanium coated RM acetabular
component at 20 years described survival of 94% with
aseptic loosening of the acetabular component as the end-
point and 82.7% for all acetabular revisions.36 Of the 14
revisions in 93 hips, five were for loosening and seven for
osteolysis when the components were found to be well
fixed. A further eight hips had acetabular osteolysis, but
were not loose or awaiting revision. The authors concluded
that the component gave reliable long-term fixation, but
that the reduction of wear remained the challenge.36
Despite improvement in the locking mechanisms newer
designs of uncemented modular acetabular components
have still been implicated in occasional liner dissociation,
backside wear and osteolysis.37-40 For the Duraloc 100
acetabular component, osteolysis was found in 41% of the
hips at follow-up at seven years, but this may have been
related to the use of Hylamer liners.41
In our series all the acetabular components appeared to
be solidly ingrown with no radiolucent lines, no migration
and no revisions for aseptic loosening. Only eight patients
had osteolytic defects greater than 1 cm in diameter in
either the proximal femur or acetabulum with a rate of
4.6% for any acetabular osteolysis. There have been no iso-
lated femoral revisions.
The mean linear wear rate in our series was 0.11 mm/year
which is comparable to those usually reported for stainless
steel on cemented conventional ultra-high-molecular-weight
polyethylene.42 The addition of a rigid metal backing to a
cemented polyethylene component has previously been
shown to increase wear rates by 37% from 0.08 mm/year to
0.11 mm/year.43 Similar increases in wear have been
described for uncemented acetabular components.44
Berli et al14 found polyethylene wear of 0.1 mm/year for
a metal-polyethylene articulation and 0.05 mm/year for a
ceramic-polyethylene articulation in Morscher acetabular
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components with 32 mm heads. We found no difference in
the wear rate between ceramic or metal in our series using
a 28 mm head, but polyethylene wear in our study was sig-
nificantly higher in patients with a steeper abduction angle
of the component. Berli et al14 also noted increased wear
rates when the abduction angle was greater than 45°
although quantitative results were not provided. The sur-
vival of the Morscher acetabular component in this series of
young and predominantly male patients, was excellent and
similar to those of the designer’s series.14
The revision rate for the Morscher acetabular compon-
ent in both our series and those from the designer’s centre is
lower than that of both first- and second-generation modu-
lar components at a comparable follow-up if exchange of
the liner is included.14
We wish to thank Dr G. Coulter, Dr W. Leight and Mr A. Ballantyne for their work
in the early stage of the project, Mr C. Fitzpatrick, Mr B. Hodgson, Mr J. Dunbar
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Background: There are relatively few 20-year results of uncemented acetabular components, and most of
these are modular designs. This study reports the 20-year results of a monoblock press-fit acetabular
component.
Methods: A total of 122 total hip arthroplasties (111 patients) using the Morscher cup were reviewed at a
mean of 19.7 years. The average age at implantation was 57.3 years (range, 36-74 years), and 81 (66%)
were men.
Results: Twenty-two patients (25 hips) had died. Seven hips were revised, including 5 acetabular
revisions. Six patients (6 hips) declined to participate but were known not to have been revised. The
mean Oxford hip score was 41.1 (range, 22-48), and the mean reduced Western Ontario and McMaster
Universities Osteoarthritis Index score was 5.7/48 (range, 0-24). Eccentric wear was seen in 13 (15.7%)
and major osteolysis in 14 (17%) of 82 surviving hips with radiographs. The all-cause revision rate was
0.32 per 100 observed component years (95% confidence interval [CI], 0.13-0.66). The 20-year Kaplan-
Meier survival was 93.4% (CI, 86.6-96.8) for all-cause revisions, 95.5% (CI, 89.4-98.1) for any acetabular
revision, and 97.1% (CI, 91.2-99.1) for acetabular aseptic loosening, wear, or osteolysis.
Conclusion: The Morscher acetabular component has continued to performwell at 20 years despite using
conventional polyethylene with results that match or surpass other cementless acetabulae.
© 2017 Elsevier Inc. All rights reserved.Uncemented acetabular components are increasingly being
used in primary total hip arthroplasty, now accounting for 95% of
hips in Australia [1], 87% in New Zealand [2], and 63% in the United
Kingdom [3]. Despite their common use, it is still not clear whether
cementless cups confer a long-term advantage over cemented cups
[4,5], with relatively little published evidence on the longevity of
uncemented acetabular components at 20 years (Table 1). The
majority of uncemented components are modular, with many
starting to fail after 10 years due to poor locking mechanisms, wear,
and osteolysis [15e17]. Monoblock uncemented components mayd any potential or pertinent
conflict with this work. For
.1016/j.arth.2017.02.052.
S, FRACS (Orth), Department
King Street, Dunedin, New
24offer an advantage by eliminating the problems of liner dissociation
and reducing backside wear. Excellent long-term survivorship has
been reported [8,18], and they may be a cheaper alternative to
modular systems [19,20].
The Morscher cup (Sulzer Orthopedics Ltd, Baar, Switzerland),
introduced in1985, is amonoblock, cementless,flexiblepress-fit cup
[21,22]. The only long-term results are those of the designer series
with a 95.3% overall survival at 15 years [23]. We have previously
reported our independent results of the Morscher cup at 9-13 years
[24]. The purpose of this study is to provide an independent,
long-term, concise follow-up of the same cohort at 18-22 years.Patients and Methods
Between January 1994 and December 1997, 122 Morscher
acetabular components were implanted in 111 patients at either of4
Table 1
Series Reporting 20-y Results of Uncemented Acetabular Components.












Kim, 2005 [6] PCA 131 (110) 19.4 33 (25) 23 (18) Not stated 79% all cause
Belmont et al, 2008 [7] Tri-Spike (DePuy) 223 (119) 22.0 50 (22) 47 (21) 74 93.6% aseptic loosening; 85.8% all cause
Ihle et al, 2008 [8] RM Classic 93 (67) 19.8 17 (18) 14 (15) 79.7 94.4% aseptic loosening; 82.7% all cause
Della Valle et al, 2009 [9] PCA 204 (124) 20-22 74 (36) 62 (30) Not stated 86% aseptic loosening, wear, osteolysis
Howard et al, 2011 [10] Various 9584 3.2-15 Not reported 1124 (11.7) Not reported 20-y survivorship: 72.8% shell, 59.3%
shell and liner
Saito et al, 2011 [11] HG1 76 (38) 22.5 4 (5.3) 3 (3.9) 86.8 92.1% all cause
Loughead et al, 2012 [12] PCA 311 (140) 23 47 (15) 35 (11) 83 88% all cause
Stefl et al, 2012 [13] HG1 120 (42) 23 22 (18) 22 (18) 76 92% mechanical failure (wear, loosening,
osteolysis); 97% aseptic loosening
Kim, 2015 [14] DURALOC (DePuy) 342 26 Not reported 74 (22) Not stated 78%-79% all cause
This study Morscher 122 (97) 19.7 7 (5.7) 5 (4.1) 93.4 95.5% all cause; 97.1% aseptic loosening,
wear, osteolysis
HG1, Harris Galante 1; PCA, Porous-Coated Anatomic.
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sphere with an inferior bevel and has 4 layers of titanium mesh
bonded to the back of the conventional ultra-high-molecular-
weight polyethylene to eliminate the potential for backside wear.
There is no option for supplementary screw fixation (Fig. 1).
The cup was typically chosen for younger, more active patients.
The type of femoral component used, the material of the head, and
the approach were at the surgeon's discretion.
Patients were invited for clinical and radiologic review. Both
Oxford hip score (OHS) and a reduced Western Ontario and
McMaster Universities Osteoarthritis Index score (RWS) were
collected [25,26]. The RWS is a shortened version of the Western
Ontario and McMaster Universities Osteoarthritis Index score and
includes 5 pain and 7 function questions scored 0-4, where 0 is best
to give a score 0-48 [27]. Questionnaires were mailed out if the
patient declined to attend with telephone follow-up as required.
Radiologic evaluation was assessed for osteolysis using the
zones described by DeLee and Charnley [28] and Gruen et al [29].
Minor osteolysis was defined as a lucency of <1 cm in diameter and
major osteolysis as one >1 cm on either anteroposterior or lateral
view as in our previous article [24].Fig. 1. The Morscher press-fit cup.
245Ethics committee approval for this study was given by the
University of Otago Ethics Committee (Health). The study was
supported by a grant from the Wishbone Trust, New Zealand.Statistical Analysis
The sts command in Stata, version 14.1 (StataCorp LP, College
Station, TX), was used to perform the Kaplan-Meier analyses to
estimate the survival functions with patients censored at time of
death or revision.Results
A total of 122 Morscher acetabular components were implanted
in 111 patients by 5 different surgeons. The predominant underlying
pathology was osteoarthritis. The mean age was 57.3 years (36-74
years), and 80 (64%) hipswere inmen. A cemented stemwas used in
63 hips (52%), most commonly themonoblock SLS (Protek AG, Bern,
Switzerland) and an uncemented stem used in 59 (48%), mainly the
CLS Spotorno stem (Protek AG, Bern, Switzerland). A 28-mm head
was used in all cases, with 57 hips (47%) having a stainless steel head
and 65 hips (53%) having a ceramic head (Table 2). Cup sizes ranged
in women from 48 to 60 mm, with a median of 52 mm and in men
from 48 to 62 mmwith a median of 58 mm.
At the time of this review, at a mean of 19.7 years from the date
of operation, 22 patients (25 hips) had died (20%). Themean time to
death from operation was 13.8 years (6.8-19.8 years) with a
radiologic follow-up mean of 12.6 years. None of these patients had
undergone a revision procedure. Two hips had osteolytic lesions >1
cm on their last radiograph. Seven hips (7 patients) have been
revised at an average of 11.9 years (0.1-17.4 years).
There were 90 surviving hips in 82 patients (Fig. 2). Of these,
there was a radiologic review on 82 hips (91%), and patients
completed outcome scores for 64 hips (71%). Two patients who
responded to questionnaires declined to undergo an X-ray. Six
surviving patients (6 hips; 4.9%) declined to participate. All lived
locally and had no record of any further surgery. Three of these
patients had radiologic follow-up to a mean of 9.2 years (7.3-12.8
years), one of whomwas known to still have a functioning hip at 17
years. Three others without X-rays were known to have well-
functioning hips at 11, 12, and 18 years. None of these patients
had a revision of their hip arthroplasty registered on our national
joint registry. Two patients (3 hips) thought to be lost to follow-up
from the original series were found to be duplicates of other
patients due to data entry errors.
Table 2
Details of Patients, Operative Approach, and Femoral Components Used.
Age, mean (range), y 57.3 (36-74)
Gender, n (%)
Men (80 hips) 71 (64%)
Women (42 hips) 40 (36%)
Approach (hips), n (%)
Lateral 63 (52%)
Posterior 59 (48%)




Cemented stem (head material), n (%)
SLS (SS) 49 (40.2%)
Exeter (SS) 8 (6.6%)
Exeter (ceramic) 2 (1.6%)
MS-30 (ceramic) 4 (3.3%)
Uncemented stems (head material), n (%)
CLS (ceramic) 58 (47.5%)
Wagner Cone (ceramic) 1 (0.8%)
SS, stainless steel head; MS-30, Morscher-Spotorno (Zimmer-Biomet, Warsaw, IN);
SLS, self locking straight; CLS, CLS Spotorno.
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In our original report, there had been 3 revisions: one cup was
revised at 2 weeks after malposition in a dysplastic acetabulum
leading to dislocation, a cup implanted at an abduction angle of 54
was revised at 7 years for polyethylene wear in a 40-year-oldFig. 2. Status of patien
24woman with acetabular dysplasia, and a 60-year-old man required
revision for deep infection at 9.3 years at which time the acetabular
cup was found to be firmly fixed.
Since then, further 4 hips have been revised giving a total of 7
hips (7 patients) revised of the 122 hips (5.7%) with 5 acetabular
revisions (4.1%). Two patients had isolated acetabular revision for
osteolysis at 15.3 and 17.4 years, respectively. There were only 2
femoral revisions: one was due to an open periprosthetic femoral
fracture sustained in a mining accident at 16.7 years and the other
was for aseptic loosening of a cemented femoral component at 17
years. In both cases the cup was well-fixed at the time of revision
surgery.
In addition, 2 patients underwent open reduction and internal
fixation of periprosthetic femur fractures (at 0.1 and 11 years). One
remained unrevised at the time of death at 17.1-year follow-up and
the other declined to participate but was known to be functioning
and unrevised at 17 years. Another patient underwent bone graft-
ing of a major osteolytic defect behind a well-fixed acetabulum at
10 years with the acetabular component left in situ. This hip re-
mains unrevised at 20 years but shows recurrent osteolysis around
both the cup and the stem.Survivorship
The all-cause revision rate was 0.32 per 100 observed compo-
nent years (ocy; 95% confidence interval [CI], 0.13-0.66). The
Kaplan-Meier curves at 20 years are shown in Figure 3. Theyts at final review.
6
Fig. 3. (A) Kaplan-Meier survival curve for all-cause revision, (B) Kaplan-Meier survival curve for acetabular revision, and (C) Kaplan-Meier survival curve for acetabular wear,
loosening, and osteolysis. CI, confidence interval.
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(CI, 86.6-96.8) and 95.5% survival (CI, 89.4-98.1) for acetabular
revision for any cause. The acetabular survival for aseptic loosening,
wear, or osteolysis was 97.1% (CI, 91.2-99.1).
Clinical and Radiologic Outcomes
Patient reported scores were available for 64 of 90 (71.1%) sur-
viving unrevised hips at mean follow-up of 18.4 years (17.1-20.7
years). The mean OHS was 41.1 (range, 22-48), with 85% good to
excellent scores. The mean RWS was 5.7/48 (11.9%; range, 0-24).
Radiology was available for 108 of 122 hips (89%), including
those revised or deceased with mean radiologic follow-up of 17.1
years (9.8-20.7 years). The distribution of osteolytic lesions for the
whole series is shown in Figure 4.
Of the 82 surviving hips with a radiologic review, no acetabular
components showed any radiologic evidence of loosening. Major
osteolysis was seen in 14 (17%) and eccentric wear in 13 (15.7%).
None of these hips are symptomatic, and no revisions are planned.
There was a major lysis behind the acetabular component in 7 hips
(8.5%), of which 3 cups showed eccentric wear. In addition, there
was a minor lysis behind the acetabular component in 10 hips
(12%), mainly in zones I and II. On the femoral side, major osteolysis
was seen in 8 hips (9.8%) and minor lysis around the femoral
component in 16 hips (20%).
Of the 8 hips that showed major osteolysis in the original series,
2 have died and 2 hips have been revised. One, as mentioned
previously, was bone grafted and remains unrevised. Of the
remaining 3 hips, 1 has shown significant progression but has not
required revision and 2 remain essentially unchanged. There247appeared to be no relationship between head material, femoral
fixation, and osteolysis or wear.
Discussion
TheMorscher cup in this series has continued to functionwell at
20-year follow-up with results that match or surpass other unce-
mented components, whether modular or monoblock. Despite the
popularity of cementless cups, there are few 20-year results pub-
lished, and these are mainly for modular first-generation designs
such as the Harris-Galante (HG1; Zimmer, Warsaw, IN) and the
Porous-Coated Anatomic (Howmedica, Rutherford, NJ) [6,7,9e14]
(Table 1). Although results of 86%-96% have been reported for
acetabular shell survival, if liner exchanges, impending revisions,
and other reoperations are included, the survival drops to 55%-74%
[7,9,10,13,30,31].
More modern designs may have improved results. McLaughlin
and Lee [32] reported 98% acetabular survival at 16 years with a
threaded hemispheric titanium shell and Rozkydal et al [33] re-
ported 86.6% radiologic survivorship of the CLS expansion cup at 16
years. However, Hallan et al [16] from the Norwegian registry re-
ported that none of themodular cups in their study had satisfactory
long-term results due to high rates of wear, osteolysis, aseptic
loosening, and dislocation. Howard et al [10] also noted an
increased risk of revisions in the second decade for these reasons
and found no evidence that more recently introduced designs
performed better than the HG1 cup.
The Morscher cup was designed and introduced in 1985. Berli
et al [23] reported 95.5% survival at 15 years for revision of any
cause in the designer series of 280 hips. There were 13 acetabular
Fig. 4. Distribution of osteolytic lesions seen for the 108 hips with radiologic review
including hips before revision (major >1 cm diameter, minor <1 cm diameter).
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of 20 of 280 (7.1%) at 15 years. The average age of the original cohort
was 71 years at operation, and 123 of the 261 patients (47%) had
died at the time of the 15-year follow-up.
Garavaglia et al [34] reported on a large series of 561 hips using
theMorscher cup at 10 years. Themean agewas 69.3 years, and 55%
were women. There was 98.8% cup survival with no revisions for
acetabular loosening. They reported no acetabular osteolysis but
8.3% stem osteolysis. However, they had only 59.7% follow-up.
In contrast to these series, the average age of our patients was
57.3 years at the time of surgery, with 66% being men. At 20 years,
there was 93.4% survival for revision for any cause, 95.5% survival
for acetabular revision for any cause, and 97.1% survival for
acetabular aseptic loosening, wear, or osteolysis. Other surgeons
may have revised the cup that was bone grafted at 10 years for
osteolysis and the femoral revision for osteolysis could be sec-
ondary towear debris. If we include these cases, the survival for any
wear-related reoperation of acetabulum or femur is still 95.2% (CI,
88.8-98.0) at 20 years.
These results compare favorably with the designer's series at a
longer term follow-up. Technical errors contributed to the imme-
diate revision at 2 weeks for dislocation and to the cup revised at 7
years for excessive polyethylene wear due to a steep abduction
angle. The inferior bevel of the Morscher cup makes it more
demanding to insert with the correct abduction angle.
The revision rate in this series of 0.32 per 100 ocy is lower than
that for the Morscher cup in our national joint registry of 0.49/100
ocy in combinationwith the CLS stem and 0.42 to 0.65/100 ocy with
cemented stems (Exeter andMS-30) [2]. It compares favorably with
the average revision rate in our registry of 0.73/100 ocy [2].
The rate of acetabular osteolysis (major 8.5%, minor 12%) and
eccentric wear (16%) of surviving hips in our series is concerning24and has progressed from our earlier study. We attribute this to the
use of conventional polyethylene. The lowest reported rates of
acetabular osteolysis at 20 years are 8%-13% [8,13]. However, rates
of 30%-54% are more typical with modular cups [6,7,9,14].
Like Garavaglia et al [34], we have seen no cases of acetabular
loosening either at revision or radiologically, whereas Berli et al
[23] reported only 2.9% acetabular loosening. The same mesh is
used in the modular Fitmore cup (Zimmer Inc, Warsaw, IN), which
has 100% survival for aseptic acetabular loosening and 94% survival
for all-cause revision at 12 years [35].
The long-term patient-reported scores are surprisingly good
and may reflect the relatively young age at time of operation. The
average OHS of 41.1 and 85% with good or excellent results com-
pares well with our joint registry 10-year average of 41.9 with 87%
good and excellent scores [2].
Other monoblock cups have promising long-term results. The
RM cup (Mathys Ltd Bettlach, Bettlach, Switzerland), like the
Morscher, is a relatively flexible cup but has a coating of pure ti-
tanium particles instead of the 4-layer titanium mesh [8,19]. Ihle
et al [8] reported 94.4% survival of the RM cup at 20 years for aseptic
loosening and 82.7% for all acetabular revisions. Biemond et al [36]
reported on 100 hips aged <50 years using the CLS stem with the
RM cup at 18.4 years. There were 15 revisions giving approximately
80% survival for all-cause revision at 19 years.
Other monoblock designs have used polyethylene compression
molded into a shell, which may result in a stiffer cup [18,37].
Poultsides et al [37] reported no revisions for osteolysis or loos-
ening at 10-15 years using a cup with a titanium backing. Recently,
De Martino et al [18] reported 100% cup survival for aseptic loos-
ening and 96.3% survival for all-cause revision at 15 years in a series
of 63 hips using a tantalum monoblock cup.
Despite these results, systematic reviews have not shown any
advantage of a monoblock over a modular cup concluding that the
purported advantages are not substantiated by lower wear rates,
frequency of cup failure, or acetabular osteolysis [38] and that both
third-generation modular cups and monoblock cups had consis-
tently good results [39].
Strengths of this study are the low loss to follow-up and the low
death rate in the cohort at 20 years due to their relatively young age
at operation. It is a consecutive series of the first 122 hips using the
Morscher cup, so, it includes the learning curve. Several surgeons
were involved, and therewere no exclusions. Aweakness is that it is
a retrospective review and a variety of femoral components were
used. Although there is no complete radiologic and clinical follow-
up, we are confident that there have been no revisions in those
patients who declined to participate.
The Morscher cup, in our series, has results that match or sur-
pass other uncemented cups at 20-year follow-up. There have been
no cases of acetabular loosening. We attribute the concerning
osteolysis rates to the use of conventional polyethylene. The com-
bination of the monoblock design to eliminate backside wear, the
flexibility of the cup, which may reduce polyethylene wear, and
titanium mesh for fixation appears to be factors in its success. The
Morscher cup is no longer available; however, long-term results
such as these can be used to guide future implant design. A similar
design with a modern highly cross-linked polyethylene would be a
logical development.
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Background: Despite increased use of uncemented and hybrid fixation, there is little evidence of their
superiority over cemented implants. The aim of this study is to compare the long-term survivorship of
cemented, hybrid and uncemented total hip arthroplasty (THA) at varying ages.
Methods: A total of 2156 hips (1315 cemented, 324 uncemented, and 517 hybrid) were performed in a
single center between 1999 and 2005 with follow-up through to 2017. Registry and local databases were
used to determine revision rates and cause. Unadjusted and adjusted competing risk survival analysis
was performed.
Results: The cumulative incidence of all-cause revision at 18 years was cemented 10.9%, uncemented
8.9%, and hybrid 6.5%. Cemented fixation had a statistically significant higher risk of all-cause revision
than hybrid in the adjusted model for all ages to 65 years (subhazard ratios [SHRs], 2.28-4.67) and a
higher risk of revision for loosening, wear, or osteolysis at all ages (SHRs, 3.25-6.07). Uncemented fixation
showed no advantage over hybrid fixation at any age, but did show advantages over cemented at younger
ages (60 years) for all-cause revision (SHRs, 2.3-4.3).
Conclusion: Hybrid fixation with conventional polyethylene shows an advantage over cemented hips at
all ages. Uncemented THA showed improved survival over cemented only at younger ages and no
advantage over hybrid THA.
© 2019 Published by Elsevier Inc.Total hip joint arthroplasty (THA) is a highly successful pro-
cedure with impressive long-term survival and low revision rates.
The average age of patients undergoing THA is 68-70 years so many
patients will die with unrevised components. However, increasing
life expectancy and the demand for surgery in younger patients
mean that an implant must often last through the second and even
third decades. Age is known to be a determinant of outcome with
younger patients having higher revision rates. The debate on theclosed potential or pertinent
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250best mode of fixation continues. Cemented stems have excellent
long-term results, but cemented cups have been less successful
although some of the implants used are now considered obsolete
[1e5]. First-generation, uncemented, acetabular components had
problems especially with locking mechanisms and accelerated
polyethylene wear after 10 years [6,7]. However, newer designs
with the use of highly cross-linked polyethylene liners have
resulted in low wear, significantly improved rates of osteolysis, and
improved survival rates [8e10,11]. There has also been increased
use of monoblock flexible uncemented cups with excellent long-
term results [12,13].
In New Zealand and elsewhere, there has been a shift away from
cemented THA over the last 20 years to uncemented or hybrid
components [8e10]. However, despite their increased use, there is
little evidence to show their superiority over cemented THA
[8e10,14]. This has been termed the uncemented paradox [15].
A.-K. Fowler et al. / The Journal of Arthroplasty 34 (2019) 2711e27172712Uncemented components may have an increased rate of early
revision most commonly due to dislocation, infection, or fracture.
However, the anticipated improvement in survival curves at longer
follow-up has yet to be seen [8e10]. Some registry data suggest that
uncemented or hybrid fixation may have improved survivorship in
younger patients while cemented fixation has better results in
older patients [8e10].
There is increasing pressure from funders to limit choice of
implant and mode of fixation. This is not new; cost constraints and
a desire to follow evidence-based practice led to the development
of a cement-only policy between 1999 and 2004 in our public
hospital with exceptions only allowed after discussion at a
departmental meeting. Therewas unrestricted choice at our private
hospital. As a consequence of this, we have observed that the
commonest revision we see is for aseptic loosening of cemented
acetabulae in the second decade after THA, while it has been very
unusual to revise uncemented or hybrid hips despite their use in
younger, more active patients.
Our hypothesis therefore is that all cemented THA has higher
revision rates due to acetabular loosening than hybrid and unce-
mented THA at long-term follow-up. The primary aim of this study
is to investigate long-term survival of cemented, uncemented, and
hybrid THA with the end points of all-cause revision for and revi-
sion for loosening, wear, and osteolysis. The secondary aim is to
determine whether this varies with age.
Methods
Setting and Patients
Our public hospital services around 200,000 patients spread
over a large geographic area with one major city of 140,000 and a
large rural farming population. There is also a private hospital with
themajority of surgeons operating at both hospitals. Over the study
period, there were 8 surgeons performing THA using a variety of
implant systems. All had extensive experience of both cemented
and uncemented systems which were introduced to our hospital
during the 1990s.
All patients who had undergone THA between July 1999 and
December 2004 at either of our hospitals were identified from the
New Zealand National Joint Registry (NZJR) which has 98% compli-
ance [8]. Data collected included details of diagnosis, implants used,
date of death, surgeon grade, and date and reason for revision. Our
departmental database was used to search for any revision proced-
ure including excision arthroplasty and cross-referenced to theNZJR
records. All reasons for revision were checked through use of elec-
tronic patient chart and radiological records and the primary reason
for revision noted. We excluded THA for acute hip fracture but
included all other indications for surgery.Table 1
Demographic Details of All Patients.
Details of Procedures and Patients All Procedur
Total
Number of procedures 2156
Public, n (%) 1333 (61.8)
Approach posterior (%) 797 (37.0)
Number of revisions (%) 163 (7.6)
Time to revision (y) for those with a revision event, mean (SD) 8.8 (4.2)
Revision rate/100cys (95% CI) 0.64 (0.55-
Distinct patients 1888
Age mean (SD), y 65.6 (11.6)
Sex male, n (%) 890 (47.1)
Deaths, n (%) 712 (37.7)
SD, standard deviation; CI, confidence interval.
25The demographic details are detailed in Table 1. The commonest
reason for THA was osteoarthritis (89%). The mean age of patients
undergoing uncemented and hybrid hips was younger than that for
cemented THA. A lateral approach was used in 1357 (63%) hips and
a posterior approach in 797 (37%). Two hips underwent a
trochanteric osteotomy and were included in the lateral group for
statistical analysis.
The most frequently used cemented combinations were Exeter/
Contemporary (Stryker, Kalamazoo, MI) and Muller straight stem
(SLS)/Muller low profile Polyethylene cup (Zimmer, Winterthur,
Switzerland). The CLS Spotorno (Zimmer) was the most frequently
used uncemented stem. A variety of uncemented cups were used
including the Morscher Press Fit (Sulzer Orthopaedics, Baar,
Switzerland), Fitmore (Zimmer), CLS Expansion cup (Zimmer),
Reflection (Smith and Nephew, Memphis, TN), RM Pressfit (Mathys
Ltd Bettlach, Switzerland), and Trident (Stryker).Surgical Technique
Spinal anesthesia was used routinely. Perioperative antibiotics
(cefazolin) were given on induction and for 24 hours. Thrombo-
prophylaxis was at surgeon discretion but was either aspirin or
low-molecular-weight heparin for standard-risk patients and
warfarin for patients at high risk of deep vein thrombosis or pul-
monary embolism. Tranexamic acid was not used routinely during
this period.
For cemented cups, the acetabulum was reamed using sequen-
tial hemispherical power reamers. Cysts were de-roofed and a
combination of pits and multiple drill holes made with the aim of
producing a porous bed of bone for cementation. Medial wall bone
graft was used as required. Hydrogen peroxideesoaked gauze was
used to dry the acetabulum after pulsed lavage. Cement was
pressurized using a commercially available pressurizer. Poly-
methylmethacrylate beads were present on the Reflection All Poly
cup (Smith and Nephew) and Contemporary cups (Stryker). All
polyethylene was standard (not highly cross-linked) for the
cemented cups.
Cemented stems were inserted using third-generation tech-
niques. After preparation of the canal with broaches, a cement
restrictor was inserted. The canal was cleaned with pulsed lavage
and a brush and packed with hydrogen peroxide or saline-soaked
gauze. The cement was vacuum mixed and inserted with a retro-
grade technique using a cement gun and a proximal pressurizer.
Insertion of uncemented cups was according to manufacturer’s
instructions. A press fit was obtained usually by under-reaming by
1-2mm. Supplementary screwswere used if required. Uncemented
stems were inserted after appropriate preparation with implant-
specific broaches.es Uncemented Hybrid Cemented
324 517 1315
112 (34.6) 158 (30.6) 1063 (80.8)
148 (45.7) 176 (34.0) 473 (36.0)
21 (6.5) 26 (5.0) 116 (8.8)
6.2 (4.4) 9.5 (5.0) 9.2 (3.8)
0.75) 0.51 (0.32-0.78) 0.38 (0.25-0.56) 0.80 (0.66-0.96)
278 448 1186
51.7 (9.2) 60.3 (8.7) 70.8 (9.2)
175 (62.9) 249 (55.6) 478 (40.3)
30 (10.8) 80 (17.9) 609 (51.3)
1
Table 2
Details of Reasons for Revision for Each Fixation Group.
Reason for Revision Uncemented (N ¼ 324) Hybrid (N ¼ 517) Cemented (N ¼ 1315) Total (N ¼ 2156)
Acetabular loosening 2 (0.6%) 3 (0.6%) 60 (4.5%) 65 (3%)
Femoral loosening 3 (0.9%) 9 (1.7%) 12 (0.9%) 24 (1.1%)
Both loose 0 1 (0.2%) 17 (1.3%) 18 (0.8%)
Wear 4 (1.2%) 0 1 (0.07%) 5 (0.2%)
Osteolysis 0 1 (0.2%) 2 (0.14%) 2 (0.1%)
Dislocation 8 (2.5%) 6 (1.2%) 5 (0.4%) 19 (0.9%)
Infection 1 (0.3%) 1 (0.2%) 12 (0.9%) 14 (0.6%)
Fracture 2 (0.6%) 4 (0.8%) 7 (0.5%) 13 (0.6%)
Other 1 (Cup malposition) 1 (Pain) 0 2 (0.1%)



























Fig. 1. All-cause revision: unadjusted competing risk regression with death as
competing cause.
A.-K. Fowler et al. / The Journal of Arthroplasty 34 (2019) 2711e2717 2713The head size was 28 mm in 1996 hips, 22 mm in 143, 32 mm in
14, 36 mm in 2, and 38 mm in 1 hip. The head material was metal
(stainless steel or chrome cobalt) in 1708 hips (79%) and ceramic in
448 (21%).
Conventional polyethylene was used for 2147 hips (95.7%),
highly cross-linked polyethylene for 93 (4.1%), and ceramic on
ceramic and metal on metal for 2 hips each.
Statistical Methods
Statistical analysis was performed using revision for any reason
as the primary end point with aseptic loosening, wear, or osteolysis
as a secondary end point. A competing risks survival analysis (with
death as a competing risk for all analyses and revision for other
reasons added as a competing risk for models investigating specific
reasons for revision) adjusting for age (as a continuous variable
which was allowed to interact with cementing group), gender,
public or private hospital, surgical grade (consultant vs trainee),
approach (posterior vs other), and bearing surface was undertaken.
Nonlinearities in the association with age were investigated, and
where appropriate modeled, through the addition of a quadratic
term with retention based on the lowest Akaike Information Cri-
terion value. Multiple procedures on the same patient (left and
right hips) were accommodated by using robust clustered (by pa-
tient) standard errors. Cumulative incidence curves were used to
show differences between cementing groups, including at selected
ages in the models including age. Analyses were performed using
Stata 15.1 with 2-sided P < .05 considered statistically significant.
Results
The revision rate/100 observed component years (ocys) was
significantly higher for cemented hips (0.80/100ocys) than hybrid
hips (0.38/100ocys). The rate for uncemented hips (0.51/100ocys)
was not significantly different from either of the other 2 groups
(Table 1).
Details of reasons for revision are given in Table 2. The com-
monest reason for revision was isolated acetabular loosening in
cemented THA. In the uncemented group, dislocation was the
commonest cause for revision (8/324 hips, 2.5%), which was
significantly higher than for cemented hips (5/1315, 0.4%; P¼ .001).
Acetabular failure due to loosening, wear, or osteolysis was signif-
icantly higher for cemented (80/1315, 6.1%) than hybrid (5/517,
1.0%) and uncemented hips (6/324, 1.9%; P ¼ .001).
Survival Analysis
All-Cause Revision and Revision for Loosening, Wear and Osteolysis
The cumulative incidences of all-cause revision at 18 years,
allowing for the competing risk of death, were 10.9% (cemented),
8.9% (uncemented), and 6.5% (hybrid) (Fig. 1).252There was a significantly greater risk for cemented compared to
hybrid (P ¼ .011) but no difference between cemented and unce-
mented (P ¼ .390) or between uncemented and hybrid (P ¼ .282).
The corresponding figures for revision for loosening, wear, or
osteolysis were 8.8% cemented, 3.8% uncemented, and 3.5% hybrid
(Fig. 2). There was a higher risk for cemented compared to both
uncemented (subhazard ratios [SHRs], 2.36; 95% CI, 1.11-5.01; P ¼
.026) and hybrid (SHRs, 2.57; 95% CI, 1.46-4.53; P ¼ .001) but not
between the uncemented and hybrid groups (P ¼ .848).
Effect of Age
All-Cause Revision
There was an age-cementing interaction with evidence that
cemented had higher risk compared to both uncemented and
hybrid at age 50 (SHRs, 4.34 and 4.84, respectively, both P < .001),
age 55 (SHRs, 3.16 and 3.83, both P < .001), and age 60 (SHRs, 2.30
and 3.03, both P  .012). Cemented had higher risk compared with
hybrid at age 65 (P ¼ .001) and age 70 (P ¼ .050), but there was no
evidence of differences at age 75 (Table 3).
Adjusting for gender, bearing combinations, hospital, approach,
and surgeon level did not alter the pattern of results as shown
above although the SHRs were attenuated (Fig. 3, Table 3).
Cemented hips had a higher risk of revision compared to hybrid at
ages 50 to 65 (all P  .026) but with no evidence of differences at
ages 70 or 75. Cemented hips had a significantly higher risk of
revision than uncemented at ages 50 and 55 (both P  .026).
Uncemented fixation had higher SHRs than hybrid at all ages in the
fully adjusted model (1.39 to 1.97) and compared with cemented at
age 75 (1.4) but none reached statistical significance. None of the
other variables in the model were statistically significant.
Table 3
Subhazard ratios (SHRs) for All-Cause Revision and Revision for Loosening, Wear, and Osteolysis at Varying Ages. Fully AdjustedModel Includes Gender, Bearing Combinations,






SHRs SHRs (95% CI) SHRs (95% CI)
All-cause revisions Unadjusted .038 1.00 1.39 (0.76-2.55) 1.74 (1.13-2.67)
Adjusted for age .007
50 1.00 1.12 (0.57-2.18) 4.84 (2.76-8.49)
55 1.00 1.21 (0.64-2.29) 3.83 (2.41-6.10)
60 1.00 1.32 (0.64-2.74) 3.03 (1.94-4.74)
65 1.00 1.44 (0.57-3.61) 2.40 (1.44-4.02)
70 1.00 1.56 (0.49-4.98) 1.90 (1.00-3.62)
75 1.00 1.70 (0.41-7.03) 1.51 (0.68-3.37)
Fully adjusted .007
50 1.00 1.39 (0.67-2.91) 4.67 (2.48-8.77)
55 1.00 1.49 (0.72-3.09) 3.68 (2.10-6.43)
60 1.00 1.60 (0.70-3.65) 2.89 (1.66-5.05)
65 1.00 1.71 (0.63-4.65) 2.28 (1.22-4.26)
70 1.00 1.84 (0.55-6.19) 1.80 (0.85-3.79)
75 1.00 1.97 (0.46-8.44) 1.41 (0.58-3.47)
Loosening, wear,
and osteolysis
Unadjusted <.001 1.00 1.09 (0.45-2.65) 2.57 (1.46-4.53)
Adjusted for age <.001
50 1.00 0.66 (0.26-1.65) 6.63 (3.52-12.51)
55 1.00 1.05 (0.43-2.56) 5.98 (3.30-10.84)
60 1.00 1.68 (0.65-4.37) 5.39 (2.90-10.03)
65 1.00 2.70 (0.91-8.03) 4.86 (2.40-9.82)
70 1.00 4.32 (1.20-15.54) 4.38 (1.92-10.01)
75 1.00 6.92 (1.54-31.04) 3.95 (1.49-10.47)
Fully adjusted <.001
50 1.00 0.92 (0.30-2.79) 6.07 (2.88-12.80)
55 1.00 1.39 (0.48-4.08) 5.36 (2.60-11.04)
60 1.00 2.12 (0.70-6.43) 4.73 (2.22-10.09)
65 1.00 3.22 (0.95-10.84) 4.17 (1.80-9.70)
70 1.00 4.88 (1.24-19.26) 3.68 (1.40-9.68)
75 1.00 7.41 (1.55-35.49) 3.25 (1.07-9.90)























































































































Fig. 2. Revision for loosening, wear, and osteolysis: unadjusted competing risk regression with death and revision for other reasons as competing risks.



























Fig. 3. All-cause revision at differing ages: competing risk regression with death as
competing cause. Fully adjusted model includes gender, bearing combinations, hos-
pital, approach, and surgeon grade.
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Again there was an age-cementing interaction with evidence
that cemented had higher risk compared to hybrid at all ages (SHRs
between 3.95 and 6.63, all P .006; Table 2). Cemented fixation had
a higher risk of revision than uncemented at ages 50, 55, and 60
(SHRs between 3.2 and 10.1, all P  .004).
Adjusting for gender, bearing combinations, hospital, approach,
and surgeon level again did not alter the pattern of results (Fig. 4,
Table 2). Cemented fixation had higher risk than hybrid at all ages
(SHRs, 3.25-6.07) and a higher risk compared to uncemented at age
50 (SHRs, 6.61; P < .002) and age 55 (SHRs, 3.84; P ¼ .026). Unce-
mented THA had a significantly higher risk than hybrid at ages 70












































































Fig. 4. Revision for loosening, wear, and osteolysis at differing ages: competing risk regres
includes gender, bearing combinations, hospital, approach, and surgeon grade.
254uncemented THA and hybrid or cemented THA reached statistical
significance. None of the other variables in the model were statis-
tically significant.Discussion
Wehave shown that cemented THA has the highest revision rate
and hybrid THA has the lowest revision rates at 18 years in all age-
groups when using the competing risk of death. This study
confirmed our observation that loosening of cemented acetabulae
is the most frequent cause of revision. There was an increased rate
of revision for aseptic loosening, wear, and osteolysis in the
cemented group even in patients aged 75 years at surgery. Unce-
mented fixation had an advantage over cemented fixation in pa-
tients aged 60 and younger. At no age did uncemented THA have
improved survivorship compared with hybrids. These findings give
support to the use of hybrid fixation for THA which combines the
advantages of an uncemented acetabular component with a
cemented stem and helps justify the decrease in the use of all-
cemented fixation to less than 10% seen in New Zealand [8]. The
Public Hospital cement-only policy gave an opportunity to perform
this study. Although based on evidence available at the time, it
appears to have contributed to additional revision procedures pri-
marily for acetabular loosening in patients aged less than 65 years
by removing surgeon choice.
The superior performance of uncemented cups in this series is at
odds with the published literature. Clement et al in a comprehen-
sive literature review, including registry results, concluded that the
overall survival of cemented cups was superior to the uncemented
alternatives and it remained the optimal mode of fixation for older
patients due to predictable outcome and lower cost. They
concluded that there was no significant evidence that younger
patients benefit from uncemented cups [14]. Howard et al sum-
marized the results using different uncemented cups over 20 years.















































sion with death and revision for other causes as competing risk. Fully adjusted model
A.-K. Fowler et al. / The Journal of Arthroplasty 34 (2019) 2711e27172716decade with none of the newer implants showing significant im-
provements [7]. Hallan et al [6] reported 81%-92% survival of
uncemented cups at 10 years with few problems until 7 years, but
no system had satisfactory long-term results.
Makela et al [16] summarized the results of the combined
Nordic registries. Cemented hips had the best survivorship at 10
years in all ages from 55 years and older and were significantly
better than hybrids. They found increased risk of early revisionwith
uncemented due to fracture or early aseptic loosening and
concluded that the increasing use of uncemented implants in pa-
tients over 65 years was not supported [16]. A recent meta-analysis
concluded that there is a tendency toward improved outcomes
with cemented compared to both uncemented and hybrid fixation
[17]. However, the studies included in the analysis all contained
older prosthesis, some of which are no longer in use, and therefore
results may not represent those of modern prostheses.
The NZJR still reports that cemented cups have the lowest
revision rate and have improved survivorship at all time periods
out to 18 years with 86.1% survival for cemented, 84.5% for unce-
mented, and 84.1% for hybrid hips [8]. For comparison, the Kaplan-
Meier (KM) revision-free rates in our series were 83.3% (cemented),
92.3% (uncemented), and 90.7% (hybrid) at 18 years. The difference
appears to be due to the improved survival of uncemented
acetabular components in our series rather than the poor perfor-
mance of cemented cups.
In this study, we used competing risk regression, which gives a
more relevant estimate of revision rates than the KM analysis. In a
competing risk regression, if a patient dies it precludes the chance
of them having a revision. Similarly, revision for another reason also
precludes the chance of a cause-specific revision [18e20]. In
younger patients with low death rates even at long-term follow-up,
it more closely approximates the KM figure than in older patients
where the KM figure may overestimate revision rates. Despite this,
we still showed that cemented fixation was associated with higher
revision rates than hybrid fixation even in older patients.
Age is a determinant of outcome with younger age associated
with poorer outcomes and survivorship of 30%-61% at 20-25 years
[21e23]. Sochart and Porter [21] reported 54% survival at 25 years in
patients under 40 years of age using cemented Charnley implants.
Swarup et al [22] found no difference between cemented and
uncemented implants in patients under 35 years.While Corten et al
[23] reported improved survival with uncemented fixation (56%)
compared with cemented fixation (30%) at 20 years in patients
under 65 years. Our revision rate of approaching 35% for cemented
cups in younger age-groups compares quite favorably with these
reports. The revision rate for hybrid THA remained relatively con-
stant for all ages and was less than 10% even at age 50 years.
The NZJR has shown differing revision rates between compo-
nent fixation when stratified by age [8]. Cemented hips perform
better than hybrids and uncemented in the over 75-year age-group.
Uncemented hips have significantly lower revision rates than
hybrid in the under 55 age-group and higher rates than both
cemented and hybrids in the over 75-year-old group. Hybrid hips
have significantly lower revision rates than cemented hips for pa-
tients aged 64 and under and no significant difference in those 65-
74 years [8,24]. We saw a similar patternwith hybrids having lower
rates than cemented but found no evidence that hybrid fixationwas
worse than cemented in patients older than 75 years.
In contrast, the Norwegian Joint Replacement Register found no
significant age stratification [25]. Both cementless and hybrid fix-
ation had significantly higher relative risks of revision compared to
cemented fixation across 1987 to 2016 (relative risk¼ 1.32 and 1.22,
respectively); however, when analyzing the data based on modern
prostheses and new surgical techniques (2006-2016), there were
no significant differences [25]. In the combined Nordic registries,25hybrid fixation had worse 10-year survivorship than cemented or
uncemented in patients aged younger than 55 years (68.5% vs 77.4%
cemented, 75.6% uncemented) and aged 55-64 years (90.0% vs
92.2%, 91.8%) [26]. We found similar survivorship for cemented
cups but much improved results with the hybrid group.
The England andWales Joint Registry report that cemented THA
had the lowest rate of revision at 14 years (4.88%) with hybrid THA
(5.38%) and uncemented the highest (8.9%). However, hybrid hips
had the lowest revision rate in patients under 65 years and the
lowest rates of aseptic loosening [9]. The Australian Joint Registry
limited their analyses in the 2017 reports to exclude those using
conventional polyethylene and metal-on-metal combinations [10].
Hybrid fixation with modern bearing surfaces had a cumulative
revision rate of 6% at 16 years [10]. They found no difference be-
tween fixation type in patients under 65 years, while uncemented
fixation had higher revision rates than hybrid in patients over 65
years, and higher than both cemented and hybrid in patients older
than 75 years. Our series differs in that we are reporting the use of
conventional polyethylene which has inferior long-term results to
highly cross-linked polyethylene.
Strengths and Limitations
Strengths of this study are that it is a large single-center series
which helps to reduce some of the confounders inherent in pooled
registry data such as multiple implant combinations, differing
modes of failure at different time intervals, varying bearing surfaces
and head sizes, surgeon variation, and failure to report all revisions.
It has long-term results up to 18 years which is important as many
implants start to fail after 10 years. Therewere relatively low rates of
revision for infection and dislocation so these results aremore likely
to represent the results of implant and fixation choice. The surgeons
were all experienced in cemented and uncemented techniques.
A limitation is that this is an observational study and the groups
were not randomized. Therefore, residual confounding from other
variables not included in our adjusted models, such as comorbid-
ities, cannot be ruled out. We have good survivorship data from our
NZJR and local audit databases but do not have clinical and radio-
logical evidence for all hips, which would be unrealistic in a study
group of this size.
The cement-only policy allowed us to compare cemented THA
with the uncemented and hybrid groups with little selection bias.
However, there was potentially significant selection bias between
the uncemented and hybrid groups. The uncemented group was
relatively small compared with the other groups, which meant that
despite apparently large SHRs the results did not reach statistical
significance due to wide confidence intervals. Therefore, it is only
possible to conclude that hybrid THA did not show any statistically
significant advantage over uncemented THA except for revision for
wear, loosening, and osteolysis in older patients. However, unce-
mented THA did show an advantage over cemented THA in younger
patients. Larger studies and longer-term follow-up is required to
determine whether there are significant differences between
hybrid and uncemented THA.
Many different implant combinations were used and not all
implants within a class may perform equally [27,28]. The polished
Exeter stem and Muller straight stem have excellent results but
good cementing technique is critical. Some of the other cemented
stems used in this series such as the Spectron (Smith & Nephew,
Memphis, TN) have been less successful [8].
Conventional polyethylene and 28-mm heads were used in the
majority of cases. Very few large head sizes or hard-on-hard bear-
ings more commonly used in uncemented systems were used. Not
all of these combinations have been successful and can confound
registry results. Conventional polyethylene is rarely used these days5
A.-K. Fowler et al. / The Journal of Arthroplasty 34 (2019) 2711e2717 2717so the results may not be generalizable to modern practice; how-
ever, the use of cross-linked polyethylene may be expected to
improve results in all groups.
Conclusion
Hybrid THA, when using conventional polyethylene, showed
improved long-term survival over cemented fixation at all ages and
some advantage over uncemented fixation at older ages. Cemented
fixation remains a reasonable option in those patients aged 70 and
over, but there was still a higher risk of revision for aseptic loos-
ening, wear, or osteolysis. Uncemented THA did not show any
statistically significant advantage over hybrid fixation but did show
an advantage over cemented THA in younger patients. This gives
support for the trend toward increased use of uncemented fixation
of the acetabulum.
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Cemented or uncemented acetabular fixation 
in combination with the Exeter Universal 
cemented stem
LONG- TERM SURVIVAL TO 18 YEARS
Aims
To compare long- term survival of all- cemented and hybrid total hip arthroplasty (THA) 
using the Exeter Universal stem.
Methods
Details of 1,086 THAs performed between 1999 and 2005 using the Exeter stem and either 
a cemented (632) or uncemented acetabular component (454) were collected from local 
records and the New Zealand Joint Registry. A competing risks regression survival analy-
sis was performed with death as the competing risk with adjustments made for age, sex, 
approach, and bearing.
Results
There were 61 revisions (9.7%; 0.82 revisions/100 observed component years, (OCYs)) in 
the all- cemented group and 18 (4.0%; 0.30/100 OCYs) in the hybrid group. The cumulative 
incidence of revision at 18 years was 12.1% for cemented and 5.2% for hybrids. There was 
a significantly greater risk of revision for all- cemented compared with hybrids (unadjusted 
sub- hazard ratio (SHR) 2.44; p = 0.001), and of revision for loosening, wear, or osteolysis 
(unadjusted SHR 3.77; p < 0.001). After adjustment, the increased risk of all- cause revision 
did not reach significance at age 70 years and above. The advantage for revision for loosen-
ing, wear, and osteolysis remained at all ages.
Conclusion
This study supports the use of uncemented acetabular fixation when used in combination 
with the Exeter stem with improved survivorship for revision for aseptic loosening, wear, 
and osteolysis at all ages and for all- cause revision in patients less than 70 years.
Cite this article: Bone Joint J 2020;102-B(4):414–422.
Introduction
The Exeter cemented stem (Stryker, Kalam-
azoo, Michigan, USA) has excellent long- term 
results with survivorship for aseptic loosening 
approaching 100% at long- term follow- up.1-4 
Cemented acetabular components have not been as 
successful but excellent results can be achieved.5,6
In recent years, there has been an increasing 
trend towards the use of uncemented or hybrid 
fixation. Uncemented acetabular components 
are now used in 72% of total hip arthroplasties 
in England, Wales, Northern Ireland, and the 
Isle of Man, and over 90% in Australia and New 
Zealand.7-9 Improvements in design and locking 
mechanisms, options for screw fixation, and alter-
native bearing surfaces may have contributed to 
this change. The hybrid construct may combine 
the advantages of a cemented stem with the bene-
fits of an uncemented acetabular component and 
has been recommended as the best option for 
all age groups.7,10 However, registry studies,7-9,11 
meta- analyses,12,13 and reviews14 continue to show 
an advantage for cemented components over 
hybrid or uncemented constructs. Excellent long- 
term results have been reported with monoblock 
acetabular components,15,16 but long- term studies 
with other designs of modular uncemented acetab-
ular components have been disappointing.17,18
The Exeter Universal stem has been used 
in combination with both cemented and unce-
mented acetabular components in our centre. Our 
observation has been that cemented acetabular 
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Table I. Details of hip arthroplasty procedures including place of surgery, fixation, age, original diagnosis, sex, approach, and deaths during the 
study period.
Characteristic Public (n = 698) Private (n = 388) Total (n = 1,086)
Cemented Hybrid Cemented Hybrid Cement Hybrid
Total, n (%) 565 (80.9) 133 (19.1) 67 (17.3) 321 (82.7) 632 (58.2) 454 (41.8)
OA, n (%) 506 (89.6) 99 (74.4) 60 (89.6) 298 (92.8) 566 (89.6) 397 (87.4)
AVN, n (%) 20 (3.5) 5 (3.8) 0 (0.0) 6 (1.9) 20 (3.2) 11 (2.4)
Dysplasia, n (%) 5 (0.9) 10 (7.5) 1 (1.5) 8 (2.5) 6 (0.9) 18 (4.0)
RA/inflammatory, n (%) 19 (3.4) 13 (9.8) 3 (4.5) 4 (1.2) 22 (3.5) 17 (3.7)
Old trauma, n (%) 8 (1.4) 1 (0.8) 2 (3.0) 5 (1.6) 10 (1.6) 6 (1.3)
Perthes/SUFE, n (%) 3 (0.5) 5 (3.8) 0 (0) 0 (0) 3 (0.5) 5 (1.1)
Pagets, n (%) 2 (0.4) 0 (0) 0 (0) 0 (0) 2 (0.3) 0 (0.0)
Septic arthritis, n (%) 2 (0.4) 0 (0) 1 (1.5) 0 (0) 3 (0.5) 0 (0.0)
Mean age, yrs (range) 68.0 (30 to 88) 53.7 (15 to 77) 70.6 (42 to 82) 62.1 (35 to 81) 68.3 (30 to 88) 59.7 (15 to 81)
Age bands/years, n (%)
15 to 39 2 (14.3) 12 (85.7) 0 (0) 5 (100.0) 2 (0.3) 17 (3.7)
40 to 49 16 (36.4) 28 (63.6) 4 (33.3) 8 (66.7) 20 (3.2) 36 (7.9)
50 to 59 76 (58.5) 54 (41.5) 0 (0) 89 (100.0) 76 (12.0) 143 (31.5)
60 to 69 214 (86.6) 33 (13.4) 13 (7.0) 172 (93.0) 227 (35.9) 205 (45.2)
70 to 79 207 (97.2) 6 (2.8) 47 (51.1) 45 (48.9) 254 (40.2) 51 (11.2)
80+ 50 (100.0) 0 (0) 3 (60.0) 2 (40.0) 53 (8.4) 2 (0)
Male sex, n (%) 238 (42.1) 71 (53.4) 28 (41.8) 185 (57.6) 266 (42.1) 256 (56.4)
Approach posterior, n (%) 294 (52.0) 80 (60.2) 17 (25.4) 83 (25.9) 311 (49.2) 163 (35.9)
Deaths, n (%) 237 (41.9) 13 (9.8) 21 (31.3) 60 (18.7) 258 (40.8) 73 (16.1)
AVN, avascular necrosis; OA, osteoarthritis; RA, rheumatoid arthritis; SUFE, slipped upper femoral epiphysis.
Table II. Acetabular implants used and numbers and proportion 
revised.
Implant Company Implants, n Revised, n (%)
Cemented
Total N/A 632 61 (9.7)
Contemporary Stryker 476 49 (10.3)
Muller PE Zimmer 114 7 (6.1)
Reflection All Poly Smith & Nephew 27 1 (3.7)
Charnley DePuy Synthes 10 2 (20.0)
Exeter Stryker 5 2 (40.0)
Uncemented
Total N/A 454 18 (4.0)
Morscher Sulzer 285 12 (4.2)
Fitmore/Fitek Zimmer 66 2 (3.0)
RM press fit Mathys 33 2 (6.1)
Reflection Smith & Nephew 30 0 (0.0)
Trident Stryker 30 1 (3.3)
Others N/A 10 1 (10.0)
N/A, not applicable.
components start to fail due to aseptic loosening in the second 
decade after total hip arthroplasty (THA), while it has been very 
rare to see femoral loosening or uncemented acetabular compo-
nent failure. A previous study from our institution has shown an 
advantage to hybrid fixation over all cemented THA, but this 
included a number of cemented implants known to have poor 
long- term survivorship.19
The purpose of this observational study was to compare 
the long- term survival of cemented and hybrid THA using the 
Exeter stem at mean 15 year follow- up.
Methods
Our public hospital services around 200,000 patients spread 
over a large geographical area with one major city of 140,000 
and a large rural population. There is also a private hospital 
with the majority of surgeons operating at both hospitals. Cost 
constraints and a desire to follow evidence- based practice 
led us to developing a cement- only policy between 1999 and 
2005 in our public hospital, with exceptions only allowed after 
discussion at a departmental meeting. There was unrestricted 
choice at our private hospital. We identified 1,086 THAs that 
were performed by eight consultant surgeons using the Exeter 
Universal stem performed between July 1999 and December 
2005 at either hospital from databases cross referenced to the 
New Zealand Joint Registry (NZJR).7 We excluded THA for 
acute hip fracture but included all other indications for surgery. 
Our departmental database was used to search for any revision 
procedure including excision arthroplasty and cross- referenced 
to the NZJR. All reasons for revision were checked through use 
of electronic patient charts and radiological records.
The patient demographic details and implants used are 
detailed in Tables I and II.
Osteoarthritis (OA) was the diagnosis in 963 (89%) of hips. 
A cemented acetabular component was used in 632 hips (58%) 
and an uncemented device in 454 (42%). Of the 1,086 hips, 610 
(56%) were performed via a lateral approach and 474 (44%) 
via a posterior approach. Two hips underwent a trochanteric 
osteotomy and were included in the lateral group for statistical 
analysis.
Surgical technique. The Exeter Universal stem was used 
throughout the study period. The taper changed to the V40 taper 
in 2001. Antibiotic- containing Simplex bone cement (Stryker) 
was used routinely with vacuum mixing and insertion using a 
cement gun with proximal cement pressurization.
The acetabulum was prepared for cemented components by 
power reaming. Pits and multiple drill holes were made with the 
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Table III. Details of revisions by hospital and fixation, reason for revision, and original diagnosis.
Reason for revision (with primary diagnosis), n Public hospital  
(n = 698)













Acetabular loosening 41 2 3 N/A 44 2
Acetabular and femoral loosening 2 1 N/A N/A 2 1
Femoral loosening N/A 2 N/A 3 N/A 5
Wear and/or osteolysis 1 N/A N/A 1 1 1
Total loosening, wear, osteolysis, n (%) 44 (7.8) 5 (3.8) 3 (4.5) 4 (1.2) 47 (7.4) 9 (2.0)
OA 40 3 1 2 41 5
AVN N/A N/A N/A 1 N/A 1
Dysplasia N/A N/A N/A 1 N/A 1
RA/inflammatory 2 2 1 N/A 3 2
Old trauma N/A N/A 1 N/A 1 N/A
Perthes/SUFE 1 N/A N/A N/A 1 N/A
Pagets N/A N/A N/A N/A N/A N/A
Septic arthritis 1 N/A N/A 1 N/A
Dislocation, n (%) 4 (0.7) 2 (1.5) 0 2 (0.6) 4 (0.6) 4 (0.9)
OA 3 1 N/A 1 3 2
RA/inflammatory 1 1 N/A N/A 1 1
AVN N/A N/A N/A 1 N/A 1
Femur fracture (all OA) 4 (0.7) 1 (0.8) 1 (1.5) 3 (0.9) 5 (0.8) 4 (0.9)
Infection (all OA) 5 (0.9) 0 0 0 5 (0.8) 0
Pain (OA) N/A N/A N/A 1 0 1
Total, n (%) 57 (10.1) 8 (6.0) 4 (6.0) 10 (3.1) 61 (9.7) 18 (4.0)
Mean time to revision, yrs (range) 9.5 (0.8 to 16.7) 9.2 (2.9 to 
14.5)
10.1 (4.8 to 15.2)8.5 (0.5 to 
13.7)
9.6 (0.8 to 16.7) 8.8 (0.5 to 
14.5)
AVN, avascular necrosis; N/A, not applicable; OA, osteoarthritis; RA, rheumatoid arthritis; SUFE, slipped upper femoral epiphysis.
aim of producing a porous bed of bone for cement engagement. 
Medial wall bone graft was used as required. Cement was pres-
surized using a commercially available pressurizer. Polymeth-
ylmethacrylate (PMMA) beads were present on the Reflection 
All Poly (Smith & Nephew, Memphis, Tennessee, USA) and 
Contemporary acetabular components (Stryker), but not on the 
Muller low profile PE (Zimmer, Winterthur, Switzerland) or 
Charnley (DePuy Synthes, Warsaw, Indiana, USA) designs. All 
the cemented acetabular implants were made from conventional 
polyethylene.
For uncemented acetabular components a press fit was 
obtained usually by under- reaming by 1 mm to 2 mm. Supple-
mentary screws were used if required but were not used for the 
nonmodular implants (Morscher (Sulzer Orthopaedics, Baar, 
Switzerland) and RM Pressfit (Mathys, Bettlach, Switzerland)). 
Polyethylene inserts were almost all conventional polyethylene. 
Highly cross- linked polyethylene was introduced in 2003 for 
the Fitmore acetabular component (Zimmer) but only used in 
36 hips.
The acetabular implants used are detailed in Table II. The 
femoral head size was 28 mm in 1,065 hips (98%), 22 mm in 
19 (1.8%), and 36 mm in two hips (0.2%). The head material 
was stainless steel in 902 hips (83%) and alumina ceramic in 
184 (17%).
Statistical methods. Appropriate summary statistics were 
calculated for all variables of interest. Associations between 
categorical variables were investigated using chi- squared tests 
where at least 80% of cells had expected counts of five or more, 
and Fisher’s exact tests otherwise. Comparisons of continuous 
variables between two groups were performed using Mann- 
Whitney U tests where data were not normally distributed with-
in each group. These analyses ignored the clustering resulting 
from multiple procedures (left and right hips) for some patients.
Survival analysis was performed using revision for any 
reason as the primary endpoint with aseptic loosening, wear, 
or osteolysis as a secondary endpoint. Competing risks survival 
analysis with death as a competing risk was used for all- cause 
revision analyses. Death and revision for other reasons were 
used as competing risks for models investigating revision for 
wear, aseptic loosening, and osteolysis. The number of esti-
mated coefficients was constrained by the limited number of 
revision events. Adjustments were made for age (as a contin-
uous variable which was allowed to interact with cementing 
group), sex (for all- cause revision only), approach (posterior 
versus other, for all- cause revision only), and bearing surface. 
An exploratory analysis adding public/private hospital and 
surgeon grade did not change the statistical significance of the 
results presented. Multiple procedures on the same patient (left 
and right hips) were accommodated by using robust clustered 
(by patient) standard errors. Cumulative incidence curves were 
used to show differences between cementing groups, including 
at selected ages in the models. Analyses were performed using 
Stata 15.1 (StataCorp, College Station, Texas, USA) with a 
two- sided p- value < 0.05 considered statistically significant.
Results
The mean follow- up was 14.8 years (11.6 to 18.3). The hybrid 
group was younger than the cemented group by eight years (p < 
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Fig. 1
Cumulative incidence graph comparing all- cause revision (unadjusted) 
with death as competing risk.
Fig. 2
Cumulative incidence graphs showing cumulative risk of revision for 
loosening, wear, or osteolysis (unadjusted) with death as competing 
risk.
0.001, Mann- Whitney U test) and there were more males. Addi-
tionally, they were more likely to have been treated via a lateral 
approach and were less likely to have died than the cemented 
group (all p < 0.001, chi- squared test). There was no statisti-
cally significant difference in original diagnosis between groups 
with the exception of acetabular dysplasia which was signifi-
cantly higher in the hybrid group (p < 0.001, chi- squared test).
In the public hospital group, 565 hips (80.9%) were cemented 
and 133 (19.1%) were hybrid. In contrast, 67 (17.3%) were 
cemented in the private hospital group and 321 (82.7%) were 
hybrid (p < 0.001, chi- squared test). The public hospital patient 
group were significantly older than the private hospital group 
(mean 65.3 versus 63.6 years; p < 0.001, Mann- Whitney U test).
In the public hospital group there were more females, a 
higher proportion of patients underwent a posterior approach, 
and more patients had died (all p < 0.001, chi- squared test) 
than in the private hospital group. A higher proportion of 
patients had rheumatoid or inflammatory arthritis (p = 0.018, 
chi- squared test) and a lower proportion of patients had OA 
(p = 0.005, chi- squared test). There was no significant differ-
ence between groups for any other diagnosis. Trainees under 
direct supervision (consultant scrubbed) performed 253 hips 
in the public hospital (236 cemented, 17 hybrid). Consultant 
surgeons performed all 388 cases at the private hospital.
The revision rate for trainees (17 of 253, 6.7%) was not 
significantly different from consultants (62 of 833, 7.4%; p = 
0.698, chi- squared test). For cemented hips, trainees had lower 
rates of all- cause revision (16 of 236, 6.8%) than consultants 
(45 of 396, 11.4%) but this did not reach significance (p = 
0.059, chi- squared test).
In total, 79 hips were revised, 18 (4.0%) in the hybrid group 
and 61 (9.7%) in the all- cemented group (p < 0.001, chi- 
squared test). This gave a revision rate for the entire cohort 
of 0.58/100 observed component years (OCYs) (exact 95% 
confidence interval (CI) 0.46 to 0.72). There was a significantly 
lower rate of revision in the hybrid group (0.30 revisions/100 
OCYs) compared to the cemented group (0.82/100 OCYs). In 
the hybrid group there were six isolated acetabular revisions, 
one liner exchange, six isolated femoral revisions, and five with 
all components revised. In the cemented group there were 43 
isolated acetabular revisions, 14 all component revisions, three 
femur only, and one modular head exchange.
The commonest reason for revision was loosening of 
cemented acetabular components. This accounted for 46 of 
61 (75.4%) revisions in the cemented group. There were eight 
revisions for femoral loosening (0.8% of all hips) of which 
three also had acetabular loosening with no statistical differ-
ence between cemented and hybrid groups (p = 0.074, Fisher’s 
exact test). There was a significantly higher revision rate for 
loosening, wear, and osteolysis in the cemented group (47 of 
632, 7.4%) than the hybrid group (9 of 454, 1.8%; p < 0.001, 
chi- squared test). There was no significant difference seen 
between the groups for revision for deep infection (p = 0.079, 
Fisher’s exact test), dislocation (p = 0.726, Fisher’s exact test), 
or femoral fracture (p = 1.000, Fisher’s exact test). Detailed 
reasons for revision are given in Table III.
The acetabular components used and numbers that were 
subsequently revised are listed in Table II. There were no 
significant differences seen in the proportion revised between 
implants in the cemented group (p = 0.057, Fisher’s exact test) 
or between monoblock and modular acetabular components in 
the hybrid group (p = 0.640, Fisher’s exact test).
Survivorship. There was evidence of increased risk of all- cause 
revision for the cemented group (unadjusted sub- hazard ratio 
(SHR) 2.44, 95% CI 1.44 to 4.15, p = 0.001) using competing 
risk analysis (Figure 1). The cumulative incidence of revision 
at 18 years was 5.2% for the hybrid group and 12.1% for the all 
cemented group. Kaplan- Meier revision- free rates, ignoring the 
competing risk of death, at 18 years were: hybrid 95.0% (95% 
CI 92.1% to 96.9%); and cemented 82.0% (95% CI 75.8% to 
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Table IV. Sub- hazard ratios with 95% confidence intervals for all- cause revision and revision for loosening, wear, and osteolysis at varying ages. 
Fully adjusted model includes age, sex, bearing combinations, and approach.
Outcome Between- group p- value Age- group  
interaction p- value
Hybrid SHR Cemented unadjusted,  
SHR (95% CI)
Cemented fully adjusted,  
SHR (95% CI)
All- cause revisions
All ages 0.001 0.095 1.00 2.44 (1.44 to 4.15) N/A
Age- specific, yrs
45 N/A N/A 1.00 7.14 (3.08 to 16.57) 7.24 (2.99 to 17.54)
50 N/A N/A 1.00 5.72 (2.95 to 11.11) 5.69 (2.82 to 11.47)
55 N/A N/A 1.00 4.58 (2.63 to 7.98) 4.47 (2.48 to 8.06)
60 N/A N/A 1.00 3.67 (2.10 to 6.41) 3.51 (1.94 to 6.34)
65 N/A N/A 1.00 2.94 (1.51 to 5.74) 2.75 (1.36 to 5.59)
70 N/A N/A 1.00 2.36 (1.01 to 5.51) 2.16 (0.89 to 5.28)
75 N/A N/A 1.00 1.89 (0.65 to 5.46) 1.70 (0.56 to 5.17)
80 N/A N/A 1.00 1.51 (0.41 to 5.51) 1.33 (0.34 to 5.16)
85 N/A N/A 1.00 1.21 (0.26 to 5.61) 1.05 (0.21 to 5.20)
Loosening, wear, and 
osteolysis
All ages < 0.001 0.625 1.00 3.77 (1.83 to 7.75) N/A
Age- specific, yrs
45 N/A N/A 1.00 9.09 (3.87 to 21.35) 8.67 (3.72 to 20.21)
50 N/A N/A 1.00 8.57 (3.95 to 18.60) 8.28 (3.80 to 18.04)
55 N/A N/A 1.00 8.09 (3.77 to 17.32) 7.90 (3.61 to 17.33)
60 N/A N/A 1.00 7.63 (3.36 to 17.31) 7.55 (3.18 to 17.89)
65 N/A N/A 1.00 7.19 (2.82 to 18.31) 7.21 (2.66 to 19.52)
70 N/A N/A 1.00 6.78 (2.28 to 20.15) 6.88 (2.14 to 22.10)
75 N/A N/A 1.00 6.40 (1.80 to 22.73) 6.57 (1.69 to 25.59)
80 N/A N/A 1.00 6.03 (1.40 to 26.05) 6.27 (1.31 to 30.06)
85 N/A N/A 1.00 5.69 (1.07 to 30.17) 5.99 (1.01 to 35.64)
CI, confidence interval; N/A, not applicable; SHR, sub- hazard ratio.
86.8%) with 18 patients (12 cemented and six hybrid) alive and 
revision free at this time.
There was also evidence of a greater risk of revision for loos-
ening, wear, or osteolysis for the cemented group (unadjusted 
SHR 3.77, 95% CI 1.83 to 7.75; p < 0.001). The cumulative 
incidences at 18 years were 2.5% (hybrid) and 9.1% (cemented) 
(Figure 2).
There was no evidence of an interaction between age and 
cement group for all- cause revision (interaction p = 0.095) 
or revision for loosening, wear, or osteolysis (interaction p = 
0.625). These remained nonsignificant with further adjustment 
(interaction p = 0.080 and interaction p = 0.711, respectively) 
(Table IV). There was a significantly increased risk of all- cause 
revision in the cemented group for all ages aside from 75 years 
and older. In the fully adjusted model the increased risk of revi-
sion in the cemented group was seen at all ages but did not reach 
significance at age 70 years and older (Table IV, Figure 3). For 
revision for loosening, wear, or osteolysis, a cemented acetab-
ular component was associated with increased risk at all ages in 
both unadjusted and fully adjusted models (Table IV, Figure 4). 
None of the other variables in the model were statistically 
significant.
Discussion
This study has shown an increased rate of all- cause revision 
for cemented THA compared with hybrid THA when using 
the Exeter stem at long- term follow- up to 18 years. This was 
primarily due to loosening of cemented acetabular components. 
It was most marked in younger patients and did not reach signif-
icance for those aged 70 years or older. An increased rate of 
revision for loosening, wear, and osteolysis was seen at all 
ages. At no age was there evidence for superior performance of 
cemented over hybrid THA after adjusting for other variables.
We have previously demonstrated an advantage to hybrid 
fixation over cemented fixation but this study included a number 
of different cemented femoral components some of which such 
as the Spectron (Smith & Nephew, Memphis, Tennessee, USA) 
have performed poorly at longer term follow- up.19 In contrast, 
the Exeter stem has excellent long- term survival with reported 
component survival of 92% to 100% in studies between 13 
and 22 years, even in young patients.1-3,20 However, in these 
series, the results for the acetabular component have been 
less successful with survival for all- cause revision of 81% to 
91%.1,2,20 Results are also poorer in younger patients with 75.7% 
survival for all- cause revision at 17 years reported in patients 
under the age of 40 years.3
Other authors have reported better results with cemented 
acetabular components. Maggs et al,6 using the cemented 
Contemporary flanged acetabular component and Exeter stem 
in patients with a mean age of 70.5 years, reported no acetab-
ular revisions for loosening. Eight acetabular components 
were revised for other reasons, giving 97.8% all- cause revi-
sion at 12.5 years. Radiolucent lines were seen in 36% of the 
surviving hips. Young et al21 reported 94.4% overall survival 
at 13 years with the Charnley Ogee acetabular component and 
Exeter stem.
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Fig. 3
Cumulative incidence of all- cause revision at differing ages (fully adjusted).
There are fewer long- term results of an uncemented acetab-
ulum with the Exeter stem. Hook et al,4 in a minimum ten- 
year review of patients with an Exeter stem and a mean age 
at surgery of 61 years, found excellent survival of the compo-
nent but varying failure rates of both cemented and uncemented 
acetabular components with survivorship for any component 
revision around 60% at 15 years.4
Jameson et al,22,23 in two studies from the England and Wales 
National Joint Registry (NJR), reported on the seven- year 
results of 34,721 THAs using the Exeter cemented Contem-
porary combination and the five- year results of 15,740 hybrid 
Trident/Exeter hips. A flanged Contemporary acetabular 
component had a seven- year revision rate of 1.16%, while a 
hooded Contemporary implant had a revision rate of 3.49% at 
seven years.22 The Exeter/Trident combination showed a 1.56% 
risk of revision at five years.23
We found no significant differences in failure rates between 
any of the acetabular components. The main cemented 
acetabular components in our series were the hooded Contem-
porary and the Muller PE. Both have been widely used in New 
Zealand and have performed reasonably well. However, the 
NZJR does not distinguish between the hooded and flanged 
version of the Contemporary acetabular component.
Our Kaplan- Meier survivorship of 82% at 18 years for all- 
cause revision in the all- cemented group is similar to the previ-
ously mentioned studies but is poorer than the NZJR rate for 
fully cemented THA (86.2%).7 We do not believe that the poor 
results of the cemented hips compared to the New Zealand 
general outcome are due to technical failures by the surgeons 
but more to do with the public hospital cemented policy. This 
led to disappointing results particularly in younger patients. 
This has also been the finding in the NZJR, where cemented 
THAs have a higher revision rate than either uncemented or 
hybrid THA in patients less than 64 years.7
The overall revision rate in this series of 0.58/100 OCYs 
compares favourably with the New Zealand general findings 
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Fig. 4
Cumulative incidence of revision for loosening, wear and osteolysis at differing ages (fully adjusted).
of 0.73/100 OCYs (95% CI 0.71 to 0.73).7 There were few 
early revisions for loosening and the mean time to revision 
for cemented hips was 9.6 years. Hanly et al24 have recently 
suggested that the proficiency threshold for cemented acetab-
ular components is greater than ten cases per year with the 
maximum benefit achieved for surgeons performing more than 
25 cases per year. All the surgeons in our study were experi-
enced in cementing techniques and during the study period, 
most surgeons performed more than 25 cemented acetabular 
implantations per year.
Our finding of improved survivorship of the hybrid over a 
fully cemented hip is in contrast to recent meta- analyses12,13 and 
registry data.7-9,11,25 Toossi et al,13 in a meta- analysis including 
only studies with minimum ten- year follow- up, concluded that 
the preference for cementless acetabular components was not 
supported by published literature. The difference in results 
between cemented and hybrid THA in our series appears to 
be mainly due to the uncemented acetabular components 
performing very well, with 95% survival at 18 years. Registry 
data typically reports all- cause revision which includes reasons 
that may not be implant or fixation specific such as infection 
and dislocation. We had low rates of revision for these compli-
cations. Classes of implant are reported which may include 
some implants that are not performing as well as others. The 
meta- analyses have included papers with short- term follow- up. 
It is known that there are higher rates of early revision for 
uncemented components. Cemented hips are less likely to be 
revised early but start to fail after ten years or more. They have 
also included older papers using uncemented components that 
may have had problems with locking mechanisms and polyeth-
ylene wear. Unlike most studies, we used a high proportion of 
monoblock acetabular components (70%) which are showing 
an advantage in the NZJR.7 We have previously reported 93.4% 
survival of the Morscher acetabular component at 20 years for 
all- cause revision and 97.1% survival for aseptic loosening, 
wear, or osteolysis despite using conventional polyethylene.15 
The RM implant also has excellent long- term results.16 Of the 
modular acetabular components we used, the Fitmore/Fitek 
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(Zimmer) use the same mesh for fixation as the Morscher 
implant, and the Trident (Stryker, Mahwah, New Jersey, USA), 
and Reflection (Smith & Nephew, Memphis, Tennessee, USA) 
acetabular component have not been reported in the literature as 
having major faults in design.
Previous papers using competing risk have noted that it 
tends to give a higher survival figure than the more widely 
used Kaplan- Meier analysis.26-28 It recognizes that death or 
revision for another reason completely preclude revision or 
cause- specific revision respectively and so does not treat these 
events as censoring (denoting that the event of interest has not 
yet happened but eventually will happen) as would be the case 
under Cox’s proportional hazards and similar models. There-
fore the revision- free survival in the cemented group was 88% 
compared with 82% from Kaplan- Meier analysis due to 42% 
dying in this group. The difference seen in the hybrid group 
between the methods was minimal as only 17% of patients had 
died. The hazard ratios would have been over 20% higher in 
favour of hybrid fixation in this study had we not allowed for 
competing risk. Therefore we believe that the use of competing 
risk analysis gives a more realistic but conservative estimate of 
the difference between the two groups.
The strengths of this paper are the size of the series and 
length of follow- up. The public hospital policy of using 
cemented components in most patients, while there was unre-
stricted choice in the private hospital, has given an opportu-
nity to compare the cemented and hybrid cohorts. The Exeter 
stem is known to perform well and good numbers had been 
used in combination with both cemented and cementless cups. 
The surgical procedure was relatively well standardized with a 
28 mm head on conventional polyethylene used in most cases. 
The surgeons were experienced and trained in both cemented 
and hybrid procedures and most operated in both hospitals. We 
saw low revision rates for infection, dislocation, and peripros-
thetic fracture. Therefore, survivorship mainly reflects acetab-
ular fixation and wear related issues, which are factors that can 
be influenced by implant choice.
A limitation of the study is that is observational rather than 
randomized and we used a number of different acetabular 
components. The public hospital policy and resultant disparity 
in use of implants is a potential source of bias. In the public 
hospital, trainees under direct supervision performed over 40% 
of the cemented hips but very few of the hybrids. However, this 
did not appear to have an impact on the results. The patients were 
not equally matched, with the hybrid group significantly younger 
and having a higher proportion of males. Registry data, however, 
suggests that this would be expected to lead to poorer survivor-
ship rather than the improved survivorship seen.7 Highly cross- 
linked polyethylene was used in a small proportion of the hybrid 
group but this was adjusted for in our model. We have used 
revision as the endpoint and clinical or radiological failures are 
not included. However we do not believe that this will signifi-
cantly alter the findings. While there may be silent wear and 
osteolysis in the hybrid group there are also likely to be radio-
lucent lines in a significant proportion of cemented acetabular 
components.6 It is not clear how generalizable these results are 
to other centres and modern practice. The most commonly used 
uncemented acetabular implant in this series, the monoblock 
Morscher design, is no longer available despite excellent long- 
term results.15 Conventional polyethylene was used in almost all 
hips with 28 mm modular heads. Despite this excellent long- 
term survival was found especially in the hybrid group.
In conclusion, this study supports the use of uncemented 
acetabular fixation over cemented when used in combination 
with the Exeter component at all ages. There is improved survi-
vorship for all- cause revision in patients less than 70 years 
of age, predominantly due to the high rate of loosening of 
cemented acetabular components. Hybrid THA has lower rates 
of revision for loosening, wear, and osteolysis at all ages. These 
results provide some evidence to justify the increasing use of 
uncemented acetabular components that has been seen in the 
last 20 years.
Take home message
  - Cemented components have a higher loosening and revision 
rate than uncemented components when used with the Exeter 
stem at long- term follow- up.
  - Hybrid fixation has excellent long- term survival.
  - This study supports the trend away from cemented acetabular 
components.
Animation
An animation is available alongside the online version 
of this article.
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Bilateral, uncemented hip replacements were performed on a 45-year-old woman with 
autosomal dominant osteopetrosis. The hips showed degenerative changes and protrusio 
acetabuli. Difficulties were encountered especially during preparation of the femoral canal. At 
ten-year follow-up she has an excellent clinical and radiological result with no sign of osteolysis. 
Uncemented hip replacement, while technically demanding, can be successful in the 
intermediate term for patients with this condition.
Osteopetrosis or Marble Bone disease is an uncom-
mon condition. The sex-linked recessive form is
associated with childhood problems and early
death. However, the autosomal dominant form is
compatible with a normal life span, and as many as
40% of patients may remain asymptomatic.1,2
Bollerslev and Mosekilde1 described two forms of
autosomal dominant osteopetrosis (ADO). In Type
1, there is increased thickness of the cranial vault,
diffuse osteosclerosis of the lumbar spine and pelvis
and symmetrical, long-bone involvement. Type 2
shows more basal skull involvement, a ‘rugger jer-
sey’ spine and ‘endobones’ within the pelvis. Type 2
patients are more prone to fractures which are diffi-
cult to treat.
Degenerative changes may occur in the hip and
knee after the fifth decade, sometimes in the pres-
ence of deformity, especially coxa vara,3,4 and some-
times without.5-10 There have been several early
reports of hip arthroplasty for this condition, but we
believe that this is the first report of an uncemented
total hip arthroplasty (THA) in osteopetrosis.
Case report
In 1992, a 45-year-old female laundry worker pre-
sented with a seven-year history of low back and
bilateral hip pain with stiffness. She had severe pain
at rest and at night, a walking duration of 10 min-
utes without aids and was unable to put on shoes or
socks. She had 80˚ of hip flexion on both sides with
no rotation, adduction or abduction. Her Harris
Hip score (HHS) was 39 (pain 10, function 21).
Radiographs showed bilateral protrusio acetabuli
and degenerative changes of the hips (Fig. 1). The
long bones were uniformly dense with very narrow
medullary canals. The lumbar vertebrae were also
dense with degenerative changes present. The radio-
graph of the skull showed thickening of the cranial
vault. These changes were consistent with ADO
Type 1.
She underwent bilateral, staged THA three
months apart. The femoral neck was very hard to
cut and the cut surface showed no obvious medul-
lary canal. A 52 mm CLS Expansion cup (Center-
pulse Orthopedics, Munsinger, Switzerland) was
inserted into the acetabulum after routine power
reaming. Drills were used to create a medullary
canal breaking two drill bits in the process. The
femur was then sequentially reamed with power
reamers and hand-held conical reamers to allow the
insertion of a 14 mm Wagner cone prosthesis
(Centerpulse Orthopedics) which has a rough-
blasted, titanium, conical stem with fins. There were
no post-operative complications.
Histopathological examination of the femoral
head revealed a thickened cortex and variably thick-
ened bony trabeculae. In some areas, the trabeculae
were markedly widened with both a woven and
lamellar pattern, and islands of pale staining, alcian-
blue positive, myxoid material (Fig. 2) which may
represent the remnant cartilaginous bridges which
are typical of osteopetrosis. Delicately vascularised
adipose tissue replaced haemopoietic marrow.
Osteoclasts were seen in neither histological nor
electronmicrographic sections. These histological
features indicate abnormal bone remodelling and,
when taken in conjunction with the clinical and
radiological findings, are consistent with ADO Type
1 as described by Bollerslev and Mosekilde.1 The
articular surface was eburnated and any remaining
articular cartilage was fibrillated, as is seen in oste-
oarthritis.
At two-year follow-up, tomography (Fig. 3) sug-
gested bone ongrowth with trabecular lines seen
running from the threads of the cup. The HHS was
93 (pain 40, function 44). At the latest follow-up
(ten years), she continues to have a good result with
an HHS of 91 (pain 40, function 42), an Oxford-12
item hip score of 25, and a WOMAC score of 60
(pain 12, motion 5, function 43). Her short-form
(SF)-12 physical score is 41.41 and her mental score
is 42.20. She has residual discomfort from her
lumbar spine but is satisfied with the results of her
hip arthroplasties. The latest radiograph (Fig. 4)
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shows apparently solid fixation of the components with no osteo-
lysis. There has been minimal remodelling of the canal created
distal to the femoral stem.
Discussion
The gene disorders in osteopetrosis result in decreased osteoclastic
resorption of bone. Where present, osteoclasts lack the usual ruf-
fled border that is important in bone resorption. The abnormal
osteoclastic function results in very hard bone with thickened
trabeculae. Coxa vara is a well-recognised complication of osteo-
petrosis with most cases developing during childhood,2,10 some-
times after fracture of the femoral neck or subtrochanteric
region.3
Degenerative changes often occur after the age of 405-10 in the
absence of deformity. Articular cartilage is not affected by the dis-
order, and it has therefore been suggested that the degeneration
occurs because of the hard unyielding subchondral bone.6,8 Pro-
trusio has not been reported previously. We speculate that it may
have occurred because the acetabular bone was relatively less hard
than the femoral head.
Fig. 1a
Fig. 1a – An anteroposterior (AP) radiograph of the pelvis showing dense sclerotic bone of osteopetrosis, degenerative changes in both hips and pro-
trusio acetabuli.  Fig. 1b – An AP radiograph of the pelvis, two years after surgery. 
Fig. 1b
Fig. 2
Photomicrograph of the femoral head showing
markedly widened bony trabeculae with central
islands of pale staining myxoid material (hae-
matoxylin and eosin x 78).
Fig. 3
A tomogram of the right hip at two years showing
bone trabeculae running from the titanium threads of
the Expansion cup. 
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There are several case reports of hip and knee arthroplasty with
follow-up ranging from six months to six years.3-10 Technical dif-
ficulty has been experienced especially on the femoral side. Drills
and high-speed burrs, guided by fluoroscopy, have been used to
help create a medullary canal. Previously, cemented components
have been used. Matsuno and Katayama4 used a press-fit acetab-
ular component with screw fixation, since it would be difficult to
obtain good quality bone-cement interface, but considered that to
use a cementless femoral component risked fracturing the shaft.
We found that the use of the Expansion cup allowed more control-
led insertion and may reduce the risk of acetabular fracture. The
shape and small size of the Wagner cone prosthesis allowed power
reaming of the femur and avoided downsizing the component to
allow a cement mantle. Poor cement-bone penetration would be
expected to occur in the dense sclerotic bone.
Fracture healing occurs slowly in osteopetrosis and slow bony
ongrowth to the titanium prosthesis would be expected, which
appears to have occurred in our case. Serial radiographs over a
period of 10 years show no progressive osteolysis despite a high
level of activity. There has been minimal remodelling of the femur
where the medullary canal was reamed out. The osteoclast has a
central role in osteolysis due to particulate debris and patients
with osteopetrosis may have an inhibited process of osteolysis.
In summary, we believe that this is the first reported case of fully
cementless THA in osteopetrosis. At intermediate follow-up of ten
years, the clinical and radiological results are good. Protrusio
acetabuli has not previously been described in this condition.
No benefits in any form have been received or will be received from a commer-
cial party related directly or indirectly to the subject of this article.
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Fig. 4
A radiograph 10 years after surgery showing no osteolytes and minimal
remodelling of the medullary canal distal to the femoral stem. 
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Between 2007 and 2018, 535 total hip arthroplasties using the uncemented Pinnacle acetabular
component (DePuy Synthes, Warsaw, IN) and polyethylene liner were implanted in our unit. Of these, 6
patients presented acutely with liner polyethylene dissociation, giving a rate of liner dissociation of 1.11%.
All dissociations were atraumatic. Failure occurred at mean 37 months (range 4.5 to 130 months).
Radiologically, all acetabular components were within safe zone of abduction and mean anteversion was
10 degrees (range 2-20). In one case, there was posterior impingement against the femoral neck due to
femoral malalignment. All patients underwent head and liner exchange with no repeat failures. Despite
excellent long-term results, the frequency of dissociated polyethylene liners is a cause of concern with
the Pinnacle acetabular component.
© 2019 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Over recent years, there has been a move toward unce-
mented acetabular components. [1,2]. The majority are modular
which allows for flexibility and adaptability in total hip re-
placements. It gives options for screw fixation, various liner
configurations, and may allow straightforward revision for
dissociation or liner wear.
Although it has advantages, modularity also has potential
problems. One issue is dissociation of the liner from themetal shell.
It wasmostly reported in first-generation uncemented components
such as the Harris-Galante 1 (Zimmer Biomet, Warsaw, IN) [3,4].
Early locking mechanisms and incongruity between the liner and
shell were thought to be the main causes of failure. Improvements
in component design have reduced the incidence of this problem
such that it is now rarely seen in contemporary designs.closed potential or pertinent
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269Current modern acetabular designs have recessed liners to
reduce the risk of rim fractures and improved locking mecha-
nisms at the perimeter [5]. The Pinnacle acetabular system
(Depuy, Warsaw, IN) was introduced in 2003. It is now one of the
most commonly used acetabular components [1,2]. It uses a
taperloc locking mechanism with 6 antirotation devices or tabs
at the periphery which provide rotational stability but do not
affect pull-out strength. This provides better conformity but
reduced pull-out strength in comparison with the DuraLoc sys-
tem (Depuy, Warsaw, IN) which used a locking ring. [6] None-
theless, clinical results from registries and prospective studies
with the Pinnacle system have been excellent and a 97% to 94%
survival is reported at 5 and 10 years, respectively, by Kindsfater
et al in a multicentre study [7]. However, there have been an
increasing number of reports of polyethylene liner dissociation
from several countries [8-12]. Dissociation can be early or late
and have usually been with no trauma. This problem has been
rarely reported with other contemporary modular acetabular
systems [11].
We have used the Pinnacle acetabular component since 2007 in
our unit and have seen 6 polyethylene liner dissociations. We are
aware of reports from other centers in our country [12]. The pur-
pose of this study is to report a further series of liner dissociations,
calculate the incidence in our center, and to identify possible rea-
sons for this uncommon complication.ciation of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-
o from ClinicalKey.com.au by Elsevier on April 01, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
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Departmental audit data identified 6 patients who underwent
revision for liner dissociation of a Pinnacle acetabular component
in our unit. Our local database was cross-referenced to the New
Zealand National Joint Register (NZNJR) to identify all patients who
had undergone total hip arthroplasty (THA) with a Pinnacle
acetabular component and a polyethylene liner in our unit since its
introduction. The NZNJR captures details of all arthroplasties per-
formed in our country and has 98% compliance. It also includes
details of revisions of registered arthroplasties performed at any
center in the country [1]. No revisions of this cohort were recorded
from other centers. The operative records and radiographs of all
patients who had been revised were checked to confirm the diag-
nosis of liner dissociation and ensure that the reason for revision
had not been miscoded.
Details of all patients identified with liner dissociation were
recorded including their history since the start of new symptoms.
Index THA operation notes were reviewed for details of the pro-
cedure and components used. Postoperative anteroposterior and
lateral radiographs were reviewed to assess acetabular cup
abduction and anteversion. Anteversion was measured on a cross-
table lateral radiograph [13]. The operative findings at revision
surgery were recorded.
Between 2007 and 2018, approximately 5200 primary THAs
were performed in our unit; of these, 535 utilized a Pinnacle
acetabular component with a polyethylene liner. Marathon highly
cross-linked polyethylene was used in all cases. All procedures
were either carried out by a fellowship trained arthroplasty sur-
geon or a senior trainee supervised by a consultant. 277 (52%) were
used in combination with an uncemented femoral component and
269 (48%) with a cemented femoral component (hybrid). A metal
head was used in 226 (42%) and a ceramic head in 309 (58%). A 32
mm head was used in 293 (55%) and a 28 mm head in 234 (44%)
with 8 cases (1%) using a 36 mm head.
During this period, 6 patients presented to us with acute liner
dissociation. Details are summarized in Table 1. Four had their in-
dex THA for end-stage osteoarthritis and two were for acute frac-
ture neck of femur. Five were performed using the direct lateral
approach and one via a posterior approach. The mean time toTable 1
Cases with Pinnacle liner dissociations.





























OA, osteoarthritis; NOF #, neck of femur fracture; KHO, high offset Corail stem; COP, cer
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27presentationwith dissociationwas 37 months (range 4.5 months to
10.8 years). There were no recorded concerns about the liner
seating during the index THA. Three patients were asymptomatic
till the failure of liner occurred. Two had a subjective feeling of
subluxation in the months before presentation and one had new
onset pain a few weeks before actual dissociation. Plain radiog-
raphy was diagnostic with asymmetry of the femoral head within
the acetabular component (Fig. 1). The mean abduction angle of the
acetabular cup was 39 degrees (range 35 to 42). The mean ante-
version was 10 degrees (range 2 to 24).
At the revision, all acetabular components were well fixed and
the liner clearly loose. Typically, the superior 3 tabs had sheared off
(Fig. 2). In 5 hips, acetabular and femoral components were well
positioned. In one hip, there was posterior impingement of the
femoral neck on the polyethylene secondary to excessive ante-
version of the femoral component. The acetabular shell was
retained, a new liner inserted, and the femoral component revised.
One acetabular component had signs of pitting due to the metal
head articulating against it. It was retained because of the age of the
patient who died 3 years later due to an unrelated medical illness.
All acetabular components were retained and a new polyethylene
liner inserted after checking the locking mechanism integrity in 5
cups. In one patient, a new liner was cemented into the metal shell
because of concerns about the competency of locking mechanism.
The femoral head was exchanged in all cases. No further compli-
cations have been recorded in revised patients at their most recent
follow-up.
Discussion
The Pinnacle acetabular system has been in use since 2003 with
excellent long-term survivorship. It is currently the most widely
implanted acetabular system in New Zealand [1]. Mid-term and
registry reports are encouraging with survivorship for all-cause
revision of 97.6% at 5 years [14] and 95% at 10 years [7]. Despite
this, there have been increasing numbers of reports of liner disso-
ciation of the Pinnacle system [8,10,11].
Liner dissociation was a problem with early designs of modular
uncemented acetabular systems especially the Harris-Galante [3]. A




Revision type Intra-op findings
8 10 Change of liner Well-fixed cup. Acceptable alignment
and no impingement
5 24 Change of liner Pitted but well-fixed cup. Accepted
due to age and comorbidities. (RIP 3 years
post revision due medical illness)
0 4 Change of liner Well-fixed cup. Acceptable alignment
and no impingement
1 2 Cemented liner
in existing cup
Well-fixed cup. Impingement against
femoral neck in external rotation due
to stem anteversion. Subsequently
revised to tapered fluted modular stem
with less anteversion.
7 10 Change of liner Well-fixed cup in acceptable alignment
and no impingement
2 11 Change of liner Well-fixed cup. Acceptable alignment
and no impingement
amic on polyethylene bearing; MOP, metal on polyethylene bearing.
tago from ClinicalKey.com.au by Elsevier on April 01, 
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Figure 1. Internal subluxation of femoral head within the socket.
Figure 2. Retrieved polyethylene insert and head showing fractured tabs and
deformed shape.
A.R. Memon, D. Gwynne-Jones / Arthroplasty Today 6 (2020) 5e8 7such as the Duraloc [6]. A taperloc mechanism was introduced in
the Pinnacle component to accept both polyethylene and ceramic
or metal bearings with 6 tabs to resist rotation. The liner was also
changed from conventional polyethylene to a highly cross-linked
polyethylene (Marathon) irradiated to 50 kGys, which improved
wear characteristics but at the expense of mechanical strength
[15,16]. The effect these changes has is a reduced pull-out strength
of the liner [17].
It is not clear what the incidence of liner dissociation is for the
Pinnacle system. The rate of liner dissociation in our unit is 1.11%.
We are confident of the rate as we were able to check operative
details of all revisions of the cohort recorded in the NZNJR. In the
largest series of liner dissociation, Yun et al reported on 23 cases of
liner dissociations in 2646 THAs from 3 arthroplasty centers in the
United States (incidence: 0.3%-0.83%) [8]. Singleton reported 6 liner
dissociations in 253 (2.4%) THAs [12]. By contrast, Napier et al re-
ported only 8 polyethylene liner dissociations from 4751 Pinnacle
acetabular components from a single center (0.17%) [11].
Increased rates of dissociation of liners from the Pinnacle
component have not been identified from registry data. Jameson
reported 10 cases of liner dissociations in 35,386 Corail Pinnacle
THAs from the National joint registry of England and Wales [14].
However, only 13,923 of these used polyethylene liners giving an
incidence of 0.07% if all dissociations were of polyethylene liners.
Registry data in Australia and New Zealand does not have a specific
field for liner dissociation as a cause. We found that the reason for
revision may be entered as dislocation, acetabular loosening, or
“other cause”. Therefore, this particular problem may be under-
estimated in registries. The Pinnacle cup is performing very well in
other respects. The revision for dissociation rate is low compared
with other reasons for early revision such as dislocation and
infection so it may go undetected in registry data unless specifically
searched for.
It is not clear why there are multiple reports of dissociationwith
the Pinnacle acetabular component and not with other contempo-
rary systems. This suggests a problemwith the locking mechanism
whichmaybe less forgiving thanother systems. ThePinnacle system
allows for the use of neutral, lipped, lateralized, and a 10 face
changing liner option. Liner dissociation may be more common in
neutral and face changing liners comparedwith lippedones. InYun’sDownloaded for Anonymous User (n/a) at University of Otag
2021. For personal use only. No other uses without permission
271series, 13 of 23 liners were neutral, 9 wereþ410 degrees lateralized
with onlyone lipped liner [8]. A neutral linerwas used in 5 of 6 of our
cases, and in all cases fromSingletonandKagan [10,12]. This is a little
surprising as an elevated lip may be more likely to lead to eccentric
loading, rim fractures, or impingement than a neutral liner. How-
ever, the polyethylene liner in the Pinnacle systemsits slightly proud
of the metal rim. Therefore, if the neck impinges on the cup, it will
contact the polyethylene first even in neutral liners. Prominence of
screw heads could potentially contribute to incorrect seating of the
liner. However, screws were not used in any of our cases and do not
appear to be associated with dissociation in other series.
There has been little discussion on surgical approach as a factor
influencing dissociation. A lateral approach was used in 5 of 6 cases
in our series. Singleton reported all their dissociations occurred
with the lateral approach and none with a posterior approach [12].
Kagan used a direct anterior approach in all their cases [10]. By
contrast, there was a very low incidence of dissociation in Napier’s
series using neutral liners and a posterior approach [11]. It is not
clear why approach should have an effect. With a lateral approach,
it is our practice to place the acetabular component in less ante-
version and to use a neutral liner rather than a lipped liner which
we prefer with a posterior approach. Visualization of the acetabu-
lum can be more difficult with a lateral approach which could lead
to problems with soft tissue interposition. A good view of the ac-
etabulum can and should be obtained with any approach and it is
important to clear any soft tissue to ensure concentric seating of the
liner before final impaction.
In our series and most other reports, most THAs were reported
to be functioning well before dissociation. This suggests that the
liner was correctly seated at the time of surgery. Early dissociationso from ClinicalKey.com.au by Elsevier on April 01, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
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ciated with acetabular malposition such as a high abduction angle
or over/under anteversion [9,18,19]. However, in our series, all were
within the safe zones of abduction described by Lewinnek et al [20].
In only one case was there posterior impingement, which was
thought to be due to femoral component malposition. In Napiers’s
series, 2 of 4 cases with overabducted acetabular components had a
recurrent liner dissociation [11]. They thus recommend revision of
the acetabular component in such cases. Late dissociations at 5 to
10 years in well-positioned THAs strongly suggest that there is a
problem with the Pinnacle locking mechanism.
There may be further patients who have some instability of the
liner but do not develop frank dissociation. Three patients in our
series had some prodromal symptoms of pain or subluxation in the
months preceding the actual dissociation. This diagnosis needs to
be considered. However, radiological diagnosis is difficult in such
patients. One had a radiograph taken due to a subjective feeling of
subluxation which showed a congruent hip joint. Computed
tomogram (CT) is a well-recognized tool in assessment of poly-
ethylene wear and component alignment in hip arthroplasty [21].
We are unaware of any cases where a CT has been used to detect
polyethylene dissociation; however, a thin-slice metal suppression
CT may detect subtle changes not evident on plain radiographs.
Treatment of liner dissociations should be individualized. In
cases where the acetabular component is well aligned with an
intact locking mechanism, a head and liner exchange may be
appropriate. We have not observed recurrent liner dissociation in
our series. If impingement or malalignment is present, a revision of
either acetabular or femoral component should be considered to
reduce the risk of redissociation. Cementing a liner into awell-fixed
acetabular component is an option if there are concerns about the
integrity of the locking mechanism.Summary
Liner dissociation is an important complication seen with the
Pinnacle acetabular component. Although some cases could be
attributable to technical issues such as incomplete seating,
impingement or malalignment, the increasing numbers reported
with this device, especially at long-term follow-up, coupled with
the lack of reported dissociations with other contemporary
modular acetabular components suggests that there are problems
with the locking mechanism. Comparative studies of similar
acetabular components and mechanical testing under different
loading conditions may help to provide the answers.Downloaded for Anonymous User (n/a) at University of O
2021. For personal use only. No other uses without permis
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Background: There are a number of reports of polyethylene liner dissociation of third-generation
modular acetabular components. This study compares our experience with 2 contemporary systems to
determine whether this is an implant- or class-specific problem.
Methods: This is a single-center retrospective study of 961 primary total hip arthroplasties using 2 third-
generation modular cementless acetabular shells: Pinnacle (535) and R3 (426) with a polyethylene liner.
Details of all revisions were obtained from local databases and the New Zealand Joint Registry. Kaplan-
Meier survival curves were calculated for all-cause revision, acetabular reoperation (including liner
exchange), and liner dissociation.
Results: There were 17 revisions in group 1 (Pinnacle; DePuy Synthes): 17 for recurrent dislocation, 6 for
liner dissociations (1.12%), 3 for femoral loosening, and one for deep infection. In group 2 (R3; Smith and
Nephew), there were 4 revision procedures: one for infection, 2 for dislocation, and one femoral revision
for periprosthetic fracture. There were significantly higher proportions revised in group 1 for all-cause
revision, acetabular reoperation, and dissociation (P ¼ .024 to 0.038). The 7-year survival for all-cause
revision was 96.1% for Pinnacle and 99.0% for R3 (P ¼ .022), and that in the acetabular reoperation group
was 96.9% for Pinnacle and 99.3% for R3 (P ¼ .035).
Conclusions: There was a higher revision rate for the Pinnacle acetabular component than for the R3 at 7
years. This was mainly due to polyethylene liner dissociation that can occur early or late. It appears to be
a problem specific to the Pinnacle cup design rather than a feature of similar third-generation acetabular
components.
© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Uncemented acetabular components are widely used in modern
total hip arthroplasty (THA) [1-3]. Most are modular, which has a
number of advantages including the ability to use supplementary
screw fixation, and allow ceramic and polyethylene bearings,
different head sizes, and the use of lipped and face-changing liners.
A problemwithmodularity is polyethylene liner dissociation,which
was a complication of older uncemented acetabular components
[4,5]. Improvements in locking mechanisms had almost eliminated
this problem. However, the problem has reemerged with theics, Dunedin Hospital, Great
999x58618.
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27development of third-generation acetabular components [6-11].
These cups have been designed to accept multiple liner options and
use a taper lock mechanismwith no locking ring. The polyethylene
liner is recessed within the shell to reduce the risk of rim fractures.
In recent years, there has been a shift away from cemented cups
toward modular uncemented acetabular components in our unit.
The most frequently used are the Pinnacle cup (DePuy Synthes,
Warsaw, IN) and the R3 cup (Smith and Nephew, Memphis, TN),
which were introduced around the same time and have a similar
design. We have previously reported a series of liner dissociations
with the Pinnacle cup from our unit and concluded that although
some cases could be attributable to technical issues such as
incomplete seating, impingement, and malalignment, the
increasing numbers reported, including late dissociations, and the
lack of reports with other systems suggested a problem with the
locking mechanism [11]. The rate of liner dissociation is reported tosociation of Hip and Knee Surgeons. This is an open access article under the CC BY-
tago from ClinicalKey.com.au by Elsevier on April 01, 
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registry studies [6]. It is not clear whether this is an implant-
specific issue or a feature of other third-generation designs.
The purpose of this study was to compare our experience with 2
similar contemporary third-generation modular acetabular compo-
nents used over the same time period from the same center. The
primary outcome was revision for liner dissociation. Secondary out-
comes were all-cause revision and acetabular reoperation. The null
hypothesis was that there is no difference between the 2 systems.Material and methods
This is a retrospective comparative study comparing all primary
THAs performed at either our public or private hospital using the
Pinnacle Cup (group 1) and the R3 cup (group 2) between August
2007 and August 2019, with minimum 1-year follow-up. All pa-
tients undergoing primary THA using these cups and any subse-
quent revision were identified from our local audit database cross-
referenced to the New Zealand Joint Registry (NZJR) [1]. Only pa-
tients with a polyethylene liner were included. All indications for
surgery including acute fracture were included. All procedures
were performed by or under the direct supervision of 10 consultant
surgeons experienced in hip arthroplasty. Approach and implant
choice were at the surgeon's discretion. All 10 surgeons used the
Pinnacle cup, with 6 also using the R3 cup.
Patient demographics and operative variables are shown in
Table 1. There were 535 hips in the Pinnacle group and 426 in the
R3 group. There was a higher proportion of females in the Pinnacle
group. The Pinnacle group was significantly more likely to have
been performed via a lateral approach using an uncemented stem, a
neutral liner, and a 28-mm metal head than the R3 group. The R3
group had significantly longer mean follow-up. The NZJR and ourTable 1
Comparison of baseline demographics and operative variables for Group 1









Male 249 (47%) 229 (54%) .03
Female 286 (53%) 197 (46%)
Age 66.3 (41-95) 63.1 (33-81) <.001
Deaths 34 (6.4%) 23 (5.4%) .58
Femoral component
Exeter (Stryker) 258 (48%) 275 (64%) <.001
CORAIL (DePuy Synthes) 274 (51%) 5 (1%)
Polar stem (Smith and Nephew) 110 (26%)
Spectron (Smith and Nephew) 19 (5%)
Synergy (Smith and Nephew) 16 (4%)
Others 3 (1%) 1
Head material
Ceramic 311 (58%) 289 (68%) .002
Metal 224 (42%) 114 (27%) <.001
Oxinium 23 (5%) <.001
Head size
28 mm 234 (44%) 99 (23%) <.001
32 mm 293 (55%) 323 (76%) <.001
36 mm 8 (1%) 4 (1%) .14
Approach
Posterior 337 (63%) 397 (93%) <.001
Lateral 198 (37%) 29 (7%) <.001
Cup
No hole 303 (57%) 314 (74%) <.001
Three-hole 224 (42%) 111 (26%) <.001
Multihole 6 (1%) 1 (0.2%)
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274audit database were used to identify any revision procedure on
these patients. Chart and radiographic reviews were used to
determine the causes of revision including specifically those due to
liner dissociation.
Design and surgical technique
The Pinnacle shell is made from titanium and has no hole,
cluster (3-hole), and multihole options. It has a short taper locking
system that allows it to take ceramic and metal inserts. Marathon
polyethylene liners were used in all cases in this study. These are
gamma-irradiated with 5 Mrad in gas and are fully annealed.
The R3 shell is also made of titanium and has a hydroxyapatite
coat. There are no-hole and 3-hole options. The highly cross-linked
polyethylene (XLPE) is gamma-irradiated in gas with 10 Mrad and
fully annealed. There are 20-degree lipped or neutral options. Our
preference is to use a no-hole shell with a central hole cover unless
supplementary screw fixation is felt necessary. Initially, we found it
difficult to seat the liner within the shell because of blood inter-
fering with the highly conforming geometry. This was less of a
problem with the cups with holes for screw fixation. We now
routinely keep our R3 polyethylene liners in the freezer at e18C.
The small degree of shrinkage of the liner allows egress of any blood
or fluid and allows secure locking.
Statistical analysis
A paired t-test was used to compare continuous variable and
Fisher's exact test for categorical variables. Kaplan-Meier survival
curves with 95% confidence intervals were drawn for all-cause
revision, acetabular reoperation (including liner exchange), and
liner dissociation. An a priori power study calculation assumed
there were no further cases of liner dissociation compared with the
6 cases we have reported previously. We estimated that we needed
400 THAs using the R3 cup to show a statistically significant dif-
ference between the groups (Fisher's exact test, P < .05).
Results
Group 1 (Pinnacle)
There were a total of 17 revisions. There were 6 liner dissocia-
tions (1.12%). All had previously been identified and detailed in our
case series [11]. The mean time to presentation with dissociation
was 37 months (range: 4.5 months to 10.8 years), with 4 of 6 pre-
senting within 13 months of the initial procedure. The remaining 2
cases were at almost 5 years and 10.8 years, respectively. Five were
male, and 5 underwent a lateral approach. Screws had not been
used in any of the shells. A 32-mm head was used in one case and
28-mm heads in the remaining 5 patients. A neutral liner was used
in all cases. The primary operations had been performed by or
under the supervision of 4 different surgeons over a 10-year period.
At revision, the liners were all grossly loose and typically the 3
superior antirotation tabs had sheared off. All shells were well
positioned and well fixed, and none were revised. One femoral
stem was impinging posteriorly because of excessive femoral
anteversion and was revised. A new liner was inserted in 5 cases,
and a liner was cemented into the shell in one case because of
concerns about the locking mechanism. There have been no cases
of repeat dissociation or failure (Table 2).
Seven revisions were for recurrent dislocation (6) or subjective
instability (1). All shells were well fixed at the time of revision. One
patient with deep infection underwent debridement with liner and
head exchange. Therewere 3 revisions for loosening of uncemented
stems.o from ClinicalKey.com.au by Elsevier on April 01, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
Table 2
Details of patients who had an acetabular liner dissociation.
Age Sex Indication for
primary THA


















Lateral 38 10 Change of liner





Posterior 35 24 Change of liner





Lateral 40 4 Change of liner














Lateral 37 10 Change of the liner





Lateral 42 11 Change of the liner
OA, osteoarthritis; #NOF, fractured neck of the femur; KHO, high offset; KLA, lateralized.
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Therewere 4 revision procedures in total. Therewere no cases of
liner dissociation. There were 3 revisions of the liner and head: one
for early deep infection and 2 for dislocation at 11 and 18 months,
respectively. There was one femoral revision for periprosthetic
fracture at 15 months.
There was a significantly higher proportion revised in group 1
for liner dissociation, all-cause revision, and acetabular reoperation
(any reason) (P ¼ .024 to 0.038, Fisher's exact test) (Table 3).
The revision rate for dislocation (excluding dissociation) was
higher in group 1 (1.3%) than in group 2 (0.5%) but did not reach
statistical significance (Fisher's exact test, P¼ .3).With a lownumber
of dissociations and dislocations observed and a large number of
surgeons, therewere no statistically significant differences between
surgeons in dissociation or dislocation rates. (Table 4).Table 3








All-cause revision 17 (3.2%) 4 (0.9%) .024
Rate/100 ocys (95%
CIs)
0.78 (0.46-1.25) 0.19 (0.05-0.48)
KM survival at 7 years
%
(95% CIs)
96.1 (94.1-98.2) 99.0 (98.1-100) .022
All acetabular
reoperations
14 (2.6%) 3 (0.7%) .027
Rate /100 ocys (95%
CIs)
0.64 (0.35-1.10) 0.14 (0.03-0.41)
KM survival at 7 years
%
(95% CIs)
96.9 (95.2-98.7) 99.3 (98.5-100%) .035
Acetabular dissociation 6 (1.12%) 0 (0%) .038
Rate /100 ocys (95%
CIs)
0.28 (0.10-0.60) 0 (0.00-017)
KM survival at 7 years
%
(95% CIs)
98.7 (97.4-100) 100 (100-100)
Ocys, observed component years; KM, Kaplan-Meier; 95% CIs, 95% confidence in-
tervals.
Bold denotes statistical significance P < .05.
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27Kaplan-Meier survival curves were calculated to 7 years (Figs. 1-
3). There was a statistically significant decreased survival in group 1
for all end points. The Kaplan-Meier all-cause survivorship for the
Pinnacle cup was 96.1% at 7 years compared with 99.0% for the R3
cup. The survival for any acetabular reoperation at 7 yearswas 96.9%
(Pinnacle) and 99.3% (R3). The hazard ratio was 3.6 for all-cause
revision (P¼ .022) and 3.9 for any acetabular reoperation (P¼ .035).Discussion
We have shown a higher revision rate for the Pinnacle acetab-
ular component than for the R3 cup at short-term follow-up to 7
years. This is primarily due to polyethylene liner dissociation that
occurred in 6 of 535 cases (1.1%). There were no cases of liner
dissociation in the R3 group, suggesting that the problem is specific
to the Pinnacle cup rather than a feature of the third-generation
acetabular design. Both cups had excellent survivorship for revi-
sion for other reasons.
The Pinnacle cupwas launched in 2003 and the R3 shell in 2008.
Both are widely used and have excellent registry results [2,3]. In the
National Joint Registry for England, Wales, Northern Ireland, and
the Isle of Man (NJR), the Pinnacle cup with a ceramic-on-
polyethylene bearing has a survivorship of 97.19% at 10 years and
a cumulative revision rate of 5.2% at 10 years in combination with
the CORAIL stem (DePuy Synthes, Warsaw, IN) [3]. In the Australian
Orthopaedic Association National Joint Replacement Registry
(AOANJRR), it has a cumulative revision rate of 6.8% at 10 years in
combination with the CORAIL stem. In other reports, it has a sur-
vivorship for all-cause revision of 95.2% to 99.2%, acetabular revi-
sion of 97.0% to 100% at 10 years [12,13], and a cumulative revision
rate of 2.5% at 10 years [14]. Our survival figures of 96.1% all-cause
survival and 96.9% for acetabular reoperation are in line with these
studies.
In the NJR, the R3 cup has a cumulative all-cause revision rate of
2.0% at 7 years and 2.6% at 10 years. The rate for acetabular revision
is 0.9% at 7 years and 1% at 10 years. This excluded metal-on-metal
bearings but did include ceramic-on-ceramic bearings [3]. The
AOANJRR reports a cumulative all-cause revision rate for the R3 cup
of 3.3% for ceramic on XLPE and 4.4% for metal on XLPE at 10 years
[2]. Others have reported similar results, but ceramic liners were
used in a large proportion of hips [15,16]. Our figures of 99.0% fortago from ClinicalKey.com.au by Elsevier on April 01, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
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Table 4
Number of procedures contributed by each surgeon with numbers of revisions for dissociation and dislocation observed for Pinnacle and R3 acetabular systems.
Surgeon Pinnacle R3
Number Dissociation Dislocation Number Dissociation Dislocation
1 77 1 0 81 0 0
2 17 1 0 111 0 1
3 25 0 0 0 0 0
4 22 0 1 0 0 0
5 42 0 0 200 0 1
6 137 3 2 3 0 0
7 151 0 3 1 0 0
8 39 0 0 0 0 0
9 19 0 0 30 0 0
10 6 1 0 0 0 0
535 6 6 426 0 2
D.P. Gwynne-Jones, A. Memon / Arthroplasty Today 6 (2020) 354e359 357all-cause revision and 99.3% for acetabular reoperation at 7 years
compare favorably with these.
There have been multiple case reports and series of dissocia-
tions with the Pinnacle cup [6-11,17]. These can be early (within 2
years) or late (2 to 10 years) [10,11]. The rate of liner dissociation
with the Pinnacle system is reported to be very low at between
0.17% and 0.8%, but it may be under-reported particularly in registry
studies [6,7]. Jameson et al reported only 10 cases of liner dissoci-
ations in 13,923 (0.07%) hip arthroplasties from the NJR [18].
We are aware of only one case report with the R3 cup that
occurred after a fall in a 56-year-old man 5 years after a complex
primary hip replacement [19]. However, a further case report of
liner dissociation leading to catastrophic failure of an oxinium head
appears to be an R3 shell [20]. There are only 4 revisions reported
for liner dissociations in the NJR out of 27,936 cups (0.014%) [3].
However, this includes ceramic and metal liners. The AOANJRR
reports 3 revisions for acetabular liner breakage with the R3 from
35,963 hips (0.008%) but does not have a specific field for liner
dissociation [2].
Most surgeons and company representatives we have spoken to
have suggested that incorrect seating of the polyethylene liner is
the reason for the dissociations seen. Although the antirotation tabs
sit flush within the shell, the liner is approximately 1 mm proud.Figure 1. Kaplan-Meier curve showing survival over up to 7 years of follow-up (all-cause rev
(95% CI: 98.1% to 100.0%); Pinnacle ¼ 96.1% (95% CI: 94.1% to 98.2%). Hazard ratio (HR) (Pin
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276This makes it harder to assess seating circumferentially by the use
of a dissector. In our experience, if the R3 shell is incorrectly seated,
it does not lock and can be easily flipped out by gentle testing at the
notch in the rim. Freezing the liner made it easier to seat if a no-
hole R3 shell was used. It was suggested by colleagues in another
center and, although this is not included in the surgical technique
or reported in the literature, we now do it routinely. However, the
absence of reported dissociations with the R3 system suggests that
this is not critical. If the liner is incompletely seated in the Pinnacle,
the locking mechanism may be strong enough to avoid immediate
dissociation but may fail early. However, this is unlikely to explain
the late cases that we saw at 5 and 10 years.
The lockingmechanism in the Pinnacle cup has a relatively short
taper and includes a ridge or barb on the liner that locks into a
single groove close to the rim of the shell. There are 6 antirotation
tabs that sit flush with the shell and resist rotation but have no
effect on pull-out strength. The polyethylene sits approximately 1
mm proud of the surface of the metal shell. In contrast, the R3 cup
has a longer taper and double-locking groove at some distance from
the rim. There are 12 derotation tabs that fit into reciprocal pe-
ripheral recesses as in the Pinnacle cup. The liner and tabs sit flush
with the face of the metal shell. In addition, there is a small cut out
in the shell that allows for gentle testing of the liner afterision, censored at the time of death). Percentage survival at final follow-up: R3 ¼ 99.0%
nacle) ¼ 3.6 (95% CI: 1.2 to 10.8; P ¼ .022). CI, confidence interval.
o from ClinicalKey.com.au by Elsevier on April 01, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
Figure 2. Kaplan-Meier curve showing survival over up to 7 years of follow-up (revision for acetabular reoperation, censored at the time of death or the first revision). Percentage
survival at final follow-up: R3 ¼ 99.3% (95% CI: 98.5% to 100.0%); Pinnacle ¼ 96.9% (95% CI: 95.2% to 98.7%). HR (Pinnacle) ¼ 3.9 (95% CI: 1.1 to 13.6; P ¼ .0353). CI, confidence
interval; HR, hazard ratio.
D.P. Gwynne-Jones, A. Memon / Arthroplasty Today 6 (2020) 354e359358impaction. It has a push-out strength of 1112 N and resists 40 Nm of
torque [21]. The manufacturer claims that it can be reinserted
without damaging the locking mechanism.
Other reasons suggested for dissociation may include malposi-
tion of the shell, use of face changing liners, impingement, poly-
ethylene fatigue, and rim fracturewith thin polyethylene and larger
heads [6,7,10,11,22-24]. There were no cases of cup malposition in
those patients who dissociated. A higher proportion of 28-mm
heads were used in the Pinnacle group, and 28-mm heads were
used in 5 of the 6 cases observed. A smaller head size may increase
the risk of femoral neck impingement on the polyethylene in the
Pinnacle system, whereas the polyethylene is fully recessed in theFigure 3. Kaplan-Meier curve showing survival over up to 7 years of follow-up (revision for
final follow-up: R3 ¼ 100.0% (95% CI: 100.0% to 100.0%); Pinnacle ¼ 98.7% (95% CI: 97.4% t
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27R3 system. The XLPE in the R3 shell has more cross-linking so
would be expected to be weaker and therefore should be more
prone to rim failure than the Marathon (DePuy Synthes, Warsaw,
IN) polyethylene. We are not aware of any change in the biome-
chanical properties of the R3 polyethylene liners from storing them
at e18C.
This study reports the experience of well-trained surgeons who
are familiar with many uncemented cups. Many used both com-
ponents in this study. We have not previously identified liner
dissociation as a problem in our unit [25]. Therefore, from our re-
sults and a review of the literature and registry data, we believe
that we are witnessing a problem with the locking mechanism,dissociation, censored at the time of death or the first revision). Percentage survival at
o 100.0%). CI, confidence interval.
tago from ClinicalKey.com.au by Elsevier on April 01, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
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D.P. Gwynne-Jones, A. Memon / Arthroplasty Today 6 (2020) 354e359 359albeit rare, that appears to be specific to the Pinnacle cup rather
than the similar third-generation cups.
A limitation of this study is that the groups are not comparable in
a number of ways including the approach, gender proportion,
femoral component used, and head size. We routinely freeze the
liners for the R3 cup to aid insertion but did not do so for the Pinnacle
system.We do not have full clinical and radiological follow-up on all
cases and did not collect patient-reported outcome scores. However,
the end point of dissociation is so dramatic that we believe that
revision is an appropriate end point to use for this study. There were
more cases in the Pinnacle group with a shorter mean follow-up.
Most occurred within the first 13 months, so it is likely that with
minimum 1-year follow-up, we have identified early failures. How-
ever, as some occurred later than 5 years, the rate may rise with
longer follow-up. Owing to the small size of our country and a rela-
tively geographically isolated area, we are confident that the com-
bination of our arthroplasty and audit database, cross-referenced to
the NZJR, has identified the correct reason for all the revisions.Conclusions
We saw a higher revision rate for the Pinnacle acetabular
component than for the R3 cup at 7 years. This is mainly due to
polyethylene linerdissociation that canoccur earlyor late. It appears
to be a problem specific to the Pinnacle cup design rather than a
feature of the similar third-generation acetabular components. The
incidence is low, and it will require large national joint registries to
collect data on liner dissociation to further address the question.Conflict of interest
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Chapter 8. Discussion 
There will never be enough capacity for the potential demand for modern healthcare, which 
results in tensions between politicians, the Ministry of Health, DHB managers and surgeons.  
The political and ministry stated goals have been to increase the number of procedures, 
maintain equity of access across the country, give patients certainty whether they qualify 
for surgery or not, and to do the worst or most severe cases.  The DHBs are expected to 
implement these goals despite their limited resource.  They must avoid ESPI breaches, live 
within their budget and try to maintain their average intervention rate compared with the 
rest of the country. Surgeons want to do the best for the patient.  If they believe that the 
benefits of surgery outweigh the risks they are likely to recommend surgery after 
appropriate discussion and informed consent.  However, the Medical Council of New 
Zealand has stated that there is a duty on clinicians to responsibly use resources in an 
environment of healthcare limitation.  Whilst able to advocate for patients, they must be a 
party to any rationing decisions. [1]  
Demand 
We have shown the increased demand for elective surgery, and hip and knee replacement 
in particular, is coupled with inadequate capacity. There is not equity of access to publicly 
funded surgery in NZ, with Southern DHB performing poorly. It appears that Otago and 
Southern DHB has been systematically disadvantaged under the PBFF and surgical services 
seem to have borne the brunt of this. There are increased costs with running two base 
hospitals within Southern DHB and the large geographical area covered. In acute specialties 
such as orthopaedic surgery there is a need for a sustainable service on both sites. The 
funding model is opaque and locally we appear to be disproportionately disadvantaged by 
the overseas tourist load, which is not directly funded. Our surgeons are probably less likely 
to offer surgery than in centres where rationing is less ingrained. We have demonstrated 
that, when capacity fails to meet demand in a system that does not have waiting lists, the 
thresholds for surgery rise. Patients end up being declined, re-referred and most eventually 
undergo surgery. In a system that is meant to be efficient, this process adds little value and 
a lot of waste.  
Carpal Tunnel Decompression 
We have been able to maintain good access to CTD through alternative models of care by 
using our day surgery unit, local anaesthetic and delegation to appropriate junior staff. 
Demand is driven by the increased incidence in elderly patients. Our results in the elderly, 
have been comparable or surpass international studies in younger age groups. We have the 
benefit of an excellent neurophysiological service which has greatly helped patient 
selection. By using a very basic DSU theatre/ procedure room we have freed up capacity in 
the main theatre suite for major cases. 
Prevention 
There remains little that can be done to prevent the burden of musculoskeletal disease and 
OA in particular. Our programme for DDH screening has helped reduce late presenting DDH 
and may have an effect on reducing acetabular dysplasia. It is a pragmatic solution with 
careful examination by experienced orthopaedic surgeons and selective use of ultrasound. 
We have found that ultrasound is particularly useful in monitoring patients with instability. 
279
Population based interventions such as bisphosphonate treatment have reduced the 
incidence of fragility fractures. This indirectly helps elective surgery by reducing the acute 
demand. Obesity is likely to continue to rise and public health measures to control this are 
urgently needed. However, there will be a long lead-time before we see any effects of this 
and the demand will rise before any potential fall.  
Joint Clinic and non-operative management 
Similar programmes to our Joint Clinic operate in Sydney and Melbourne in Australia and 
Denmark. [2-4] In most instances their patients have had less severe disease and there has 
been ready access to surgery when indicated. In contrast, the Joint Clinic has provided 
mixed results. It has undoubtedly improved access and been useful as a triage tool though 
this was not the goal the Ministry of Health was interested in. It confirmed that patients 
with knee OA were more likely to benefit than those with hip OA. It was a little surprising to 
find the high proportion of patients with knee OA that were still being managed non-
operatively at 5-7 years without a major decline in condition specific scores such as the 
Oxford Knee score. This justifies the increased use of good non-operative management 
including exercise therapy in patients with milder knee OA that can delay or even avoid 
surgery for a clinically relevant time. However, our paper comparing functional outcomes at 
5 years does suggest that suitable patients are likely to be significantly better off with 
surgery that should not be delayed if non-operative treatment has failed. 
Advocates for the introduction of widespread supervised exercise therapy as part of non-
operative treatment are making claims on the basis of relatively small randomized 
controlled trials. [3-5] The Management of Osteoarthritis (MOA) group in Dunedin 
calculated the cost/ Quality Adjusted Life Year (QALY) of their physiotherapy programme as 
$26,000 (1x GDP) at 2 years. [5] This may be cost effective but many of these patients will 
eventually need TJR as well. To roll out supervised physiotherapy programs across countries 
such as Canada, Australia and as proposed in NZ at significant cost needs to be carefully 
compared with the long-term results of surgery. [7] 
Despite the high initial cost, TJR gives a better return on investment. Both THR and TKR 
were highly cost-effective after 3 years using a threshold of $33,000 /QALY (0.5xGDP) falling 
to $6000/QALY for THR and $7500/QALY for TKA at 15 years using SF-6D. If EQ-5D is used 
the cost falls to $2700 and $3500 at 15 years.  This is similar to the results calculated using 
the methodology of Jenkins et al from Edinburgh [6] where the lifetime QALYs gained after 
THR or TKR in patients with a preoperative OHS/OKS of 12 are 9.4 (THR) and 6.3 (TKR) and 
the cost/QALY $2222 and $3424 respectively.  
Scoring tools 
We have shown that scoring tools do work and correlate with condition specific scores. 
Using a prioritization nurse added little with surgeons generally scoring consistently. 
However, when there is a mismatch between demand and capacity there tends to be 
clustering at certain scores, score creep and little ability to discriminate around the 
threshold score.  
The latest iteration of the orthopaedic surgical prioritization tool attempts to use a general 
score to cover all condition and includes a patient impact on life score. It is hoped that it 
will allow some comparison and access for patients with conditions other than hip and 
knee OA. Many of these patients would fail to qualify for surgery in the current climate. We 
are 
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seeing a lot of clinical over-ride used for carpal tunnel decompression because patients 
would not otherwise qualify. We believe that there should be separate thresholds for 
conditions such as carpal tunnel syndrome or Dupuytrens disease that can be effectively 
and efficiently treated in a day surgery facility allowing major inpatient cases to be 
performed in a fully equipped theatre. However, this has not been well received by the 
Ministry of Health who believe that the resources used for these procedures should be 
reallocated to areas that have higher need. 
The new National Referral Prioritization Tool (NRPT) also includes the patient impact on life 
(IOL) score with the two scores correlating reasonably strongly. It has been of some use in 
our pilot but we found it to be labour intensive. Most surgeons believe that, while they are 
in the best position to triage these referrals, their time would be better-spent seeing 
patients instead of scoring and rejecting them. Its purpose was to restrict the number of 
referrals accepted to 50%, which it may have done, but this does not really mean success 
for those patients or the service.   
The real value of national scoring tools will be in comparing threshold scores between 
specialties and DHBs to help inform resource allocations. However, this has not happened 
with the national orthopaedic surgical scoring tools to date. We know from talking to 
registrars and colleagues in other centres, and from published papers that there have been 
significant differences in access threshold across NZ. An anaesthetist from North Shore 
Hospital, writing in the latest edition of the ASMS publication ‘The Specialist’, was surprised 
to see an 88 year old lady coming to preadmission for a THR on crutches. [8] This has almost 
been a prerequisite for access in Otago for more than 10 years! The Ministry has been loath 
to release threshold scores to allow comparison between DHBs questioning the 
consistency of scoring within and between DHBs. It expects that DHBs should allocate their 
resources depending on local need. With limited budgets and a traditional split between 
the Planning & Funding and Provider arms of a DHB this has not happened and has been 
the source of great frustration. 
Consequences of rationing 
While rationing to a point is a reality, I believe it has gone too far when successful 
procedures such as THR and TKR surgery are restricted to patients with an OHS/OKS of 
around 10 points. This will have an impact on patients in that, although gains in scores and 
HRQoL are greater, the final outcome score is lower so patients lose potential QALYs both 
before and after surgery. Patients get re-referred, rescored and usually end up getting their 
surgery but in a more disabled state. It adds little value and encourages gaming by patients, 
GPs and surgeons. I do not think that the public sector should fund a TJR for anyone who is 
having some pain after 18 holes of golf despite finding, in our cost-effectiveness paper (5.7) 
that THR and TKR were highly cost-effective by 5 years even in patients with a preoperative 
OHS/OKS above 25. The argument from the UK that TKR is cost-effective in patients with 
preoperative OKS of 35-40 is, in my view, not relevant to the realities of public hospital 
practice in NZ. [9] Interestingly, it has been shown that patients with better scores and less 
radiographic change are more likely to be dissatisfied with the results of surgery. [10,11] 
Paradoxically our good results may be because of some degree of rationing. 
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Improving perioperative management 
Our ERAS programme was successful. Buy-in by nursing and physiotherapy staff was key and 
was the biggest gain of the OPP.  It is interesting to compare the modern results of ERAS 
with the best practice care pathways we used when I first returned as a consultant.   
However, it is hard to see how further significant gains can be achieved as we get down to a 
length of stay of 2-4 days. Day case THR is now being done in some centres but only in 
carefully selected patients. As our ERAS paper shows, over a third of our public patients are 
ASA grade 3 and 4, mean BMI is 30-32, the mean age is 68-70 years and pre-operative 
Oxford score is 10-12 points. Despite this almost all patients were discharged home rather 
than to step down facilities. We have continued to collect LOS data and by 2018 had 
reduced ALOS to 4.0 days for THR and 4.17 days for TKR. Unfortunately recent changes on 
the ward and a reduction in bed numbers have undone many of these improvements. 
Patients are rarely mobilized on the night of surgery and the LOS has recently increased 
again to 4.3 days for both THR and TKR.  
Surgical outcomes 
Our surgical results for hip replacement as demonstrated in the Morscher cup studies and 
the survivorship studies of the hybrid combination, match or surpass best international 
results. We have reported functional outcomes after hip and knee replacement that again 
match or surpass published results despite coming from a severely disabled public hospital 
population. Our poor outcomes after TKR are lower than that usually quoted. Several 
surgeons in Dunedin, including myself, have revision rates for THR and TKR significantly 
lower than the NZ average as reported by the NZ Joint Registry.[12] Our surgical site 
infection (SSI) rate after THR/TKR of 0.7% compares with the NZ average of 1.3% and is 
amongst the lowest in the country. [13] All this contributes to a lower revision burden, 
which frees up time for elective surgery.  
What has been achieved in Otago 
The original proposal for the Orthopaedic Patient Pathway programme (OPP) anticipated 
transformational change occurring due to all of the inter-connected projects, with the hope 
that efficiencies gained would thereby increase capacity. I had hoped that improved 
efficiency meant doing a lot more with a little additional investment. However it became 
clear that the goal was doing more with less, with no mechanism to return any of the gains 
to the orthopaedic department. This was both disappointing and disillusioning for the staff 
who had enthusiastically engaged in the programme.  
The larger gains have come subsequently, when there has been investment. We 
commissioned a new theatre by upgrading an old plaster room adjacent to the orthopaedic 
theatre and now have access to an orthopaedic trauma theatre 6 days a week. This has had 
a limited effect on separating the acute and elective streams and reduced elective 
cancellations due to acute list pressure. However, the number of orthopaedic beds has 
fallen by a quarter from 54 to 40, so acute patients waiting for surgery cannot be admitted 
and now wait at home. Appointment of a new full-time arthroplasty surgeon and 
implementation of limited out-sourcing to the private sector has resulted in an increase in 
the number of primary hip and knee replacements from 358 in 2013/14 to 511 in 2018/19 
as we predicted we needed. However, our standardised intervention rate (SIR) remains 
significantly below the NZ average for TKR as it has done for at least 10 years. During the 
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last 5 years we have under-provided on average 107 TKRs per year (28% shortfall) across 
Southern DHB compared with our expected share of the NZ total.  
Other health care systems 
Other public health care systems face similar challenges. Wherever we visit there are issues 
with wait lists of some form, lack of resourced beds due to acutes or out-lying patients 
(usually medical), a backlog of acute patients waiting for surgery leading to cancellations of 
elective lists and more patients being referred than can be seen by a specialist. Various 
strategies have been employed to try and improve access to elective surgery. Usually this is 
in the form of targets with bonuses or penalties for failing to comply. In the United 
Kingdom (UK), treatment centres for hip and knee replacement were developed with 
mixed results. Despite patients being healthier, outcomes on Oxford hip and knee score 
were a little worse and the risk of complications higher (OR 1.3) in patients managed at a 
treatment centre.[14]  In the UK the 18-week target was introduced by which time patients 
had to be seen and treated.   This was initially accompanied by significant increases in 
funding and capacity.  Despite this, problems have continued with increasing demand for 
elective orthopaedic surgery outstripping capacity.  Weekend, evening and extra lists are 
arranged at short notice, and high cost, to try to resolve the backlog and avoid financial 
penalties. Staff overtime then tends to lead to burn out and high turnover.  
Canada has had similar problems and also introduced scoring systems. They were part of 
the approach used in Sakatchewan to improve wait list compliance. [15] However whole of 
system changes and out-sourcing were also used. Factors credited with success include 
management of the whole of care continuum, strong clinical leadership, and a culture of 
trust and innovation. Pomey in a review across several provinces of Canada noted strong 
funding, stakeholder engagement, physician involvement, human resource capacity, 
dedicated staffing, and financial incentives as factors for success. [16] In smaller centres 
wait lists in excess of 12 months for a routine (26 week) joint replacement remain. [Dusik 
personal communication].  
In Australia, Walters et al reported on perceptions of snakes (barriers) and ladders 
(facilitators) and noted the main barrier was inadequate resources but highlighted a need 
for system change. [17] Ladders included pooled or generic wait lists and separation of 
acute and electives. Prioritization systems were perceived as ‘wobbly ladders’ of limited 
benefit. However, I believe that it is likely that scoring systems which are the norm in NZ 
will become more common overseas in public health care systems.  It is important that 
there is transparency and consistency of scoring. Rather than condition specific tools, more 
generic HRQoL scores can be used to help compare the need between specialties, other 
conditions and alternative therapies. 
The future in New Zealand 
There is not equity of access across the country to elective orthopaedic surgery. Many 
factors may contribute to this including the age of patients, the relative size of the private 
sector and private insurance levels, under-provision in previous years, and the allocation of 
resources within a DHB. The funding model including funding for the care for overseas 
tourists probably needs some adjustments.  
The demand will continue to rise as increasing numbers of patients get older and their 
expectations rise. This will need to be matched by an adequate number of staffed beds to 
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service the acute and elective load, more theatre time and more theatre staff. Obesity 
should not be regarded as acceptable from a health perspective and its management needs 
to be a priority in primary care. Culture and attitude changes are necessary which may 
require legislation. Exercise programmes such as those used in Joint Clinic should be 
available via primary care for patients with early stage hip and knee OA. This should have an 
effect on patients’ perceptions that surgery is not the only solution but is reserved for 
failure of other treatments.   
Prioritisation and rationing are necessary, but the bar is currently too high in Otago and 
some other DHBs. In these papers we have demonstrated clear evidence of inadequate 
capacity to match the demand. This is shown by the need to ration 50% of referrals, 
consistently declining 30% of wait-listed patients, the poor preoperative scores of patients 
who do qualify and wait times in excess of the 4 month target. The emphasis at DHB level 
should be on doing more work, rather than avoiding it in order to achieve ESPI compliance. 
This may require reallocation of resources from other areas within a DHB if there is no more 
funding from the Ministry of Health. The problems are not isolated to Dunedin and 
Southern DHB. As I predicted in 2016 in the conclusion to “Rationing of hip and knee 
replacement: Effect on the severity of patient-reported symptoms and the demand for 
surgery in Otago” they have become increasingly widespread across New Zealand as 
budgets fail to increase to match the demand.  
Improving perioperative management and reducing complications remains important 
especially as patients become older and frailer. The ability to reduce length of stay is limited 
by this and the fact that stays are already short compared with historically. Making patients 
wait until they have deteriorated is counter-productive and is likely to increase LOS.  
Avoiding lengthy inpatient rehabilitation will have an impact at the hospital level and on 
orthopaedic bed availability if patients become stranded. Our surgical outcomes and 
revision burden have been very good but quality must not be sacrificed in the quest for 
efficiency. A significant concern is the expectation of a first class, error-free service by the 
public and the Health and Disability Commissioner despite economy class funding. It is not 
clear how long this expectation can be achieved without further investment. 
There will never be enough money to run the health service and informed decisions need to 
be made which may not be popular. Hopefully national benchmarking, and outcomes data 
including cost-effectiveness, will lead to improved allocation of resources for high value 
interventions. Currently surgical rationing is being performed face to face with the patient. 
This interferes with the fundamental doctor-patient relationship, which is to try and help 
the patient without doing harm. While clinicians may be in the best position to judge, there 
also needs to be debate in the public arena about which services will be funded and to what 
level. In time this may be to only provide acute services. An honest open approach would be 
to inform the population so that they can take out private insurance or make other 
provision. However, this is likely to be politically unacceptable. Instead politicians of both 
sides promote the increasing numbers of procedures done and shorter wait times for those 
that qualify) which may give patients false hope.   
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The importance of these publications. 
This can be judged either by the quality of journal in which they have been published or by 
the number of subsequent citations, although the two may not be related. 15 papers have 
been accepted or published in high-ranking peer-reviewed quartile 1 journals including the 
Bone and Joint Journal and Journal of Arthroplasty. 8 have been published in leading sub-
speciality journals such as Foot Ankle International, Journal of Hand Surgery and Journal of 
Paediatric Orthopaedics. The issues pertinent mainly to New Zealand have been most 
appropriate to publish in either the Australian and New Zealand Journal of Surgery or NZ 
Medical Journal (9 articles). (Appendix 2)  
As a result of these publications I have been asked to review articles in this field for leading 
international journals including the Bone and Joint Journal, BMJ Open, Arthritis Care and 
Research and Hip International. 
The field of health service provision has not been particularly popular in the orthopaedic 
literature. Despite this papers such as our Care Pathway and ERAS papers, even though 
published in lower ranking journals, have been frequently cited. Seven papers have been 
cited on 20 or more occasions and 10 of the papers cited on more than 10 occasions. 13 of 
the publications contributing to this thesis have been published in the last 2 years so have 
not yet generated many citations. Several of the papers pertaining to New Zealand have 
achieved extensive media coverage including national TV and radio interviews, newspaper 
articles and editorials, and led to questions being asked in parliament. It is my hope that this 
work has helped to increase investment in orthopaedic surgery locally and nationally and 
will continue to do so.  
Conclusion 
In Otago we are currently under-servicing our population with respect to publicly funded 
elective orthopaedic surgery.  Hip and knee replacement are established, highly successful 
interventions, not new innovations or fringe procedures of limited effectiveness. The 
burden for elective orthopaedic surgery will continue to grow rapidly with population 
growth, ageing and increasing rates of obesity. There are limited options to prevent this 
with efforts to reduce obesity having a lead-time of many years before we see any decline 
in demand. We feel that we are at the limit of rationing and it will become increasingly 
common in other centres in NZ and around the world. 
In response to this increased demand, we have adopted new models of care, developed 
programmes to improve non-operative management, implemented scoring and 
prioritization systems, improved perioperative management and maintained excellent long 
term results that match or surpass national and international studies. The papers in this 
thesis have reported, audited and analysed the outcomes, consequences and results in a 
rigorous manner. The OPP programme did not achieve “transformational change” but we 
have achieved improvement. Efforts will continue to improve the whole system, which 
requires a collaborative approach between surgeons, non-medical staff, funders, 
management and politicians. The most significant underlying problem remains the lack of 
capacity compared with the increasing demand. This is due both to lack of infrastructure 
(operating theatres, physical beds) and staff (surgeons, theatre staff, ward nurses and 
allied health staff and staffed beds). There is a clear need for investment in the service 
which includes beds, theatre time, nursing staff and surgeons. We have done the 
groundwork and provided informed analysis on the scale of the problem, what works and 
what does not. 285
Now I believe it is time for funders, DHB management, the Ministry of Health and politicians 
to take note and play their part.  
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